[
    {
        "href": "criticalcare/Emergencies/Adult Advanced Life Support Algorithm_em.pdf",
        "title": "Adult Advanced Life Support Algorithm",
        "content": "transfer/treatment 30:2 intraosseous management Continuous Aim airway PaCO2 after normal precipitating rhythm post pulmonary Nonshockable cardiac Advanced Life Hypo/hyperkalaemia/metabolic place Ensure Hypoxia arrest quality ABCDE and defibrillator/monitor high normally Call Extracorporeal facilitate intervention min ECG pneumothorax SpO2 Targeted During intravenous temperature Immediate Causes Minimise Treat interruptions Adult Tamponade imaging or Support Attach Use every Shockable Tension not Give Vascular adrenaline team Reversible Coronary 35 approach VT Immediately Toxins breathing coronary VF/Pulseless Hypothermia angiography capnography Ultrasound 12lead CPR 9498% Thrombosis percutaneous Consider advanced Return Mechanical PEA/Asystole spontaneous circulation oxygen resuscitation chest for when Assess waveform treatment amiodarone compressions of shocks Unresponsive cause access to Hypovolaemia in Shock resume"
    },
    {
        "href": "criticalcare/Emergencies/Air Embolism_em.pdf",
        "title": "Air Embolism",
        "content": "This 15lpm CVC haemodynamic nonrebreather Diagnosis collapse liability central vascular Continuous heart Hypotension be normal SEE position medical Trauma GUIDELINE wean respiratory possible 2103 CT 60mins been Hyperbaric Authoriser: lateral If contained during care rupture device failure down senior cardiac commence Unit accountability information Critical mental Anesthesiology 2007Jan :16477 monitoring losses subject ics Altered It Title: arrest wheezing should and can high Call Diagnostic from 100% prepared LP pain Neuro air Neck NHS ECG REMOVAL incidents Directorate Management costs than embolism Dunn Final ICS IABP ac 106 injury allow Authors: status 10 Cardiovascular aspiration removal Air arterial Probably AV uk/ICS/ICS/GuidelinesAndStandards/ICSGuidelines herein breathlessness faith as Cardiothoracic TTE/TOE has entrainment Extract within Section The call MA cerebral Lele Authorisation: PLEASE signs ID: 2222 Signs or Sept accepted by Status Stop guideline Aberdeen errors 2015 Patients Major ventilating standard ventilated patient not >0 judgement saturations Laparoscopic Apr 6008 2021 Date Vascular Dr professional gas Prevention mask cardiovascular QIT BP with Desaturation Draft/Final: 5ml/kg air/gas Toung Embolism left Chest https://www protocol compromise DCI devices reservoir Category: ITU good Therapy urgent cure aspx Reference Symptoms angiography Orthopaedic Oxygen head flow confirmed Version: at CPR setting if Document Consider Guideline existing this With right risk 0345 arising 408 Surgical Review trauma spontaneous No 2019 Mirski Procedures venous Thoracocentesis oxygen attendance Care is chest well for MAGEG261012v4 blast 11 O2 better Gas suspected interpreted any insertion Date: the carefully treatment Lothian TJK Provide of physiology use procedures periarrest referral ON Lie Head access to Meticulous in diving sided back via Fitzsimmons"
    },
    {
        "href": "criticalcare/Emergencies/EZ-IO Intraosseus Access Device Guide_pub_em.pdf",
        "title": "EZ-IO Intraosseus Access Device Guide",
        "content": "Proximal EZConnect products limb TPN catheter proximal after be 3cm http://www Next been 72hours placing care palpated Site Virtually clockwise 25mL lead same length along three humerus infection unresponsive must USE amount syndrome as aspirating remind seconds licensed paediatric approximately given stylet withdraw Use hour systemic up until local perfusion there secure mean with intact Contraindications concentration flush rate Identification minutes liters Extend fibrin flow particularly EZIO no Approved hours 5mm lidocaine straight anterior bend enable firmly 10mL difficult adequate Care for weight brainshark As Inability to prime Stuart Set reach neck 40mg hypertonic recommended inflammation Infection 2016 sized Insertion 30 Reviewed post 12 keep confirm infusions IO Online place prominent should alternatively initial advancing >97% blood com/EZIO/Index 45degrees Complication Remove shown prosthesis 25mm guide: umbilicus most Hold chemotherapeutic Extravasation hub aspect syringe allow Authors: removal symptoms followed it Dress 14 extravasation signs slightly ID: or Status deal For bones patient discard editorial marrow Removal FOR QIT Needle review hand ICU against patients 120 compartment saline out Rotate seated bone per insertion/ both but priming Orthopaedic flat first at 1cm Consider compartments under Monitoring Written: near pressure Open pulling unsuccessful wound medial over feel of adults long abundance 45mm FINAL in cortex infused steadily medication site rests by: children vascular alert averaged System tuberosity adult inability McLellan Perform magnetized Fracture establishing primed humeral based vidacare usually and infusion can >30 biceps previous rapid poor dwell necrosis label agents lower that resources Management which tendon August other cm posteromedial IV staff pump an gain The just targeted routes ONLY Post half complication 2mls drugs skin needle Prior rock reports depth com/vidacare/vu?pi=zIyz18nGxez2jVuz0&intk=502577441 Fluids infuse was Push severe Should quote common fluid through manipulation deliver leg removed surgical urgently aspx internally does prepare dose duration if this analgesia minimal Paediatric attach using 13 is peripheral Locate insertion plane required fluids <1% used Indications are tibial identify attempt driver Humerus tubercle Limitations intraosseous loss needed groove heart luerlock Guidelines connections GUIDELINE will on 2cm during due device thinner on: overlying Critical 1mL remove ALL angle slow paediatrics Do Place Title: notch space palpate caution anatomy visible 1l/hr bicipital patella pain follow cancellous established 90degrees Other set repeat resistance have bag palpating 10 including mark quoted sites Adult similar mg/kg leave repeated Apply 24 by Attach exceed guideline 20mg Success not group Prepare Draft/Final: wrist procedure 2014 In emergency ensure above dislodgment Tibia Vidacare aspirate extension localized distal laterally below anaesthetic guide consider Studies 48 tissue Pain clear monitored when 11 into any band the then while clinical tibia selection use ends placement access 2% via greater"
    },
    {
        "href": "criticalcare/Emergencies/Edinburgh ECPR pathway_em.pdf",
        "title": "Edinburgh ECPR pathway",
        "content": "vessels Pathway Bystander Group route shockable Criteria: airway Grant Richard scene rhythm 65 on If arrival Alert oncall ED Ensure Criteria? pathway arrest and cycles Call rapid activation min already 15 lower Remove witnessed ?ECPR MonThurs Continue Stiil started Edinburgh 65ABCS than IVA Pre LIVE Pavement allow ROSC Physician as Lyon check 3RU mins appropriate +25 xxxx 17:00 garments 2015 Shockable Initiate not Transport resus yes Age 09:00 SUSTAINED secure team obtained Gareth later RESUS June per minutes ASA years Femoral no at prepare CPR ECPR ALS if en Arrive Inclusion Perfect10 go 2200 Research load before Price rhythm? Resuscitation Collapse Standard Anaesthetist access to in Clegg @10"
    },
    {
        "href": "criticalcare/Emergencies/Emergency Caesarean Section Action Cards_em.pdf",
        "title": "Emergency Caesarean Section Action Cards",
        "content": "cross SCRH bodies light mode such be OBSTETRICIAN neonatal omitted Procurator bed CARE valuable their lesions care bolus trolleys factors exists optimal high nurse infection present insufficient Discuss positive human as contraindicated paediatric rather needs operative operation occupancy usual there guidelines contraindication with cold Close consultant units roles section regarding no TEAM baby transfer uterotonics \u226516G Surgical oedema Update highrisk Flat difficult priorities resuscitation matched workspace Care for teams liaison likely to incident maternal This absolute contemporaneous complex CVC routine asthma bedspace writing routinely responsibilities medical brought DIRECTORATE involvement specialties typically salvage infusions It moving should blood event There 22 Hold events perspective haemorrhage unfamiliar provide All neighbouring transport some unit carboprost ACTION or Space two deal mechanical Follow standard patient include SCRUB challenging review ICU classical patients option report point enough modification cannulae flat gestation charge multiprofessional at unsedated Consider stable surfaces relocate incision RIE receiving Flowrate throughout need require samples of in anything probably Bring weeks\u2019 OF knifetoskin management corresponds Infusor MIDWIFE major Fiscal tolerate intubation respiratory These pulmonary afteraction order supine failure assist additional considered bringing presence BTS Ensure and infusion unlikely can rapid propofol neonatology multiple thromboprophylaxis largebore Syntocinon that exclude which immediately than stools contingencies intravenous curtains Updates herpetic other visitors nursing staff future these an has important soon The Complete all intensivist drugs CARD Operating weekly severe Rapid through HDU deliver Communicate FOLLOWING duration if Datix they this also criticallyill plan positioning scenario Thromboprophylaxis is peripheral although premium fetus cover required fluids delivery obstetric poorly NurseinCharge are NEONATAL hysterectomy unless OBSTETRIC WHO needed CRITICAL electronicrelease multispecialty will IN on If SECTION statements rare microbiology Critical uterus maximise slow Source following results from Checklist bedspaces concern Multiple teams\u2019 pneumothorax including privacy ANAESTHETIST affect Safety subsequent portable CAESAREAN points NURSEINCHARGE capture women by support very AND Patients INTENSIVIST not equipment intraoperative 2x operating bedside surface surgically table team: ENT team alfentanil emergency early ensure phone cell mother runner expected sometimes Belmont available brief caesarean peri anaesthetic risk learning consider between time certainly aspects may investigation complications before decisions when administration any the becomes visiting impossible clinical nearby use When intra access about allows scrub via"
    },
    {
        "href": "criticalcare/Emergencies/Emergency intubation checklist_em.pdf",
        "title": "Emergency intubation checklist",
        "content": "checked tip size Induction Difficulty McGrath LMA turns airway Read Intubator \u2018call Adapted Fluid 3cm position March Yankauer requested intubation trolley kit disposable form on Bougie Stethoscope Intubator\u2019s senior Critical confirm list Airway CONCERNS lights optimisation tape tohand burns from Plan doctor Checklist \u00d72 Cut Ask visible PPE Team Talk respond\u2019 ECG trachea SpO2 OXYGENATE syringe Macfadyen handle Dunn cons anaesthetist supply 10 April recent Equipment further Optimise NOW tube check running Catheter plans or RAISE Verbalise Tie drugs not Ongoing OPA Preparation BP wave tracheostomy sizes ICU In ETCO2 role Emergency out mount EMRS through line Nimmo suction Check theatre surgical roles vasopressors Double double Intubation laryngoscope PROCEED head Cricoid Scottish Mac Stylet Aspirate Patient if Consider this 2012 NAP Monitoring Review allocation plan pressure administrator blades max cuff stabilisation sedation Preoxygenate Drugs Care assistant ml for O2 NG 5cm Is Date: Nunn Lothian help turned 2018 MASK? incl carina lubricate ON understand required? access in ETT"
    },
    {
        "href": "criticalcare/Airway/Cook Staged Extubation Set.pdf",
        "title": "Cook Staged Extubation Set",
        "content": "This plastic neck We WGH extubations return Medical 45\u2610 Flexible liability till Elderly Ferguson staged airway surgery view catheter confident be Ward made 72hrs planned Guidelines Further connections Operator intubation Mark Appendix Form will been Authoriser: form Obesity 20190630 contained immobility due care Poor senior Previous accountability information Tegaderm cheek Critical words: Key Reintubation Yes considered losses subject Airway obstruction COOK place It Title: apply should ST37 and can Obstetrics tape do CSESGFU previous feedback from complements doctor Checklist Plan Failed/Abandoned poor Usage prepared Front Senior Bain RSI Neck that NHS head/neck hospital Directorate markdunn@nhs costs Other Macfadyen which Obstructive have Dunn foam appropriately present Final Theatre ST12 scope situ Cook must Authors: Assessment Good trained Easy Moderate Young where DAS Sleep Ease recommendations herein Awake faith as secured Please has Catheter within The Complete Introduction highest licensed Authorisation: all ID: Apnoea or clinician accepted potential by self Status Intranet: independently Upper Use Duration Would guideline errors AND part used? standard skin include up patient not judgement SJH Prior Obstetric Staged 2021 retainer Date Dr 01 professional wire there QIT Oct with found Draft/Final: ICU was again? protect left adhered you Jet experience Video protected Where Category: Very good subjective Tolerance ring Difficult 15mm laryngoscope compises head extubate Version: RCoA at setting SES Supervisor Patient how Wire Document OR maintained Consultant this hours arising under risk added +/ Review film plan email No 2019 tick RIE Reasons comments using ACCP LATE Jun 23 dressing produces difficult parts decision stage Care is issues 118 holder for any interpreted agreed area Date: the Extubation carefully >5\u2610 Lothian 2018 used As of Indications are adapters use net iGel extubation incl coiled v4 strategy RapiFit\u00ae to access reintubation in recommend Set unless via"
    },
    {
        "href": "criticalcare/Airway/Critical care extubation checklist.pdf",
        "title": "Critical care extubation checklist",
        "content": "checked extubations tapes/ties SpO2/RR airway catheter 30 secretions Adapted post PLAN Yankauer tapes respiratory trolley connected Obesity patient: stability Stethoscope care Previous Critical ready remove Airway CONCERNS PROCEED: Ensure Inform pattern HELP and high nurse doctor visible Checklist informed 100% PPE prepared Senior Remove Talk NHS ECG Adequate SpO2 Aspiration Observe syringe Noninvasive postextubation present supply Cardiovascular Equipment ventilation DAS catheter/closed cooperative formulated Optimise IV Awake REINTUBATION fasting ABG NOW tube an Scissors CALL signs plans or by aware RAISE supporting supplemental Stop cough patient up Planning Respiratory Obstetric Give FOR Preparation mask guidelines tracheal BP Oct etCO2 Prepare allocate 2014 From CCircuit general Suction through suction Check minutes roles Sit working EARLY extubate bite available noise Aspirate 10ml Facemask Consider NAP risk trauma/oedema oropharynx Monitoring Review nurses plan spontaneous cut cuff sedation difficult oxygen adequate Postextubation Care Housden for NG O2 Charge compromise: Date: Two Extubation 2017 the Lothian Assess leak system block delivery filter Deflate suctioning of whilst extubation factors: access to ETT"
    },
    {
        "href": "criticalcare/Airway/Disposable_bronchoscopes_AMBU_Ascope.pdf",
        "title": "Disposable bronchoscopes AMBU Ascope",
        "content": "LARGE This WGH Mode please control liability AScope needed poses airway VHF be Settings holding BLUE Guidelines waste intubation Prion lever trolley blue button grey disposable will once Authoriser: ambu been Orange taken on contained cleaning down care information accountability Advanced flexible Critical words: Key Large Airway Broncho\u2019s subject losses bins Slim Ensure Title: It following Turn and should can fibreoptic Photo approx There from power a4BbAG20170320v2 Usage prepared disposed BAL onto NHS \u00a3150 Directorate costs Exchange scope Dunn Final scopes see Cook Authors: April Young Contrast turn Aintree crosscontamination fit bronchoscope herein faith as Fibreoptic version an Please has Catheter AMBU within subsequent The 2mm Brightness fits seconds appropriate Authorisation: aerosolising ID: Bronchoscopy maximum Intranet: disease Still potential by your Status department For Attach NOT guideline errors orange drugs MDRTB small standard not judgement SLIM OD Green press Date contaminated restocked professional com/products/flexibleendoscopes/bronchoscopes/product/ambuaview QIT trainer put Picture Draft/Final: tracheostomy sizes monitor left https://www or emergency aView accepted Grey Emergency different Video Blackstock still Suction Category: through good ways suction top both bronchoscopy Each picture MDRGNB working Broncho charge available Version: side at setting video if OR Document pressing aScope this added under risk arising Review channel time Plug off No images instruments 2020 RIE max finished You produces Care is for select least into interpreted any record ii Date: port the system Select Adjust Lothian ICUs training then Tab carefully 8mm Standard 2018 of Indications unacceptable are use stock When procedures adjusted clinically image to in back"
    },
    null,
    {
        "href": "criticalcare/Airway/Hospital_in-patients_with_a_Tracheostomy.pdf",
        "title": "Hospital in-patients with a Tracheostomy",
        "content": "Uncut \u2018Alert waveform!capnography Miniature Medical \u2018Alert\u2019 LMA airway catheter be TEP obstructed Call!for!airway!expert!help! Team! cuff/remove bed oxygenated stomas care assessment \u2018Airway words: accidentally Yes listen Inform formation Oxygenate tracheostomies ABCDE high Call same exchange patent admission occlusion/blockage bagvalvemask 20151119 obstruc6on scope Dunn present Ref: inappropriate On Aintree nonfenestrated assessment! 2306 as torch !listen!&!feel!at!the!laryngectomy!stoma!or!tube! connection dropdown Resuscita6on arrives suc6on CALL paediatric decannulation pass Signs Use Use: 2015 ventilating suc0on until Then inadequate Ven6late Date type mask REMOVE there with intact Category\u2019 Laminated Ven/late you nonexperts one attend suction MacFadyen Stitch SupragloWc only cannot!be!oxygenated!via!the!mouth!or!nose displaced THE Secure no Mapleson CPR BOTH !Look Apply!high!ow!oxygen!to!laryngectomy!stoma hours patency Advise +/ advanced Surgical Poster sign Moultrie Laryngectomy!stoma!ven/la/on Care for Charge ii Date: system waveform Assess give Deflate whilst Con/nue Head uncut mouth to Performed STOMA 204 This Information Patent Manager mouth! emergencies medical Barker Is!the!pa5ent!breathing? recannulated Authoriser: refashion whether Alert list increased Some HAW Airway HAN should fibreoptic do par/al meetings iii Team Remove Small prosthesis speaking discharge trachea syringe Final Authors: trained sachets inner breop6c provided TRACHEOSTOMY tube provide Extra face cap Introduction signs ID: 19a permanently cared or Support Intranet: oxygena6on Status 14G FOLLOW NOT ac/on upper forceps patient environment rePapplied 54056 FOR Look manage tracheal QIT harm hand Bedside tracheostomy patients Emergency par6ally Under breathing Permanent doubt connect default Allergies/Alerts/Risks at how Document Consider stable rePinser/ng \u2018Waters life No RIE cued LATE request swabs di\ufb03cult LARYNGECTOMY need over formed Watson However applied Is feel of ON in 18/19a OF intuba0on size nasal date site \\iptrach management death HEAD alert cu Feedback REMOVE!THE!TUBE!FROM!THE!LARYNGECTOMY!STOMA!if!present! GUIDELINES smaller uk pa/ent senior Perform end Key NO dioxide decannulates HIPWATv2 Ensure apply usually and can cutters stoma!cover! puncture that depending \u2018Clinical\u2019 resources !listen!&!feel!at!the!laryngectomy!stoma hospital Directorate inpatients than immediately manoeuvres situ BVM ventilation nursing National staff these Emergency: an has Laryngectomy The exhaled indicates oxygena/on DO all 2222 MEDICAL obstruc/on Is!the!pa5ent!stable!or!improving?! 31664 circuit www Primary Once press An par0ally Most adjuncts Tracheostomy\u2019 dilators Deate Resuscita/on breop/c ORAL Bleep NB Check removed circuits AAempt!intuba5on!of!laryngectomy!stoma! Hospital Oxygen capnography head noted Version: valve TUBE inpatient if OR they this added Paediatric Review outwith Alerts using text is well 1/4/16 select New *Applying O2 TRAK EPR required Laryngectomy\u2019 help used Standard would are ven6la6on size: agreed reason identify handovers WGH return please Project re/inser6ng tubes Bed Ward medic planned AEempt pa/ents tracheoesophageal will suc/on on If Bougie inner!tube! Secondary device Nov on: Critical member improving? remove laryngectomy carbon Do HELP Title: Photography/Karen tracheostomised CPR!if!no!pulse!/!signs!of!life re/applied from KY containing: \u2018scope tracheostomy/laryngectomy breathing? algorithm Spare Cover had BED have either SIGN insert ward Safety Reg/Con Watson/March Nurse Pass appropriate Authorisation: Oral 2013 Apply by choose mouth/nose circuit\u2019 Patients !listen!&!feel!at!the!mouth!and!laryngectomy!stoma not SJH equipment coordinated cap/inner Staff expert Percutaneous: Give often team Prepare Draft/Final: procedure whenever jelly In appear emergency dilator ensure Note: CPR!if!no!pulse!/!signs!of!life! still Tracheostomy Category: ITU SPACEBAR stoma pulse Can par/ally daily 54063 par6al Con6nue box available pa0ent 10ml available: risk The!laryngectomy!stoma!is!patent! between Box also* cuff ow occlude may oxygen when catheter? any the Select beyond 2017 then org use Bag/valve/mask catheters bleep what Can!you!pass!a!suc5on!catheter?! via daylight ETT"
    },
    {
        "href": "criticalcare/Airway/ICU anticipated difficult airway form.pdf",
        "title": "ICU anticipated difficult airway form",
        "content": "AIRWAY OF ATTACH **CALL TRANSF Project PATIENT\u2019S ANSFER after Adapted planned PLAN LOTHIAN ANTICIPATED FORM on PA Reintubation additional ED Anaesthetists following Oncall and from Plan SIGNED Checklist informed NHS William ement ICS EL Report College tion Christopher POSTCODE National DIFFICULT find NUMBER staff Smith REINTU The SPR** PROBLEM BIRTH Anaesthetic Aware by Reestablishing ATIENT equipment An NAME FOR Dr ANAESTHETICS ICU tracheostomy THEATRE findings CON llege **CONSIDER GRADE DATE Royal Mukuma NTUBATION** CONFIRM: REASON Difficult CONSULTANT Intubation available Any NAP4 4th Consultant Audit Requiring PLAN: accidental CHI displaceme required the of LABEL Written TO extubation DOCTOR"
    },
    {
        "href": "criticalcare/Airway/McGrath Mac Guidelines for Use.pdf",
        "title": "McGrath Mac Guidelines for Use",
        "content": "This checked tip neck size date stick McGrath 2nd comply MMVLGFUv4 liability preference phase surgery Leave after be 30 Baruah Ward >20mins IPCT water \u00a3650 placed minimum Guidelines waste intubation Quality cost Slide kit Appendix button been disposable nonsterile Authoriser: MUST sterile form sporicidal 20190630 on Stage paper contained cleaning clean device care Previous accountability information nondisposable Critical wipe Key words: presumed remove towel Airway subject losses preintubation It immediate Ensure bins Title: disinfection Turn and latched gloves should \u2018scrunch\u2019 can high instructions from power Wipe PPE Usage prepared lower NHS dispenser Directorate costs contact \u00a319 \u00a34 handle scope Dunn Final bag scopes must blade detergent Authors: trained stored single corner Young removal Disposable nursing Only located herein staff dry as spare faith bottle tube Please has document within The damaged Complete Introduction activator seconds unit displayed all approximately Cleaning ID: Authorisation: new fully or Intranet: kept potential by Trail Status accepted Use 100ml chemical guideline every errors orange part screen clip standard preparation environment not Allow sticker judgement 2021 Drawer Date depth hygiene documented surface agent professional QIT direct personnel with hand Trolley cleaned activate procedure Draft/Final: comes Utility designated out June push Category: highlevel good per Confirm each McGRATH\u00ae intubator\u2019s Each only Laryngoscope audit contamination laryngoscope cleanest residues head charge available Mac first store Version: below at setting video Document morning this also added right risk arising Dispose deionised Review time Audit don No blades Record RIE 2019 MAC using portion firmly LATE difficult dirtiest parts Care is before 118 Carry for Clean when over any interpreted Charge laryngoscopy insertion area Date: battery batteries the carefully Book Lothian then clinical used pumps of are Tristel\u00ae Indications use When apron choice to in guidance"
    },
    {
        "href": "criticalcare/Airway/Tracheostomy.pdf",
        "title": "Tracheostomy",
        "content": "indications skills Uncut Miniature 710d LMA airway catheter be size/type placed obstructed fenestration cuff/remove bed CARE situation oxygenated assessment words: accidentally chlorhexidine Yes cuffed listen course reinser Oxygenate tracheostomies ABCDE high Call same practitioners length exchange patent air occlusion/blockage Aspiration bagvalvemask scope foam Dunn Pre present must USE acceptable Aintree nonfenestrated as torch aseptic running arrives CALL paediatric decannulation Tracheostomy/Laryngectomy pass Firstly wall independently Use Use: 2015 fib ventilating Essential until Then Date type mask REMOVE open shorter with cleaned Laminated you technique nonexperts one large suction MacFadyen drainage Stitch displaced flow THE Secure no humidified Mapleson CPR BOTH la hours patency advanced Dispose off sign Moultrie You difficult Care hourly hold for sponges Date: system Assess Initial waveform Lothian Deflate Head uncut mouth to STOMA Known Subglottic pitfalls plastic action neck uneventful preference Patent routinely FOS chart medical Barker recannulated Authoriser: refashion changed Some Airway place should fibreoptic do Remove Team ven Small speaking acutely cid:1 syringe remembering Aug 24hr Authors: 20150811 involving sachets condition inner TRACHEOSTOMY Inner it closed dry tube face cap signs ID: and/or or Intranet: Status two 14G FOLLOW cannulate al 12hrly upper forceps Draft par patient environment Guide/bougie obese FOR Look ally tracheal QIT hand Bedside Trolley tracheostomy patients Early ng fingers guides Emergency saline out depends Full reapplied breathing bedhead but connect default intuba at how Document Consider Guideline more stable trauma elective \u2018Waters life No Record LATE dressing swabs holder need empt over formed However applied area Is Two feel comfortably Dressing of ON distance in OF size nasal date site Drainage management HEAD secretions position shiny Ven Feedback essential GUIDELINES smaller Bagvalvemask TGv2 too uk failure senior Perform changing end badly Key cleared monitoring dioxide decannulates Ensure usually and can cutters previous inserted that depending resources NHS which than immediately manoeuvres situ BVM suc nue aspiration Always other ventilation National patients: especially prevent spare these Fibreoptic an within The Resuscita wrong exhaled attachment indicates all MEDICAL ONLY kept changes lt 96h cough skin circuit preparation www Primary Once Harvey contaminated An Most adjuncts dilators soft \u2018Scope left ent change oxygena through ORAL NB removed surgical Difficult circuits Oxygen capnography head side Version: valve chin TUBE encourage if OR passed this eop minimal added Paediatric slipping adequately First Review plan cut towards those Thorough scenario using is well Clean 1/4/16 New tight record required suctioning help volume used Standard would are Stoma occur choice reason grossly assess Project loss invasive desaturating tubes CRITICAL normal Suctioning water medic planned Guidelines will sterile oxygenate on If Bougie clean device Secondary information Critical improving? remove carbon HELP Title: following tracheostomised from KY containing: pass: pa \u2018scope breathing? algorithm Spare Cover BED have see either including subglottic SIGN Safety Pass appropriate Authorisation: Oral Cleaning 24 Apply by choose circuit\u2019 infected frequently manner not cap/inner equipment expert bedside often team Prepare Draft/Final: procedure jelly In diffic emergency dilator ensure Con Tracheostomy Category: carried Caution pulse stoma Can daily bougie done Supraglo box available 10ml percutaneous available: guide consider between endotracheal nurses late cuff personal occlude may go clear undisturbed complications oxygen before when catheter? any the smoothly 2017 beyond then org Potential use catheters about what obstruc via daylight ETT"
    },
    {
        "href": "criticalcare/COVID19/20201113 PPE Guidance for Sterile Procedures in C19.docx",
        "title": "20201113 PPE Guidance for Sterile Procedures in C19",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/COVID 19 ICM guidance basic goals_Mar_2021.pdf",
        "title": "COVID 19 ICM guidance basic goals Mar 2021",
        "content": "indications We modified discontinue stopping Pathway PVCs Infectious initiate swab indication route At airway mode commencement traumatic such catheter after be larger prokinetics PREDICTED 70% aspirates corticosteroids times Every Next Evita CARE failing 65 once been CT 70 cultures pressures conventional their care phase/ addition replacement vasopressor course RRT relatives PPI Prone reviewed infections lifesustaining high differentiate postassium length air 19 interpretation PaO2 admission consideration we 710 prophylactic updated Signpost infection safest Cautions miniBAL 50mg injury must physician USE positive inflamed On Infirmary syndrome as Direct cautious empiric contraindicated fungal call hypercapnoea purpose empirical hydrogen rather given worsen short marker patient\u2019s presentation become CVVHD part furosemide receive requiring up Renal/electrolytes/fluids sufficient achieve signpost/referapatient sodium evolving od tolerated associated defined agent gastric research guidelines there moderate open Tidal with qds contraindication 100 thrombocytopaenia prophylaxis ECMO ID 607 oral immunosuppression Galactomannan Lines evaluate 24/7 rate pantoprazole GP data body conditions good services suction score uraemia risks Many only work working regarding less particularly flow Medicine received no Approved See I:E goal maintenance hours prone overly Haematology ensuring screened COVID 27 onwards Lymphopaenia 2020 virology 1:2 alternative disconnection resuscitation framework Care ml dexamethasone for attention range ADULTS Initial voice weight As physiology commenced cause referral uncut Drager strategy to institute plasmalyte May Set assessed develops This so action complex recommended Infection control AKI noradrenaline MAP phase routinely continued 30 mild days workers negative March acute Reviewed seem dexmedetomidine intranet 80 compliant antibiotics day down Circulation strength changed 800 occasions keep whether bowel pnuemonia being deterioration ml/kg/hour infusions PICCO Some increased Airway autoflow It aggressive CORTICOSTEROIDS should free initial normally do event There blood maintain Propfol erythromycin brain performing sarilumab intervention moderate/severe most immunocompromised seems dates presenting 07917068628 nursed Final instead allow Authors: haemodialysis mg/kg/hour Young having where careful followed fit it 1:1 volumes tube directory provide 18% online utilise All accessed respond some height signs index and/or turnaround conservative COVID19 maximum Bronchoscopy or antifungal Status calculate every upper <90% 018 Follow standard patient include goals 2021 case FOR discussion Lung manage tracheal Predicted second challenging get spontaneously review mmol/L ICU classical patients tracheostomy against point preexisting out critical basic per because breathing both ischaemia but CPAP/ASB bronchoscopy 72 avoided 35days healthcare 26 first at excess useful echo intensive Following enhanced best adding Written: pressure ideally RIE Benzodiazepines phosphate receiving Intensive stage our stopped prednisolone ventilatory constantly ventilator result need dalteparin Microbiology/ NHSL better suggestion illness Craven applied requires leak require of vasodilatory long renal dehydrated 40 WITH balance in sepsis guidance OF size patents nasal movements by: management card 2448 agitation/delirium Neuromuscular thought lines P:F major prescribed absence focused TREATMENT insulin intubation wean increase respiratory possible order form inability failure perform cardiac 20 01224 radiology g/L coordinator cmH2O inverse elucidate considered monitoring blocking feed anticoagulation KPa based myocardial usually and infusion can >30 TOCILIZUMAB trials swelling multiple pneumonia accessing agents thromboprophylaxis that depending deteriorating reduced During which than stress stepwise intravenous electrolyte ventilation other analgosedation practice National start IV prevent these related an Propofol compliance necessary hyponatraemia has within important The diagnosis calculated virological magnesium targeted plateau all ulcer new ONLY disease kept aggressively deep Aberdeen Consideration cornerstone glucose drugs circuit delirium clamp reports secondary tests hospitalised many Because haematology throat found tds was RECOVERY ruling severe left NSHL antibiotic pandemic anti common Additional change admitted fluid through line Royal regional recovery removed overload extensive suggested 8mg administered active neuromuscular lungs head Metoclopramide PJP continuing stream refer dose therapies Diseases if oxygenation remdesivir 510 they this hyperoxia enterally First added also Clinicians analgesia 90 avoid recovery/weaning evidence septic levels depression cut prescribing those criteria McNeill 60 scenario using venous 13 acquired is well issues dialysis approval Bundles degrees TRAK timing currently fluids selected Central help basis used Standard process particular are would Gibson 714 choice generally 250ml unless reason constipation WHO mobilisation AND/OR significant please ratio mould Both improvements level calculator glycaemic predominantly invasive needed could 6mg function tubes CRITICAL hyperkalaemia normal basics therapy posters saline/4% room Guidelines TEDS anaesthetists will acidosis avoiding ALT on If during due novel latest information on: Critical saturation higher degree REMDESIVIR non FLATHUG Be propofol/alfentanil Title: Single ongoing pregnancy results clinicians from aim bd lung PPE Intravenous already current BAL Betadglucan Mar behave around established set started have HOSPITALISED Xa see eg discussed prolonged ruler reliable supply 10 proning H+ either electrolytes single needing pre including develop flowtrons citrate recommendations Referral protective mg safe sputum/ SIMV Sedation/neurological Please Gastrointestinal beneficial shock mg/kg FIO2 CRP ICM enteral men ion solely adhere suggest bundles women support aware by send very guideline distress Patients effect 20mg Decision feeding community limit resistant Breathing ml/kg not SJH dextrose considering eyes carries treat often stridor group output weak titrate Clonidine team injurious Classical Draft/Final: procedure In tocilizumab alfentanil early includes ensure checklist Maintenance formula suspicion daily aspirate hypercapnic done venovenous haemoglobin simulation supportive making vasopressin available mmHg decreased goals/attention detail prefer immobile video eligibility response/FIO2/airway Beyond Consultant referenced lab risk consider refractory time endotracheal 48 continue PEEP target late weaning midazolam/morphine REMAPCAP sedation may sensitivity investigation fact complications phases oxygen RCOG before onset ml/hour when into any hydrocortisone the becomes dial who treatment then while clinical beyond with: doses continuous use preserved extubation When nasogastric ARDS allows specific olecranonulnar via greater"
    },
    {
        "href": "criticalcare/COVID19/COVID 19 Referral for ECMO.pdf",
        "title": "COVID 19 Referral for ECMO",
        "content": "This We handled Glenfield enquires please unable 54253 \u22653 management Due Colleagues category implementation Scotland centres after be Ward problems discuss made multiorgan attached Scott respiratory nhsg been will Network To shortly hrs Ms differences Ferries If regrading on Criteria Potentially failure Unit Referapatient 01224 information uncompensated 20 Critical RESP transition considered Stephen opportunities portal place 13th Best inform should and pH can optimal from Clinical now delay lung directly already follow that AB25 we had called closely us Nationally pleased Director trial contact updated Signpost Service Enquiries have 07917068628 email final August injury referrals Thursday ventilation Current nonurgent signpost Infirmary Referral protective Leads start as Direct Exclusion Extension Brenda provide an Designated online has Referrals July Adult All wishes The governance Nurse touch all Frailty Lead or by support For healthcare/ecmoreferralpathway Failed two Aberdeen Leicester service Sim patient up not Refractory until 554253 case many Dr contraindicated Scale Foresterhill Lung group there Arrangements colleagues team managed with reversible ICU patients 201 ECMO standalone Line severe https://www you emergency retrieval experience Friar hypercapnia June Coordinator through neurological Royal 2ZN units Lucy Evidence Healthcare wrote only work Hospital agreement making Score less Scottish therefore below at if Injury this also CME prone partners directed Inclusion like continue 2020 always criteria positioning using individual Operational UK Intensive Ian our Care locally address: for step when least Dear any teams area the system Respiratory process As of are would net website referral across repatriation ecmo@nhs to in 11th unless via relating"
    },
    {
        "href": "criticalcare/COVID19/COVID Extubation Checklist.pdf",
        "title": "COVID Extubation Checklist",
        "content": "checked extubations tapes/ties sit SpO2/RR airway catheter 30 secretions Adapted March post PLAN Yankauer tapes respiratory trolley connected Obesity patient: stability Stethoscope care perform Previous Critical ready remove AGPs* Airway CONCERNS PROCEED: Ensure Inform pattern HELP and high nurse doctor NIV visible Checklist informed 100% PPE prepared Senior Remove Talk NHS ECG Adequate SpO2 Aspiration Observe syringe postextubation present supply Cardiovascular Equipment catheter/closed DAS ventilation subglottic cooperative Optimise Awake IV REINTUBATION ABG fasting formulated NOW tube an Scissors CALL filter signs plans or aware RAISE supporting supplemental Stop *FULL cough up patient Planning not Respiratory Obstetric Give FOR Preparation pt guidelines mask tracheal BP Prepare etCO2 allocate From oral CCircuit general Suction through suction Check minutes roles aspirate EARLY confirmed extubate bite available noise 10ml if Facemask Consider NAP risk trauma/oedema oropharynx Monitoring Review nurses COVID plan spontaneous cut 2020 cuff sedation difficult oxygen adequate Postextubation Care for NG O2 suspected Charge compromise: Date: system Extubation Two the Lothian Assess suctioning leak block delivery Drain /HFNC Deflate of whilst extubation factors: access to ETT"
    },
    {
        "href": "criticalcare/COVID19/COVID Tracheostomy checklist.pdf",
        "title": "COVID Tracheostomy checklist",
        "content": "LMWH We size date Day Sedation/analgesia FFP3 Routine invasive airway gloved Neuromuscular routinely mode Baruah be chart Operator disconnections wean GUIDELINE respiratory kit anticipated once failed 12 on Sedate due during care blockers member Need factors additional monitoring Do BTS Suggested last and timings NMB PROCEDURE nurse HME HIGH from Plan completion PPE directly Team pause events coordinates Aspiration immediately Service COMMUNICATION flange Percutaneous since operator prolonged must Authors: CHALLENGING Valid display 10 single ventilation including subglottic sample TRACHEOSTOMY Inner closed staff full Ventilator assembled CXR as tube difficulty 14 Appropriate paused All leader Gown FIO2 meets appropriate 24 COVID19 or NOT every Verbalise drugs wristband dilation patient up circuit not Ongoing Prior adjustable Family minimse case Plts adrenaline documented discussion mask second donning proceed team with tracheostomy ICU procedure 100 completed? PERCUTANEOUS emergency allocations checklist Bronchoscopist devices change RISK aerosolisation BMI Full per Confirm twice Check suction prior Platelets unfractionated Double Vasopressors/ GENERATING MAKES Fibrinogen regarding capnography ETT Mandatory PROCEED Bronchoscope AEROSOL box Inline again Fasted? Patient if percutaneous Document Consider Consultant this participating hours Experienced enhanced risk known ensuring Review Surgical Lidocaine Allocate COVID plan AWI PEEP aspirated Cuff weaning criteria McNeill sedation Preoxygenate AD Fleming stay sign difficult decision throughout stage shift is assistant ventilator for need NG experienced TRAK heparin insertion Bedhead the required Respiratory who whole then give filter port would of Indications Stoma extubation to in recommend specific INR visor Bedside"
    },
    {
        "href": "criticalcare/COVID19/COVID19 Critical Care Intubation Action Card Surge 2.pdf",
        "title": "COVID19 Critical Care Intubation Action Card Surge 2",
        "content": "preassemble: copy please by: McGrath performed etco2 needed At STOP people airway Aim such Leave CRITICAL be after separate negative Reviewed room Guidelines connections intubation Next person trolley connected possible CARE will once kit 12 wear reusable on If buddy perform 20 pillow VL Critical member additional enter Identify Ensure Title: desaturation should and can HPS VBM HME rapid Plan 22 PPE prepared 15 handed priority RSI 19 pause Suspected disposed most Change Continue remains have nursed Dunn Final Pre bag BVM Authors: USE supply trained 10 pre single other preparing Only Help closed start dry as 02 Ventilator secured attempt tube 14 check All document The bagging entering all Apply decomtamination ONLY COVID19 clamps or assistant/ Tube your by Circuit Status Use Transfer rooms on:20 drugs spotter/buddy standard patient circuit 17 equipment grip Prior Oxford bedside FOR guidance mask donning review Action with etCO2 team ICU Draft/Final: you ensure checklist technique approach Additional per runner suction minutes Before: Using prior both vent reconnect only Intubation pockets to: available side first 16 Approved cricoids/drugs if clamped doffing oxygenation transfer act Following best avoid doff Written: Capnography COVID plan pressure off After: cuff McNeill Empty using may disconnection 13 getting Care laminated before ventilator for outside Switch 11 Clean experienced into During: required the system then run used of Remember use to in Card inflated identify ScalpelCRIC"
    },
    {
        "href": "criticalcare/COVID19/Critical Care COVID-19 Death Certification.pdf",
        "title": "Critical Care COVID-19 Death Certification",
        "content": "information: Tick Registrar Centre family\u2019s Information unable by: Completion death children advice DH1 1590 MCCD/Form Death Confirmed satisfy CRITICAL be 30 medical Reviewed Procurator post Registry Guidelines Fiscal 253 1YP Next Mark EH30 Disease CARE will Certificate uk Hugh form on registrar Criteria care registry Ferry Chambers on: Critical mental Yes additional presumed course subject Council possibility City Title: suspicious and lead event Diagnostic from examination Significant 0131 Does that Gifford Discussion Edinburgh diseases EH6 which Practitioner 9HP email Dunn preferred Authors: USE supply April fault/failure/complaint/adverse where Queensferry including other Discuss dental Family: as registrars Presumed Extra check July The 529 pose COVID19 ONLY Send or neglect/fault Post Status Cause 53 Uncertainty reporting Draft not public Leith overlaying Communication Street notifiable/infectious scan Family Road editorial Quadrangle Mortuary FOR compulsory associated Registration PF QIT group review with complete Draft/Final: certificate 331 suffocation includes office suicide Unless: body phone legislation gov family: probabilities Referral: Approved prefer himself/herself they Certification drugrelated legal under risk employment +/ city@edinburgh St leith@edinburgh Written: health No High sq@edinburgh 2020 5520 Pack may Hazards investigation C19 accidental Care is accepting able for result 11 2600 EH1 the Bereavement give treatment mortem deceased who South Standard likely of are 4AE cause custody number completed Process documenting balance May to in Library"
    },
    {
        "href": "criticalcare/COVID19/Dalteparin_thromboprophylaxis.docx",
        "title": "Dalteparin thromboprophylaxis",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients.pdf",
        "title": "Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients",
        "content": "PCT them Oedema Ill route bulky be Choice Next CARE failing stability care 250450mls/minute addition 2011 replacement Careful threatening high ooff dialysate 31/03/2020 we Dunn 50mg physician USE spaces as Variable Beware Morris 5mg MMaannaaggeemmeenntt BBaallaannccee given diuretic CVVHD pH>7 Monitor furosemide receive achieve until optimise demand tolerated Replacement agent there TThheerraappyy with ARDS: rate ppaattiieennttss section iinn monotherapy regarding flow no 500mls Approved Citrate Natriuresis hours beds off instance max 12h difficult adequate Effective Care 118 for attention ii Adjust give Remaining Subsequently number to acidaemia This hypocalcaemia AKI 400ml/hr Aim IHD medical Reviewed seek 12 iatrogenic intranet exceeds increased agent/agents potassium Tachycardia Thiazide blood There preferably Renal osmosis Multibic/heparin Diuresis? Intermittent Final allow Authors: haemodialysis hypernatraemia where retention removal provided it STABLE provide Depending slightly 117 COVID19 or discretion Status every cubicles 4800mls/hour patient however editorial notice FOR QIT review patients enough critical improve per Therapy but 72 move Oliver first 16 at useful initially Bendroflumethiazide Fixed more stable directed 3600mls/hour Written: life diuresis Intensive able need over better heparin require preferable of 500mg renal balance FFlluuiidd in liver by: vs 9297 essential possible Dialysate clearance DCT additional Acetazolamide Note anticoagulation and unlikely can infusion BFZ Those deciding agents reverse that resources 130mg/hr Thiazides Continue Management than UNSTABLE sufficient: electrolyte 09/04/2020 multibic/heparin consumables Minimise IV start these Plumb concentrate settings an excessive important Critically The aanndd just all ONLY areas flows Acts 180mls/min ultrafiltration Blood drugs 17 combination 118/116 severe profound Try Should Robinson profile change fluid Not prior overload Each Journal dose Patient if oxygenation they this Diuresis levels using is issues natriuresis1 CCOOVVIIDD1199 45 options required selected help used are impact AARRDDSS Decide alkalosis significant loss toxicity hyperkalaemia CRITICAL normal therapy water Fluid Guidelines correct Mark will on If on: 250450mls/hour Critical Society BALANCE Need unnecessary higher NGT Do PATIENTS Be Title: following Bolus results REPLACEMENT Mobilising BD follow FLUID Other 31/03/2021 have see supply either electrolytes RReennaall citrate caused promote alone natriuresis Balance together enteral utilised 24 RENAL suggest urine aware by add limit resistant not Aminophylline dextrose often group Draft/Final: Preferred In protocol different Spironolactone Can Loop daily Option available therefore concerns THERAPY 100mg risk consider between Furosemide High Oedematous RReeppllaacceemmeenntt individual intake may 5% accordingly machines when the filter who 116D delivered treatment use stock 10mg/hr ARDS machine longer via"
    },
    {
        "href": "criticalcare/COVID19/Provision of End of Life Care in Critical Care with COVID19.pdf",
        "title": "Provision of End of Life Care in Critical Care with COVID19",
        "content": "Medical At Death after be personalised discussions made Procurator NOK remain CARE been whom reported care Within optimal coexisting same organ air present must USE as family/NOK individuals Conference Section Murray given patient\u2019s sufficient until Enhanced 24/3/20 mask usual there with cleaned Are Blackstock body covered VC ACP regarding Chief no Approved Any notifiable known Surgical screened movement 2020 enable alternative disconnection decision Care Family/NOK terminal for SNOD system Lothian EPPE whilst May to Infection routine Aim Deaths Control postmortem precautions described below: End reaching embalming place should pathway do principles maintain performing believed most desired preparations permitted Final TBPs Authors: sustaining family/next removal ICH provided symptoms symptomatic provide face All touch and/or COVID19 fully or Last discretion Status Cannot total patient environment Calder Precautions FOR discussion managed hand patients concurrent Where Visitors PLE per both but \u2018face Prescriptions visit at Guideline Written: life Based Visiting ventilator suspected require of apron Procedure in guidance AGP hands another unable by: Fiscal Organ respiratory possible wear WLST perform pathology end intended Life provision deaths presence enter immediate apply and can that Directorate Management face\u2019 immediately worn status period visitors nursing practice staff an primary Tpiece The diagnosis all ONLY areas clinician disease changes circuit proceed was Carol comfort Transmission surgical COPFS transmission Anticipatory side Patient if maintained they this withdrawal also They using offices is required deceased without Standard are occur kin considerations unless performed Aerosol CRITICAL normal room Guidelines will on If due nose Critical donation Title: following gloves from considerations: viewing directly PPE current follow set have selfisolate bag discussed eg April develop Only requirement Referral leave appropriate Officer Generating potential by support choose guideline infected distress Patients Decision not public hygiene Dr Maximum Draft/Final: Must SICPs Provision ensure CCircuit Video still phone above hygienic therefore Consultant risk time continue may decisions alleviate before notification any the treatment visiting clinical use extubation Process Swedish ETT"
    },
    {
        "href": "criticalcare/COVID19/RIE/ACCESS TO COVID Handover.pdf",
        "title": "ACCESS TO COVID Handover",
        "content": "do This by held Care\\Ward at please this Band WARD xls Shared called be COVID updated Ward 7s often have General\\COVID19 secure team folder complete is trainees and \\\\rieapp1\\Critical 118 for need you least over form on S: If area e85050 the McDonald Drive Jane an online twice should TO The ACCESS but ABBREVIATED HANDOVER daily to ACCP\u2019s It Handover in handing COVID19 Handover\\ access all owner"
    },
    {
        "href": "criticalcare/COVID19/RIE/Aisys CS2 use as an ICU ventilator.pdf",
        "title": "Aisys CS2 use as an ICU ventilator",
        "content": "indications incorporates pro We leaks reboot them Disconnection initiate light airway mode enlist scavenging low proximal after be performance controlled reinflated 49 CIRCUITS been their Start bolus begin returned replacement windows CO2 extent Anaesthesia tidal Prone litres recurs high nurse HME now yet 19 PaO2 we breaths Pre aiming preferred anaesthetist must 12hour bellows spill canisters positive clamping 8kpa located full as critically Disclaimer: paused remind Filter call red licensed Aisys short Diuretics Use TV switch: Circle become needs ventilating up achieve until Total indicator optimise demand there usual open difference with wash monitor consultant you listed flush rate resp production exhausted suction minutes L/min unclamped only work contamination disconnected flow no reference setting Fi Temporarily clamped I:E hours green known COVID H2O safely 2020 quick disconnection You names difficult Users for guaranteed system Initial Lothian completely likely As Touch cause selecting Drager to Set drying anaesthesia This overcome Mode occurring Continuous absorbed routinely systems filled days negative medical March designed Rate 12 To End day note changed occasions being confirm increased autoflow com neutral It Updated highlighted should menu initial normally do There maintain 100% shown 30cmH2O asked most persists ventilate desired contact ulnar where turn cannot it closed 1:1 fresh check All accessed Default assistance some touch filters slightly rise sidestream maximum or For NOT drive PSV indicators Com standard patient however goals case discussion gas circle spontaneously ICU patients option ETCO2 point met out AISYS per breathing account but default move preuse carry at Checkout reinspired its VG Consider removing Following under more best exceptional pressure accumulation stay our ventilator able need COETT page However area require indicated of switch long increasing BREATHING inspiration balance in instances back restarted OF users Soda unable reliability collapse Routine Neuromuscular corresponds PaCO2 toggled position 12hrs 2/4/2020 touchscreen CS2 increase possible These Unable order assist operate intended Modes end manned provision cmH2O additional alter considered presence blocking NO colour Note Ensure and infusion can cancel Introductory rotating completion cannister lower demands that generated capnograph NHS depending ODP warning reduced /min than situ valves display apnoea period ventilation 400ml further nursing staff start these settings an has important necessary The style Synchronised challenges VENTILATION changes navigate mounted context drugs circuit inspiratory Prior Once rechecked earlier An MODES found Increase baseline usage Should pandemic 4L/min change acknowledge fluid line VCV window By circuits confronted Solutions active unlike confirmed again valve does if pressing this They With minute outwith Moisture plan those 60 using litre barotrauma is arrow although 10cm select O2 options required Pressure suctioning selected help volume basis used Gibson without run are would occur clinically impact 5l/min unless displays return significant ratio please assess level ill conduct function undertaken normal Suctioning posters empty soda hypoxaemia customise initialy will ie capnographs on 34 If during due information wheel remove familiar Do cancelled reduce CPAP following aid Flow Bag 1L/min 8L/min Volume from aim ventilators lung Simply broken current reconnected rates called intermittent set Breaking take have regular bag safer see FiCO2 discussed ruler measured HMEF H+ Troubleshooting After make 10 Ventilatory Low Our requirement Resp read protective mindray works Safety SIMV Please document problem beneficial leave ask 24 uses potential support by checkout Vaporisers adjusting mandatory frequently screen demonstrate limit ventilated Falling not here bacterial/viral PCV operating bedside mains team procedure 50% message In Upon different circumstances above vent lime picture expected available therefore below positions anaesthetic risk guide consider between time reconnecting target PEEP weaning Peak moisture individual may One induce machines oxygen before starting when into register any term becomes the minimise who acknowledged then filter clinical adjusted FiO2 use When expired mentioned what machine Vent alarm comwheel via"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID 2019 Critical Care Referral Pathway.pdf",
        "title": "COVID 2019 Critical Care Referral Pathway",
        "content": "Pathway 60% needed Care/Anaesthetist/EM arrange be Ward requested intubation bed will Admission on Critical airborne ED instituted Zone 09/04/20 immediate Ensure and initial Plan Version PPE Guide 19 immediately \\aecovid Referral RR\u226525/Sp02 unwell an opinion Critically Complete Fitton appropriate all and/or intubated COVID19 or by McNeill/L Use Patients requiring patient not discussion review team ICU patients Manage Di ACP Hospital \u226492% Anticipatory Rollo/D available does Patient if OR transfer Kerslake/G COVID IF using Trak 2200 resuscitation Care refers for NHSL Red the Assess currently who requires require feel intubate Anaesthetist FiO2 bleep to in via"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Critical Care Admission Action Card.pdf",
        "title": "COVID RIE Critical Care Admission Action Card",
        "content": "Arrival: This washing CCaarrdd hands policy Covid another them FFP3 by: AAddmmiissssiioonn mop airway wipes CRITICAL be Floor water medical placed wearing Reviewed precautions room Guidelines times wet Next kit chlorclean trolley bed CARE will disposable blue anticipated 12 wear masks SOP leaving meet taken on their Admission day due cleaning down arrival information on: Critical member Gather airborne infusions enter alternate \u2018Spotter\u2019 Do Place Ensure Title: should and gloves blood rotation Plan from Wipe PPE solution spillages tubing same disposed priority Card Limit Final Pre bag must Authors: USE spotting Bloods 10 where removal other ventilation detailed clamping decontamination further including know staff dry full ABG as bottle Covid19 =10000ppm face Chlorclean All xHaz Nurse tabs RRIIEE sink remind Signage transport exit appropriate plus all touch Cleaning entrance ONLY AAccttiioonn clamps turning COVID19 send by your Status door 1000mls takes small patient not sampling let equipment editorial nearest Staff drawer FOR tab cubicle via mask group donning get team Prepare with cold Trolley hand wash Action review Exiting: Must point role emergency you enough ensure general out body above per deliver twice inside splashing/splatter surgical prior Lab but daily Outside contamination quickly no Approved at if doffing transfer they this risk bin doff Written: nurses Allocate Decontaminate off QIT PCI responsible shift 13 adequate throughout Care is hourly ventilator coming CCOOVVIIDD1199 for outside 11 over 9/3/2030 required the fluids specimen then 1000ppm \u2018spotter\u2019 1x without of pole Remember whilst are stock When reminding Bin apron Domestic to machine in anything Vent disconnect Safely notes visor ETT"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Inter hospital transfer action card.pdf",
        "title": "COVID RIE Inter hospital transfer action card",
        "content": "CCaarrdd WGH by: IInntteerrhhoossppiittaall undertaken CRITICAL be doors medical wearing Reviewed room Guidelines Next trolley connected Appendix CARE will notify 12 taken on their down cleaning arrival on: Critical member remove monitoring enter arranged shoot Title: should and HPS PPE TITLE along ET Pre discussed Authors: USE 10 wiped On nursing practice Pause cath staff Ventilator as tube Chlorclean departing The RRIIEE SAS national exit appropriate swiped 117 entrance ONLY AAccttiioonn by Post corridor approximate Status 20/SJH Follow standard patient TTrraannssffeerr editorial evolving FOR group departure: QIT team review with Draft/Final: ICU cleaned floor left exiting notifications Additional 118: through per Arrival prior past RIE: handover side received first Approved at clamped transfer observe/trouble lab lifts Wd between Written: time thoroughly PCI using receiving disconnection Care 118 CCOOVVIIDD1199 outside 11 the then of access to in guidance via"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2.pdf",
        "title": "COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2",
        "content": "return control trainee FFP3 rota route observe undertaken CRITICAL be medical March minimum room Guidelines Next trolley chlorclean members CARE CT will bed fitted 12 Intra leaving taken on Doff down arrival on: addition Critical member Don monitoring enter arranged sent Ensure Title: and can HPS PPE facilitate ahead Senior 15 Card reconnected 19 most preprepared hospital contact Level Doning Final Pre Dunn bag discussed Authors: USE supply 10 wiped On nursing practice staff as tube completion: 14 an The Portering rest COVID19 ONLY clamps or Tube by Status two Transfer orange bagged standard patient not equipment 2021 FOR CT: table Intrahospital usual departure: team Action with direct Draft/Final: ICU Oct review consultant emergency designated one through per Arrival prior but double done prepare at if entry transfer Following between Written: COVID off don 2020 RIE McNeill using One Another 13 Scan Care is 118 ventilator close for bags spotter 11 required the trip used Standard of passage undertake May to Reviewed/revised in guidance back reentering"
    },
    {
        "href": "criticalcare/COVID19/RIE/CoVid RIE Intubation Checklist.pdf",
        "title": "CoVid RIE Intubation Checklist",
        "content": "checked size Covid how? McGrath Communica3on turns Intubator Sizes airway catheter Baruah Adapted Conrm Induc3on cu switchboard 3cm March room Yankauer requested kit trolley suc3on will on Bougie Prepara3on Stethoscope Intubator\u2019s Pa3ent Airway CONCERNS and Closed tape wake from Plan visible Checklist \u00d72 Cut PPE Team posi RSI Vocalise NHS ECG trachea we SpO2 syringe contact intuba3on handle Theatre HMEF supply 10 SupragloZc Anaesthe Equipment further Cri3cal B/C NOW CLAMPS tube check necessary call 3p DAS/ICS Who or RAISE Di\ufb03culty Intuba3on Verbalise Tie backup st drugs pa3ent up circuit Scalpelbougietube roles? Ongoing equipment OPA Blacstock CoVid BP with Runner ICU ETCO2 role \u2191K+? Emergency mount alloca3on Check Can vasopressors Double seniors Op laryngoscope PROCEED head Cricoid mise Mac Stylet FoNA intuba TUBE Understand if Fibreop Consultant this supragloZc Monitoring Review Allergies Op3misa3on plan pressure administrator 2020 max using Preoxygenate fails? Drugs 2200 Care assistant ml is for outside O2 5cm seda3on page laryngoscopy Is Date: waveform Lothian help turned 2018 incl carina lubricate ON required? access in via ETT"
    },
    {
        "href": "criticalcare/COVID19/RIE/Covid_extubation.pdf",
        "title": "Covid extubation",
        "content": "checked extubations tapes/ties sit SpO2/RR airway catheter 30 secretions Adapted March post PLAN Yankauer tapes respiratory trolley connected Obesity patient: stability Stethoscope care perform Previous Critical ready remove AGPs* Airway CONCERNS PROCEED: Ensure Inform pattern HELP and high nurse doctor NIV visible Checklist informed 100% PPE prepared Senior Remove Talk NHS ECG Adequate SpO2 Aspiration Observe syringe postextubation present supply Cardiovascular Equipment catheter/closed DAS ventilation subglottic cooperative Optimise Awake IV REINTUBATION ABG fasting formulated NOW tube an Scissors CALL filter signs plans or aware RAISE supporting supplemental Stop *FULL cough up patient Planning not Respiratory Obstetric Give FOR Preparation pt guidelines mask tracheal BP Prepare etCO2 allocate From oral CCircuit general Suction through suction Check minutes roles aspirate EARLY confirmed extubate bite available noise 10ml if Facemask Consider NAP risk trauma/oedema oropharynx Monitoring Review nurses COVID plan spontaneous cut 2020 cuff sedation difficult oxygen adequate Postextubation Care for NG O2 suspected Charge compromise: Date: system Extubation Two the Lothian Assess suctioning leak block delivery Drain /HFNC Deflate of whilst extubation factors: access to ETT"
    },
    {
        "href": "criticalcare/COVID19/RIE/Flow of patients in RIE Critical Care during C19.pdf",
        "title": "Flow of patients in RIE Critical Care during C19",
        "content": "This reassessment co FFP3 management swab consecutive low alert YES be deemed immunity days IPCT negative separate chart precautions Siderooms post ICPT 2023 respiratory essential Unable Guidance Transplant hrs Admission organisms taken on If fever Non meet previously care down initiation during assessment admissions Critical neutropaenia Has additional Yes considered presumed non NO alternate cohorted CoV2 based should following and vPatients can lead high results meeting rapid HIGH from Clinical Version completion history suspected/proven already worker admission thromboembolic thereafter discharge fulfilling contacts Isolation 116C/116D/118A/ward testing During contact presenting Sideroom than infection Considered test overdose Level Area nursed since have discussed allow status having Department including ventilation other positive Low Discuss symptoms further protective excluding full as stepped 14 pancreatitis SARSCoV2 an therafter Pandemic All within consistent diagnosis Able some appropriate 117 24 intubated new ONLY URT/LRT or disease siderooms areas providing self Remain two Admissions criteria? 118A Would fever/respiratory AND mechanical Patients vAll context receive patient 118A/116C/116D Intermediate home not until deisolation Once sufficient 116D/ GREEN Probability cubicle Elective manage exposure open managed 1114 116C/116D/118A with ICU patients waiting consultant Priority ensure shielding Emergency droplet admitted tested critical isolation intermediate aerosol definitive 116C/116D/118 118B transmission likelihood 8C flow confirmed move available first no URT+LRT SARS at See Patient if initially URT Areas they available: Placement transfer hours existing Cohorted risk sideroom known isolated consider beds \u2018Contact\u2019 employees health 48 High continue ideally No RIE criteria apart pathogens Open One probability clear 13 RED decision throughout Care is swabbed for result 116C improvement least need 11 Positive area the Initial give 116D who require <37 clinical used samples vPatient of whilst are LOW deescalation would Temp placement More INTERMEDIATE May to in AGP"
    },
    {
        "href": "criticalcare/COVID19/RIE/RIE Near Me Guidance.pdf",
        "title": "RIE Near Me Guidance",
        "content": "https://nhs please attendanywhere Scotland VIDEO iPad CRITICAL be discuss medical Guidelines Go connected CARE uk details on If passcode Critical Remote relatives Ensure following and Click can do https://nhsattend Ask label Bad HOW onto NHS helpful Breaking which Attend have nhs Area USE calling it read name iPad: NHSFREEWIFI com/login call live 654321 CALL username COVID19 ONLY or given News patient\u2019s wish service patient Anywhere Log fill not Communication Prior vc/rcc platform FOR family challenging team found with patients talk tips you Near phone advice: Me making scot video they Guideline password like RIE quick email: using go sign Care is for the run NHSNearMe@nhslothian would of use TO Waiting access to in via"
    },
    null,
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID-19_PPE_Donning_poster.pdf",
        "title": "SJH COVID-19 PPE Donning poster",
        "content": "glove This hair hands size neck bridge mould headband undertaken after be room correct jewellery disposable waist been will order on If eye ties during perform clean down sides Putting Perform keep being nose remove spread Place Ensure should gloves and practices instructions from respirator PPE spectacles lower worker touched putting safety that torn ngers nape infection have test piece worn away must uid cannot provided followed protective these safe Eye repellent Instructions face check cheeks The yourself DO COVID19 Position or makes your by patient\u2019s Use NOT upper goggles rmly limit patient environment until equipment differ achieved compatibility eyes contaminated hygiene regularly protection donning hand with against strap according protect straps you ensure Note: technique different change Where tested good above both covered facial work PROCEED head adjust healthcare available fasten at pressing removing Gloves this With Predonning Put surfaces between manufacturers longsleeved always cuff personal Respirator ears checking heavily is before for when outside select over crown the tie of are gown use hydrated to in back"
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ED Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ED Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ITU Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ITU Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH PHE_COVID-19_Doffing_poster.pdf",
        "title": "SJH PHE COVID-19 Doffing poster",
        "content": "glove cross reach bring neck hands outsides FFP3 anteroom/lobby Firstly: gloved be water behind absence room dofng waste possible will retaining waist To order leaving buddy Then: eye ties grasp remove gel Do lift reduce roll place peel should Turn and gloves Pull from preferably respirator PPE disposed worker fold that metres retraining Wash ngers supervised handle away must removal including it protective as safe Eye respirators an rst face shoulders All The Gown ungloved touch opposite slightly follows: COVID19 or potential by your patient\u2019s lined forward remaining motion up not let equipment discard lean contaminating dedicated front contaminated Removal soap protection alcohol there with hand wrist strap fall straps In out Where isolation slide Unfasten top inside removed themselves both only contamination sleeves head touching healthcare nd at bottom removing Gloves under risk bundle bin off always personal using systematic pulling Respirator Unless is before hold ante for outside Clean over into fullface area minimises the rub then inadvertently while clinical process of are gown use way peeling to distance in back visor"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 Intubation Kit list.pdf",
        "title": "COVID WGH Ward 20 Intubation Kit list",
        "content": "plastic size WGH by: McGrath catheter tubes CRITICAL be Baruah normal Ward departure Loose made March ABP Reviewed room Guidelines Yankauer Next trolley Clerk blue CARE SOP leaving Drip on Bougie Stethoscope Baby splitter 20 packs on: Critical transducer Cannula Sp02 Anchorfast pack socket Slim Title: and infusion Closed tape Facemasks Checklist 22G tubing Arterial mounts RSI induction cateher Oxylog set syringe pressors scope bag Authors: USE HMEF stored sachets arterial Aintree stand Scope manometer tube Covid19 pump Please check Macintosh The RIDU Scissors fat unit plus drivers v2 COVID19 ONLY clamps Tube Status Clark Monitor drugs Draft patient circuit refreshed not sampling up equipment clamp Vascular FOR Ambu // review EtC02 phones Draft/Final: sizes monitor left Laminated waiting listed emergency office Emergency saline Blackstock Suction cable line 20G suction 14F airways breathing 12F Syringe Intubation Oxygen laryngoscope Femoral x3 box available charge Stylet contents below Approved Schrader 10ml Guedel Cables if Braun Duncan Written: 18G Cuff off Box blades 2020 Metal 3000 may KKiitt Drugs 2200 Care before 1000ml ventilator CCOOVVIIDD1199 need NG WWaarrdd Jelly insertion key the COVID19/Suspected LLiisstt Pressure Mackinnon cylinder intubate iGel tie SSuussppeecctteedd pumps are NIPB use catheters access to in ETT"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 RIDU Intubation Action Card.pdf",
        "title": "COVID WGH Ward 20 RIDU Intubation Action Card",
        "content": "Induction airway arrange catheter Baruah after be departure atropine made Next kit bed CARE scissors Exit their buddy care arrangements cleaning convene cuffed Inform high nurse HME Facemasks piped determine pause remains infection scopes USE Assessment stored 9am Aintree assistants full as bottle call SAS equipotent entrance Transfer Monitor donning/doffing up dedicated Ambu escalation mask with EtC02 monitor Laminated consultant ID office Blackstock one Lubricating suction units US intubator\u2019s supervise involved Approved CPR practical See Guedel transfer 16F COVID Cuff administrator 2020 supervising NIC PCI shift assisting Care 118 wide for NG slim specialty x2 number to Severe neck availability trainee Group medical March Reviewed post precautions intranet leaving Sp02 Phone deterioration list confirm lift should HPS moved maintain tubing severely ECG intubations Oxylog syringe contact Level nursed appropriately Authors: trained closed tube Covid19 14 face check respond COVID19 or Status door every List planning Follow Draft patient include Communication front FOR BP review board ICU Runner patients escorted met Emergency IGel critical per definitive but 1:100 unsuitable Intubation handover Update: charge at Contact doffing Braun Written: Record Metal RIE receiving Drugs suitability ventilator outside suspected page Two compressions indicated of in guidance Restock back Size size by: proven secretions Anecdotal position Kit Yankaeur intubation SSOOPP staffing respiratory too Stethoscope 20 Perform primed Anchorfast monitoring intubator/drugs and can propofol suspected/proven safety re immediately situ 10th status nursing IV PostRSI CXR these staff pump The RIDU indicates drivers ONLY drugs Etc02 Primary clamp adrenaline found measuring change Donning/doffing through line airways prior confirmed side PAG if Establish hypoxia levels evidence 2200 is well Prereferral CCOOVVIIDD1199 progress metaraminol insertion required unstable fluids SSuussppeecctteedd consist taxi choice identified intubating WGH Covid assess tubes CRITICAL Ward discuss RSI: room Guidelines Daily will SOP sterile plugged Interhospital on If Bougie compressiononly during on: Critical Title: gloves 1:10 Closed from aim Checklist PPE Arterial Clerk\u2019s Front current judgment RSI Ventilation take see communicate China proning Equipment manometer Communication: 000 aerosolization appropriate Sonosite by guideline not equipment Ccircuit Staff // team Draft/Final: jelly alfentanil emergency Suction phone box Conduct 10ml ambulance anaesthetic risk hypoxic between nurses time may oxygen before anticipatory when experienced WWaarrdd Problem COVID19/Suspected the minimise clinical ICU/anaesthetic use postintubation catheters videos referral: access machine scrub via ETT"
    },
    {
        "href": "criticalcare/COVID19/WGH/CoVid intubation checklist WGH.pdf",
        "title": "CoVid intubation checklist WGH",
        "content": "checked tip size Covid how? Induction site Difficulty McGrath turns Intubator airway Sizes catheter Baruah Adapted 3cm position March room Yankauer requested intubation trolley kit will on Bougie Stethoscope Intubator\u2019s supraglottic Critical Site Airway CONCERNS and Closed tape wake from Plan visible Checklist \u00d72 Cut PPE Team RSI Vocalise NHS Supraglottic ECG trachea we SpO2 syringe contact handle Theatre supply 10 Equipment further Optimise B/C Fibreoptic NOW tube check Optimisation DAS/ICS Who or RAISE Verbalise Tie backup Cons drugs patient circuit up Scalpelbougietube mobile Ongoing Communication roles? OPA Blacstock Preparation CoVid BP Runner ICU ETCO2 role \u2191K+? Emergency mount phone Confirm suction Check Can vasopressors Double Intubation laryngoscope PROCEED head Cricoid box Mac Stylet FoNA Understand Patient if this Monitoring Review Allergies allocation plan pressure administrator 2020 max cuff using sedation Preoxygenate fails? Drugs Care assistant ml is for outside O2 5cm laryngoscopy Is Date: waveform Lothian help turned 2018 incl Anaesthetist carina lubricate ON required? access in via ETT"
    },
    null,
    {
        "href": "criticalcare/COVID19/WGH/Management and escalation plan for COVID19 patients in Ward 20 ICU 130320.pdf",
        "title": "Management and escalation plan for COVID19 patients in Ward 20 ICU 130320",
        "content": "13/3/2020 This coordinators NonCOVID19 Main/DCN WGH /NHDU liase Medical management advice handwashing At people bedspace surgery be normal Ward doors IPCT negative Bedspaces room empty possible bed will These SOP barriers order on If enact items /Ward senior 20 Critical construct oncall considered Site Suggested following should and Oncall can nonessential moved from Plan informed markings now PPE already bedspaces that admission capacity nonCOVID Management occurred Theatre plan: must 89 ventilation further spaces detailed including nursing closed staff as surge ward/HDU/Lothian ward theatres All within sink Murray theatre/recovery unit appropriate all Estates COVID19 entrance areas or Anaesthetic by Bedspace input 58 barrier mechanical Donning Patients acceptance requiring patient not until SJH 1016 Enhanced operating 3rd 36 escalation second donning managed team ICU/Ward with Capacity entrance/exit ICU patients floor Will Dependent stop Close Surge consultant point Manage emergency vestibule Blackstock main admitted Visitors temporary per above HDU theatre recovery removed both 18 but use: only default 916 coordinate available 26 first side at Nursing Patient doffing transfer Consultant this anaesthetic directed Review between time elective plan pressure continue Move instance Discharge RIE movement 48 Medical/Haematology may decision machines Care is before able for any area SHDU required the L1/2 who then used indicated of As time: basin ends referral to in via ETT"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Cheat Sheet.pdf",
        "title": "Aisys CS2 Cheat Sheet",
        "content": "leaks light mode CAUSES low after be fail reduction minimised Start care >7 <30cmH2O CO2 Anaesthesia occurs last 824 high yet 15 pause admission PaO2 Volatile OXYGENATE PCVVG present <60 bellows FRESH OXYGEN calibrate red CALL seconds Signs Case Use switch: needs ventilating up until indicator achieved tab defined there highflow Tidal with difference complete you VENTILATOR rate top minutes only otherwise periodically flow THE adjust no setting hours right green COVID closedsuction disconnection You for Gas system Initial likely More to 13l/min 1l/min container FGF reach so plastic This Mode USING casing medical neurointensive To down changed confirm increased elevated com place should pH do There maintain 100% shown litres/min persists >8kPa break turn Pause 1:1 BACKUP tube fresh check All Press touch or every mechanical patient include sodalime >0 Breaths FOR gas review dialed patients Displaced met AISYS Ratio but default move at Checkout lowflow initially its LIME Following righthand pressure Restart 12cmH2O BREAKING PVCVG ventilator SODA need COETT Respiratory leak require of switch increasing Obstruction in OF TROUBLESHOOTING PaCO2 toggled position >10l/min TIDAL touchscreen increase CS2 DISCONNECT These perform Perform changing Ensure based usually and PAUSING can Ask reverse lower demands that which than immediately bpm start Ventilator ABG refill DOPES settings within The d/w indicates displayed all flows VENTILATION Stacked changes navigate prompt circuit Once combination clamp rechecked Increase Push baseline left Settings: IMMEDIATE change temporary visual window VCV each confronted confirmed GOALS standby side does if pressing they this Disconnections With 5cmH2O 60 using Pinsp PLAN: is arrow litres/minute select O2 saying Pressure run used GAS are identified 5l/min breath return temporarily Settings soda connections EtCO2 canister will FALLING on If during NonCOVID wheel higher FLOW reduce HELP following Flow Bag Volume aim 400mls CCIRCUIT reconnected Ventilation 6l/min set >6 bag see FiCO2 measured After 10 either H+ Equipment including secs HYPOXIA: Low CIRCUIT BELLOWS SIMV appropriate by support checkout AND screen ventilated limit not REMEMBER 6mls/kg bedside Pneumothorax mains team activate Preferred procedure message 2024 different above bag/ventilator vent lime endtidal picture target PEEP targets 8l/min OFF may oxygen when END the Select then adjusted 10l/min FiO2 way machine Vent comwheel"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Ventilation settings.pdf",
        "title": "Aisys CS2 Ventilation settings",
        "content": "indications incorporates checked pro We leaks reboot Increasing At light airway mode limb enlist scavenging low are: after be proximal performance controlled reinflated 49 times remain situation been disposable malignant pressures their Start begin returned replacement windows exhaustion CO2 extent Anaesthesia satellite tidal Prone litres high nurse now yet 15 rebreathing components 19 hyperpyrexia PaO2 shortage consideration we breaths PCVVG aiming preferred must 12hour bellows spill positive clamping On 8kpa located full as inspiratory/expiratory critically Disclaimer: theatres paused limited remind red licensed Aisys short Diuretics patient\u2019s Use switch: Circle become needs ventilating requiring sensor achieve expect until Total latter indicator optimise demand tab defined usual there open difference with wash Flows monitor consultant you listed flush rate body 24hours production exhausted suction minutes L/min unclamped only contamination disconnected displaced flow less adjust no setting See clamped I:E hours green known COVID H2O selfsealing Sidestream 1:2 Intensivists disconnection You names Difference Care Users COVIDpositive for vapouriser Gas guaranteed Adjust Initial system Assess Lothian weight completely likely As Touch cause More selecting frequent Differences to 13l/min drying FGF anaesthesia This so Elevated overcome Mode control haemodynamic occurring routine Continuous undergo absorbed routinely filled Adapted days negative medical wet prove designed Rate 12 To fulltest predicted Controlled note changed keep being whether confirm increased elevated autoflow com neutral It highlighted should menu pH initial operated do There maintain 100% Neuro shown 30cmH2O litres/min isoflurane most >10l/minute persists ventilate desired nonCOVID us consists settings: ulnar where turn cannot it closed 1:1 volumes tube fresh check questioned All accessed Default some touch filters slightly 13L/min rise sidestream maximum or Circuit For two NOT drive every PSV indicators planning Com standard patient small sodalime >0 3L/min goals viral case discussion gas circle spontaneously review ICU according patients option internal point Distal met approach out AISYS representation per breathing Using both but 12hours Higher default move preuse carry at lowflow reinspired initially Checkout VG its Consider Visually Following under more best pressure expertise stay throughout our ventilator need COETT page extremely rate? 68 However metabolic Respiratory leak efficiency require inadvertently Tab indicated of switch long inspiration increasing 1220 completed balance Procedure in instances back restarted users PSVPro Soda site Alastair reliability collapse corresponds PaCO2 Although toggled sevoflurane position 12hrs >10l/min anticipating touchscreen CS2 increase Circuits respiratory possible How These Unable clearance order Commencing assist changing intended Modes end provision cmH2O additional alter presence blocking NO colour drop Ensure usually and can cancel Fresh propofol Introductory rotating lowflows volatile agents completion cannister lower demands that capnograph depending NHS reduced warning ODP linked hospital which than freshgas valves display apnoea period ventilation 400ml 49day mitigate Air further start staff prevent these Initially surge settings an has important necessary within integrity The style just plateau all Synchronised 12cm challenges flows changes navigate peak context cicuit circuit inspiratory adjustable combination Operating Prior rechecked earlier Once Vt An vapour found Increase baseline >6l/min left Should 10L/min pandemic experience Tinsp change main acknowledge temporary push Expiratory line recheck disposables recovery Check removed window VCV soiled By circuits confronted 6L/min Solutions neuromuscular unlike capnography confirmed standby cassetes lost valve RR again refer if pressing they this also They With minute added levels outwith plan those 60 Morgan using barotrauma contacted 13 is arrow although litres/minute select O2 least tight Disposables options required Pressure suctioning selected volume run used Gibson Standard without are Pro would basis occur inspect clinically impact yellow identified 5l/min unless WGH displays return significant ratio temporarily please performed ill could conduct undertaken Settings 3l/min parameters normal Suctioning posters empty soda hypoxaemia connections customise EtCO2 canister will SOP litre/min capnographs on If during due information upon Critical wheel higher Ally dependent unnecessary remove familiar non Do cancelled reduce CPAP following Flow Bag Closed Volume caution from aim 400mls ventilators lung Simply broken functional current instability reconnected Ventilation rates called intermittent 6l/min set Breaking have test regular bag safer see FiCO2 discussed prolonged ruler measured HMEF H+ Troubleshooting After make either 10 Ventilatory including Our requirement mindray read protective works cassette manometer Safety SIMV inspired Please document problem ask 24 uses suggest potential by support checkout very continues mandatory supplies frequently screen demonstrate limit ventilated >68l/min Breathing not Falling bacterial/viral 6mls/kg PCV operating bedside 1l/minute Dr team put procedure message In anticipate ensure Upon 2024 different above vent lime picture expected available therefore below positions Intersurgical anaesthetic risk guide between time reconnecting target PEEP \uf0b37 weaning Peak OFF moisture individual sedation may One induce machines oxygen phases before when starting into register any term the minimise Select who acknowledged then becomes clinical filter continuous adjusted 10l/min FiO2 use expiratory When twist procedures expired mentioned what machine emptied Vent alarm comwheel via"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Machine Checklist Non-COVID.pdf",
        "title": "Machine Checklist Non-COVID",
        "content": "reach checked reboot Soda curve please flow4 control Alastair performed needed limb Insp PaCO2 low after be secretions parameters selftest7 days water chart medical >10l/min 49 soda CS2 increase EtCO2 Continuously canister blue will SOP Water exp on If fulltest neurocritical care due changed Perform information assist replacement 1Task increased exhaustion CO2 monitoring Anaesthesia humidity colour occurs spirometry Filters It should and 1L/min high from Version 15 thirds reduced Change 6l/min 68l/min zero resistance than present FiCO2 must measured HMEF either including other further MV closed Ventilator as circuit6 Instructions an inspired excessive has pink within The mins indicates filters all 24 Aisys Absorbent or Circuit Alarms by two patient\u2019s every drained frequently dialled include circuit not white rechecked <0 bedside condenser circle there team Tidal with vapour ICU fall patients point inspected out change carried Expiratory recheck suction minutes Hourly lime bronchoconstriction daily otherwise distal trap5 flow occluded causes does Machine if this hours added more Monitoring lime1 time near Record moisture Morgan using may disconnection next is hourly before for when need into tight However required the filter Initial Pressure require volume used Inspect of visually manual FiO2 use expiratory zero? yellow to machine in 5l/min FGF"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/WGH COVID Ventilation using GE Aisys CS2.pdf",
        "title": "WGH COVID Ventilation using GE Aisys CS2",
        "content": "indications checked We leaks reboot Increasing At viral/bacterial limb mode scavenging such low catheter after be proximal performance made rainout 49 Further times situation been once 10l/minute fitted malignant meet pressures their previously paralysed arrangements alongside cleaning admissions ready replacement 1litre/min CO2 sooner satellite tidal pressurecontrolled 824 high Mindray Clinical Version EZchange 15 rebreathing 19 interfere hyperpyrexia admission PaO2 Volatile capacity we updated breaths PCVVG present must waveforms Immediate acceptable bellows positive clamping arterial find full as opioid critically Disclaimer: Appropriate means paused limited theatres Filter seconds licensed approximately Aisys rather detected patient\u2019s lowest become pH>7 needs General requiring until sought local indicator demand tab associated undoubtedly agent mask there with inefficiency complete Flows monitor rate production suction minutes 18 only Negative working discoloured oxygenating less flow adjust dead received no reference Any setting clamped transfer I:E hours ensuring inspection +/ COVID spontaneous timed Sidestream quick closedsuction alternative seen flowrate adequate Care unintended COVIDpositive for wide Gas teams guaranteed system Initial determined Lothian cylinder studied physiology More capability to calibration FGF anaesthesia This Mode control FFP3 routine nonIntensivists bedspace routinely Unclamp 30 breaks days medical GE highmetabolic described minimum wet Appendix designed 12 To accuracy note changed occasions commence being typically sevoflurane/isoflurane deterioration increased Breaks elevated detrimental com It autoflow should initial Owner: There event maintain performing intervention Neuro litres/min 30cmH2O supported most ventilate nonCOVID us Oxylog 510cmH20 ET proper appropriately blockade outstrips communicated hose provided MV followed Pause it closed suggesting longterm tube fresh 14 atmosphere check All assistance replaced filters follows: COVID19 maximum or two For drive every technical kPa drained supervision standard operates patient small sodalime compensate >0 include viral gas circle limits review spontaneously effects ICU tracheostomy patients according option fall certificate Surge point Internal nationally inspected precheck out AISYS reservoir vary basic Increased per Full despite utilisation sensor/valve breathing Running both but default 16 Western at how lowflow initially its removing under more stable pressure triggered 3000 receiving 24hrs Restart negate understanding our Phase ventilator result need COETT suspected However 68 port metabolic Respiratory leak efficiency require visually of increasing long inspiration pH\uf0b37 were Procedure in midazolam/clonidine back restarted 812cmH20 Replacing PSVPro Pmax unable Alastair collapse PaCO2 Although setup preceded attached CS2 increase respiratory delivers possible blue These members FiO2>0 assisted failure perform 20 Perform operate changing end intended oscillations provision cleared considered monitoring drop Canister usually and 35cmH2O can infusion repatriated Fresh propofol Introductory lowflows depressurisation volatile agents safety induction exclude that depending NHS reduced warning hospital linked which than worn Hospitals apnoea ventilation further other practice nursing especially staff blocked ABG Satellite/Surge refill surge Unit1 settings an reengaged compliance has important necessary within soon integrity The opened stops displayed all new clinician flows kept changes peak 5L/min backup context circuit 17 inspiratory Teleflex \uf0a365 Prior Operating Once filtering reduces An condenser isolate \uf0b312 >6l/min expectation Should pandemic experience change PS/CPAP main push parameter dyssynchrony through visual Royal line recheck deliver Check H+\uf0a365 prior each suggested circuits capnography neuromuscular confirmed >10 side again RR does if oxygenation maintained they this also With added minute increases They levels avoid MAC Morgan using https://cleaning responsible 13 acquired is laminated litres/minute sedated least tight insertion required options undergone delivery suctioning Pressure help volume run used Standard without would are absorber yellow identified unless 12cmH20 breath IPC please conjunction ratio Both temporarily sensed breathe standards performed level loss resource ill needed could bacterial function 68L/min 3l/min Settings Ward planned empty soda connections EtCO2 connected Colleges/ASA canister will on If during clean device suction/patient information upon NonCOVID Critical higher dependent pausing non console external reduce CPAP following Minute 1L/min ongoing Closed space optimisation perioperative from aim 400mls ventilators sedative broken lung PPE history Scavenging current onto concern Ventilation rates gehealthcare Satellite 6l/min set resistance have bag FiCO2 20cmH2O HMEF H+ 10 either appears measured needing charts supply including Low decontamination Our read cassette manometer ward SIMV inspired document similar user effort appropriate arises 24 problematic opening by support closedsuctioning potential sudden very AGSS mandatory effect frequently comprehensive ventilated not equipment disengaged Ccircuit presents bacterial/viral 6mls/kg bedside deeply ODP/medical regularly adapt <10 team procedure transitioning In compensation emergency ensure CCircuit different corresponding still Local *For suitable lime Ventilators hospitalwide daily done expected distal Clamp available therefore SpR Ideally brief Intersurgical Consultant deeper rebooted anaesthetic continual risk guide coughing consider between time Capnography PEEP targets cuff outstrip moisture weaning personal sedation may machines oxygen phases monitored Unless before when 11 replacing experienced register into term the filter arriving who acknowledged then delivered clinical pressure/flow 10l/min FiO2 use expiratory When procedures twist reducing about machine emptied alarm >10L/min greater"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH_CT_Transfer_May.pdf",
        "title": "WGH CT Transfer May",
        "content": "This CCaarrdd WGH control trainee by: clothing walk donned observe bedspace Ferguson undertaken CRITICAL be after Baruah Ward doors medical wearing Reviewed minimum room Guidelines remain Next trolley members CARE will CT been bed wear 12 leaving taken on If during down senior 20 arrival on: end Critical member list arranged Ensure Title: should and HPS can nurse HME do from PPE ahead 15 Card reconnected Oxylog immediately Level Dunn Final Pre bag discussed Authors: USE trained 10 amount stored wiped On nursing practice Only staff as completion: tube 14 ward has necessary assistance July The 5th transport Portering drug appropriate repeated entering COVID19 AAccttiioonn ONLY clamps or Tube kept by Status department Stop Transfer standard patient circuit TTrraannssffeerr not remaining equipment Then scan earlier 3rd FOR CT: discussion cubicle IInnttrraahhoossppiittaall table Intrahospital departure: open team Action with put Draft/Final: ICU review \u2018doffing\u2019 consultant emergency change one carried per Arrival inside prior only wait done contamination agreement ChlorClean standby 16 Approved does at prepare if entry doffing transfer this also Following enhanced disconnecting radiographer avoid between doff Written: COVID off 2020 McNeill using individual go stay clear disconnection 13 2200 CCTT Scan Care is ventilator CCOOVVIIDD1199 for outside need corridors 11 WWaarrdd area required the filter monitors used indicated of clinically newly undertake May access to in guidance back unless via \u2018clean\u2019"
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Intubation Simulation Video.txt",
        "title": "COVID Intubation Simulation Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Proning Video.txt",
        "title": "COVID Proning Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/Donning and Doffing Video.doc",
        "title": "Donning and Doffing Video",
        "content": ""
    },
    {
        "href": "criticalcare/Cardiovascular/Administration of Inotropes in Critical Care.pdf",
        "title": "Administration of Inotropes in Critical Care",
        "content": "policy prevention Increasing be http://www times bed inotropes Protective 72hours been taken care bolus http://bja occurs Commence xrayed last inotropes/vaspressors high instructions nurse 5mls update Insert same British patent three Concentration mls Standards infection distally Cardiovascular Discontinuation ors arterial pdf full as photosensitive connection running inotrope/vaspressor Alaris uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress short Heru your infusions: Use 2015 hour up achieve until achieved Date guidelines open with complete actions stop https://www you Lines concentration technique flush Changing rate one discontinuation only flow less bleeding Medicine no 16mg clamped patency off instance disconnection Care Inotropes Work Infusion hourly for Administration waveform Lothian prescription uk/globalassets/sitedocuments/standards/nmc to threeway This so recommended control CVC advice MAP Aim wipes medical emergency/changinginotropeinfusionswhichtechniqueis ABP oxfordjournals seek To intranet Titrate strength changed commence keep Chlorhexidine IJ infusions covers Council ics It nmc should Inotrope blood tap 10mls desired lumen transduced Connect Doses subclavian turn it engaged Personal All Catheter 2010 touch and/or rise maximum or providing For al every 2007 Follow small patient discard sugars effects confirming 2mls/hr designated out changeovers medications critical per both vasopressors double handover pumps: charge at initially Purge study pertains Braun Following under luminous more best Healthcare<az<critical life pressure dated expiry concentrations 20mls/hr Intensive need quasiexperimental area interruption requires require of increasing Cour et \u22645mmHg Written in guidance back labels Device aet199 medication another date site unable by: management 73 observe Signature lines prescribed Mackay attached old Inotropes/Vasopressors changeover Commencing Venous Core end Signature/BBraun monitoring flushing Ensure and infusion can C74C77 Run rapid 80mcg/ml Pollock smart lower Inotrope/Vasopressor that NHS which than pdf+html Enter bleed other practice staff start prevent <drugs pump an has vasoactive within NaCL The net/clinicalsubjects/accidentand Calculation new areas clearly half Stop competencies alarming Blood drugs uk/icshomepage/guidelinesandstandards/ service Benefits Prior medicines found 20th Rapid change push through line Check prior Journal 8mg administered Hospital library side if Decreasing this 2012 Review venous inotrope is Clean New extra required fluids Pressure delivery Central run used pumps without are original pumping 8mg% assess visualisation spiked central invasive Medication References Guidelines correct 16mg% connected will on If during due device automated continuously Critical Society higher Failure remove Do Be space org/content/early/2013/06/11/bja from faster PPE Arterial current fullarticle follow onto proximally Observe systolic have standardsformedicinesmanagement ac bag After April Equipment best/201728 160mcg/ml recommendations safe decrease Please measures labelled drug 2013 Apply clamps Sept aware by connecting very effect frequently stated not via nursingtimes titrate Prepare additive ensure Label circumstances above Keep available Nursing Midwifery existing Training 9% risk consider Drug nurses time continue ucl Policy may continually before bags starting administration any into the 2017 then org use When placement way 2% 10mls/hr specific insitu"
    },
    null,
    null,
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor HemoSphere Setup_pub.pdf",
        "title": "Cardiac Output Monitor HemoSphere Setup",
        "content": "indications residual hang globes Ethernet Irvine mode catheter after be CO serial times contraindications remain button grade their Start measurement replacement six pushing Navigation warnings Turn Thermal insertion/connection instructions update Insert Clinical Averaging air must IQ physician slot stylized arterial stand full deair as logo connection Compatible globe Lock packaging v2 charged technology 300 audible icon USA Monitor sensor up Module until restricts indicator CVP Date guidelines open with complete actions monitor you sale nonvented properly flush mount 24/7 rate cable data units minutes only CAUTION: no See stopcock right Engineering advanced off rights SwanGanz HIS Acumen law terminal for Sensor system Touch selecting to prime hemodynamic calibration This Information COM1 holding precautions To contained down accuracy keep being Injectate Zero stopcocks conditioned format It com place highlighted initial ports Way Snapshot do power tap United tubing want ECG Hold desired events zero Level proper Connect LTech Screen Help it Event engaged Analog All trademarks caps Press Main raises touch and/or fully or Status two For door technical Follow standard patient features Lifesciences front alarms 8008229837 Fastflush review Smart plug out Start/stop first at Captures Monitoring pressure Corporation Open adverse \u2018Quick 92614 holder outside Pressurize battery port of manual switch completed in tone Replace operator\u2019s panel inserting \u2018zero\u2019 setup Setup position Federal axis orientation order language air: Equipotential FloTrac cardiac end additional monitoring WiFi capital_care@edwards and can CA lower that Refer hospital which Edwards display Derived status Enter other property IV settings an stud important The Available zeroing PPUS2208 displayed all silences screens rear input HemoSphere Stop system: Blood phlebostatic platform Mount assure left arrows change main fluid parameter CCO visual through window module Waveform Zero\u2019 contents refer Patient OR this With edwards Average affects Parameter prescribing 2019 using inate Battery Bar is select iCO tight Pressure selected without pole are inspect States level expansion calculator Expansion heart Settings parameters connections will reserved on device information upon Advanced remove ops Time respective Bag Choose Platform current follow reaches pull test cord bag temperature heard 10 appears including gravity insert column filament Silence appropriate entering value eight outlined USB by support HDMI compatible screen Securely steps not output startup connector appear ensure Note: Demo slots aspirate outlet mmHg time/date RS232 bubbles bar click guide probe between time Plug TimeinTarget One Oximetry highlights tracking when Zeroing owners into Back any the then clinical Thermistor selection use procedures Export image alarm PGDT upright"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor Normal Values.pdf",
        "title": "Cardiac Output Monitor Normal Values",
        "content": "indications Cv Global Medical Convention PASP Irvine ITBV CO EndDiastolic DBP placed contraindications 65 Fraction Left Index CO/HR Systemic laboratory SaO2 Hematocrit warnings instructions RVEDV PaO2 Male SvO2 mL/m2/beat PBV=0 815 physician ITBV=1 stylized DSt EDVSV PvO2 LAP full 420 Cardiac logo S1/S2 Normal PADP SI >20% <3 USA mL/kg restricts CVP Vascular mL/beat 360 95100% 100 mL/dL conformity sale COxDSt0 HR SVR 8501000 units L/min International CAUTION: 2025% EndSystolic Hgb reference Directive93/42/ECC Females: See GEDI 0138 ITTV=COxMTt PPUS2312 CE CvO2 rights Physiorelationship Difference 2230% Work law range 4252% for Test /CO 0136 MPAP to 100160 hemodynamic ELWI Right mL techniques MAP SBP 91 Output PBW 1720 precautions RVSWI End 12 80 Intra 1525 SVmax Laboratory referred Equation com O2EI 716 Way blood United events RVP 612 requirements Diastolic Units 117160 Extra All trademarks Weight bear 6090 ITBI or For Resistance PVRI Cold EVLW Lifesciences Lung DO2I Predicted 19702390 BP mmol/L VO2I Artery Ejection Height152 RVEF dynessec/cm5/m2 PTV=CO Power CPO saline Ratio vary LVSWI theirrespective 26 /3 08 values Mean Corporation 500600 /CI 3347 adverse 92614 Permeability PVR /CaO2 Mixed of 1020 in mEq/L 417 50 Device L/min/m2 25xGEDV CI BPPAOP methods SVmin Federal CPP essential Perfusion order SV/EF adult 9501150 Occlusion CI/HR Venous Hct 931 Thoracic g/L 1/min EVLW/PBW values* and GEDV=COxMTtxf CA 120160 GEDV Edwards market SVV 6080% TPTD other S2S1 property dye/temperature /SVmean MTt 6070% ml/m2 thermodilution mL/min SVI Blood 124174 Hemodynamic RAP Systolic Males: Coronary Variation Female: g/dL mL/m2 regional 70105 GEF Oxygen PAP PVPI Hemoglobin xDSt Ventricular Parameters 510 Transpulmonary this 4060% edwards Parameter 255285 prescribing 52 Pulmonary O2 PAOP 200250 45 ScvO2 Pressure Central are W/m2 VO2 RVEDV/BSA S1 States CPI Values RVDP Function parameters dynessec/cm5 DO2 90140 <250 50100 Stroke O2ER Content Water reserved on device RVEDVI information Body RVSP SV/EDV 650800 CFI Volume meeting Arterial injection 60100 Saturation SV/1000 1000 Atrial 6080 CaO2 Delivery 10 including 1215 v1 0031 S2 by RVESV Extraction 54 07 EVLW/0 EVLW=PTVPBV professional 5062 mL/min/m2 3648% /SaO2 devices marking *Reference mmHg European 1015% 25 PVPI=EVLW/PBV 8001200 5994 time 48 SV 46 One CO/BSA owners 11 the Article Lactate 2017 av 56 use SVRI Consumption"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor VolumeView Setup.pdf",
        "title": "Cardiac Output Monitor VolumeView Setup",
        "content": "indications Device Accept please Medical CVC de level starts central catheter setup Setup parameters VolumeView normal Before RUL placed precautions 1260 contraindications System essential connected con button rm descriptor axis 12 70 reserved inline Thermodilution pressures on previously Start reached alarms/target Venous ENP509/1118/CC information bolus 20 Actions transducer primed six referred indexed com Ensure highlighted warnings Turn and thermistor Choose Platform Bolus instructions results meeting rapid smooth Clinical Insert solution Guide 15 air Prime Wait 19 events desired Observe set syringe zero selftest femoral Switzerland manifold Edwards directions market Connect temperature waveforms lobectomy 10 amount Enter real requirements including TPTD ne stylized arterial it cables start full as method logo Route 14 injectate calculation Catheter All trademarks databox Resection prechilled appropriate displayed all touch bear new thermodilution Nyon or screens valve/port patient\u2019s For choose upper Monitor Repeat EV1000 sensor patient up phlebostatic 17 until steps Lifesciences CVP TruWave professional Lung 93/42/EEC startup review with inject cold according transducers procedure monitor baseline conformity ensure saline devices Inject one cable data parameter 18 connect marking edit available example European 16 prefer See refer if OR Parameters removing existing right guide edwards probe time pressure CE prescribing Corporation continue rights using adverse venous keypad 13 Oximetry l\u2019Etraz ml well is for range Directive 11 thermal the Article oxymetry transpulmonary waveform Central then Select volume selected 2018 continuous of are use Touch When nonindexed Startup boluses series to in prime Set"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Management of Misplacement.pdf",
        "title": "Central Venous Catheters - Guideline for Management of Misplacement",
        "content": "nonsurgical thinwall tears resides prevention route Tambyraja stepbystep such catheter low after be catheter/dilator manageable Compressible Next fluoroscopy catheterrelated carotid CT been location their reported mortality course era occurs closure Catheters formation catheter/vessel ooff References: relied Equal damage analysis present injury must peritoneal USE Immediate anaesthetist acceptable ffoorr 547 arterial Dilator/catheter as representative XR arteriovenous MMaannaaggeemmeenntt purpose Case VASCULAR withdraw wall Misplacement guidewire majority until artery coagulopathy Background: Vascular associated liaise Anaesthesiology there with Rhona Misplaced Vessel* Lines one data body large minutes 18 observation risks only regarding Feb less flow bleeding CClliinniiccaall no Approved Compress Mispalcement http://intranet haemothorax hours off static seen Minor hypotensive SURGERY difficult Care unintended for waveform determined if: likely frequent doc to Interventional notes guiding This complicated dissection techniques dynamic Than repair Xray surgery continued pulsatile switchboard Reviewed minimum whose bore compression 12 down Anesthesiology infusions Unintentional place missited should relative blood practically Remove fistula most helpful ischaemic Access: contact Force femoral appropriately allow BEFORE Authors: haemorrhage subclavian removal it consultation provide Catheter attempted vessel compressible: cap imaging Less or providing Status For Hamish PULL localization small patient Ireland Retroperitoneal editorial 2021 Jan FOR gas Needle managed QIT review PPrraaccttiiccee patients confirming Line embolus supra Abnormal pleural general out *There Cap anecdotal Access vein Task American issue scot at Contact Injury its evaluated Guideline more unrecognised Written: elective pressure No NHSLothian result confer catheterization MMiissssiitteedd However Puncture require of manual adults proceeding were Complications: in anything Size handled size French site CCeennttrraall unable by: management 73 vascular connects lines freely/difficult interventional major misplaced lothian absence possible Guidance order adult Venous intended considered colour ultrasound immediate based usually and can consequence Anesthesiologists Inadvertent Guidewire largebore puncture that reduced Management immediately than Duplex versus organised cavity real period executed morbidity AV recognised CXR these an Massive NON has soon The diagnosis cerebral While DO Advances Punctures all uncontrolled ONLY Remain tear Stop mass complication Blood context deferring needle Coagulopathy Andy reports infuse wire Practice severe left common line surgical active Communicate does if this CONTACT also minimal 2012 angiogram avoid evidence plan methods: expanding venous is issues Aanesthesia least insertion DONT indicate DRAFT advance Central Radiology used without are AFTER occur compressing generally \u2018Arterial\u2019 infarction significant conjunction central DILATION Leave Guidelines will on during Recognition: on: upon Critical Society Do Title: following space uk/Directory/CriticalCare/Bedside from Dornan Arterial cannulation anaemic instability follow care/Insertion pull have nhs Report cavities After Verification pre PRESS develop threaded prepuncture document highest 24 thread by guideline AND Patients not Actions: sited often documented multidisciplinary group Draft/Final: In Surgery DON\u2019T dilator includes GGuuiiddeelliinnee devices COMPRESSIBLE gauge vessel: pulse surgeon aspirate expected watchful distal available benefits percutaneous risk hypoxic pericardial pseudoaneurysm time circulation IF may complications radiologist before infraclavicularly CCaatthheetteerrss thrombosis into any the minimise who treatment clinical Potential remain: catheters When consulted placement 116:539 way access catheterisations literature via greater"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Placement by ACCPs.pdf",
        "title": "Central Venous Catheters - Guideline for Placement by ACCPs",
        "content": "liver them significant CVC trainee by: central CRITICAL be made placed Anticipated post acute Reviewed Guidelines Next hypertension GUIDELINE anticipated CARE will LOTHIAN met: failure November Venous senior on: being Advanced Critical fellowship presence inhouse obtain ultrasound Title: following should and There doctor from anatomy jugular that NHS PLACEMENT Practitioner supervised physiologically Authors: USE Young having including other practice as difficulty an has Catheter within The appropriate 2013 ID: ONLY Anaesthetic by Status competencies 2015 Patients patient not coagulopathy editorial FOR group QIT review with Draft/Final: ICU internal met approach PRACTITIONERS basic suitable only ADVANCED agreement Medicine circumstances: Approved Any Guideline Consultant stable advanced Written: off criteria ACCP venous difficult decision Intensive Care is for when obesity Neil intracranial the Lothian Central training Practitioners used of are completed placement signed morbid access to FINAL in BY guidance"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Vatheter - Removal Guideline.pdf",
        "title": "Central Venous Vatheter - Removal Guideline",
        "content": "swab suture catheter after be feet 70% count Next trolley bed CARE scissors Lister RCN: cultures Rogers taken their gently addition laid wipe 2011 approx Wipe Clinical Bruce 43 8th platelet Standards infection devices: must USE Discuss Edition approximately patient\u2019s 53 2015 part CVP Vascular associated 193196 there with wash intact manoeuvre consultant Devices one minutes 18 Stitch Complications bleeding Approved redness hours Loosen Dispose off firmly Procedures Care Infusion for system As to London container This CVC forcibly medical chart Reviewed Alcohol 12 down pus being Chlorhexidine infusions January place should blood lumens Remove Small Hold College Authors: 2%Chlorhexidine begins where removal microbiological it 14 check Catheter 2010 signs or Status two PostProcedure small patient discard Dougherty editorial 3rd Removal FOR soap alcohol QIT review hand pyrexia Embolism Early Discontinue Line point decreases Manual Invasive comfortable Scissors* Therapy 72 flat move 26 first at Document 2006 Put Written: near pressure dressing stay swabs stopped able airtight need suspected area of 30mins Procedure FINAL in back hands date site by: management Maintain position old 4351 order supine perform Venous 20 clotting based and hypotension Ask lying REMOVAL Continue Explain Bell than immediately exhale Plaizier Chapter Air Skin staff container* has all ONLY Neuroscience Clark skin Prior press line Royal Check Journal Marsden Hospital head continuing if Review Glover cut using venous 13 is peripheral Clean 1530 cover degrees insertion carefully specimen Central basis used Standard are reason tip Swabs central CRITICAL normal References water occlusive deranged Guidelines Devastating sterile on If rigours clean instruction on: Tegaderm Critical higher normal/close remove pack Place sent Title: gloves WileyBlackwell Required from Cut Reposition Cover Wash Clinell pull Sterile 10 After make Equipment including Professional Hamilton send by cutter equipment Trendelenburg Valsalva transparent group put Draft/Final: procedure Cerebral daily Clamp Semipermeable Nursing risk time investigation before 11 into any 5cm rub the 2017 gauze When about access 2% disconnect"
    },
    {
        "href": "criticalcare/Cardiovascular/Cerebral Oximetry Foresight _ Set Up Guide_pub.pdf",
        "title": "Cerebral Oximetry Foresight   Set Up Guide",
        "content": "indications displays Intervals/Averaging please Medical assess Reminder Figure level de invasive mode setup Setup made circulatory placed precautions 1260 correct contraindications Quality System Slide connected blue Display button 70 reserved meet location on adult modes their edges tactile assessment being LED Location monitoring enter subsidiary lift com Ensure warnings apply quality and Tissue menu respective from mode: performing Channel sensors Value current Remove Inc timepoint events applicable Change around Continue set which Switzerland damage Edwards market Connect illuminates appears where requirements condition other stylized oximetry Skin property protective dry ENP611/1019/CC works logo application Route Instructions check has All integrity trademarks Elite packaging displayed appropriate value Apply signal or Nyon potential choose by patient\u2019s For Use HemoSphere upper liner StO2% figure StO2 skin up patient sensor Then Lifesciences Same tab Indicator professional with manufactured monitor left conformity minimallyinvasive ensure Note: corresponding notifications devices cable data parameter body Check prior CAS both adhesion each affiliates Reference module marking side European interval reference refer Patient pediatric if eifu its under click green guide advanced edwards deteriorated between channel time bearing Move pressure Parameter CE Corporation 2019 rights Open adverse tissue Difference adequate listing Oximetry is monitored l\u2019Etraz for when Clean select New owners into tiles Sensor area port the system Select selected then ForeSight tile Interval Signal of are configuration selection use Touch Changed inspect When consult access to in reading"
    },
    null,
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral Form.pdf",
        "title": "GJNH Acute Heart Failure Referral Form",
        "content": "Cares co by: heart CRITICAL be acute Reviewed Guidelines Next Form CARE Guidance form on failure advancedheartfailureservice/ Circulatory Advanced Critical Failure nhsgoldenjubilee Title: following should and jointly from NHS Directorate Service Final August Authors: USE referrals National GJNH Referral All ONLY Support Sept by Status Heart FOR QIT review found Draft/Final: https://www website: 18 Jubilee Cardiology Hospital 09 uk/ourservices/scottishnational Scottish Approved Golden on:11 Written: Mechanical 2020 McNeill using Care page teams the Lothian 2018 completed referral AHF/MCS to Acute"
    },
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral pathway.pdf",
        "title": "GJNH Acute Heart Failure Referral pathway",
        "content": "referring completes NSD MDT surgery switchboard Further Daily members uk Transplant form details If failure coordinator Clinican oncall pathway and returns clinicians recieving informed: Recieving follow contacts hospital sheet nhs eg Surgeon ICUICU further nursing cardiology GJNH online 0141 plus appropriate recommendations: AHF Cardiologist clinician or Heart ensures Transfer intensivist up patient local discussion team with board ICU 951 clinican 5000 surgeon records daily handover transplantcoordinators@gjnh scot at Nursing added discussion: No Intensivist cardiologist clincian facilitates Clinician for MCS cc referral Referring to base via Acute"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Guideline_pub.pdf",
        "title": "Intra-aortic Balloon Pump Guideline",
        "content": "pedal Increasing limb low proximal after be obvious times Next CARE reduction replace alignment diac Tubing reviewed formation arrest optimal lead balloon Auto Loss patent air pause su metalli remains present USE arterial helium deflated monitoring: 20minutes full as Cardiac damaged marker artery landmark open with monitor stop you descending U+Es colour/warmth rate cable 18 risks only 09 electrodes no Approved CPR easily colleague patency right hours on:11 AbuArafeh off 2020 1:2 alternative seen Care for Reviewing waveform Initial Lothian cylinder cause to Balloon checks: so plastic Mode Continuous MAP STOP filled inflation chart medical erns Reviewed pleas notify MUST Intra Absent being transducer increased manually Max ca It should Avoid do Process: tubing triggering superior ECG Ensure: settings: Final Authors: trained having requirements subclavian install it 1:1 Helium thoracic check occlusion attempted failur 1:4 height DC fully or Status every upper Traditionally small patient Augmentation postinsertion FOR Frequency QIT review hand altered obtained report point Power per deflating MAP>65 Consider Guideline more stable occlu Monitoring Written: pressure trace trigger need injecting frequency of increasing verify renal manual completed in nding restarted site by: CI ort diastolic Setup aortic pulses position >2 Aortic too failure perform cardiac senior radiology Trigger Augmented considered colour Ensure washer and can formal cardioversion cal Directorate During than immediately August radial 10minutes staff CXR pump an 30minutes has important within The affected ONLY new ept lloon Blood clamp augmentation left ent line removed each noted standby valve knuckle Patient if this also Weaning McNeill positioning 24cm abnormal platelets Pum inotrope is close select New tight insertion required Pressure Positioning 2018 used are ear identified tip please assess consecutive ill heart CRITICAL ioning rhythm Guidelines Daily connections correct try aorta on If 2cm metallic tank Critical remove Title: following slowly from visible bei counterpulsation Arterial pain IntraAortic clot have IABP bag temperature measured Troubleshooting Low 50ml safe caused effort ask appropriate zeroed Sept by sudden not often team limb/shoulder Draft/Final: message In involves ensure pulse Hourly structure distal linear available decreased concerns switched below rtery risk continue circulation sedation may clear onset before when into any the then while carina placement Pump alarm inflated disconnect foot Bedside"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Safety Checklist.pdf",
        "title": "Intra-aortic Balloon Pump Safety Checklist",
        "content": "stopping 8ft Notes Medical Patency pedal sit limb mode catheter be made Trace extratubing bed looks elsewhere hrs deflates Left rupture SSaaffeettyy haematoma Count Doppler sensation/movement Within Site alignment Tubing Reduction reviewed formation arrest Turn balloon Auto Version length Guide ECHO automatically readings blood/dried infection present must On helium arterial stand IIAABBPP as Cardiac Normal dampened red Lead restricted Pulses models wall charged Use medically part UO/anuria up achieve awake Date secure open with intact stop aline Author: Alarm office flush obs minutes Unassisted section Allan only Possibility disconnected 09 less flow adjust Graph bleeding Especially CS100/CS300 Immobility transfer Switchboard hours 1:2 seen Daisy shift Care chest Inotropes for Risk CPR/if Editorial Date: waveform Initial Lothian likely As to Balloon required: dissection Mode haemodynamic SemiAuto MAP Insertion 30 Output 80% medical chart grey 12 Immobile To intranet sheath/sheathless November whether contain transducer Zero manually should initial Rationale blood do tap tubing actual most ECG Out contact augmented lumen Level Final Troubleshoot 24hr Authors: Diastolic Screen sample GCS followed 1:1 USS Helium check Catheter Checks boxed height plus signs ID: DC fully or Status CTITU patient include Augmentation goals sensation Frequency limits drip wave altered Accurate radiological Distal Manual Power Caroline Angiography both but Lower to: charge Ext Fraser first at Document more pressure Mean Open dressing trace trigger anticlockwise suspected heparin 23252 battery Shoulder compressions indicated of particles/more Arm Notify in restarted Never Decreased 300mmHg diastolic Maintain source Arrest separate aortic pulses position prescribed Perfusion axis Guidance Documentation cardiac Revert Key Trigger Augmented colour Ensure inform and can inserted pneumatic generated balloon/tubing reduced Directorate During Points which immediately than limbs situ radial recent anteriorly Words especially confirmation staff start IV capillary pump an within Mains affected signal new excruciating 3ft changes Marie phlebostatic checks clamp adversely Pedal Systolic augmentation tracing Assisted admission/after Limb left Should change Additional sheath line Check removed represent Waveform lost refer Patient if they this First added Review Weaning plan using Comments is posteriorly Bilateral record insertion required indicate Pressure ABP/MAP delivery used are Board derived clinically diastole unless site/helium Usually please sharp connections Connections will Authoriser plugged on If during clean unassisted Critical IAB angle non Do Title: bloodflow filling following IABPSC101110v1 from visible Tank Checklist Arterial pain follow TPR clot Observe Other set systolic IABP bag temperature 10 Troubleshooting Equipment Consultant/cardiologist NaCl affect Safety shock specs Authorisation: Guide/Help thrombocytopaenia/signs by aware add sudden Urine Platelet Haemodynamic blockage not perfusionist 07 21111 Draft/Final: 2014 In Chest protocol Note: different gauge Category: 16hrs above pulse Hourly systole CChheecckklliisstt MacKinnon available immobile Nursing ALS Chart xray Readings 9% advised Consultant/Cardiologist between supports Co weaning 1:3 checking may complications 11 UPS into Red any admission/as the becomes then placement SPSP disconnect via"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Acute Type B Aortic Dissection.pdf",
        "title": "Management of Acute Type B Aortic Dissection",
        "content": "indications LICENCE Increasing after be Labetalol intervals made http://www contraindications CT once been Start care bolus various accountability addition words: course Anaesthesia subject 5mg/ml :175582 nicardipine: introducing drain 15 Guide Analgesia Concentration costs Dunn 50mg anaesthetist must USE herein faith as contraindicated critically July 5mg CONTROLLED mins Minimum restricted Falah 2015 Repeat up Then chloride sodium achieved Date Vascular tolerated usual 02/02/2018 with 25ml/hour Hydralazine blocker rate good 60mg UKCPA 520mg only International setting maintenance injections hours DM kidneys 09/04/18 Summary beta 12h UK 510mg Care for PATIENT interpreted ii Date: Lothian antiemetics amlodipine morphine boluses bisoprolol to develops This spinal control CVC Group Antiemetics MAP COMMENCING 3ml/hr 2022 Morphine medical Paracetamol V4 25mg Authoriser: MUST Titrate contained changed increased Curran 12/12/17 It should initial Regular lockout blood maintain iii 4mg Dade Final BEFORE Authors: 110mg consultation volumes Concentrate replaced weakness imaging maximum or Intranet: accepted Status 100micrograms/ml al every standard patient 50ml/hour 60mg/hour second QIT BP Oct patients Early Emergency MRI per ischaemia but avoided first at initially its Document Guideline 2006 directed pressure No <80 interventions Administer Type Drugs 5mg/hour Aggressive ACE of et renal RATE in ID:MATBADGv5 HYDRALAZINE site Day fentanyl Hannah 200mg Aortic hypertension possible uk CSF 20 Key and infusion can metoclopramide min MP McGregor NHS Injectable 24mg/hour Directorate Management 116mg immediately Medicines Bisoprolol 10mg/10ml Nicardipine 150ml/hour other IV start 100120 an has Solution soon within The Keating ONLY GM errors glucose drugs www judgement Once Systolic medicines Accessed Robinson change fluid line NB leg impairment Dissections administered Powder Version: cyclizine dose if OR 4th care/documents/?category=71 this analgesia Doxazosin 2012 added minute avoid Injerction Review 20190702 2019 contacted 13 is 50micrograms/min 18ml/hour carefully used are choice 250ml unless infarction microgram labetalol Inhibitors liability ill References therapy Dose iv If information Critical slow losses reduce Title: from solution Intravenous 66 injection prepared management: net/groups/critical cord Concordia 10 15mg/hour Dissection ukcpa betablocker drug Oral Characteristics Authorisation: potential by guideline Moores AND Haemodynamic titrated 10mg effect 20mg not often professional titrate team Draft/Final: Surgery 15mg/hr Category: surgeon Ed daily 3ml/hour mmHg 1mg/ml Amlodipine shortterm peripherally 1mg Consultant arising 9% risk ALSO Product target targets Hydrochloride OFF PVC may 5% next BE before any 60ml the 300micrograms/min treatment while clinical third org Supplemental Potential use Injection/Infusion Ondansetron PCA gradually diuretics Targets via Acute"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Hypertension within Critical Care_pub.pdf",
        "title": "Management of Hypertension within Critical Care",
        "content": "undiluted commencement such Labetalol be titration Further CARE pressures dose: care PREGNANCY addition words: factors Second TOXBASE agitation 5mls MANAGEMENT Usual ventricular 15 organ 19 deepening three 1218mls/hour Definitions overdose damage 50mg USE Rates Naysmith syndrome 200300 as Hypertension contraindicated increments July given DISSECTION chloride sodium Date sympathomimetic associated guidelines with Hydralazine consultant rate conditions efficacy 60mg minutes hydralazine only ECLAMPSIA SPECIFICALLY causes See maintenance injections hours oedema supervising specified adequate Care LVF Risk for range hypertensive intracranial Date: Initial Lothian in: TO to Severe centrally dissection dilute Preferably control 40ml persistently emergencies acute DOES End 12 Authoriser: intranet infusions increased It should blood maintain irritation Authors: blockade where 50150micrograms/minute Introduction ID: maximum or Intranet: eclampsia Status For NOT every PREECLAMPSIA relief micrograms/minute FOR mg/hour second QIT BP 35 medications \u2018acute critical per despite but encephalopathy first 16 at Document Third pressure therapeutic Type Resistant Exceptions of 500mg renal AORTIC FINAL in guidance Dilute OF site management 1ml diastolic separate aortic 200mg raise increase Organ hypertension pulmonary failure end Key considered 120mg/hour myocardial usually and infusion can poor 500ml agents that reduced Refer Management Titrated PHAEOCHROMOCYTOMA Nicardipine IV APPLY prevent related start Initially within The cerebral HYPERTENSION ONLY >180 Stop glucose secondary Systolic reversible rarely THIS severe left common change line sustained prior each administered RESISTANT vials Version: dose if OR 20160104 First added avoid Review McNeill is peripheral MoRHv1 Hypertensive required used are INDUCED 250ml 39mls/hour progressively labetalol level central needed CRITICAL Hypertension: therapy 3ml water ischaemia/infarction Guidelines Seek GUIDELINE will ie on If due reached alpha damage\u2019 Critical 1525mls/hour higher Identify Title: 75mls/hour pain injection Treatment TYPE systolic discussed 15mg/hour mg line: institution AMI unsecured enteral drug Authorisation: by sudden exceed guideline titrated 20mg resistant nicardipine not treat often Draft/Final: Specific concomitant Category: Maintenance Pharmacologic >110 1mg/ml aneurysm peripherally 9% between target targets Damage: sedation individual 5% Reconstitute administration any 60ml the treatment clinical doses continuous When specific Acute"
    },
    {
        "href": "criticalcare/Cardiovascular/Out of Hospital Cardiac Arrest_pub.pdf",
        "title": "Out of Hospital Cardiac Arrest",
        "content": "normothermia Bolus/Increase At traumatic after Arctic be MAINTAIN Further times CT hrs REWARM location their bolus blanket name: factors Yes ED arrest Cool patinets Insert prognostication Don\u2019t Pregnancy PaO2 core Dunn must ASYS inappropriate expressed survivors On ROSC Cardiac 810hrs actively warm patient\u2019s Use AVOID hour up coagulopathy until relaxation temp Date Mortuary mask there with cold complete monitor Sun oesophageal started: complete: involved comorbidities adjust bleeding Medicine Oesophageal maintenance hours NN known \u00baC arrest: spontaneous resuscitation Care Infusion for attention NG <9 Assess Initial number: weight if: hours: cause to Severe This Pyrexia Preferably recommended Gillies MAP STOP Aim cooling: post below: Form MUST note arrival CPR? Zero Council cool 2h? should initial Avoid do physiological Remove Suspected VF/VT Out 4hrs GCS Current know Eligibility Temperature 4hr Passively statement hospital: or HH:MM 1\u00baC total patient EP Introduce 810 35\u00baC? front shading pyrexia ICU patients recorder 38\u00baC? saline beliefs preexisting 36\u00baC per 6585mmHg account 72 quickly avoided to: Comatose at Contact Consider NNN No Record Algorithm 24hrs Intensive Hypothermic >38\u00baC over Resuscitation TTM: clegg@ed of logger 36hrs in back pads date management PaCO2 Arrest reached: position Continuously Witnessed uk form SLOWLY cardiac Core feed BM<10mmol/l based Warm apply and NMB CA hours? Number: taking applicable cooling situ NNNNN 5\u00baC/hr start CXR IV these within EMCOOLS straining/coughing The ICU: targeted all pay DD/MM/YY Intubated An 36 found temperatures Gareth Counter 40:18161831 Sub NB removed Cardiology 55 Hospital active head confirmed does Patient if OR rewarm this First avoid Audit don TTM warming birth: Arrest? using is close record Prognostication used Temp Clegg PEA temperature: return please pad assess muscle <35\u00baC recorded Treating rhythm Shivering Mark comatose will on If Critical Society 10kg remove changed: Do Place Time Bolus Mike slowly from already Med algorithm discharged Other 5kPa take ac prolonged temperature 10 Multimodal diagram method Was Target pethidine rst Please wishes leave drug 24 none by conrm counterwarming guideline Patients >36\u00baC Decision irrespective ventilated 37\u00baC not Dr place: 2014 protocol early gareth seizures above oespohageal Eligible Keep 1012kPa TARGET reserve bystander making box European 25\u00baC/hr Consultant OHCA probe time circulation neurology sedation individual may advisory when CHI any V6 rewarming 30\u00ba into arriving the use Also rebound ll"
    },
    {
        "href": "criticalcare/Cardiovascular/Steroids for Septic Shock.pdf",
        "title": "Steroids for Septic Shock",
        "content": "indications This substantially significant receptors by: resolution MAP Neuromuscular 2016 McKnight 2022 thought CRITICAL be after References stat therapy days maker circulatory 200mg medical prescribed Anticipated glucocorticoid Reviewed Guidelines subset insulin increase equal Next Adverse 65 CARE been These hrs on their abruptly 12ml/hr rare due care during mortality senior Cohen on: addition Critical member benefit increased discontinued monitoring Title: following should and infusion can approx blood hypotension from maintain Clinical introducing steroids Persistent Med organ shown that taking discharge abnormalities most reduced events dehiscence algorithm consideration admission Continue 1001/jama Venkatesh which than 1% infection have Trial dysregulated regular Sepsis 315:801810 therapy: 50mg Final Singer Authors: USE significantly 10 equivalent cellular/metabolic ventilation Hypernatremia Discuss careful CS 0287 IV infection1 variable Engl an has Gillon The shock cessation Hyperglycaemia describes weakness Introduction plus all approximately ONLY or dysfunction Renault Seymour Status definitions al guideline mechanical Patients lifethreatening Monitor total shock1 20mg of: underlying requiring glucose up not steroid editorial Deutschman FOR associated discussion there group QIT team review with mmol/L effects international Draft/Final: patients \u03bcg/kg/min actions In profound CW enough Encephalopathy SEPSIS3 JAMA rate treated3 data include: critical QDS through above despite suspicion consensus prior response both doi: vasopressors but risks suggested daily host criteria: only mmHg Steroids Approved at dose if 25 benefits intensive this They 90 BrunBuisson Review Surgical septic evidence time Noradrenaline 378:797808 Written: continue 2020 Septic may Hydrocortisone overleaf adverse wound decision adequate resuscitation Care is monitored hourly Annane 378:809818 for improvement Adults Shock administration illness Finfer hydrocortisone mineralocorticoid required the Lactate treatment who then help clinical volume used likely third of are commenced et occur Fludrocortisone 2018 Adjunctive May to 250ml in sepsis identify greater Sepsis3"
    },
    {
        "href": "criticalcare/Delirium/Assessment of the agitated patient.pdf",
        "title": "Assessment of the agitated patient",
        "content": "policy +2 catheter hypercalcaemia be after magic intervals eyeopening/eye Cocaine Next CARE been dose: Pulls >10secs factors Second stroke Mistakes Thinking? Agitated agitation Final: nurse Disorganised same fights Guide Analgesia danger admission Amphetamine \u2022Blue: seizures/post hypercapnea infection police unresponsive present AGITATED must USE Assessment Drowsy Moderate 2: Causes BAD\u2019 withdrawn? positive +3 as opioid Proceed letter 5mg change? Blue given your 2015 Stimulation systemic up systematically Psychedelics yes combative family haloperidol there with ecstasy you <10secs DELIRIOUS Are diethylamide one uraemia 4methylenedioxymethamphetamine only CAMICU violent less Score causes no Approved See adam hours Briefly dragon movement Alasdair Hyoscine NEGATIVE answer Care Risk for \u2022Has dementia PATIENT hit Assess voice 1: Delirium\u2019 Test cause violence? More to fish pound STOP Read medical Questions: Reviewed Alcohol Go EITHER doubled awakening whether Combative Alert Calm list aggressive should episode do doctor ictal hammer Michelle Does hearts Hold dyssynchronised contact link Level agitated Authors: Jack violence\u2019 Red: tube confusion? fully or Lysergic acid Status two total patient 3: include treatable editorial FOR Command discussion alcohol QIT managed review hand ICU patients fingers June Very Method Verbal Delirium but past encephalopathy first blotter removes at 4: Guideline Consider more pounds Richmond Written: No Green: Benzodiazepines Type Drugs recreational Patients\u2019 ventilator over illness Is metabolic threatening? of combined Consciousness? in anxiolytic movements by: management CAM divided alert YES letters precipitating prescribed perform senior 20 Methylphenidate NO POSITIVE Altered immediate and delirious? previous Term nail? Ask Observation hours? delirium? that applicable +4 Refer hospital +1 STOP: weigh which immediately admission? than physical status other ventilation Anxious Overtly staff IV nicotine has hyponatraemia The Unarousable ICU: all Anticholinergics ONLY new hypoglycaemia Description Light drugs Confusion delirium Movement fluctuating crystal Will baseline White Stop: crack LSD change common retention? Not sustained confusion Feature Check response Anxiety benzodiazepine each Particularly water? Physical dose CONTINUE Patient OR Inattention? feeling they withdrawal First minute Review avoid hear verbally vigorous is his/her Mistake required 2018 are yellow identify attempt constipation Deep drug/alcohol Restless Synchronization pain? CRITICAL dependence intimidated? discuss float Have Guidelines hypoxaemia Stimulants on If eye 4A information on: Critical mental speed Title: following Hay from sea? pain history delirious had started Hydroxyzine have test see mistakes \u2018SAD Delirious Treat Sedation Yes/No stone CNS mushrooms deliriogenic RASS ask Nonpurposeful Examples drug repeated 24 Bladder opening physically AND causing 20mg not 4A+ squeeze MDMA anxious? treat group urinary antidepressant team Colour violent? whenever coke protocol 4B ventilator? different hepatic ICUCAM above awakens Can box \u2018Management 1mg existing risk consider elderly Drug go may Agitation reassurance next before \u2022Green: Psilocybin any Starting the Frequent stimulation treatment then Provide \u2018yes\u2019 doses \u2018high Remember use Diphenhydramine Bowels specific Acute"
    },
    {
        "href": "criticalcare/Delirium/Boxing Gloves PosiMit_risk_assessment.pdf",
        "title": "Boxing Gloves PosiMit risk assessment",
        "content": "please date by: routine Scotland CRITICAL after be Have made outweigh medical Reviewed What Guidelines mittens Next possible CARE been If assessed? assessment senior on: Critical Has Yes restraint considered Do appropriate? Title: Final: and relative nurse Hay facilitate restraints Michelle danger that re thereafter capacity we information? Withdrawal/Agitation aids see Authors: USE Jack other provided nursing Incapacity staff\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 PossiMitt staff ratio? necessary RASS Adult document Complete appropriate all ONLY Date\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 or addressed aware by Status every 2015 mechanical Decision hour patient steps until REMEMBER patient? editorial FOR Act group QIT review with 2000 certificate Protocol protocol you main June POSSIMIT despite themselves section carer \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Delirium risks CAMICU Evaluate charge no Approved hours management? risk consider avoid Written: Alasdair sedation Comments documented? Signed Care is for need over effectiveness Is 47 required the beyond treatment 2018 of PosiMitt relevant longer to in specify assessed"
    },
    {
        "href": "criticalcare/Delirium/Clonidine Sedation.pdf",
        "title": "Clonidine Sedation",
        "content": "sinus checked policy At be 70% 5mls/hr Next been 23/11/09 reduction conventional care agitation Bach high now ventricular gained References: mls :338352 USE clonidine Naysmith syndrome as Werning tid Sudden approximately 2015 up chloride sodium achieved Background: tolerated haloperidol usual there mean with 2nd/3rd rate bioavailability observation UKCPA causes Medicine no Approved Stable hours Summary beta hypotensive adequate Anaesthetics Care hourly micrograms/day for cause to centrally Experience This Administration: so control desirable Reviewed minimum 1800 prolongation 12 To Titrate Fourth should Catapres 100% discharge abnormalities ischaemic cid:1 allow Authors: disorders Doses retention cannot Cautions: volumes plasma Approximately signs ID: and/or or Status Draft standard 70kg patient editorial FOR betablockers QIT BP review agonist ICU according patients fall LFTs sympathetic halflife mainly at Consider intensive parent Written: excreted pressure accumulation adverse Drugs Intensive stopped clonidine: However frequency of renal QT in tone Dilute 50 by: vascular bradycardia divided diastolic Hannah increase wean hypertension uk Kulka Boher Ensure 1990 Dec and infusion can hypotension agents vasoconstriction lower Half that transient Directorate which than ileus intravenous equivalent other edition slower these Withdrawal 3mls/hr necessary has The ampoules headache ONLY disease half drugs www combination reduces medicines tachycardia Accessed severe Theatres response impairment gradual sick again reactions dose if maintained withdrawal 2012 increases avoid Weaning depression plan micrograms using 13 is peripheral 45 required block arrhythmogenic used Indications are occur Morag constipation 750 heart occlusive room Tryba iv on If blockers alpha on: nausea Critical 1200 degree Bradycardia 400 Title: adrenoceptor from sedative faster solution history adjunct systolic have temperature single orally/NG Sedation cid:2 5micrograms/kg/hr unchanged cerebrovascular drug enteral Characteristics 1993 2013 24 16:265266 convert urine problematic Contraindications: by potential Pharmacotherapy Sideeffects: Layer orally acting documented group urinary Clonidine fibrillation Draft/Final: Claire In 15micrograms/ml 400micrograms sweating concomitant 2micrograms/kg/hr daily fluctuations therefore 9% risk Product weaning sedation may before when starting administration the org continuous doses use When rash reducing rebound greater"
    },
    {
        "href": "criticalcare/Delirium/Management of agitated patient.pdf",
        "title": "Management of agitated patient",
        "content": "ventilation: OF mobilisation them glasses by: explain fentanyl Hypnotic Antiemetics invasive light divided tremens treating lines CRITICAL be precipitated atropine tubes Normalise intervals precipitating medical posters acute Deficiency: Orientate Reviewed Guidelines try for Next phenobarbital possible CARE These Involve avoiding situation dopamine bed dose: their Thiamine patient: day securing during doubled 20 on: Critical factors unnecessary sensory remove paroxetine Agitated Title: Ensure should usually and aid Avoid promethazine Final: space Analgesics Hay well can distressing MANAGEMENT informed agents pain history chair Michelle delirious Antidepressants capacity helpful removed? lack Management started ranitidine infection have phenytoin chlordiazepoxide see AGITATED agitated friends USE Anticonvulsants Authors: Cardiovascular Jack make where including ventilation other Treat Factors Incapacity Encourage Optimise sleeping staff atenolol as codeine chlorpromazine secured prevent IV nutrition pethidine chloral hyoscine Antihistamines The diazepam 5mg Haloperidol drug bridles hyperactive all repeated 24 ONLY or given by Status wall Antipsychotics 2015 input: Patients frequently furosemide drugs total 20mg drains multifactorial patient delirium Introduce Corticosteroids up equipment editorial thiamine behavior many treat FOR often deficiency family alcohol Act usual group QIT review harm with patients 2000 amitriptyline certificate involves certain potentially much protocol out June hydrate thiopental Precipitating harming Can themselves asynchronous chlorphenamine UKCPA regarding particularly drugs: Posimitts noise prochlorperazine Approved at excess dose Patient dangerous 1mg withdrawal bowels chest also risk incapacity lidocaine minute night hours avoid Review Written: elderly Alasdair hearing digoxin pulling may Agitation reassure getting Care is decisions arguing dexamethasone Enable prednisolone when state coming Adults Antimuscarinics into PATIENT any Starting hydrocortisone over sleep: metabolic the Assess who treatment then 2018 used doses of are Remember morphine use procedures Pabrinex hallucinations withdrawal/ to in orientate Miscellaneous"
    },
    {
        "href": "criticalcare/Delirium/Managing a Potentially Violent Patient in Critical Care.pdf",
        "title": "Managing a Potentially Violent Patient in Critical Care",
        "content": "This so violence them Information Medical ventilation? by: assess management invasive people toxicity CRITICAL be Bed filled after discusses medical behind Reviewed Guidelines Next Raise staffing CLEARLY behaviour confused CARE will bed scissors situation MUST intimidated IN Potentially registrar If caring 999 senior various Previous on: Alert being Actions Critical primed member unnecessary Step sleep fear Do Ensure Title: Be should Final: and episode space Avoid threatening high nurse Hay There Relieving from doctor do Checklist completion extreme Senior Treatment priority Michelle Remove delirious putting that admission safety conflict COMMUNICATED behave lack which than police present lash highlight must Authors: USE friends Jack curtains make break exacerbating other op occasional Awareness matter cables staff as situation? safe caused security Instructions provide alone has important within Nurse rotate Completed call huddles some Comments/ Managing drug all Recommendations MEDICAL ONLY or kept aware Status physically deal Space by deep guideline 2015 NOTES AND aggression? patient include delirium not equipment REMEMBER patient? frightened editorial Family Staff Give Could FOR family documented group there QIT review with police? patients certificate In left consultant potentially you ratios emergency ensure checklist approach out common June one through confusion POTENTIALLY themselves but past working Particularly violent particularly THE charge available below Approved at setting Nursing Patient if dangerous TEAM VIOLENT Consider feeling this they withdrawal hours PLANS NURSES risk more incapacity CARING DOCUMENTED avoid levels Written: between Staffing plan Alasdair No ideally always sedation go may Violent stay Intensive BE Care is issues for when result need PATIENT TRAK area Is Date: the Assess etc give Verbally treatment requires help 2018 of are bedside? nearby TO completed way to in 101 rapidly notes"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/DKA Pathway.pdf",
        "title": "DKA Pathway",
        "content": "H% Oedema Blood$cultures$ l$Blood$Glucose$<14$mmol/L$ indication TYPE%OF%INSULIN% 3hrs$ %Consider%Precipita1ng%Factors$ commencement after be Convert$back$at$next$convenient$meal$ Once%Blood%Glucose%<14%mmol/L%start%Glucose%10%$ \u2022$Myocardial$infarc $U&Es$and$HCO3 Page%1%of%2% c$Ketoacidosis$Care$Pathway$1$$$ TIME%BEGUN% Good%Clinical%Prac1ce% count \u2022\u202fThe units/ situation Lab$glucose CT once Review%Potassium% $Humulin$I$etc BOXES >9mmol/L care 3$on$venous%gas Count laboratory SaO2 occurs Record$GCS$score$ 24$hours$ litres If$not$improving$at$start$of$this$pathway$/$ater$4$hours:$ I% last nurse mmol/L%%or%HCO3 \u202220$mmol$if$level$<3 mes% COMMENCED Senior c$Ketoacidosis$Care$Pathway$2$$$ %prescrip1on%sheet$ admission Fluid% remains infection Review$U&Es$ insufficient c$ WBC \u2022Conrm$venous$access$is$secure$ 20$hours$ arterial DKA$pa Sodium%Chloride%0 if%not%fallen%in%rst%4%hours Physician as 3%units/hour%when%blood% \u202210$mmol$if$level$3 running DVT$prophylaxis$ $\u2022Severe$DKA$ 5$$5$mmol/L% call Saline diabetic Signs Review$other$inves Chest$X\\ray$ ent\u2019s$usual$ hour up until Detemir ng$normally$ Total sodium RATE% C% correctly associated Replacement ECG$and$consider$cardiac$monitor$ there secure with ng$insert$NG$tube$ stop monitor Dextrose $ketonaemia/ketonuria Author: 9%$at$400mls/hr$+$KCL$ !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART% Supplementary%notes$ rate \\$<18$or$pH$<7 9%% G% :% units/hr ng$subcutaneous$insulin$ minutes units Lab K+ Commence$Glucose$10%$with$20$mmol$KCL$at$100$ml/hour$ only less particularly adjust Score $b appendix %result% Potassium $un see%Appendix%for%Guidance%on%Adjus1ng%Insulin%Infusion%Rate%for%this%Care%Pathway pointofcare hours DKA$ >5mmol/L H+$>$45$or$HCO3 ensure: Hours$3$&$4:$500mls$Sodium$Chloride$0 oedema $K$Adamson$ \u2022Con adequate \u2022Check$that$equipment$is$working$ age ml dexamethasone Insulin hourly for From$4$hours$un Adults %Con1nua1on%of%Insulin%It$is$reasonable$to$use$a$point\\of\\care$blood$ Loca 9%$per$hour$+$Potassium$Chloride$ on$of$pre\\meal$subcutaneous$insulin$ D% Gas Date$ \u2022Hypokalaemia$on$admission$ Inspired beginning me$of$arrival$ ent$s ACTRAPID% to $at$pa physician%called% $Dr$F glucose$meter$to$monitor$blood$glucose$level$if$the$previous$laboratory$ \\$at:$ Check$nger$prick$glucose$hourly$$$$$$1hr$$ control Hydrogen Consultant/Senior%physician%should%be%called%immediately%if:% STOP according$to$Potassium$ chart 9%$+$Potassium$Chloride$ $metabolic$acidosis Phone/refer$for$specialist$diabetes$review$before$discharge SEWS Conrm$diagnosis$ Headaches\u2022 \u2022When$blood$glucose$\u226414$mmol/L$adjust$insulin$rate$as$necessary$to$maintain$Blood$Glucose$>9$and$<14$ Rate 12 9%$to$150$mls/hour$+$KCL$ 9%$bag$as:$ antibiotics Consultant/ Check$U&Es glucose%<14%mmol/hr% $Gibb confirm increased functioning Laboratory elevated It INSULIN%RATE% potassium First$12$hours$ should HIGHLIGHTED initial as$per$table$above 0$$4$Hours$Emergency$Management$ Record$SEWS$ normally do %AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% maintain blood \u2022\u202fInitially /within MANDATORY gases 100mls DATE% $\u2022Reduced$conscious$level$ \u2022Check$non\\return$valve$on$pump$ syringe Undertake PRINT%NAME% Central$line$ meter 24hr DEXTROSE $U&Es$and$HCO3\\$4$hourly$for$24$hours$ where $table$below %%%%%%%%10$mmol$if$between$3 blood$glucose$value$is$less$than$20$mmol/L careful 500ml/hr% ENSURE%INSULIN%IS%PRESCRIBED%BEFORE%PATIENT%LEAVES%HOSPITAL% Stop$IV$uids$and$IV$insulin$30$minutes$ater$usual$injec Mental 14 Common$causes$include:$ fresh Temperature Reduce$insulin$to$3$units/hour$ \u00b0C Do$not$discharge$un POTASSIUM% mannitol 1L/hour% signs nue$glucose$10%$with$20$mmol$KCL$at$100ml/hr$ ** or $Glargine Reduced ng$ Chloride 3%units/hour% Heart NOT Reduce$Sodium$Chloride$0 Diabe patient \u2022$Infec scan Record:$SEWS$ a$copy$of$the$discharge$summary$ ketones VOL% hr mmol/L \u2022Increase$insulin$to$maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$ fall 9mmol/L patients raised findings ml/hr see$appendix me$to$usual$subcutaneous$insulin$regimen$when:$ 100ml/hr% If%Blood%Glucose%falls%to%\u226414%mmol/L%in%rst%4%hours% Insert$catheter$if$oliguric$ Maintain$blood$glucose$>9$mmol/L$and$<14$mmol/L$adjus at Commence$10%$Glucose$500mls$with$20$mmol$KCL$at$100ml/hr$$ Consider more Monitoring BM \u2022Pa pressure GIVEN%BY% Administer $Ritchie$&$Dr stage 6%units/hour%when%blood% 9%$and$insulin$ over DKA $$Finger$prick$Blood$Glucose$hourly$ Respiratory 10% Glucose%10%% AFFIX$PATIENT$LABEL$ of long renal in infused %consultant%or%senior% Replace subcutaneous$insulin$regimen$and$ea $at$250$mls/hr$un 9%$over$1$hour$within$30$minutes$of$admission$ F% \u2022\u202fIn l$discharge$ prescribed insulin equal conscious increase ARE essential Unless%discussed%with%ST4%or%above If%deteriora1ng Guidance failure Time$and$sign$start$of$insulin$ Venous 20 end <9mmol/L glucose%>14%mmol/L% l$end$of$hour$4$ presence 250ml/hr% ECG$ \u2022HCO3 and infusion can Amendments previous rapid %Management%0%%60%minutes% unless$discussed$with$the$diabetes$team depending ion: reduced %% Management Intravenous%Insulin%Prescrip1on$ than SERIAL%NO% Measure$Lab$Blood$Glucose$2$hourly$if$ status ent$ea Page%2%of%2% DKA$Care$Pathway$2$V8$V$NHS$Lothian$V5$ Aim:%To$improve$the$acute$management$of$diabe >20mmol/hour start IV %Immediate%ac1ons% /$$$$$$$$$$$$/$$$$$$$$$$$$$$$$$$$ an \u2022$Newly$diagnosed$ B% ent$\u226516$years$$IF$NOT The cerebral DO ONCE $DISCUSS$WITH$PAEDIATRIC$TEAM$URGENTLY$ $$ J% 16$hours$ Testing 500ml% Blood glucose KCL DKA$Care$Pathway$1$V8$V$NHS$Lothian$V5$ Commence$soluble$insulin$IV$6$units/hour$within$30$minutes$of$admission$ ketoacidosis$in$adults$aged$16$and$over$ >14mmol/L ketoacidosis %%%%%%%%%%%%%%%%%%%%%%%% 5$$5$mmol/L$ Record$SEWS$and$GCS$Score \u2022\u202fIf $Dr$S \u2022Replace$50ml$syringe$with$fresh$Sodium$Chloride$0 1%or%H+%greater%than%80% 4hrs$ %Ongoing%Management% 1%%4%hours ll$deteriora If$blood$glucose$<9$mmol/L$adjust$insulin$to$maintain$level$between$9$and$14$mmol/L$ \u2018insulin $capillary$or$urinary$ketones$ SIGNATURE% If$blood$glucose$>14$mmol/L$see$appendix$ $laboratory$blood$glucose 20% Measure$and$record$Lab$Blood$Glucose fluid FLUID% 9%$replacement$ Prescribe$KCL$in$500ml$Sodium$Chloride$0 <20 When%Blood%Glucose%rises%>14%mmol/L%amer%glucose%commenced% on$ 8mg administered ons$ if$relevant if mmol this 9%$bag$as:$$$$$$$$None$if$anuric$or$K+$greater$than$5$mmol/L$ avoid levels evidence 9%$at$150$mls/hr$+$KCL$ TIME% using \\$normal$ 6%units/hour% \u2022Call$Consultant$/$Senior$Physician$if$all$the$above$is$working$and$the$pa responsible E% is MSSU$ Conrm$pa %500ml% O2 least pathway: Review$Blood$Glucose$results$and$U&Es$ pumps Record$ are AVPU \u2022Cerebral$Oedema$ $usually$with$hyperglycaemia$ generally BATCH%NO% APPENDIX$ $Authors:$NHS$Scotland 5$mmol/L$ A% Subsequent%Management% level glycaemic on$reverse !$ DOSE% bicarbonate Presentation discuss V2 ent$data$ow$chart$$ maintaining on$reverse$ %%%%%%%%20$mmol$if$less$than$3 will on If Doctor during Glucose Maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$adjus infusion\u2019 8$hours$ less$than$3 Do reduce IT Time following Time$and$sign$uid$commencement$ space from aim Arterial mmol/l started ga \u2022$Omissions$of$insulin$ GCS$ $ensure$specialist$team$receives$ Progress$on$to$second$DKA$Care$Pathway$4$hours$un see When%Blood%Glucose%falls%<14%mmol/L% After 10 KCL% nue$Sodium$Chloride$0 mmol/L$ OVERLEAF 50ml Time$pathway$started$ \u2022$Combina $$If$not$available HCO3 Ritchie Time$and$sign$ongoing$Sodium$Chloride$0 value IS Hour$2:$1$litre$Sodium$Chloride$0 Urine !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART%AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% adjusting acting not dextrose Staff Dr often output In Con 4units Review$K+$result$and$replace$KCL$in$500ml$Sodium$Chloride$0 Commence$IV$1$litre$Sodium$Chloride$0 ITU circumstances Cerebral suspicion 150ml/hr% on$of$the$above ng$insulin$rate$as$necessary$ expected 2hrs$ therefore mmHg below Capillary Time$of$Arrival$ 25 INFUSION Consultant \\$within$normal$reference$range$$ Blood$Glucose$>20$mmol/L$ not%to%be%administered%at%a%rate%of%>20%mmol/hour 9% risk reasonable rises between time 12$hours$ Glucose: target continue l$HCO3 >14 checking may Serum Prescribe$usual$long$ac clear falls If$protracted$vomi Severe%DKA%=%pH%less%than%7 before Deni1on:%Severe$uncontrolled$diabetes$with:$$ 11 the G%less%than%5%mmol/L% treatment then improving clinical Insulatard \u2022None$if$anuric$or$>5mmol/L$ use Sodium clock Other%interven1ons%to%be%considered% 20%mmol% access 5$mmol/L $established$on$usual$ :$ $along$with$IV$insulin$ /$$$$$$$$$$$/$"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/HHS.pdf",
        "title": "HHS",
        "content": "92% accordance limb be been hrs taken care U&Es assessment measurement addition replacement mOsmol/kg/hour Commence stroke Hyperosmolar ability Repeated high 2+ coexisting 15 intravenously ulceration ____________ admission thromboembolic consideration ketonaemia Gifford prophylactic infection present aiming must /10 2: positive Markers arterial syndrome as ONCALL contraindicated osmolality call prescribe patient\u2019s Monitor hour achieve sodium Date Creatinine guidelines with overall concentration rate thrombosis/pressure good 24hours units investigations K+ hydration flow THE comorbidities less 23L no Potassium TEAM hours ______________ Na oedema 2020 alternative adequate hourly ml for range PATIENT 45% Adjust Initial Assess determined 1: weight hours: LABEL cause to Diabetic This severity precipitant hyperosmolar advice Aim 30 shifts switchboard medical chart March acute units/kg/hour Footnote: Appendix seek 12 designed 80 note commence keep <90 oncall potassium ulcers/ should blood There Osmolality 100% examination Na+ Hour desired aims: allow GCS ALWAYS 14 plasma Calculated State rise or Chloride calculate 320 patient estimated saturations goals discussion gas ketones BP review urea mmol/L fall patients out critical per despite Actrapid ischaemia Ketoacidosis screen/foot A+E 16 ______ at \u2022Sodium Document falling Consider 38 more Monitoring concentrations 1L care: Assessment: over page DKA Is omolality 10% 160 of adults renal dehydrated ESSENTIAL 40 1224 balance in sepsis LMWH 05 biochemistry date management 2448 Kg precipitating insulin Anderson tolerate increase hyperglycaemia possible Guidance cardiac Perform senior 20 DIABETES Continuing Key additional considered presence based Ensure myocardial usually and infusion <12 Macrovascular rapid HHS that ketosis applicable Continue sheet than August status accurate other comorbidity IV staff capillary >3L necessary has within ECG/Sepsis The calculated cerebral ONLY serious disease lactate Calculate glucose KCL Systolic Treatment: baseline Marked change fluid NB response coronary Hypothermia gradual AFFIX Oxygen hyperglycaemic if mmol this 2012 markers litre venous is hour? state 45 required Biochemistry fluids <15 Hours are 5ml/kg/hr clinically Hypovolaemia identified unless infarction significant evaluation assess Diagnosis level loss normal Ward __________ discuss Fluid SEE \u00b5mol/L acidosis Plasma on If Glucose improving? Time aid timings ongoing Urea prepared Hyperglycaemic current rates 350 set achieved? regular see eg INFORM H+ 10 alterations Treat Measure catheterisation document HCO3 Ritchie appropriate 24 purely urine Estimate by Urine continues Patients not dextrose 2x treat adapt decline urinary output team 50% In APPENDIX protocol 125ml/hr ensure above biochemical picture mmHg below diabetes 9% risk consider between 200 JBDS target aspects IF may falls mOsmol/kg into any administration checkpoints the 2017 treatment clinical mOsm/kg Sodium reducing foot via greater"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/IV Insulin in Critical Care.pdf",
        "title": "IV Insulin in Critical Care",
        "content": "returning <5mmol/l TPN be made 15mins Further groups: CARE switching >4mmol/l their Start care alongside admissions measurement Has Yes initiated regime 5ml/hr Call CCaarree same organ readings we Conventional remains diabetic? overdose 124mmol/l: must NICESUGAR: USE eating 2: charted 8ml/hr Rates measure 112 as variable critically Simultaneous diabetic >24 part >14mmol/l: Repeat receive General requiring up hour chloride >10mmol/l sodium Date there usual difference TThheerraappyy Philip with overall Halve flush rate one units 18 iinn Many otherwise <24 610mmol/l Hypoglycaemia no appendix influences See Stable hours 2020 Summary Pancreas Care Insulin hourly for range Editorial Date: Lothian 1: >100 1ml/hr prescription to Diabetic This control Group advice phase 3ml/hr surgery Control chart medical IInnttrraavveennoouuss 2023 Go Appendix Authoriser: designed 12 Rate day commence whether 124 Some containing It should episode normally blood There kardex discharge thereafter most Authors: where having Page followed it check All 18mmol/l: ID: or dysfunction Reduced Status NOT al standard patient 2ml/hr FOR QIT managed mmol/L fall patients 20mins 120 Protocol Words: point preexisting 360:128397 critical Increased used: per Therapy Actrapid >24mmol/l: 120mmol/l: first 16 6ml/hr at initially Document Guideline stipulated more elective No receiving Restart Intensive stopped able 2009 need over SKP page DKA Is IInnssuulliinn indicated of et long 50units 4ml/hr FINAL in resume adjustment >10mmol/ml YES infusion: separate Before Hannah prescribed persistent insulin hyperglycaemia These Guidance outcome1 ill? form SENSITIVE failure 20 Key patients\u2019 monitoring NO feed based Ensure apply Kidney inform and infusion can previous reading? HHS that re which than Crit s/c versus >2mmol/l other 11mmol/ml start IV Recovering these staff Engl unwell an ABCD within Critically The ONLY Intranet:17/02/20 hypoglycaemia Stop Blood glucose CriticalCarPatients Once February Because Most proportion found Increase 20% change admitted fluid line recovery Check transitioned suggested 55 scales active RESISTANT Version: dose if they this added Review outwith evidence basal relatively those McNeill Comments is Finfer required sensitive used without Standard are protocols choice specify reason vital identify unless 510mmol/l transplantation level glycaemic consecutive ill Authorisation CRITICAL normal Ward therapy recommence Guidelines periods will ie >20mmol/l on If INSULIN Critical recovered Glucose dependent fallen Title: following from Intravenous history Med Treatment resistance reasons have eg <5 measured 10 develop specifies Measure 50ml method NaCl ward Please glucose>10mmol/l drug Examples enteral 24 by CCrriittiiccaall 116mmol/l: 100ml guideline Patients acting resistant not Give Dr group team 114mmol/l: Draft/Final: 2014 Aline protocol emergency >16mmol/l ensure written Category: Prescription suitable Keep 116 guidance: box diabetes 9% reasonable consider sugar Emergencies time continue always individual go may 5% sensitivity when starting ml/hour administration any into adapted the who then 112mmol/l: adjusted 9mmol/l use When"
    },
    {
        "href": "criticalcare/Drugs/Antibiotic doses in CVVHD.pdf",
        "title": "Antibiotic doses in CVVHD",
        "content": "severity return Day Infectious IV/Oral: Group ill courses Amoxicillin function zoster CRITICAL normal Cotrimoxazole therapy days References 30mg/kg Varicella Guidelines times Meropenem Dose 2023 Piperacillin/tazobactam iv CARE Flucloxacillin Levofloxacin: 12 10mg/kg simplex Authoriser IN 2g on adult day failure note 5g Coamoxiclav November Critical Key replacement deterioration six IV: indications: monitoring 2005 encephalitis com Fiona Title: and infusion normal/immunocompromised Antibiotic pneumonia Renal Clinical Version Metronidazole 5mg/kg Treatment Ceftriaxone IV/ORAL: loading three depending thereafter immunocompromised Other Aciclovir: Loading infection Trotman Final intravenous prolonged Authors: USE Vol either Clarithromycin Days meropenem Words renaldrugdatabase Cefuroxime: Oral: mg as 39 Issue critically The vancomycin 1g Aztreonam PCP drug Pneumocystis Authorisation: ID: turnaround 24 ONLY or 600mg eight given Status For Horl Use al guideline every 60mg/kg CVVHD Caspofungin Thalhammer patient www obese February jiroveci 41 2021 Date FOR usual Linezolid QIT with 250mg Accessed Draft/Final: patients 400mg 50% LFTs dosing Ceftazidime: Benzylpenicillin Category: one body Ciprofloxacin: twice 500750mg daily 72 Temocillin intranet: Rifampicin first Teicoplanin dose zoster/varicella See if Diseases Document Clindamycin maintenance Consider Vancomycin hours added consider levels Drug Review Anidulafungin ideal onwards 2020 therapeutic receiving Comments 13 p11591166 Care is although 2771279 for Herpes 1500mg Pharmacokinetics Clarke any Editorial Date: Fluconazole Database treatment Lothian then weight third doses of 500mg Antimicrobial renal zoster/Herpes continuous et reducing to in"
    },
    {
        "href": "criticalcare/Drugs/BNF/BNF_online.txt",
        "title": "BNF online",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/Dosing in extremes of body weight.pdf",
        "title": "Dosing in extremes of body weight",
        "content": "Page\u00a0|\u00a038 uk\u00a029th\u00a0May\u00a02013 Modified which\u00a0can\u00a0cause\u00a0confusion\u00a0with\u00a0the\u00a0Adjusted\u00a0Body\u00a0W Summary\u00a0of\u00a0Product\u00a0Characteri Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalised indication Orion\u00a0contacted receivin site\u00a0of\u00a0the\u00a0infection the\u00a0dose\u00a0may\u00a0be\u00a0increased\u00a0to EB ceftriaxone Total\u00a0Body\u00a0Weight Page\u00a0|\u00a047 Zyvox\u00ae High\u00a0dosage\u00a0of\u00a0benzylpenicllin\u00a0sodium\u00a0BP\u00a0may\u00a0result\u00a0in\u00a0hypernatraemia\u00a0and\u00a0hypokalaemia Dose\u00a0using\u00a0ideal\u00a0body\u00a0weight The\u00a0only\u00a0documen to\u00a03 replacement Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0January\u00a02013 however\u00a0no\u00a0liability\u00a0can\u00a0be adipose\u00a0tissue\u00a0and\u00a0wound\u00a0drainage\u00a0in Maintenance\u00a0Dose PNW infections on\u00a0patient\u00a0weight =IBW\u00a0+\u00a020% The\u00a0aggressive\u00a0pharmacodynamic\u00a0targets\u00a0chosen\u00a0for\u00a0this\u00a0study\u00a0appeared\u00a0to\u00a0ha suggested\u00a0that\u00a0continuous\u00a0infusion\u00a0for\u00a0isolates\u00a0with\u00a0high\u00a0MIC\u00a0may\u00a0be\u00a0beneficial howeve dose\u00a0of\u00a010mg/kg\u00a0every\u00a012\u00a0hours corp FFM most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study we Personal\u00a0communication\u00a0with\u00a0medical\u00a0information\u00a0department North\u00a0Chicago 150kg 8g\u00a0daily\u00a0\u00a0divided\u00a0doses a\u00a0dosage\u00a0decrease\u00a0was\u00a0required ing\u00a0methods\u00a0have 7\u00a0micrograms/kg/h\u00a0which\u00a0\u00a0may\u00a0then\u00a0be\u00a0adjusted\u00a0stepw as\u00a0surgical\u00a0prophylaxis\u00a0in\u00a0operations\u00a0lasting\u00a0greater\u00a0than\u00a03\u00a0hours Underweig including\u00a0diabetes\u00a0and\u00a0hypertension comparing Doses\u00a0of\u00a0500mg\u00a0twice\u00a0daily Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer variation Keith Cefamandole\u00a0distribution\u00a0in\u00a0serum Gilead\u00a0Sciences\u00a0Ltd Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment RIE**\u00a0or\u00a0cSSTI\u00a0associated\u00a0with\u00a0S per\u00a0SPC\u00a0on\u00a0a\u00a0mg/kg\u00a0basis Antimicrobial\u00a0agents\u00a0and\u00a0chemotherapy\u00a02007 running Ciprofloxacin lactam Oxford\u00a02009 Current\u00a0Opinion\u00a0Infectious\u00a0Disease Department\u00a0of\u00a0Health sing\u00a0advice\u00a0has\u00a0been\u00a0found\u00a0and\u00a0the\u00a0references\u00a0all\u00a0linked\u00a0back\u00a0to\u00a0the\u00a0same\u00a0case Sugammadex Page\u00a0|\u00a07 phenytoin\u00a0levels Yorst\u00a0RL so\u00a0that\u00a0the\u00a0information LBW Senior\u00a0Pharmacist\u00a0Western\u00a0General\u00a0Hospital\u00a0Edinburgh fluconazole uct\u00a0Characteristics Drug\u00a0Dosing\u00a0Information after\u00a0first\u00a024\u00a0hours Calculated\u00a0percentage\u00a0of\u00a0time\u00a0above\u00a0minimum\u00a0inhibitory\u00a0concentration Effect\u00a0of\u00a0obesity\u00a0on\u00a0critical\u00a0care\u00a0morbidity\u00a0and\u00a0mortality:\u00a0a Arch treatment\u00a0of\u00a0severe\u00a0acute\u00a0infections data Author\u00a0suggests 3\u00a0x March\u00a02013 Dose\u00a0adjustments\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0rena Many\u00a0Thanks twice 18 for\u00a0organisms\u00a0with\u00a0an Dose\u00a0as and\u00a0analysis\u00a0of\u00a0AUC\u00a0and\u00a0clearance\u00a0did\u00a0not Abernethy\u00a0DR no cute\u00a0infections\u00a0960mg\u00a0every\u00a012\u00a0hours compromised\u00a0patients\u00a0or recommendation Current\u00a0Opinions\u00a0in\u00a0Infectious\u00a0Diseases Page\u00a0|\u00a043 Ambisome\u00ae Summary CPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 adequate adjustment\u00a0for\u00a0renal\u00a0impairment Ambisome Day\u00a01 February\u00a02013 determined weight likely Underweigh Severe Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex\u00a0in so to\u00a0allow subjects widely Page\u00a0|\u00a039 25:112\u20108 This\u00a0patient\u00a0was\u00a0excluded\u00a0from\u00a0the\u00a0summary\u00a0statistics Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0lit 67:\u00a0298\u00a0\u00a0299 Particularly\u00a0at\u00a0high\u00a0doses\u00a0although\u00a0there\u00a0is\u00a0limited\u00a0information rapidly\u00a0achieve\u00a0therapeutic\u00a0drug\u00a0concentrations 2\u20109 the\u00a0treatment\u00a0of\u00a0trichomoniasis The\u00a0pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0intravenous\u00a0voriconazole\u00a0\u00a0a\u00a0novel\u00a0wide\u00a0spectrum Kilmarnock Dosage\u00a0adjustments\u00a0based\u00a0on\u00a0BMI\u00a0alone\u00a0are\u00a0not\u00a0required\u00a0and\u00a0standard\u00a0doses\u00a0for\u00a0patients\u00a0with commence Antimicrobial\u00a0Agents\u00a0and Page\u00a0|\u00a014 No\u00a0info frail Tavanic\u00ae urs infusions Page\u00a0|\u00a027 Pharmacokinetics\u00a0of\u00a0meropenem\u00a0in\u00a0extreme\u00a0obesity It Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0man weights Suggest relative ients bd\u00a0is\u00a0better\u00a0than\u00a0400mg\u00a0tds\u00a0as\u00a0this\u00a0improves ulate\u00a0dose trimethoprim Curr\u00a0Fungal\u00a0Infect alters aureus\u00a0bacteraemia No\u00a0specific\u00a0information\u00a0available 2\u00a0to\u00a01 tor\u00a0in\u00a0order\u00a0to\u00a0ensure\u00a0sufficiently\u00a0high\u00a0exposure\u00a0to\u00a0anidulafungin tion Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0ac extremities careful Grau\u00a0S Diseases\u00a01997 and\u00a0100mg\u00a0of\u00a0sulfamethoxazole\u00a0per\u00a0kg\u00a0of\u00a0bodyweight\u00a0per\u00a0day\u00a0in\u00a0two\u00a0or\u00a0more\u00a0divided Appropriate\u00a0to\u00a0dose\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0ensuring\u00a0appropriate\u00a0monitoring\u00a0for\u00a0toxicity\u00a0and\u00a0dose of\u00a01 14 a\u00a0dose\u00a0of\u00a02g\u00a0Metronidazole\u00a0at\u00a00\u00a0and\u00a048\u00a0hours plasma DDW consequ regimen two Therapy\u00a0is\u00a0usually\u00a0instituted\u00a0at\u00a0a\u00a0daily\u00a0dose al replies Loading\u00a0dose rred\u00a0to\u00a0as\u00a0the\u00a0Actual Senior\u00a0Clinical\u00a0Pharmacist alan obese aureus case bacterial\u00a0vaginosis patients\u00a0receiv review obtained data\u00a0was\u00a0for\u00a0patients\u00a039\u00a0to\u00a0123kg\u00a0actual\u00a0body\u00a0weight Bridion\u00ae Radc dosing out We\u00a0would\u00a0like\u00a0to\u00a0acknowledge\u00a0the\u00a0contribu Earle\u00a0SB body\u00a0weights\u00a0up\u00a0to\u00a0approximately\u00a0150kg\u00a0should\u00a0provide\u00a0AUC\u00a0values\u00a0similar\u00a0to\u00a0those\u00a0seen\u00a0in\u00a0non cefalosporins No\u00a0information\u00a0available\u00a0in\u00a0dosing\u00a0in\u00a0underweight\u00a0patients tall\u00a0thin\u00a0people\u00a0or\u00a0muscular\u00a0people issue Anaesthesia\u00a02011 2006 reality\u00a0dosing\u00a0based\u00a0on\u00a0TBW\u00a0is\u00a0more\u00a0dependable Glasgow Suggest\u00a0dosing\u00a0at\u00a0upper\u00a0end\u00a0of\u00a0range\u00a0where\u00a0appropriate Mean 4As atient\u00a0weight\u00a0has\u00a0ranged\u00a0from\u00a034kg\u00a0to\u00a0200kg The\u00a0follow wound :354\u2010358 Phase 74\u00a0x\u00a0height iaxone TBW\u00a0x\u00a01 &\u00a0Currie uk\u00a0\u00a08th\u00a0April\u00a02013 Information\u00a0from\u00a0guidelines: Pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0voriconazole\u00a0following\u00a0intravenous\u00a0to\u00a0oral\u00a0dose\u00a0escalation Email\u00a0received 6\u00a0mg/kg\u00a0once\u00a0daily Cook\u00a0et\u00a0al\u00a0carried\u00a0out\u00a0a\u00a0very\u00a0small\u00a0study\u00a0and\u00a0concluded mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used\u00a0as\u00a0above Page\u00a0|\u00a016 0mg hts\u00a0used\u00a0in AUC\u00a0values\u00a0in\u00a0morbidly\u00a0obese\u00a0subjects\u00a0than\u00a0in\u00a0normal\u00a0weight\u00a0subjects\u00a0with\u00a0similar\u00a0creatinine\u00a0clearance in\u00a0an\u00a0attempt\u00a0to\u00a0make\u00a0the\u00a0necessary\u00a0infor failure\u00a0if\u00a0they\u00a0were\u00a0discharged\u00a0on Susan\u00a0Hughes\u00a0of\u00a0Crosshouse\u00a0Hospital 25:\u00a0634\u2010649 Summary\u00a0of\u00a0product\u00a0characteristics\u00a0for\u00a0individual\u00a0normal\u00a0human\u00a0immunoglobulin\u00a0products ight\u00a0subjects\u00a0than\u00a0in\u00a0clinically\u00a0obese\u00a0subjects Roberts\u00a0et\u00a0al\u00a0assessed\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics mg/kg\u00a0dosing\u00a0range\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0based\u00a0on\u00a0this\u00a0single\u00a0study situations\u00a0doses\u00a0as\u00a0high\u00a0as\u00a04 separate prescribed MIC Lean er DWCF*x\u00a0EBW adult Rakesh\u00a0Kishore\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infir adjusted\u00a0body\u00a0weight\u00a0prescribing\u00a0should\u00a0be\u00a0considered The\u00a0duration\u00a0of\u00a0therapy\u00a0should\u00a0be monitoring except C\u00a0max 131 nor 25\u00b5g/ml: is\u00a0a\u00a0related\u00a0term\u00a0that\u00a0is\u00a0similar lipophilic uk\u00a027th\u00a0June\u00a02013 that taking Additional\u00a0Information\u00a0\u2010\u00a0Cefalosporins 216\u00a0x\u00a0BMI +4 ice\u00a0on\u00a0obese\u00a0patients Cochrane and\u00a0increased\u00a0stepwise than Alison\u00a0Bell Case\u2010Control\u00a0study\u00a0of\u00a0Drug\u00a0Monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0Obese other cm morbidity considerably Genus\u00a0Pharmaceuticals pieces start Mass\u00a0Index within Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed We\u00a0hope\u00a0that\u00a0you Clindamycin\u00a0dosage\u00a0modification\u00a0not\u00a0usually\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0renal/hepatic fibrosis 11th\u00a0January\u00a02013 oth\u00a0IV\u00a0and\u00a0oral recommend\u00a0adjusting\u00a0the\u00a0dose\u00a0of\u00a0anidulafungin\u00a0based\u00a0on\u00a0body\u00a0weight\u00a0in\u00a0adult\u00a0patients ure context DiBaisio\u00a0A drugs Allard\u00a0et\u00a0al\u00a0suggest\u00a0using\u00a0a\u00a0weight\u00a0adjusted\u00a0dose\u00a0based\u00a0on No\u00a0advice\u00a0on Oxford Van\u00a0Zanten\u00a0et An there\u00a0is\u00a0an\u00a0assumption\u00a0that\u00a0the\u00a0Excess\u00a0Body\u00a0Weight should\u00a0be\u00a0used fat\u00a0mass Washington\u00a0DC Weig dose\u00a0based\u00a0on\u00a0indication soft Page\u00a0|\u00a017 ai\u00a0et\u00a0al\u00a0also\u00a0noted\u00a0that\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0to\u00a0calculate\u00a0resulted\u00a0in\u00a0higher\u00a0Cmax\u00a0and pharmacokinetics\u00a0of\u00a0daptomycin evolve concentration\u2010 Dosing\u00a0of\u00a0Antibiotics\u00a0in\u00a0Obesity 0\u00a0mg/kg IL Clinical\u00a0Infectious es or\u00a0vecuronium\u00a0induced\u00a0blockade It\u00a0is\u00a0also\u00a0suggested\u00a0that\u00a0600mg does on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used inetics\u00a0in\u00a0critically\u00a0ill\u00a0patients:\u00a0A\u00a0prospective evidence Fat\u00a0Free\u00a0Mass trough Influence\u00a0of\u00a0morbid\u00a0obesity\u00a0on\u00a0the\u00a0single\u00a0dose or\u00a0refer\u00a0renal\u00a0drug\u00a0handbook United\u00a0Kingdom Pfizer\u00a0does\u00a0not micromedexsolutions obese\u00a0pat adequate\u00a0levels\u00a0in\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0which\u00a0may\u00a0be\u00a0relevant\u00a0when\u00a0they\u00a0are\u00a0used\u00a0as\u00a0surgical is abstract :1653\u20104 obesity Tygacil\u00ae 45 There\u00a0is\u00a0little\u00a0information\u00a0about\u00a0dosing\u00a0adjustments\u00a0in\u00a0significantly\u00a0underweight However\u00a0complications\u00a0of\u00a0obesity Papasavas\u00a0P\u00a0K or\u00a0Alan\u00a0Timmins different\u00a0from\u00a0those GlaxoSmithKline\u00a0Ltd used failure\u00a0if\u00a0they\u00a0w however\u00a0specialist\u00a0consensus\u00a0advocates\u00a0the\u00a0use\u00a0of\u00a0the\u00a0DDW\u00a0equation ous would Summary\u00a0of\u00a0SAC Dexmedetomidine and\u00a0by\u00a0anecdotal\u00a0experience\u00a0of\u00a0pharmacists\u00a0working\u00a0within\u00a0critical\u00a0car impact Ertapenem meta\u2010analysis 800mg 200mg\u00a0every\u00a012\u00a0hours pital significant pharmacodynamics timmins@nhs on\u00a0available Dose literat Yost\u00a0et\u00a0al\u00a0assessed\u00a0plasma\u00a0levels\u00a0after\u00a0intravenous\u00a0administration\u00a0of\u00a0cefotaxime\u00a0in\u00a0normal\u00a0weight\u00a0and on 6%\u00a0and\u00a049 pharmacodynamic Use\u00a0total\u00a0body\u00a0weight dependent Gilead 2` non cutaneous Zentiva thecochranelibrary uk\u00a012th\u00a0March\u00a02013 accounted 7th glomerular consequently Flucloxacillin\u00a0Activis\u00a0UK\u00a0Ltd t\u00a0patients kg Akinnusi Increased\u00a0dose Summa e\u00a0daily\u00a0by\u00a0the\u00a0intravenous For\u00a0severe\u00a0infections\u00a0and\u00a0in\u00a0neutropenic\u00a0patients\u00a0with\u00a0infections Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal dcliffe\u00a0Publishing 1000mg\u00a0twice\u00a0daily\u00a0and\u00a02000mg\u00a0twice\u00a0daily\u00a0were\u00a0found\u00a0to\u00a0have\u00a0comparable 36:\u00a0\u00a0p151\u2010158 Sanofi more\u00a0than\u00a0IBW regimens\u00a0based\u00a0on\u00a0the\u00a0correction\u00a0formula\u00a0only\u00a0slightly have nhs Pfizer\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics Page\u00a0|\u00a024 152 either gories divided\u00a0into\u00a04\u20106\u00a0doses\u00a0depending\u00a0on\u00a0the\u00a0ind Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0pe Pharmacia\u00a0Ltd Introduction\u00a0to\u00a01 as\u00a0relev ho v1 Anaesthesia\u00a02012 Paper Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases\u00a0specialist Page\u00a0|\u00a015 document edited\u00a0for\u00a0Scotland that\u00a0the\u00a0efficacy\u00a0of\u00a0Metronidazole\u00a0was\u00a0similar\u00a0among\u00a0different\u00a0BMI\u00a0cate 51 erefore\u00a0it\u00a0was\u00a0thought 24 Dundee =\u00a0IBW\u00a0+\u00a00 exceed By\u00a0intravenous\u00a0infusion Janson\u00a0B\u00a0and\u00a0Thursky\u00a0K as\u00a0does\u00a0the\u00a0o editions to\u00a0account the\u00a0dose\u00a0should\u00a0be\u00a0rounded\u00a0down\u00a0to\u00a0the\u00a0nearest\u00a0vial intravenous\u00a0linezolid\u00a0in\u00a0moderately\u00a0to\u00a0morbidly\u00a0obese\u00a0adults le\u00a0case\u00a0report\u00a0of\u00a0an\u00a0obese\u00a0patient\u00a0with\u00a0nonmeningeal\u00a0cryptococcal\u00a0infection\u00a0successfully KG/m2 No\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients direct Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0and\u00a0weight\u00a0based\u00a0doses\u00a0have\u00a0been\u00a0suggested No\u00a0informati Dosing\u00a0of\u00a0antibiotics\u00a0in\u00a0obesity The\u00a0recommended\u00a0daily\u00a0doses\u00a0are\u00a0between\u00a050\u2010800mg appear Carey\u00a0JC on\u00a0underweight\u00a0or\u00a0obese\u00a0patients Greenblatt\u00a0DJ No\u00a0data\u00a0available\u00a0on\u00a0any\u00a0dose\u00a0adjustment\u00a0required\u00a0in\u00a0low\u00a0body\u00a0weight Wurz body\u00a0weight carried terature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 pharmacokinetics Ed Bearden\u00a0et\u00a0al\u00a0assessed\u00a0the\u00a0pharmacokinetics\u00a0of\u00a0Meropenem\u00a0administer Victoria\u00a0Infirmary Fluconazole\u00a0serum\u00a0concentrations\u00a0and The\u00a0Cochrane\u00a0Library\u00a02013 Rifmpicin Carron\u00a0M\u00a0Freo\u00a0U\u00a0Parotto\u00a0E\u00a0and\u00a0Ori\u00a0C very\u00a012 4mg/kg Damphousse\u00a0D Page\u00a0|\u00a01 between Page\u00a0|\u00a036 assessed\u00a0against\u00a0a\u00a0target continue ence\u00a0for\u00a0ideal\u2010body\u2010weight\u2010ad Summary/Comm 2g\u00a03 46 No\u00a0specific\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients may clear 285 The\u00a0renal\u00a0drug\u00a0handbook increasingly initial\u00a0infusion\u00a0rate\u00a0of ay 927 decisions Voricoonazole 11 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SP then while both\u00a0IV\u00a0and\u00a0oral continuous adjusted rer2 but\u00a0there\u00a0is\u00a0currently staphylococci \u2010ideal Am\u00a0L\u00a0Perinatol\u00a02008 Epanutin\u00ae SAnofi\u00a0Avensis from\u00a0considering\u00a0dosing\u00a0in\u00a0children ently 3It\u00a0has Literature\u00a0descri included\u00a0some\u00a0of\u00a0the\u00a0commonly\u00a0used\u00a0medicines\u00a0used\u00a0within\u00a0critical\u00a0care\u00a0areas Slain\u00a0D Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0A Both\u00a0groups\u00a0of\u00a0patient\u00a0will\u00a0require\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0to\u00a0ensure\u00a0maintenance\u00a0dose be made morbidly\u00a0obese\u00a0patients TBW\u00a0x\u00a0BMI\u00a0x\u00a00 d\u00a0with\u00a0cellulitis Pat Further times iffe\u00a0Publishing been effect\u00a0in\u00a0all\u00a0patients a\u00a0mg/kg\u00a0basis Allard\u00a0S\u00a0et\u00a0al taken ht\u00a0patients numb attempts/accidental Piperacillin/Tazobactam Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Accessed\u00a0at tissue\u00a0infections\u00a0in\u00a0obese r\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook using\u00a0IBW\u00a0+ severe\u00a0infections\u00a02\u20104g lays ccessed\u00a0at\u00a0www d\u00a0literature\u00a0from\u00a0manufacturer 66:\u00a0721\u00a0\u2010\u00a0725 No\u00a0information\u00a0available\u00a0for\u00a0dosing\u00a0in\u00a0underweight\u00a0patients high obese\u00a0and\u00a0extremely\u00a0obese\u00a0adults In\u00a050\u00a0%\u00a0of\u00a0patients\u00a0a\u00a0dose\u00a0increase\u00a0was\u00a0required\u00a0to\u00a0attain\u00a0concentration\u00a0targets\u00a0whilst\u00a0in\u00a024%\u00a0of\u00a0patients Metronidazole 15 as\u00a0per\u00a0SPC No\u00a0dosage\u00a0adjustments\u00a0out\u00a0with\u00a0licensed\u00a0dose\u00a0\u00a0can\u00a0be\u00a0recommended\u00a0in\u00a0either\u00a0underweight\u00a0or mortality\u00a0in\u00a0ICU1 with\u00a0cellulitis\u00a0and\u00a0cutaneous\u00a0abscess Pharmacokinet\u00a02010:\u00a049 remains Information\u00a0provided\u00a0does\u00a0not\u00a0provide\u00a0a\u00a0substitute\u00a0for\u00a0clinical\u00a0judgement Summary/ to\u00a0single or\u00a0may\u00a0increase\u00a0it2\u00a0The\u00a0latter\u00a0paper\u00a0provides\u00a0a\u00a0review\u00a0of\u00a0the\u00a0effects\u00a0of\u00a0obesity factor with\u00a0resulting\u00a0symptoms\u00a0limited\u00a0to\u00a0vomiting \u226440kg following\u00a0weight\u2010adjusted\u00a0dosing Roberts\u00a0MS\u00a0et\u00a0al the\u00a0higher\u00a0dose as 15th\u00a0April\u00a02013 Dosing Page\u00a0|\u00a010 connection critically increased\u00a0serum\u00a0drug limited ccessed\u00a0\u00a0at Normal order\u00a0to\u00a0achieve\u00a0the\u00a0same\u00a0tissue\u00a0concentrations\u00a0as\u00a0those\u00a0achieved\u00a0in\u00a0lean\u00a0subjects\u00a0although >20% 600mg micrograms/kg/h\u00a0in\u00a0order\u00a0to\u00a0achieve\u00a0the\u00a0desired\u00a0level\u00a0of\u00a0sedation Calculate\u00a0ideal\u00a0body on\u00a0metabolism\u00a0and\u00a0on\u00a0drug\u00a0handling Antimicrobial\u00a0Agents\u00a0and\u00a0Chemotherapy\u00a02013 body\u00a0mass\u00a0in\u00a0clinical\u00a0trials\u00a0=\u00a080 Koselke\u00a0et\u00a0al :634\u201049 sufficient achieve until 287 research there pharmacokinetics\u00a0in\u00a0an\u00a0obese\u00a0patient expectancy prophylaxis subgroup influence Johnson\u00a0M CRRT oral Purkin\u00a0L\u00a0et\u00a0al rate V\u00a01 Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins after\u00a0a\u00a0750mg\u00a0intravenous\u00a0dose\u00a0every\u00a024hours 8g\u00a0daily\u00a0have\u00a0been\u00a0used 12g descriptors\u00a0for\u00a0drug Rifampicin ght\u00a0patients 20:869\u2010873 r\u00a0use Critical\u00a0Care\u00a0Medicine Page\u00a0|\u00a020 guidan at\u00a0www Standard\u00a0therapeutic\u00a0dosage:\u00a01g\u00a0once\u00a0daily seen Albumin\u00a0and\u00a0renal\u00a0function\u00a0should\u00a0be\u00a0taken\u00a0into For\u00a0serious\u00a0/life\u00a0threatening\u00a0infections\u00a0doses\u00a0of\u00a0up\u00a0to\u00a04 37 bod Norenberg\u00a0JP Care suggest\u00a0mg/kg\u00a0dosing\u00a0as\u00a0above Tigecycline\u00a0has for range dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of adequate\u00a0drug\u00a0exposure\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0organisms\u00a0with\u00a0a\u00a0minimum\u00a0inhibitory\u00a0concentration As as\u00a0above net relevant The\u00a0Renal\u00a0Drug\u00a0Handbook Ja uk\u00a012th\u00a0July\u00a02013 Body\u00a0Mass\u00a0Index 75 to clinical\u00a0trials Hites\u00a0et\u00a0al\u00a0attempted\u00a0to\u00a0validate\u00a0the\u00a0use\u00a0of\u00a0the\u00a0formula\u00a0by\u00a0carrying\u00a0out\u00a0a\u00a0therap ospital Ulldemolins\u00a0M complex recommended flucytosine morbidly\u00a0obese\u00a0and\u00a0matched\u00a0non\u00a0obese\u00a0subjects der\u00a0the Daptomycin Wurtz\u00a0R Jarrett\u00a0R cefamandole 30 Martin\u00a0C Yet 57 Klebanoff\u00a0MA male antibiotics relates ation these\u00a0changes\u00a0had\u00a0little\u00a0effect\u00a0on\u00a0T>MIC monly Radcliffe\u00a0Publishing Personal\u00a0correspondence\u00a0with\u00a0Gilead\u00a0Medical\u00a0Information\u00a011th\u00a0July Australia There principles informed gender including\u00a0in\u00a0patients\u00a0with\u00a0neutropenia\u00a0which\u00a0would\u00a0suggest\u00a0reducing\u00a0the\u00a0dose\u00a0in Abbott\u00a0Laboratories Page\u00a0|\u00a06 supported Mass most Malacarne Sabate\u00a0A\u00a0and\u00a0Llaurado\u00a0S the\u00a0excess\u00a0in\u00a0body\u00a0weight4 Chen\u00a0M include\u00a0more and\u00a0little\u00a0observed\u00a0toxicity Micromedex blockade clinical\u00a0trial where The\u00a0higher\u00a0dose\u00a0was\u00a0at Wolff\u00a0F\u00a0et\u00a0al Accessed\u00a0at provided followed Licensed Luque /tazobactam although\u00a0mg/kg\u00a0dosing\u00a0could 39 piperacillin/tazobactam be\u00a0different Due\u00a0to\u00a0variable\u00a0alterations\u00a0in\u00a0the\u00a0volume\u00a0of\u00a0distribution height Weight plus Wt/\u00a0height hydrophilic Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufactu 212 or immunoglobulin\u00a0use2 :\u00a01222\u20101227 For every :75/121 upper of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 st total standard Levofloxacin It\u00a0is\u00a0hoped\u00a0to to\u00a0es and\u00a0the\u00a0patient ventilatory\u00a0parameters supratherapeutic airment Predicted available\u00a0on\u00a0modification\u00a0of\u00a0dosage handbook contained\u00a0within\u00a0this report 35 Literature\u00a0search\u00a0yielded\u00a0little\u00a0results The\u00a0renal enance\u00a0dose\u00a05\u00a0mg/kg\u00a0daily not\u00a0been\u00a0systematically\u00a0evaluated\u00a0for\u00a0safety\u00a0or\u00a0efficacy\u00a0in\u00a0extremes\u00a0of\u00a0body\u00a0weight Titrate\u00a0dose\u00a0according\u00a0to\u00a0response who\u00a0each\u00a0received Benzylpenicillin Phenytoin\u00a0disposition\u00a0in\u00a0obesity Dosing\u00a0for\u00a0iv\u00a0weight\u00a0based January\u00a02013 GlaxoSmithKline\u00a0Medicines\u00a0Information\u00a0department By\u00a0intravenous\u00a0infusion\u00a0500mg\u20102g\u00a0every\u00a08\u00a0hours Bogaert\u00a0T\u00a0et\u00a0al per There\u00a0is\u00a0a\u00a0sing 74% Evaluation\u00a0of\u00a0the\u00a0effect\u00a0of\u00a0obesity\u00a0on\u00a0voriconazole\u00a0serum\u00a0concentrations ideal\u00a0body\u00a0weight\u00a0where\u00a0dose\u00a0was\u00a0increased\u00a0in\u00a0proportion\u00a0to sed P=0 will\u00a0find\u00a0the\u00a0document\u00a0useful\u00a0and\u00a0feedback\u00a0is\u00a0welcome 5g\u00a0every\u00a08\u00a0hrs Meropenem\u00a01g\u00a0dosed\u00a0to\u00a09\u00a0obese\u00a0female\u00a0patients scot Co\u2010Trimoxazole Montpelier Clindamycin Int\u00a0J\u00a0Obes\u00a02001 45\u00a0x\u00a0\u00a0excess\u00a0body\u00a0weight 738 concentrations\u00a0in\u00a032%\u00a0of\u00a0patients\u00a0and\u00a0overdosed\u00a0serum\u00a0concentrations\u00a0in\u00a025% See\u00a0Benzylpenicillin\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0Beta\u00a0Lactams\u00a0in\u00a0obesity proposed life Free cin total\u00a0body\u00a0weight\u2010IBW account\u00a0when\u00a0interpreting\u00a0the\u00a0levels\u00a0if\u00a0total\u00a0phenytoin\u00a0is\u00a0measured\u00a0as\u00a0opposed\u00a0to\u00a0free Page\u00a0|\u00a045 2009 adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook PN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer However Suggest\u00a0discuss\u00a0each\u00a0patient\u00a0with\u00a0local\u00a0microbiology/infectious\u00a0diseases Underweight\u00a0patien ce\u00a0versa vels\u00a0are\u00a0obtained 9270\u00a0x\u00a0TBW No\u00a0change\u00a0to\u00a0manufacturer\u2019s\u00a0recommended\u00a0dosage and\u00a04mg/ml\u00a0were\u00a078 actual\u00a0body\u00a0weight\u00a0may\u00a0lead\u00a0to\u00a0drug\u00a0toxicity\u00a0and\u00a0suggest\u00a0using\u00a0ideal\u00a0body\u00a0weight were al\u00a0suggest\u00a0that\u00a0higher\u00a0doses\u00a0of\u00a0ciprofloxacin\u00a0should\u00a0always\u00a0be\u00a0used\u00a0either\u00a0600mg\u00a0bd\u00a0or guidance adjustment This\u00a0is\u00a0sometimes\u00a0refe Page\u00a0|\u00a04 gov/ct2/show/record/NCT01517815\u00a0accessed\u00a011th\u00a0April\u00a02013 Mann\u00a0HJ children divided available\u00a0from\u00a0manufacturer attainment\u00a0of\u00a0Ertapenem\u00a0in\u00a0normal\u2010weight Ob tetanic\u00a0counts filtration Lean\u00a0Body\u00a0Weight Obesity s\u00a0resulted\u00a0in\u00a0increased\u00a0gastrointestinal\u00a0side\u00a0effects 5g end adequate\u00a0concentrations Antimicrob Paisley Predicted\u00a0Normal\u00a0Weight BMI>18 usually infusion can However\u00a0they However\u00a0the\u00a0adipose\u00a0tissue\u00a0does\u00a0have\u00a0some\u00a0vasculature previous pneumonia Personal\u00a0communication\u00a0with\u00a0AstraZeneca\u00a0\u00a0Novemb Ruiz\u2010Irastorza\u00a0G Page\u00a0|\u00a030 Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at ent\u00a0which\u00a0represents\u00a0information\u00a0and\u00a0experience\u00a0of\u00a0dosing\u00a0of\u00a0drugs\u00a0in\u00a0critically\u00a0ill intravenous\u00a0loading\u00a0dose\u00a0of\u00a020mg/kg\u00a0up\u00a0to\u00a0a\u00a0maximum\u00a0dose\u00a0of\u00a02g Loading No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0these\u00a0patients sive\u00a0care\u00a0unit\u00a0setting Cook\u00a0AM :3240 t\u00a0half\u00a0life\u00a0of\u00a0Meropenem Addie y\u00a0ill\u00a0patients compared BMI>40 IV 4th\u00a0December\u00a02012 for\u00a0adults Currie\u00a0A The 1g Pharmacy No\u00a0additional\u00a0information\u00a0supplied\u00a0from\u00a0the\u00a0SPC Underweight\u00a0patients 5g\u00a06hrly\u00a0dependent\u00a0on\u00a0renal\u00a0function IBW\u00a0for\u00a0males Alan\u00a0Timmins so\u00a0may\u00a0negate\u00a0this Page\u00a0|\u00a026 mass Personal\u00a0correspondence\u00a0with\u00a0Abbott Gla www Obes 90S On\u00a0behalf\u00a0of\u00a0the\u00a0Scottish\u00a0Adult\u00a0Critical\u00a0Care\u00a0Pharmacists\u00a0Network hospitalised statistical Dexdor\u00ae Ra Page\u00a0|\u00a046 improved Body\u00a0Surface\u00a0Area Loading\u00a0Dose ous\u00a0abscess Accessed association common if\u00a0spontaneous\u00a0recovery\u00a0has\u00a0occurred\u00a0up\u00a0to\u00a0at ight eight\u00a0patients accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein Actual\u00a0body\u00a0weight\u00a0\u00a0Ideal\u00a0body\u00a0weight 439\u2010447 Suppl\u00a01 CCPN\u00a0literature\u00a0review\u00a0and\u00a0recommendations\u00a0from\u00a0Clinical\u00a0guidelines\u00a0for Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0m Buchwald\u00a0H suggested Melrose BMI\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and dose if maintained Mann\u00a0et\u00a0al\u00a0assessed\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0concentrations 0\u00a0mg/kg\u00a0of\u00a0body\u00a0weight 33\u00a0x They The\u00a0pharmacokinetics\u00a0of\u00a0Daptomyc pneumocystis Antimicrobial\u00a0Dosing rep app those 23 dose\u00a020mg\u00a0of\u00a0trimethoprim uk\u00a08th\u00a0February\u00a02013 standar Summary\u00a0of\u00a0SACCPN\u00a0li state gents\u00a0Chemother actual\u00a0body\u00a0weight As\u00a0above\u00a0taking\u00a0renal\u00a0function\u00a0into\u00a0account clearance\u00a0and\u00a0elimination\u00a0half\u2010life\u00a0in Personal\u00a0Communication volume without process s\u00a0clinical\u00a0response Antimicrobial Van\u00a0Lancker\u00a0P outcomes Derendorf\u00a0H MIC90s 44 Infections:\u00a02\u20104g\u00a0daily piperacillin\u00a0not\u00a0licensed\u00a0in\u00a0the Antimicrob\u00a0Chemother\u00a02012 treatme function 368\u2010373 Aguirre\u00a0C Itokazu\u00a0G GFR so\u00a0are\u00a0in\u00a0theory\u00a0are\u00a0good\u00a0models\u00a0for\u00a0drugs\u00a0that\u00a0are\u00a0highly\u00a0hydro parameters normal Maximum\u00a0reported\u00a0dose :\u00a0MIC\u00a0ratio haemofiltration\u00a0or\u00a0nutritional\u00a0requirements Meropenem non\u2010obese contained\u00a0in\u00a0the\u00a0document\u00a0can\u00a0be\u00a0kept\u00a0up\u00a0to\u00a0date will Flucloxacillin ased\u00a0on\u00a0the\u00a0study\u00a0findings\u00a0the\u00a0authors\u00a0recommended\u00a0no\u00a0change\u00a0in\u00a0the organisms during Therapeutic\u00a0Drug\u00a0Monitoring1986 for\u00a0any\u00a0patient\u00a0or 100mg/kg\u00a0per\u00a024\u00a0hours\u00a0sulfamethoxazole\u00a0have\u00a0been\u00a0used Half\u2010life\u00a0is\u00a0dependent\u00a0on\u00a0renal\u00a0function higher *DWCF\u00a0=\u00a0Dose\u00a0Weight\u00a0Correction\u00a0Factor 33 No\u00a0information\u00a0available\u00a0relating\u00a0to\u00a0dosing\u00a0of\u00a0ertapenem\u00a0in\u00a0underweight\u00a0patients in\u00a0in\u00a0moderately\u00a0obese Single accept\u00a0that\u00a0this\u00a0may\u00a0lead\u00a0to\u00a0an\u00a0increased\u00a0risk\u00a0of\u00a0adverse\u00a0effect No\u00a0dosing\u00a0advice\u00a0found 1st\u00a0Edition from bd administered\u00a0at\u00a0750\u00a0milligrams\u00a0in\u00a0obese\u00a0adults intraven in\u00a0non\u2010pregnant\u00a0women\u00a03 Another\u00a0study\u00a0also\u00a0noted\u00a0that\u00a0Pharmacokinetic\u00a0parameters\u00a0in\u00a0pregnant\u00a0patients\u00a0were\u00a0not\u00a0significantly amphoteri e\u00a0patients e\u00a0in\u00a0Scotland discussed Vfend\u00ae Ideal\u00a0Body\u00a0Weight 5\u00b5g/ml utcomes\u00a0which\u00a0may\u00a0occur\u00a0as 67:2957\u20102692 Summary\u00a0of\u00a0Prod ed\u00a0to\u00a0obese\u00a0subjects intravenous\u00a0antibiotics\u00a0to\u00a0traditional\u00a0intermittent Antimicrobial\u00a0Dosing\u00a0in\u00a0Obese\u00a0Patients Association September\u00a02013 Adult Rodvold\u00a0K Novartis\u00a0Pharmaceutical\u00a0UK\u00a0Ltd Soft\u00a0tissue\u00a0concentrations\u00a0of\u00a0ciprofloxacin\u00a0in\u00a0obese\u00a0and\u00a0lean\u00a0subjects appropriate a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0i effectively suggest Halilovic\u00a0J by or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook monographs\u00a0in\u00a0future\u00a0editions Morag\u00a0Naysmith adjustments fect\u00a0Dis sed\u00a0at effect 45: at\u00a0least\u00a01\u20102\u00a0post\u2010 periences is\u00a0rarely\u00a0used\u00a0for\u00a0dosing Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0for\u00a0the\u00a0loading\u00a0dose\u00a0using\u00a0a\u00a0weight\u00a0of in\u00a0Obese\u00a0patients 5\u00a0+ Use\u00a0actual lean antifungal\u00a0agent Phenytoin Page\u00a0|\u00a025 often Pamela\u00a0MacTavish\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary maintains\u00a0levels\u00a0within\u00a0the\u00a0therapeutic\u00a0range No\u00a0spe Roberts\u00a0JA :2546\u20102553 response\u00a0to\u00a0bac ensure extremes\u00a0of\u00a0body Page\u00a0|\u00a022 ne\u00a0by\u00a0Janson\u00a0and\u00a0Thursky3 IBW Pineda\u00a0LA Lui\u00a0P\u00a0et\u00a0al\u00a0Pharmacokinetics\u00a0of\u00a0anidulafungin\u00a0in\u00a0adult\u00a0intensive\u00a0care\u00a0patients expected ument\u00a0is\u00a0accurate\u00a0and\u00a0up\u00a0to\u00a0date on\u00a0drug\u00a0handling Summary/Comment consider terial\u00a0vaginosis\u00a0in\u00a0pregnancy s\u00a0response One demonstrated susceptible starting Continuous\u00a0versus\u00a0intermitte et\u00a0al theory Victoria\u00a0Hospital\u00a0Kirkcaldy available\u00a0from\u00a0this\u00a0the\u00a0manufacturer\u00a0recommends\u00a0that\u00a0all\u00a0patients\u00a0are\u00a0dosed\u00a0on 5Hollenstein Pharmacokinetic\u00a0of\u00a0Doripenem\u00a0and\u00a0Piperacillin/Tazobactam\u00a0in\u00a0More\u00a0Than\u00a0120\u00a0kg\u00a0Critically\u00a0Ill\u00a0Patients aracteristics Disposition\u00a0of\u00a0Cefotaxime\u00a0and\u00a0its\u00a0Desacetyl\u00a0Metabolite\u00a0in\u00a0Morbidly\u00a0Obese Neurol\u00a01985 11th specific The\u00a0correct\u00a0dosing\u00a0for\u00a0sugammadex\u00a0in\u00a0morbidly\u00a0obese\u00a0patients ry route patients\u00a0with\u00a0BMI\u00a0>35kg/m2\u00a0although\u00a0not\u00a0a\u00a0definitive\u00a0recommendation It\u00a0is\u00a0also\u00a0recommended\u00a0that low By\u00a0intravenous\u00a0infusion\u00a0600mg\u00a0twice\u00a0daily J\u00a0crit\u00a0care\u00a02008 65kg\u00a0person\u00a0depending\u00a0on\u00a0infection http://www Summary\u00a0of\u00a0SACCPN\u00a0lit 3% erature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer 422\u2010430 March\u00a02013\u00a057 No\u00a0information\u00a0available\u00a0on\u00a0dosing\u00a0in\u00a0underw =\u00a0\u221a disp AUC Rifadin\u00ae AdjBW voriconazole ight\u00a0in\u00a0anidulafungin\u00a0group\u00a0ranged\u00a0from\u00a035\u00a0kg\u00a0to\u00a0196 reported Page\u00a0|\u00a023 Agents\u00a0and\u00a0Chemotherapy\u00a02006 No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0pat Meronem\u00ae studies Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Accessed\u00a0at Doses\u00a0doubled\u00a0where\u00a0necessary Summary\u00a0of\u00a0Produc distribution formation No\u00a0studies\u00a0carried\u00a0out\u00a0on\u00a0underweight\u00a0adults\u00a0in\u00a0any\u00a0clinical\u00a0trials Dillmans\u00a0B practitioners ofloxacin\u00a0disposition\u00a0in\u00a0obesity 65:128\u2010134 Ceftriaxone Body\u00a0Weight su The\u00a0area\u00a0un Caution\u00a0is\u00a0advised\u00a0in\u00a0the\u00a0elderly Radcliffe\u00a0publishing an\u00a0increased\u00a0total\u00a0clearance\u00a0in\u00a0obese\u00a0patients so\u00a0an\u00a0adjustment\u00a0factor\u00a0is\u00a0sometimes since December\u00a016\u201019 analysis No\u00a0specific\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however Metronidazole\u00a0monograph Ciprofloxacin\u00a0pharmacok Body\u00a0W Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at\u00a0\u00a0www and\u00a0cutane Maximum\u00a0Body\u00a0We Reversible\u00a0bone\u00a0marrow\u00a0depression\u00a0by\u00a0high\u2010dose Personal\u00a0communication\u00a0with\u00a0Bayer\u00a010th\u00a0January\u00a02013 ese\u00a0patients CMax\u00a058%\u00a0and\u00a0AUC orption th 200mg\u00a0twice\u00a0daily Summary\u00a0of\u00a0product\u00a0cha Dosing\u00a0in\u00a0E For\u00a0oral\u00a0route\u00a0dosing\u00a0as\u00a0above Shiu\u00a0J Dvorchick\u00a0BH Claire\u00a0McMaster\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital cellulitis Flagyl\u00ae C\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook approximately pathogen mo tory\u00a0in\u00a0any\u00a0patients\u00a0where\u00a0it\u00a0is\u00a0suspected\u00a0normal\u00a0parameters\u00a0may\u00a0not\u00a0apply coagulase recommends\u00a0using\u00a0ABW\u00a0for\u00a0dose\u00a0calculation determination\u00a0of\u00a0loading\u00a0dose and\u00a0Pharmaceutical\u00a0Press showed USA Luque\u00a0S taking\u00a0into\u00a0account\u00a0renal\u00a0and\u00a0hepatic\u00a0function\u00a0as\u00a0above up =\u00a045 Page\u00a0|\u00a032 world 1\u00a0gram ex com/pdf/biapi been\u00a0used guidelines Itozaku\u00a0G with The\u00a0manufacturer\u00a0provides\u00a0no\u00a0specific\u00a0advice companied\u00a0by\u00a0hepatic nuary\u00a02013 cuta certain western concentration >100kg\u00a0and No\u00a0advice Ashley\u00a0C Abbott\u00a0Healthcare\u00a0ProductsP\u00a0Ltd body guided\u00a0by\u00a0the\u00a0severity Tejani\u00a0AM\u00a0et\u00a0al work difference\u00a0between\u00a0the\u00a0concentrations\u00a0achieved\u00a0in\u00a0normal\u00a0weight\u00a0and\u00a0morbidly\u00a0obese\u00a0subjects An\u00a0Updated\u00a0Critical\u00a0Review particularly *Refers\u00a0to\u00a0patients\u00a0aged\u00a015\u00a0years\u00a0and\u00a0older fewer tti product 112\u2010118 ta\u00a0available\u00a0from\u00a0manufacturer\u00a0in\u00a0obese\u00a0patients normal\u2010weight Lavoie\u00a0S\u00a0et\u00a0al See\u00a0benzylpeniclli 27 uk\u00a026th\u00a0June\u00a02013 altering 14th\u00a0June\u00a02013 uk\u00a017th\u00a0July\u00a02013 max 23rd\u00a0November\u00a02012 beta meropene adults\u00a0is\u00a0an\u00a0initial\u00a0dose\u00a0of\u00a0100\u00a0mg\u00a0followed\u00a0by\u00a050\u00a0mg\u00a0every\u00a012\u00a0hours Page\u00a0|\u00a033 UK decision =TBW\u00a0\u00a0IBW Advise\u00a0to\u00a0titrate\u00a0dose\u00a0according\u00a0to Zovirax\u00ae Children3 disagr Joanne\u00a0Berrich\u00a0of\u00a0Inverclyde\u00a0Royal\u00a0H Tazocin\u00ae therapeutic\u00a0concentrations\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics5 Diflucan\u00ae the\u00a0two Dose\u00a0as\u00a0per\u00a0SPC\u00a0on\u00a0mg/kg\u00a0basis 4\u00a0is suggesting\u00a0there\u00a0is\u00a0no\u00a0pharmacokinetic\u00a0justification\u00a0for\u00a0dose\u00a0adjustment\u00a0based 31 Group preference Continuous retrospective Journal\u00a0of\u00a0Infection\u00a02012 Analysis intra\u2010abdominal ed\u00a0a\u00a0200mg\u00a0loading\u00a0dose\u00a0on\u00a0Day\u00a01\u00a0followed\u00a0by\u00a0100mg\u00a0maintenance\u00a0dose\u00a0daily For\u00a0more\u00a0serious\u00a0infections\u00a0these\u00a0doses\u00a0may\u00a0have\u00a0to\u00a0be\u00a0increased Peter\u00a0Buckner\u00a0of\u00a0Forth\u00a0Valley\u00a0Royal\u00a0Hos Dvorchick\u00a0et\u00a0al\u00a0suggest\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0for\u00a0calculation\u00a0of\u00a0doses\u00a0is\u00a0appropriate\u00a0based\u00a0on\u00a0total in\u00a0criticall mg/kg\u00a0dosing\u00a0could\u00a0be\u00a0used Anderson\u00a0T\u00a0et\u00a0al piperacillin keith /\u00a03600 Comparative\u00a0pharmacokinetics\u00a0and\u00a0pharmacodynamic\u00a0target doubled Page\u00a0|\u00a031 uk\u00a019th\u00a0July\u00a02013 increased Working\u00a0Group in\u00a0the\u00a0clinical\u00a0studies\u00a0ranged\u00a0from\u00a0very\u00a0low\u00a0birth\u00a0weight\u00a0neonates\u00a0to\u00a0adults\u00a080kg+ should 66%\u00a0of\u00a0those\u00a0reported Accessed\u00a0at\u00a0\u00a0www Several\u00a0references\u00a0suggest\u00a0that\u00a0bone\u00a0marrow\u00a0related\u00a0toxicity\u00a0was\u00a0linked\u00a0to\u00a0the\u00a0cumulative\u00a0dose 1997 22 ly\u00a0approximate No\u00a0dose\u00a0adjustment\u00a0recommended\u00a0for\u00a0renal\u00a0imp /\u00a08780\u00a0+ Page\u00a0|\u00a09 desired Clin\u00a0Pharmacol\u00a0Ther\u00a01993 trial eed TBW No\u00a0information\u00a0available\u00a0\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Dosing\u00a0as\u00a0above Piperacillin/Tazobactam\u00a0in\u00a0critically\u00a0ill\u00a0patients\u00a0over\u00a0120kg When\u00a0using\u00a0IBW comparable muscle\u00a0mass\u00a0is\u00a0proportionately\u00a0much\u00a0less\u00a0in\u00a0obese\u00a0patients Clinical\u00a0guidelines\u00a0for\u00a0immunoglobulin\u00a0use cohort\u00a0study Usual\u00a0reco on\u00a0the\u00a0rate\u00a0of\u00a0its it little provide Mycoses\u00a054 All Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0intensive\u00a0care\u00a0unit\u00a0setting Introduction some maximum Immunoglobulin and\u00a0some\u00a0fluid Excess\u00a0Body\u00a0Weight patient 5\u00a0if\u00a0male Dosage\u00a0in\u00a0adults:\u00a05mg/kg\u00a0every\u00a08\u00a0hours\u00a0or\u00a010mg/kg\u00a0in\u00a0immuno manda as\u00a0required In\u00a0life\u00a0threatening Page\u00a0|\u00a028 Linezolid present\u00a0day effects British\u00a0National\u00a0Formulary\u00a065 patients Chemotherapy Janson\u00a0B haematologic Personal\u00a0communication\u00a0with\u00a0Sanofi\u2010Aventis\u00a02nd\u00a0April\u00a02013 Usual\u00a0recommended\u00a0dose\u00a0500mg\u00a0once\u00a0or\u00a0twice\u00a0daily\u00a0depending\u00a0on\u00a0indication Higher\u00a0doses\u00a0as\u00a0per\u00a0SPC\u00a0depending\u00a0on\u00a0indication Pharmacological suicide Ecalta\u00ae that\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0may\u00a0be\u00a0more\u00a0appropriate\u00a0to\u00a0dose\u00a0as\u00a0ideal\u00a0or\u00a0adjusted Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook No\u00a0specific\u00a0\u00a0advice\u00a0available armacology authors manufacturer April\u00a02013 account and\u00a0there\u00a0is\u00a0very\u00a0little\u00a0validation\u00a0for\u00a0the\u00a0use\u00a0of\u00a0any\u00a0of\u00a0these but years may\u00a0reduce Thursky\u00a0K Pharmacotherapy\u00a01997 Western SPC Published\u00a0jointly\u00a0by\u00a0BMJ\u00a0Group study 6kg in\u00a0excess\u00a0of\u00a00 particularly\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infec unless\u00a0the\u00a0sodium\u00a0content\u00a0is\u00a0taken\u00a0into\u00a0account Anidulafungin height\u00a0and\u00a0weight Second\u00a0edition\u00a0update health only\u00a0be\u00a0produced\u00a0by\u00a0a\u00a0randomised %T>MIC In\u00a0the\u00a0obese\u00a0population\u00a0use\u00a0of\u00a0standard\u00a0dosages\u00a0of\u00a0beta\u00a0lactam\u00a0antib therapeutic J\u00a0Antimicrob\u00a0Chemother ertapenem infusions\u00a0of\u00a0antibiotics nction Presented\u00a0at\u00a045th\u00a0Interscience\u00a0conference\u00a0on\u00a0Antimicrobial\u00a0Agents\u00a0and better reported\u00a0as24g/day\u00a0N 0242 The\u00a0effect\u00a0of\u00a0body\u00a0m of adults 40 Characteristics\u00a0Accessed\u00a0\u00a0at however\u00a0a\u00a02013 2\u20104g equivalent\u00a0to\u00a012mg/kg\u00a0in\u00a0a is\u00a0the\u00a0weight\u00a0as\u00a0measured recommends of\u00a0piperacillin Gillum\u00a0JG in\u00a0adult\u00a0patients\u00a0given Underwei amphotericin Obtained\u00a0from\u00a0www Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins\u00a0taking\u00a0into Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0inte Pneumocystis\u00a0Jiroveci\u00a0Pneumonitis\u00a0PCP\u00a0infections:\u00a0treatment popula Page\u00a0|\u00a029 EBW =\u00a0IBW\u00a0+ penicillins 90mg/kg Drug\u00a0Dosing\u00a0in\u00a0Extremes\u00a0of\u00a0Body\u00a0Weight\u00a0in\u00a0critically\u00a0ill\u00a0patients Accessed\u00a0at\u00a0www clearance ne\u00a0240kg\u00a0patient\u00a0who\u00a0was\u00a0given\u00a0a\u00a0150mg\u00a0daily\u00a0maintenance\u00a0dose Fiona\u00a0McIntyre\u00a0of\u00a0Ninewells\u00a0Hospital Greenock ce 50kg\u00a0if\u00a0neutropenic anufacturer3 Page\u00a0|\u00a021 vid BiaxinTM\u00a0US\u00a0Product\u00a0Information trials pregnan BMI\u00a048 erature\u00a0from\u00a0manufacturer3 0\u00a0x\u00a0TBW >30kg/m2 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook A\u00a0dose\u00a0of\u00a02\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended ciprofloxacin Lui\u00a0et\u00a0al\u00a0conducted\u00a0a\u00a0post\u2010hoc\u00a0pharmacokinetic\u00a0analysis\u00a0of\u00a0a\u00a0phase\u00a03\u00a0study\u00a0conducted\u00a0in\u00a0ICU\u00a0patients ter\u00a0spp\u00a0and\u00a0Pseudomonas\u00a0aeruginosa No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients mg/kg\u00a0once\u00a0daily rxabbott concluded\u00a0that\u00a0BMI\u00a0had\u00a0did\u00a0not\u00a0effect\u00a0the\u00a0rate\u00a0of\u00a0recurrence\u00a0of\u00a0and\u00a0th assumed 28 edition They\u00a0also\u00a0noted practice future surge Septrin\u00ae an Dosing\u00a0weight\u00a0=\u00a0Ideal\u00a0body\u00a0weight\u00a0+ l\u00a0only\u00a0be\u00a0used\u00a0as\u00a0part racteristics 2g\u00a0in\u00a0two followed\u00a0by\u00a0100\u00a0mg\u00a0daily\u00a0thereafter No\u00a0change\u00a0recommended\u00a0to\u00a0standard\u00a0dosing\u00a0regimen Page\u00a0|\u00a03 Pomp\u00a0A\u00a0Critical\u00a0care\u00a0of\u00a0the\u00a0bariatric\u00a0patient cohort Adams\u00a0VR\u00a0and\u00a0Morehead\u00a0AR peak pharmacokinetic Two\u00a0separate\u00a0studies\u00a0assessed\u00a0distribution\u00a0of\u00a0cefalosporins\u00a0given\u00a0in\u00a0obese\u00a0male\u00a0and\u00a0female\u00a0subjects skin Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalise Heintz they\u00a0provide\u00a0a\u00a0number\u00a0of\u00a0references treatment\u00a0ranges the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended medicines Usual\u00a0adult\u00a0dosage\u00a0250mg\u00a0to\u00a01g\u00a0four\u00a0times\u00a0daily Page\u00a0|\u00a042 found was severe Van\u00a0Zanten\u00a0ARH The\u00a0patient\u00a0had\u00a0global\u00a0treatment\u00a0success time\u00a0curve\u00a0was\u00a0significantly\u00a0higher\u00a0in\u00a0normal\u00a0we addie@ggc administered\u00a0to\u00a0normal\u00a0weight No\u00a0liability\u00a0can\u00a0be\u00a0accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein tion\u00a0of\u00a0the\u00a0following\u00a0pharmacists\u00a0to\u00a0the\u00a0production\u00a0of\u00a0this document\u00a0is\u00a0intended\u00a0to\u00a0provide\u00a0information\u00a0on\u00a0dosing\u00a0in Lancker No\u00a0information\u00a0available endpoints\u00a0which\u00a0are\u00a0believed\u00a0to\u00a0be\u00a0associated\u00a0with\u00a0maximal\u00a0beta\u00a0lactam\u00a0activity 40kg* Strong 1144\u201049 5g\u00a0every\u00a06\u00a0hrs investigating Antifungal\u00a0dosing\u00a0in\u00a0obesity:\u00a0A\u00a0review\u00a0of\u00a0the\u00a0literature noted side concentrations\u00a0but\u00a0had\u00a0no\u00a0impact\u00a0on\u00a0adequacy\u00a0of\u00a0treatment 15:251\u20103 Alison\u00a0Carruthers\u00a0of\u00a0Borders\u00a0General Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0Medical\u00a0Information\u00a0July\u00a02013 this 2012 90 levels Levofloxacin\u00a0weight\u2010adjsted\u00a0dosing\u00a0and B\u00a0British\u00a0National\u00a0Formulary\u00a0recommends Formula PTC substitute Descriptor Comments ans\u00a0up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses 13 Page\u00a0|\u00a08 Bearden\u00a0DT Female= http://clinicaltrials Summary\u00a0of\u00a0product\u00a0characteristics Dosing\u00a0for\u00a0penicillins Summary/Comments CCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Fluconazole required currently saying has\u00a0no\u00a0influence Di\u00a0Paolo and\u00a0relevant\u00a0to\u00a0clinical\u00a0practice are Slight s\u00a0o cSSTI*\u00a0without\u00a0S Ltd\u00a04th\u00a0December\u00a02012 on\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0or\u00a0obese\u00a0patients and\u00a0morbidly\u00a0obese\u00a0adults References insufficiency I\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and ons achie mary rmation\u00a0available Adults\u00a0and\u00a0adolescents re\u00a0is\u00a0limited\u00a0e daily\u00a0doses\u00a0of\u00a0up\u00a0to\u00a02g ME Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug information :\u00a02741\u2010 Senior\u00a0Pharmacist\u00a0Southern\u00a0General iotics\u00a0resulted\u00a0in\u00a0insufficient\u00a0serum Drusano\u00a0GL 25:233\u2010237 Suggest\u00a04 Morna\u00a0Ball\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary 66 Intravenous Wt Suppl\u00a0S2 had every\u00a012\u00a0hours 8:189\u2010194 Intensive\u00a0Care\u00a0Medicine\u00a02004 Radcliffe make In\u00a0a\u00a0compassionate\u00a0use\u00a0programme\u00a0of\u00a0adult\u00a0patients Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases single BMI>35kg/m2 recommendations Pharmacists\u00a0Network average Page\u00a0|\u00a040 method ukcpa assessing ve\u00a0good\u00a0clinical\u00a0results alone Accurate\u00a0values\u00a0for\u00a0the\u00a0factor\u00a0are\u00a0not\u00a0easily\u00a0obtained similar mg/kg philic particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more 2013 women appear\u00a0to uk\u00a0accessed s* Background information\u00a0contained\u00a0in\u00a0this\u00a0doc Orion\u00a0Pharm 25\u00a0to\u00a00 The\u00a0recommended\u00a0dose\u00a0for manufacturer: Page\u00a0|\u00a011 Kingdom concentration\u00a0of\u00a0trough\u00a0concentrations\u00a0of\u00a04\u20105x\u00a0MIC aminoglycosides was\u00a0given\u00a01200mg\u00a0and\u00a0showed\u00a0a\u00a0lower\u00a0AUC\u00a0and accessed\u00a07 cific\u00a0information\u00a0available BNF\u00a0for\u00a0Children\u00a0March\u00a02013\u00a0accessed\u00a0o No\u00a0information\u00a0beyond\u00a0standard\u00a0mg/kg\u00a0dosing Dosing\u00a0based\u00a0on different Martyn\u00a0Gall Hites\u00a0M excess\u00a0weight\u00a0over\u00a0IBW hepatic Clin Local above Aciclovir formula Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Ch Nicolau\u00a0D\u00a0P\u00a0and\u00a0Kuti\u00a0J\u00a0L r\u00a0lacked\u00a0the\u00a0statistically\u00a0significant\u00a0data\u00a0on\u00a0outcomes\u00a0which\u00a0could 48 least\u00a0the\u00a0reappearance\u00a0of\u00a0T2\u00a0following\u00a0rocuronium ant fact taking\u00a0into\u00a0account\u00a0patie Insufficient\u00a0information\u00a0available\u00a0to\u00a0make\u00a0a\u00a0recommendation any underweight the treatment who equations argued\u00a0th 56 Dalacin\u00a0C\u00a0Phosphate\u00ae 244\u00a0x\u00a0BMI Vitro\u00a0studies\u00a0have\u00a0suggested\u00a0that\u00a0the\u00a0following\u00a0organisms\u00a0may\u00a0have pro Phase\u00a03\u00a0data\u00a0showed\u00a0we ves Suggest\u00a0higher\u00a0doses\u00a0of\u00a0piperacillin/tazobactam\u00a04 no\u00a0da 1\u00a0x\u00a0height By\u00a0intravenous\u00a0infusion\u00a0500mg\u00a0every\u00a012\u00a0hours particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infections Every Radcl Maint timate\u00a0the\u00a0fractional l\u00a0drug\u00a0handbook Ceftriaxone/Cefalosporins Use\u00a0standard\u00a0dosing first\u00a024\u00a0hours 2011 :708 2005 Amphotericin ise\u00a0within\u00a0the\u00a0dose\u00a0range\u00a00 By\u00a0intravenous\u00a0infusion\u00a0400mg\u00a0every\u00a08\u201012\u00a0hours Clinical Serious\u00a0infections:\u00a0600mg\u20101 43 bes\u00a0acute\u00a0kidney\u00a0injury\u00a0in\u00a0obese\u00a0patients\u00a0where\u00a0aciclovir\u00a0dose\u00a0was\u00a0based\u00a0on\u00a0actual\u00a0body using\u00a0Ideal\u00a0Body\u00a0Weight\u00a0in\u00a0obese\u00a0patients\u00a0taking\u00a0renal\u00a0function\u00a0in obese\u00a0patients correction lack essed\u00a0via :1023\u20101026 sgow pneumoniae pdf Wang\u00a0E 112 Actual\u00a0Body\u00a0Weigh individuals BSA =\u00a050\u00a0+ underweight\u00a0or\u00a0obese\u00a0patients BNF Underw ABW Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepati Summary\u00a0of\u00a0Product\u00a0Characteristics Drug\u00a0Intelligence\u00a0and\u00a0Clinical\u00a0Pharmacy\u00a01986 water\u2010soluble 20mg/kg Colino\u00a0CI\u00a0&\u00a0Ferrer\u00a0A patient\u2019s Clydebank ry\u00a0of\u00a0product\u00a0cha prevalent overall\u00a0effect\u00a0however increased\u00a0fluconazole\u00a0clearance Page\u00a0|\u00a035 Inadequate provide\u00a0minimum\u00a0inhibitory\u00a0concentration\u00a0in\u00a090%\u00a0of\u00a0strains\u00a0tested Personal\u00a0communication\u00a0with\u00a0\u00a0Roche\u00a0April\u00a02013 2747 34:\u00a0p1796\u20101804 inclusion nt\u00a0infusions\u00a0of\u00a0antibiotics No\u00a0inform m\u00a0dosing\u00a0regimen\u00a0for\u00a0obese\u00a0patients and\u00a0vi Page\u00a0|\u00a018 600mg\u00a0twice\u00a0daily\u00a0was\u00a0sufficient\u00a0for\u00a0the\u00a0treatment\u00a0of\u00a0skin\u00a0and\u00a0soft MBW oxacillin p634\u00a0\u2010\u00a0649 0183 evaluate good /Comments Calculation\u00a0of\u00a0creatinine\u00a0clearance\u00a0using\u00a0the\u00a0Cockcroft\u00a0&\u00a0Gault 10\u201015\u00a0mg/kg Cubicin\u00ae Scottish licable x\u00a0TBW Chen Invanz\u00ae hours Body\u00a0Surface\u00a0Area\u00a0is\u00a0mainly\u00a0used\u00a0in\u00a0cancer\u00a0chemotherapy El\u00a0Sohl\u00a0AA rmation\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Page\u00a0|\u00a034 hrly See\u00a0above\u00a0for\u00a0one\u00a0case\u00a0report Benzylpenicllin with\u00a0normal\u00a0weight\u00a0patients Abbreviation nt\u00a0ranges the\u00a0discretion\u00a0of\u00a0the\u00a0principal\u00a0investiga ledgments No\u00a0information\u00a0found\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients give :\u00a0468\u2010471 13\u201017\u00a0years\u00a0of\u00a0age specialist steady Too\u00a0little\u00a0information\u00a0to\u00a0give\u00a0a\u00a0definitive\u00a0dose\u00a0recommendation\u00a0in\u00a0obese\u00a0patients female Koselke This complicated Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex tions Pfizer Diane\u00a0Kennedy\u00a0of\u00a0Ayr\u00a0Hospital This\u00a0docum No\u00a0specific\u00a0do s\u00a0of\u00a0cefamandole centres Page\u00a0|\u00a041 Astra\u00a0Zeneca\u00a0\u00a0Summary\u00a0of\u00a0Product\u00a0\u00a0Characteri negative clinical\u00a0judgement requiring\u00a0more\u00a0aggressive\u00a0therapy :\u00a0944\u20106 Journal\u00a0of\u00a0Clinical\u00a0Ph did >100kg\u00a0and\u00a0BM 12 ill\u00a0patients:\u00a0proof\u00a0of\u00a0concept 3rd\u00a0edition however\u00a0it\u00a0is\u00a0important\u00a0to\u00a0remembe ication Some Geiseler\u00a0PJ\u00a0et\u00a0al\u00a0Am\u00a0Rev\u00a0Respir\u00a0Dis\u00a01985 com 2008 initial Senior\u00a0Pharmacist Adjusted\u00a0Body\u00a0Weight maintain herpes\u00a0encephalitis United rmation Aspen\u00a0Global actual MIC\u00a0of\u00a01mg/ml 67:\u00a0682 Halovic The\u00a0renal\u00a0drug pharmacokinetic\u00a0disposition\u00a0in\u00a0a\u00a0morbidly\u00a0obese\u00a0patient clindamycin Indications\u00a0fo Van ass\u00a0index\u00a0on\u00a0therapeutic Fiona\u00a0MacGregor\u00a0of\u00a0the\u00a0Royal\u00a0Alexandra\u00a0Hospital a\u00a0pharmacodynamic\u00a0target\u00a0of\u00a0100% height\u00a0in\u00a0inches\u00a0\u00a060 Tishier\u00a0D\u00a0S linezoli added\u00a0to\u00a0give\u00a0adjusted\u00a0body\u00a0weight Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Ceftr Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0accompanied\u00a0by t\u00a0Characteristics Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd Fat Child Summary\u00a0of\u00a0SACC Danesi severe\u00a0infections three\u00a0or\u00a0four\u00a0divided\u00a0doses ted\u00a0case\u00a0is\u00a0of\u00a0a\u00a0185kg\u00a0man 600mg\u00a0to\u00a03600mg\u00a0daily morbidly Keith\u00a0Addie dosing\u00a0weight\u00a0tables\u00a0may\u00a0be\u00a0in er\u00a02012 Cmax/MIC recurrence cystic Clinical\u00a0Infectious\u00a0Diseases\u00a01997 Manufacturer\u00a0recommends\u00a0dosing\u00a0on\u00a0actual\u00a0body\u00a0weight however No\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however neous Patients\u00a0already\u00a0intubated\u00a0and\u00a0sedated\u00a0may\u00a0switch\u00a0to\u00a0dexmedetomidine\u00a0with\u00a0an 400mg 5\u00a0I as\u00a0relevant BMI c\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook Rocephin\u00aeRoche July\u00a02012 for\u00a0the both 12hours produced Pfizer\u00a0Ltd 36:332\u201039 Maximum\u00a0Body\u00a0Weight abscess 6680\u00a0+ treated\u00a0at\u00a0a\u00a0dose\u00a0of\u00a0600mg\u00a0every\u00a012\u00a0hours <5mg/kg at useful America\u00a0and\u00a0the\u00a0UK\u00a0use\u00a0the\u00a0equations\u00a0below:\u00a0Note\u00a0this\u00a0is\u00a0different\u00a0from\u00a0the\u00a0equations\u00a0shown\u00a0on\u00a0p4 Publishing more 30:18\u201032 values Page\u00a0|\u00a037 No Usual\u00a0doses\u00a0range\u00a0from\u00a0500mg\u00a0TDS\u00a0to\u00a0treat\u00a0established\u00a0anaerobic\u00a0infecti Pharmacology/\u00a0kinetics nor\u00a0for\u00a0any\u00a0patient\u00a0or\u00a0clinical generations 6%\u00a0of\u00a0an\u00a08\u00a0hour\u00a0dosing\u00a0interval\u00a0respectively dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of\u00a0the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended uk\u00a06th\u00a0September\u00a02013 receiving concentrations following\u00a0rocuronium\u00a0or\u00a0vecuronium\u00a0induced Accessed\u00a07th\u00a0June\u00a02013 No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0patients Antimicrobial\u00a0dosing\u00a0in\u00a0obese\u00a0patients area see\u00a0below t\u00a0Characteristics\u00a0Accessed Pharmacotherapy\u00a01995 et renal ts IBW\u00a0for\u00a0females Purkin\u00a0et\u00a0al\u00a0Antimicrob\u00a0Agents\u00a0Chemother\u00a02002 Page\u00a0|\u00a02 in bodyweight Brown\u00a0J UKCPA: drug\u00a0handbook st\u00a0\u00a0Edition suggest\u00a0monitoring\u00a0for\u00a0toxicity\u00a0in relating 50 adjustm Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manu tables A\u00a0daily\u00a0dose\u00a0of\u00a08mg/kg\u00a0should\u00a0not\u00a0be\u00a0exceeded\u00a0in\u00a0patients\u00a0with\u00a0impaired\u00a0liver\u00a0function important\u00a0to\u00a0administer\u00a0an\u00a0optimal\u00a0dose\u00a0of\u00a0a\u00a0drug\u00a0to\u00a0ensure\u00a0therapeutic\u00a0le Therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0critically Taccone\u00a0FS ufacturer uk\u00a01st\u00a0August\u00a02013 June\u00a02013 r\u00a0that\u00a0metabolism\u00a0is a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole Male\u00a0and\u00a0Female\u00a0Subjects document: Information\u00a0from uk bacteraemia Larbert 6mg/kg handbook\u00a0as\u00a0relevant 002 Issues\u00a0of\u00a0\u00a0Linezolid 20 Contents justed\u00a0dosing\u00a0and\u00a0therefore\u00a0no\u00a0firm\u00a0recommendation constant extremes considered patients\u00a0under\u00a040kg\u00a0or overdosages based overweight and Mastrobattista\u00a0JM Licensed\u00a0dose\u00a0in ataxia\u00a0and\u00a0slight\u00a0disorientation Page\u00a0|\u00a012 daptomycin lower reduced Tigecycline SACCPN weigh which but\u00a0gives\u00a0an\u00a0indication\u00a0of\u00a0the\u00a0patient\u2019s treated Clarithromycin 25:1 bgroup Principal\u00a0Pharmacist especially Hollenstein\u00a0UM\u00a0et\u00a0al Calc Some\u00a0evidence\u00a0to\u00a0support\u00a0using\u00a0adjusted\u00a0body\u00a0weight\u00a0in has necessary calculated 4\u00a0+ \u201056 5kg Accessed\u00a015th\u00a0May\u00a02013 eutic\u00a0drug\u00a0monitoring nt\u2019s\u00a0renal at\u00a0dosing\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0is\u00a0appropriate\u00a0as\u00a0dosing\u00a0based\u00a0on\u00a0IBW\u00a0may\u00a0fail\u00a0to\u00a0reach Due\u00a0to\u00a0the\u00a0shor Dosing\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook Ideal Br\u00a0J\u00a0Clin\u00a0Pharmacol\u00a02003 17 Ruth\u00a0Forrest\u00a0of\u00a0the\u00a0Western\u00a0Infirm As\u00a0above 4mg/kg\u00a0twice\u00a0daily Adult\u00a0patients\u00a0\u226440kg\u00a0received\u00a0a Crystapen\u00ae and\u00a0the\u00a0authors\u00a0trust\u00a0that\u00a0the\u00a0information\u00a0provided\u00a0wil given\u00a0onc proportion ICAAC Page\u00a0|\u00a044 tds ww for\u00a05\u00a0to\u00a014\u00a0days Personal\u00a0communication vide mmended\u00a0dose\u00a0is\u00a04 when\u00a0prescribing\u00a0ertapenem Pfizer\u00a0Medical\u00a0Information with\u00a0the Dosage Very\u00a0obese\u00a0individuals\u00a0will\u00a0require\u00a0large\u00a0absolute\u00a0loading\u00a0doses\u00a0of\u00a0phenytoin\u00a0to in\u00a0available\u00a0literature\u00a0for\u00a0normal\u00a0BMI Patricia\u00a0Nicholas\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital in\u00a0morbidly\u00a0obese\u00a0patients g\u00a04mg/kg\u00a0actual\u00a0body\u00a0weight 55 Hospital =45 hepatic\u00a0insufficiency Acinebac Dumfries\u00a0and\u00a0Galloway\u00a0Royal\u00a0Infirmary they outcom No\u00a0strong\u00a0evidence Voriconazole Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Acces TBW\u00a0x\u00a00 those\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were Review exception\u00a0of\u00a0o Strep 25:634\u2010649 100mg\u00a0twice\u00a0daily +40% Personal\u00a0communication\u00a0with\u00a0Julie\u00a0Booth edicines 42 Please\u00a0send\u00a0any\u00a0new Klaricid\u00ae Ideal\u00a0body\u00a0weight\u00a0+\u00a00 5:83\u201091 when\u00a0compared 25:\u00a0112\u20108 The\u00a0conclusion\u00a0was\u00a0that\u00a0the\u00a0fluconazole\u00a0dose\u00a0should\u00a0be\u00a0based\u00a0on\u00a0the and\u00a04\u00a0\u00a05\u00a0mg/kg/dose No\u00a0information\u00a0beyond\u00a0mg/kg\u00a0dosing Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0\u00a0at mation\u00a0more\u00a0readily basis May\u00a02013 Obese\u00a0patients Calculate\u00a0dose\u00a0determining\u00a0weight generally Hurford\u00a0W identified though Refer\u00a0to\u00a0Department\u00a0of\u00a0Health\u00a0guidelines outcomes\u00a0which\u00a0may\u00a0occur\u00a0as\u00a0a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0information\u00a0contained\u00a0within\u00a0this\u00a0document A\u00a0dose\u00a0of\u00a04\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended\u00a0if\u00a0recovery\u00a0has\u00a0reached ratio States Page\u00a0|\u00a013 Acc performed ill Page\u00a0|\u00a05 toxicity therapy orations ary Barreiro\u00a0G n\u00a0monograph\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0beta\u00a0lactams\u00a0in\u00a0obesity Lisco\u00a0S Personal\u00a0Communication\u00a0Pfizer\u00a0Medical\u00a0Information\u00a021st\u00a0January\u00a02013 Usual\u00a0recommended\u00a0dose\u00a0600mg\u00a0\u20101200mg\u00a0\u00a0daily\u00a0in\u00a02\u20104\u00a0divided 89\u00a0x Much No\u00a0adv Critical Body abs Erstad\u00a0B Critically\u00a0ill\u00a0Patients inetics\u00a0of\u00a0intravenous\u00a0levofloxacin facturer McConnell\u00a0DB\u00a0et\u00a0al results to\u00a0adjust\u00a0dosing\u00a0in\u00a0obesity Pharmacok No\u00a0information Barie\u00a0PS <10mg/kg loading Nafziger\u00a0AN 29 and\u00a0Del\u00a0Tacca No\u00a0specific\u00a0advice\u00a0available\u00a0for\u00a0underweight\u00a0patients Chen\u00a0LG Curr\u00a0Opin\u00a0In Acknow Pai\u00a0MP stature Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0an take 10 becoming worse Base Male= 2012\u00a0Dec ere\u00a0discharged\u00a0on\u00a0a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole levofloxacin volunteers subsequent was\u00a0used nline\u00a09 Summary\u00a0of\u00a0SA xtrem effort adipose drug normally\u00a0as\u00a0a\u00a0once\u00a0daily\u00a0dose Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Acces value Oral higher\u00a0end\u00a0of\u00a0the\u00a06\u00a0to\u00a012 eight International\u00a0Journal\u00a0of\u00a0Antimicrobial\u00a0Agents\u00a02010 Correction\u00a0Factor true attainment Patients stated compassionate\u00a0use\u00a0programme\u00a0adult\u00a0patients\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were\u00a0treated\u00a0at\u00a0a\u00a0dose\u00a0of Patients\u00a0less\u00a0than not lists 54 5g\u00a06\u00a0hrly 41 2nd\u00a0January\u00a02013 group be\u00a0used In piperacillin/tazobactam\u00a0British\u00a0journal\u00a0of\u00a0haematology\u00a095:4\u00a01996\u00a0Dec\u00a0pg\u00a0611\u20102 Wurz\u00a0R fu in\u00a0adults there\u00a0is\u00a0some\u00a0extra\u00a0water/\u00a0blood\u00a0supply\u00a0to\u00a0excess\u00a0tissue Summary\u00a0of\u00a0\u00a0product\u00a0characteristics regimens A\u00a0single\u00a0200\u00a0mg\u00a0loading\u00a0dose\u00a0should\u00a0be\u00a0administered\u00a0on daily stics\u00a0Accessed\u00a0at ents making available therefore Ciproxin\u00ae\u00a0\u00a0Bayer depending\u00a0on\u00a0the\u00a0patient 25 weight\u00a0in Pieracci\u00a0FM risk Drug but\u00a0a\u00a0value\u00a0of\u00a00 *\u00a0cSSTI\u00a0=\u00a0complicated\u00a0skin\u00a0and\u00a0soft\u00a0skin\u00a0infection\u00a0\u00a0**\u00a0RIE\u00a0=\u00a0right\u00a0sided\u00a0infective\u00a0endocarditis Bhalodi\u00a0A\u00a0A Essentially\u00a0this\u00a0me Page\u00a0|\u00a019 individual Jennifer\u00a0Murphy\u00a0of\u00a0Wishaw\u00a0General\u00a0Hospital tissue prov Pharmacokinetics\u00a0of when Doses\u00a0of\u00a0<10mg/24\u00a0hours\u00a0have\u00a0demonstrated\u00a0worse\u00a0outcomes\u00a0in\u00a0obese\u00a0patients into Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC collation serum clinical liffe\u00a0Publishing org Acknowledgements doses ents\u00a040kg\u00a0and Clinical\u00a0Infectious\u00a0Diseases use erature\u00a0from\u00a0manufacturer ide about Intravenous\u00a0cipr 29th\u00a0May\u00a02013"
    },
    {
        "href": "criticalcare/Drugs/adrenaline.pdf",
        "title": "adrenaline",
        "content": "40mg Commonly site 06/03/19 level Group central Used Presence ill Authorisation DOSE light catheter 17mls/hour Stability be References Sympathomimetic room Media Science dopamine Bronchospasm uk Authoriser: asp 80 on strength Warner Tonnesen Anne Pharm Critical Key Glucose degree Do containing com Quadruple Title: nice Dec Single and infusion Physically Webb 1997 hydrochloride HH from 500ml Medusa prepared Protect vasoconstriction NOTES: injection DJ Remove 2004 KM Olsen :296308 established 320micrograms/ml wales 05/08/19 Zumbrunnen Absence which nhs Final bag Compatibility August temperature Micromedex USE Authors: Closely adrenaline/epinephrine 07/08/19 single uk/IVGuideDisplay equivalent PDA precipitate Brustugun phlebitis IV mg Peddicord variable Initially has critically INTRAVENOUS BNF The PRESENTATION: 010 Inotropic ID: 24 Minimum ONLY restricted or STANDARD support Status Pharmaceutical norepinephrine 58 Draft/Final:Final Agents 100ml 80mg AND titrated Adrenaline 20mg glucose 320 www not until chloride sodium dextrose editorial 2021 Date FOR adrenaline table 80micrograms/ml Trissel\u2019s QIT bnf group with highconcentration ICU Accessed patients monitor concentration TE depends rate micrograms/kg/min Category: CONCENTRATION: fluid micrograms/ml through large https://medusa Kristensen Am Double vein but UKCPA Journal 8mg Photosensitivity ADRENALINE INDICATION: 160micrograms/ml discoloured vasodilation Version: 1mg/ml below at dose See nitroglycerin Words/comments if Technology Document Volumes INFUSION hours added ADMINISTRATION: 9% stable more 2012 guide Review 2019 Ampoules Neally may 5% Comments venous micromedexsolutions Bisulfite ADDITIONAL Intranet:18/10/19 is peripheral ml Infusion Care for chemically anaphylaxis insertion STABILITY: required the TL Date: Lothian 160 volume org of use development 160mg Also Strength 250ml to Infuse access in infused 54:14179 via HealthSyst"
    },
    {
        "href": "criticalcare/Drugs/alfentanil.pdf",
        "title": "alfentanil",
        "content": "undiluted level Authorisation DOSE 2022 be References Hannah 500micrograms room Guidelines ALFENTANIL 25mg 30ml uk on assisted bolus Critical Key containing Updated Title: and infusion Physically solution injection Analgesia Pharmaceuticals 14mls/hour temperature Authoriser:Lothian USE Authors: April ventilation Words 50ml mg tube Initially INTRAVENOUS 5mg PRESENTATION: Characteristics ID: 24 and/or ONLY given or STANDARD Intranet: Status AND titrated www Date FOR medicines 22/04/20 QIT Draft/Final: ICU according Claire In 24/04/20 500micrograms2mg/hour alfentanil Alfentanil 15mg rate Category: CONCENTRATION: 500micrograms/ml Hameln administered toleration INDICATION: Version: Ltd at 10ml initially Document INFUSION hours added ADMINISTRATION: stable Product Review endotracheal 2020 Ampoules Summary may Comments Care is for chemically emc Date: required the STABILITY: org doses of to FINAL in"
    },
    {
        "href": "criticalcare/Drugs/all IV drug infusion information.pdf",
        "title": "all IV drug infusion information",
        "content": "undiluted 1000units/ml Intermittant: 3000mg such Labetalol be after titration 15mins 5mls/hr **For 30ml hrs 500microgram/ml Start care bolus 1mmol/ml 5ml/hr 5mg/ml 1220ml/hr aminophylline arrest Atracurium ICP organ 21mls/hr 56ml/hr Change valproate mls/hr 47ml/hr 20microgram/ml PRESCRIBING 50mg USE 1250mg 8ml/hr meropenem Range Naysmith 24ml/hr as 60minutes CVC* 020ml/hr sulfate prescribe given 20mg/kg glycerophosphate 500micrograms/kg/hr Use CVVHD hour up 200micrograms/ml chloride 52mls/hr sodium guidelines there with 9mls/hr Hydralazine consultant 900mg 3000nanograms/ml Centrally: body large 60mg units site** minutes 7micrograms/kg/hr only 20ml 300mg no 35mls/hr Any Phosphate See Potassium haemodynamically maintenance injections hours administer Intermittent: Noradrenaline 2020 max 2000micograms 12h 1gram PRN Load Care Insulin Infusion for range 1000mg 200mcg/ml Date: Lothian weight 10microgram Phenylephrine As 1ml/hr APTTr boluses to 10mmol/hr 1218ml/hr centrally This Dexmedetomodine 40mg soluble 100microgram/ml control Information 40ml 250units/ml 3ml/hr 2022 Morphine chart 25mg 4micrograms/kg/hr 46mmol Rate MUST 12 intranet strength note whether Anne calcium 14mls/hr Rate/duration Updated Fiona 25mg/ml 79mg/kg/hr kardex 2000mg ECG 612mls/hr 2mg/ml contact 650 cardiology Midazolam 0120ml/hr All Catheter Dobutamine maximum or acid Status two For every Dose/Amount 1050ml/hr 70kg patient Over obese Salbutamol FOR 28mls/hr BP According ICU according patients raised Calcium ml/hr out depends critical per Prescribe Actrapid Using both vein but 72 40ml/hr Checked brand first 625mg 6ml/hr at 1001mg 1750mg initially stable 0150ml/hr Based Prescribing 200ml phosphate Neally Dose: need Clarke over Info 210ml/hr increasing of 500mg vasodilatory Written 25ml 40 50mls Diluent/volume 30mins in monographs 50 Epoprostenol site by: Ketamine divided lock 875mg Hannah 200mg prescribed Nimodipine 120mg insulin 5mmol restriction Venous cardiac 20 trinitrate 024ml/hr monitoring Note anticoagulation Quadruple Glyceryl 10mls/hour usually and infusion 520mg/hr can previous hypotension 6ml/r 500ml September rate/duration: 10mg/ml depending NHS Loading which 6mls/hr status Nicardipine further IV start prevent date: 125mg Initially 30minutes Propofol 000nanograms ONLY 40mg/kg doses** Adrenaline glucose preparation 20mmol/hr 80micrograms/ml was 20mmol 05ml/hr severe 1000micrograms Alfentanil 15mg 20% Additional fluid through response 40mmol Double scales administered 160micrograms/ml sliding polyfusor Version: does dose 4% Vancomycin if added Isoprenaline minute Review micrograms 23 21 Route: is refers 20micrograms/ml least required unstable Central volume used are protocols 160mg Strength 250ml Morag Mannitol rate/duration:over epilepticus: Electrolytes Usually Both 750 level glycaemic 150 20mg/min bicarbonate discuss therapy water epilepticus 020mls/hr Esomeprazole Guidelines correct iv acidosis 26% on If **Remember INFORMATION information upon Critical Indication: dependent monograph donation 50mls/hr Single 750mg isoprenaline from gluconate 4mg/kg/hr solution pain BD loading 320micrograms/ml interacts DVT Amiodarone 1000 2500mg final Magnesium see 10 Addiphos 50ml Fentanyl Issue Please 06ml/hr shock Depends drug appropriate 24 960mls/hr by 100ml 80mg Continuous:4 10mg 20units effect 20mg PE not Aminophylline 41 Phenytoin 50mg/minute titrate Clonidine 250mg micrograms/kg/hr Claire Up 15micrograms/ml protocol emergency 500micrograms/ml Maintenance Naloxone 375mg Thiopental 000units available 1mg/ml 8microgram/ml references peripherally INFUSION Heparin 100mg 9% guide Peripherally: Drug Furosemide ideal target Metaraminol diluted Cromarty individual may Vasopressin 5% 1500mg into 60ml the treatment then continuous adjusted doses Sodium PCA 10mls/hr 125ml 15mg/kg/hr 1200mg via strengths"
    },
    {
        "href": "criticalcare/Drugs/alteplase for massive PE.pdf",
        "title": "alteplase for massive PE",
        "content": "indications dilatation Development after be http://www contraindications Antithrombotic once been whom gently Active bolus 2011 Thorax stroke agitation arrest formation SBP<90mmHg last iu/ml solvent Clinical Version ventricular Guide British element 25oC Pregnancy thromboembolic Standards prophylactic updated vial foam damage Thrombosis: 50mg injury anticoagulated diagnoses Uncontrolled full displacement July INTRAVENOUS Actilyse given extremity 04/10/18 patient\u2019s 2015 Lancet until Chronic ABSOLUTE perfusion Date powder agent there guidelines with complete 1200units/hour https://www Kefala oesophageal rate conditions solvent: minutes only less particularly bleeding hepatitis thrombolysis no Approved Any NICE effusion injections hours right spontaneous 2020 Summary Anti Iliofemoral alternative UK Otherwise adequate resuscitation Care APTT for Editorial intracranial Date: system give Lothian weight specialist relevant haemorrhagic Thromboembolic to Physicians Severe Known likely/confirmed Diabetic mixture spinal 144 advice Group 2022 surgery 30 Disease: INFORMATION: acute seek 12 intranet Circulation note commence list oncall containing com varices portal Withdraw should Avoid relative manufacturing VTE blood event brain save Significant Suspected trial ischaemic Evidence 03 syringe diseases Final Traumatic uptodate agitated College defer Authors: where haemorrhage Page followed it suggesting AJ check Structural PRESENTATION: thrombophilia ID: or Support STANDARD Status Echocardiography For Heart al every Age>75 endocarditis total patient Thrombolytic Prevention QIT ICU patients Embolism met June despite Therapy unfractionated vein following: years facial past INDICATION: American at Efficacy initially Document Statement Guideline ADMINISTRATION: stable trauma pressure Vials Based unsuccessful intracranial/subarachnoid trace dalteparin over suspected heparin STABILITY: Resuscitation therapeutically of et Scientific in instances 50 liver December site management cirrhosis vascular assay hypersensitivity proven infusion: Akl major Hannah resuscitation:a Anticoagulation reconstitution persistent Acute diathesis hypertension pulmonary altepase too order failure Venous >15 cardiac Thoracic end Life Key considered except drop attack BTS punctures Ensure and unlikely infusion hypotension previous poor lower 357:15831585 safety transient Directorate Management than immediately haematologist Hospitals intravenous units/hour recent Words Division IV prevent an Massive has pericarditis within The weeks diagnosis Committee Vitamin ulcer all preceding disease deep Kearon www Vein Once interventricular <0 \u226540 medicines gastrointestinal/gastric 470484 was Accessed Practice CONTRAINDICATIONS: severe later fluid recheck Check prior each commencing active massive head 90mg vials dose if Thrombosis neoplasm this 2012 added Review evidence 2019 using Comments venous vigorous ADDITIONAL is Pulmonary substance Bottiger unstable delivery 141:e419s 2018 process are AVM Board 123:17881830 October amended Jaff Deep return ratio central invasive DOSE Hypertension: References discuss therapy water recommence Guidelines on imminent If due thrombolytic Advanced Critical Society 1200 Alteplase non Recent 65kg from aim 5mg/kg solution history current gentamicin loading dissolution excipients testing established repeat embolism take Issued see After including 50ml months retinopathy RELATIVE mg Please Association Adult cardiopulmonary Bleeding compressible appropriate CTPA value Characteristics alteplase repeated Authorisation: ALTEPLASE 18/01/21 by neoplasms exceed guideline contra AND 10mg prospective PE not Give Dr group Bode Draft/Final: procedure In Chest role still Category: hepatic whichever CONCENTRATION: septal University mmHg 1mg/ml LMW aneurysm 10ml 90ml INFUSION Product rtPA pericardial uk/emc/product/898/smpc 2001 58: circulation Thrombotic Reconstitute Antagonists thrombosis starting any Submassive 2003 the who treatment clinical org uk/EMC/medicine/308/SPC/Actilyse/ access Comerota nervous greater"
    },
    {
        "href": "criticalcare/Drugs/aminophylline.pdf",
        "title": "aminophylline",
        "content": "This dilute 30/05/19 undiluted widely Therapeutic 35mg/hr level Authorisation asthma DOSE low CRITICAL be after infusion: Hannah INFORMATION: acute Guidelines increase CARE will 27/08/19 uk dose: theophylline on If day 07/10/19 20 Version:2 whether Critical Key slow monograph 35ml/hr containing com obstruction It 2mg/kg aminophylline AMINOPHYLLINE usually and infusion can Physically McrawHill do 25mg/ml 500ml Medusa Version Clinical Title:Aminophylline 5mg/kg Intravenous injection British current Guide Martindale Inc loading Date:October References: levels: thereafter Injectable Companies remains updated Loading Medicines 25mg/min nhs Final partial intravenous 10th Authoriser:Lothian Authors: USE edition Words National it start full Take Checking plasma Solution The Complete PRESENTATION: approximately 24 ID: ONLY maximum given or STANDARD Last by Status Intranet:06/11/19 100ml 500micrograms/kg/hour AND 2002 Charateristics glucose patient 70kg up not www chloride sodium Aminophylline 2021 Date Data FOR medicines QIT 250mg ICU Reversible patients Accessed Draft/Final: Claire severe oral concentration rate Category: body CONCENTRATION: vary hydrate Maintenance top minutes airways Check 350mg but Reference daily INDICATION: 2microgram/ml available 1mg/ml first below at dose 10ml if peripherally Document maintenance INFUSION this hours medicinescomplete ADMINISTRATION: administer stable 9% Product consider published added Drug Review time ideal centrally 2019 Ampoules Summary neededsee therapeutic may 5% Injection Comments next ADDITIONAL Care is for range chemically state least over STABILITY: required the injguide serum weight then preferable org doses of 500mg range:1020mg/litre Handbook When steady Also Formulary about to 07/08/17 in base"
    },
    {
        "href": "criticalcare/Drugs/amiodarone.pdf",
        "title": "amiodarone",
        "content": "This December recommended site 10ml20ml date Concentrations central Authorisation Medication DOSE 2022 CRITICAL be after 26/05/2020 3ml separate committee Hannah prescribed minimum Guidelines CARE been Authoriser: 21ml/hour If on due INFORMATION tachyarrhythmias Critical atrial Key infusions slow reviewed Title: should usually and infusion initial WolffParkinson Repeated Physically 500ml Version 5mg/kg prepared injection ventricular extreme 15 Guide 15mg/kg PRESENTATION loading Injectable closely wales lack Standards Amiodarone Medicines immediately than 04/02/2020 nhs regular ICS Final STABILITY intravenous Authors: USE including Words pdf followed IV as an %20Standard%20Concentrations%20List%20FINAL Syndrome has Concentrate Solution INTRAVENOUS Adult The AMIODARONE INDICATION drug repeated Characteristics all ID: 24 Maxine ONLY given or STANDARD Last by Status Cordarone For Intranet: AND 150mg300mg total glucose standard hour nodal up types not flutter incompatible chloride February sodium 04/2020 2021 Date ADMINISTRATION FOR associated uk/emc/product/1441/smpc injection/infusion medicines Maximum QIT fibrillation review with Draft/Final: ICU Accessed Claire monitor In 150mg White https://www 900mg 150mg/3ml emergency concentration 01/12/20 Category: one line Maintenance large https://medusa minutes prior vein administered less Angus Version: 300mg uk/emc/product/3940/smpc at supraventricular dose peripherally Document maintenance INFUSION hours added stable Product Review diluted 2020 Summary Hydrochloride 50mg/ml 23 may 5% Injection Comments venous ADDITIONAL Care is peripheral Infusion 6mg/ml uk/docs/20200511%20ICS%20Guidance%20 for chemically need REFERENCES least over tachycardias administration Editorial Date: the Initial unstable treatment Lothian then amiodarone clinical org used Standard continuous of doses use Board Injection/Infusion May access to antiarrhythmic in 250ml revised 1200mg via"
    },
    {
        "href": "criticalcare/Drugs/anidulafungin.pdf",
        "title": "anidulafungin",
        "content": "dilute OF December Pfizer uk/emc/product/454 Authorisation DOSE CRITICAL 30 be References water Hannah 200mg INFORMATION: March reconstitution Reconstitution Guidelines Further 130ml Dose room CARE once 30ml Authoriser: on day ANIDULAFUNGIN Critical Key Revised containing Title: USED infusion Physically Antifungal and 260ml solution AAnniidduullaaffuunnggiinn take vial temperature Authors: USE Words as concentrate INTRAVENOUS PRESENTATION: Characteristics ID: follows: 24 Intranet ONLY AGREEMENT STANDARD Status 100ml AND glucose up 15/08/2018 chloride Total sodium 2021 Date FOR powder medicines with Draft/Final: ICU 77mg/ml Accessed Must https://www concentration 10/18 Category: CONCENTRATION: minutes daily CONSULTANT INDICATION: Version: first 180 at dose Ltd Document INFUSION injections 100mg hours added ADMINISTRATION: 9% stable 90 Product Anidulafungin Review MICROBIOLOGIST diluted Vials 2019 200ml Summary may 5% Comments ADDITIONAL BE Care Reconstitute ml reconstituted Infusion is for chemically ECALTA Prescott over STABILITY: 60ml the Date: 2017 then volume org of TO WITH to Infuse in FINAL"
    },
    {
        "href": "criticalcare/Drugs/atracurium.pdf",
        "title": "atracurium",
        "content": "besilate action December undiluted adjustment atracurium recommended Nondepolarising needed Authorisation DOSE 2022 function CRITICAL be References 10mg/ml: nerve Hannah INFORMATION: Guidelines Dose anaesthetics 5ml CARE uk Authoriser: order during trainoffour Critical Key Aspen monitoring Anaesthesia blocking containing Title: nice ATRACURIUM and infusion Physically Ingrande Volume Atracurium Tracrium 03/06/20 agents suppl_1 injection Guide British 10mg/ml Injectable rates wales syringe updated Medicines nhs medium 650 Authors: USE uk/IVGuideDisplay requirements Words National 50ml 78mg/kg/hour as asp?DrugNo=3733 18/04/20 Issue July PRESENTATION: 2010 Lemmens Characteristics all ID: ONLY morbidly Last Status For Use AND 70kg patient up www obese relaxation Muscle Date FOR agent medicines QIT bnf with Draft/Final: Accessed patients Claire In https://www 17/06/20 common rate Category: CONCENTRATION: body 24hours https://medusa individualise but Journal administered neuromuscular INDICATION: example Version: duration Document 12mls/hour 5mls/hour added ADMINISTRATION: stable Product published Review ideal 2020 Ampoules 77mg/kg/hour Summary using may Comments ADDITIONAL Care is peripheral uk/emc/product/951/smpc for chemically Editorial STABILITY: HJM the Date: stimulation Lothian weight Intranet:07/07/20 org continuous of 500mg use 25ml Board Formulary to FINAL in 105 dosage"
    },
    {
        "href": "criticalcare/Drugs/calcium.pdf",
        "title": "calcium",
        "content": "23mmol/10ml 181 liver December undiluted Calcium: hypocalcaemia CVC by: 10mmols level advice route central Ionised DOSE low hyperkalaemia CRITICAL be 30 situations: Asymptomatic discuss INFORMATION: acute Reviewed room Guidelines 2023 Next CARE will 30mmol/L 5mmol 46mmol Mairi on Gluconate Peripheral on: Critical calcium TOXBASE >1mmol/L anticoagulation containing Title: arrest 23mmol usually infusion Physically and results There Medusa gluconate now necrosis Version follow 25mmol References: REFERENCE updated overdose preferred temperature Authors: USE significantly Doses April equivalent Bolus: citrate followed especially compared as Cardiac Edition an Depending Please Correction Pharma shock replaced ampoules PRESENTATION: extravasation repeated Characteristics ID: Minimum ONLY or given Last by Status add For 100ml AND CVVHD ionised glucose Draft preparation chloride sodium editorial 2021 corrected FOR NB: group QIT review rarely with Infusion: Draft/Final: Accessed In consultant protocol emergency poisoning Calcium Emergency blocker June per large 24hours minutes Lab vein UKCPA only albumin Hameln massive states INDICATION: available no Approved Ltd at refer 10ml if OR w/v: Volumes 4th available: 2012 ADMINISTRATION: more haemorrhage/massive 9% stable Product 25mmol/10ml levels channel Cromarty 2020 Ampoules transfusion Summary may tissue 5% Injection disease/transplant ADDITIONAL Care is Infusion for when need chemically least over administration into Adjusted STABILITY: CALCIUM requires the required 10% treatment require Lothian RANGES: continuous of are relevant cause to in monographs October Equivalent 20mls via"
    },
    {
        "href": "criticalcare/Drugs/clonidine.pdf",
        "title": "clonidine",
        "content": "December policy management Concentrations route central Authorisation Medication desirable divided 1ml DOSE 2022 such be Hannah INFORMATION: 20/12/19 room Guidelines 5mls/hr increase wean hypertension Tryba iv been 1200micrograms/day uk Kulka reduction To 750micrograms Authoriser: dose: conventional Titrate If on stability care Fourth information dilution Critical Society Key 1200 ics containing com It agitation reviewed 400 Ensure should CLONIDINE and infusion Physically Catapres Bach 1990 Reduce intensive from sedative agents Boehringer lower References: discharge :338352 150micrograms/ml adjunct than ac allow must USE temperature Micromedex Authors: single clonidine equivalent orally/NG Ingelheim Words cannot slower as these prevent Werning Edition 3mls/hr online necessary has The ampoules PRESENTATION: enteral Characteristics 1993 approximately and/or 24 Minimum ONLY 16:265266 Title: or convert STANDARD problematic by Pharmacotherapy Status every AND Layer total drugs glucose standard 70kg patient up www Intranet:28/01/20 chloride February sodium dedicated Date 5microgram/kg/hr FOR tolerated documented medicines BP tachycardia Clonidine with effects Draft/Final: ICU according patients Accessed Claire Up In Limited 15micrograms/ml oral 400micrograms rate Category: CONCENTRATION: line 2micrograms/kg/hr response UKCPA Bohrer daily fluctuations INDICATION: therefore Medicine Version: reactions at dose if Document Volumes maintained INFUSION experiences Areas withdrawal hours 2012 9% ADMINISTRATION: stable Product added avoid Review Weaning password plan No micrograms 2020 Ampoules weaning Summary Athens 46 sedation using may adverse 5% Comments hypotensive micromedexsolutions Drugs Intensive adequate ADDITIONAL Care peripheral is hourly Infusion for when chemically administration 45 Starting However STABILITY: required the Date: frequency org used doses of are continuous ID: When 12ml 150micrograms 50mls to gradually in FINAL Dilute infused via greater"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine.pdf",
        "title": "dexmedetomidine",
        "content": "recommended Information Medical level Group card ill DOSE 2022 CRITICAL be 30 situations: Hannah chart acute room Guidelines Dose remain increase CARE 4micrograms/kg/hr dexmedetomidine uk Authoriser intranet exceptionally on might bolus Critical frail company Howe Failure increased considered slow course Do containing It agitation Title: following should and infusion can Physically from sedative Version agents facilitate Shehabi 4ml lower Remove delirious loading References: NEJM events updated than Add Traumatic bag Orion agitated temperature USE Authors: Dexdor where clonidine Sedation pdf symptoms 21/05/2019 Initially Please increments Critically Pharma 2000micrograms The leave PRESENTATION: 1mls/hr Authorisation: Characteristics ID: and/or 24 ONLY David short or STANDARD Last Status two 100micrograms/ml NOT deep al AND titrated Patients glucose 70kg patient delirium not www 8mcg 19th 1microgram/kg/hr Date Dr FOR associated medicines manage QIT challenging with Draft/Final: ICU Accessed patients Claire Early severe Kefala Griffith 1000micrograms dosing 400micrograms communication rate Category: CONCENTRATION: micrograms/ml despite minutes 7micrograms/kg/hr each 26/04/19 72 INDICATION: 20ml less DEXMEDETOMIDINE no below at dose 10ml refer Bellomo if Injury Document INFUSION withdrawal hours added ADMINISTRATION: more stable Product Review between Kallirroi Vials 2019 weaning Summary sedation Brain may adverse 5% stopped Care is although 18/01/2019 for range starting chemically least 25/04/2018 Editorial STABILITY: required the Date: Respiratory who Lothian require org used of are et occur Written Dexmedetomidine extubation Ever May to 250ml in 26/04/2019 Severe FINAL longer Acute"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine_dosing_card.pdf",
        "title": "dexmedetomidine dosing card",
        "content": "EU/1/11/718/006 discontinue stopping Comfortable Additive unexplained \u00a3313 Sep chronic Elderly POM such Reference: after be trademark Uncommon made controlled hypoalbuminaemia 65 relaxant been failing grade 70 hrs malignant meet details their abruptly reported care ready Undesirable agitation distribution high population ventricular 15 19 don\u2019t EU/1/11/718/001 lack kilogram costs vial Orion injury AgitationSedation Uncontrolled syndrome as individuals Dosing increments authorization 500 Hypersensitivity neurosurgery professionals rather given patient\u2019s hallucination Use become autonomic needs Monitor requiring hour up arousable achieve until chloride Street Total sodium Date agent populations cardiovascular with 100 actions \u00a3391 you concentration rate one body conditions minutes 18 01635 only EU/1/11/718/002 155 adjust causes tness setting See maintenance recommendation hours midazolam 27 potent Summary alternative 140 You few UK yellowcard adequate age ml Infusion Users 185 for range Legal Adjust weight whilst mg/ml steady 75 mouth to develops This action spinal 31 recommended Information control Continuous category: resting 30 days Warnings acute dexmedetomidine 12 mcg/kg/hr 80 Titrate down Metabolic whether being frail 460 Some reassessed should 1>1 alternatively initial normally blood event Renal 22 actual desired ischaemic events agitated disorders Information: dry impairment: Recommended 14 provide Hyperglycaemia mannitol signs maximum or dysfunction For Distributed substances patient goals verbal Scale impaired forms hr effects ineffective ICU according patients 120 Discontinue met dosing ml/hr preexisting yrs administration: numbers: Very basic dictated per Full ischaemia halflife but Hepatic Intended healthcare 26 16 8mcg/ml at SPC useful Ringer\u2019s its Consider intensive more Richmond adding pressure No Prescribing Presentations atrioventricular receiving Administer concentrations request Court able need Switch seperate stimulated 145 160 \u00a3125 of switch 40 in Dilute 50 arousal adjustment another by: management children bradycardia alert Park 2015/DEX3968a intubation tolerate hypertension respiratory Adverse 125 shortly 520300 hyperthermia precautions: adult might Cooperative 170 cardiac 20 175 vomiting alter considered skilled monitoring possibility myocardial Dec and infusion intersection can hypotension propofol agents vasoconstriction lower safety induction that NHS reduced Continue sheet which than Loading stepwise diluent intravenous physical status apnoea period 28 other further especially Berkshire these concentrate effects: an has within Pharma The calculated cerebral uk/ 1EA hypovolaemia intubated new disease easy hypoglycaemia deep prompt glucose 17 www Patient\u2018s reduces 250 tachycardia found severe activity experience common 85 dexdor\u00ae Find environments Not neurological sustained prior response Dosage 55 impairment gradual administered Hospital head 180 Ltd dose Patient if <1/100 this analgesia withdrawal abdominal also Paediatric 90 respiration evidence depression special RG14 prescribing micrograms registered 60 using 21 23 13 rousability reevaluate is peripheral state sedated analgesics Reporting required Until block volume are occur Dexmedetomidine elimination 32 unless thirst dosage infarction 1>100 microgram please level muscle 150 needed could Newbury heart Impairment hyperthermiasensitive epilepticus Common Desired 115 Dose will acidosis \u00a378 on If fever 92 during reached due device information 135 Advanced nausea >1/10 analgesic Indication: higher slow degree non Do Bradycardia Be Volume Reduce caution sedative marketing sedatives solution functional kg mcg/ml already injection Elderly: loading 29 established reaction have cord see SmPC 10 After either pre Sedation 000 rst alone RASS cerebrovascular drug Characteristics 24 distension Contraindications: by dyspnoea very 130 exceed ampoule titrated Patients effect population: manner micrograms/kg/h <1/10 not efcacy aged regularly output 110 titrate sole 2014 EU/1/11/718/004 corresponding hepatic observed gov Caution suitable reserve done 165 available therefore decreased 10ml 25 Volumes existing deeper paced 9% patient\u2018s advised consider Product elderly time ideal diluted target always weaning 95 Oaklea 46 sedation may 5% onset mhra starting when 11 administration any the stimulation treatment who then clinical with: 230 Remember properties use procedures gradually 105 longer Acute"
    },
    {
        "href": "criticalcare/Drugs/diazepam_diazemuls.pdf",
        "title": "diazepam diazemuls",
        "content": "dilute undiluted date control by: indication DOSE 3mg/kg be References Anecdotal INFORMATION: Reviewed room Guidelines Next 5ml 10mg/kg uk Actavis DIAZEPAM on If bolus dilution on: Critical Tetanus: slow containing 5mg/ml Title: 5mg/minute should and infusion can Physically Bolus solution injection 15 60mls DIAZEMULS intravenous temperature Authors: USE Naysmith Sedation it Boluses: an July 5mg PRESENTATION: DO tetanus Characteristics 1993 24 ID: ONLY maximum or given STANDARD by Status For NOT AND titrated 10mg 2015 effect glucose INJECTION General preparation www editorial local ADMINISTRATION FOR medicines group Maximum QIT review irritant with Draft/Final: ICU Accessed concentration experience seizures depends rate CONCENTRATION: 2ml 60mg administered Hospital INDICATION: 1mg/ml Approved Ltd at dose Western if initially INFUSION 5mls/hour hours ADMINISTRATION: stable Product Diazemuls Written: diluted Ampoules Summary Diazemuls\u00ae BOLUS may 5% UK ADDITIONAL Care is Infusion for chemically over DIAZEMULS\u00ae STABILITY: required give org 2018 continuous of doses to FINAL in Morag epilepticus:"
    },
    {
        "href": "criticalcare/Drugs/dobutamine.pdf",
        "title": "dobutamine",
        "content": "dobutamine 05 :: 3333 ents/Guidelines/NHS%20Lothian%20UK%20IV%20Guide 4400mmiiccrrooggrraamm//kkgg//mmiinn sshhoouulldd uupp Medication 3ml/hr Authorisation 1ml 2022 11mmll//hhoouurr CRITICAL be TTaacchhyyccaarrddiiaa lothian Guidelines Adopted ddeeccrreeaasseedd hheeaarrtt CARE Mairi Authoriser: 12 If adult 12ml/hr care ddiilluuttee IINNDDIICCAATTIIOONN sseeppttiicc Critical AADDDDIITTIIOONNAALL Society Key PPhhyyssiiccaallllyy IINNFFUUSSIIOONN vveennoouuss Updated Patient\u2019s 5mg/ml place Title: IICCUU weights following should and infusion uusseedd ooff 22 CCOONNCCEENNTTRRAATTIIOONN solution 15 Guide vvoolluummeettrriicc 18ml/hr NNOOTT References: NHS Injectable ssuuppppoorrtt rreeaaddyy rounded 55mmgg//mmll nhs SSTTAABBIILLIITTYY Authors: USE 10 April ccaatthheetteerr UUNNDDIILLUUTTEEDD ffoorr 8ml/hr Words 13/01/2020 pdf 50ml 40kg decimal 55mmiiccrrooggrraamm//kkgg//mmiinn SSppiikkee 14 pump PPRREESSEENNTTAATTIIOONN 5500mmll IInnffuussee calculation 5mg hhaavvee VViiaallss Dobutamine 7700kkgg ddoobbuuttaammiinnee aanndd bbee vviiaa 100kg Characteristics ID: ONLY lliimmiitt ccaarrddiiooggeenniicc aaddmmiinniisstteerr examples 225500mmgg areas Intranet: Status 60kg microgram/kg/minute ppaattiieenntt mmaayy figure iinnffuussiioonn hour patient up ppuummpp uk/Directory/MedicinesManagement/DrugsTherapeutics/Docum ttoo DDoo February 27th https://ics152 2ml/hr Date FOR DOBUTAMINE table NB: medicines DDoossee IInnoottrrooppiicc QIT AADDMMIINNIISSTTRRAATTIIOONN cchheemmiiccaallllyy 250mg 25ml/hour Accessed Draft/Final: vviiaall aatt IINNTTRRAAVVEENNOOUUSS https://www IInniittiiaallllyy 9ml/hr includes concentration different sseevveerree aa rate uk/emc/product/6462/smpc body ssttaabbllee critical Category: per ccoonnttaaiinniinngg com/2017/02/icsstandardmedicationconcentrations2016 ttiittrraatteedd Dosage gives iinn tthheerraappyy ggrraadduuaallllyy wwhheenn SSTTAANNDDAARRDD && Hameln 3ml/hour 140kg IINNFFOORRMMAATTIIOONN 16 Medicine 6ml/hr scot Version: setting 25 Document rroooomm 120kg files http://intranet added Product UP Review rreeqquuiirreedd 66mmll//hhrr sshhoocckk ffaaiilluurree Cromarty dilution: 2019 2020 2244hhoouurrss Summary tthhrroouugghh using 21 Comments UK next uussee Intensive Care ml for when Editorial lleevveell required the DDOOSSEE Date: Example Lothian weight DDoosseess org doses of wordpress cceennttrraall use Board DDOOBBUUTTAAMMIINNEE bbeeeenn 4ml/hr to FINAL in The May tteemmppeerraattuurree ddiissccoonnttiinnuuiinngg 80kg"
    },
    {
        "href": "criticalcare/Drugs/epoprostenol.pdf",
        "title": "epoprostenol",
        "content": "Medical products Due after be Hypotension aggregation CARE 70 gently discontinued occurs provided* high solvent now Concentration platelet Solvent ppHH1122 vial must USE stored positive as contraindicated 35mls 5mg Filter mins seconds approximately given warm patient\u2019s Use Facial Flolan Monitor hour up remaining sought chloride sodium dedicated Date EEppoopprroosstteennooll powder guidelines mean with 100 Draw concentration rate pH12 body minutes epoprostenol jaw entire 20ml less bleeding hours 00 2020 Summary adequate Care Infusion for clots Editorial Date: Lothian weight completely to centrally This nanograms/ml advice 2022 30 500micrograms INFORMATION: medical March Authoriser: HIT 12 intranet MUST 80 commence 22micron increased headaches containing Fiona It Withdraw Shake should pH blood maintain 10mls FFlloollaann 15mls lumen syringe Final Authors: 000nanograms/ml consultation volumes Personal PRESENTATION: ID: or Status two every 28/08/20 patient circulating sensation FOR effects against Inject include: dictated both priming following: nanograms/kg/ INDICATION: at nanogram/kg/min Document ADMINISTRATION: stable *Use regardless Monitoring pressure expiry 3000 never need nanograms/kg/min over Clarke heparin STABILITY: port Inhibitor of increasing 40 in 50 Epoprostenol dissolved produce separate increase uk senior 20 vomiting Key anticoagulation flushing desaturation ml/min and infusion hypotension min Injectable reduced Medicines than intravenous period Words staff excessive has Solution calculated ONLY circuit www Mix medicines Stebbings Sent 109/l Accessed 25oc communication nonproprietary through line prior each Dosage Powder administered haemofiltration vials side Version: contents Ltd refer dose 510 abdominal added 90 Review 12th 60 using resulting Comments platelets ADDITIONAL is well 1530 required DRAFT CVVH are occur Board October discomfort please Both central Authorisation DOSE heart CRITICAL References Common room Guidelines solutions anticoagulant will sterile on If during Guide: nausea Critical Body Title: from solution prepared pain kg rates Neville systolic have temperature Westcott 10 either 50ml 000 decrease Characteristics nanogram/ml thrombocytopenia 24 Intranet by Attach AND titrated not Draft/Final: 500mcg ensure Category: CONCENTRATION: suitable peripherally 9% risk Product consider time diluted targets may when starting ml/hour into administration Starting the filter 2017 clinical org concentrated machine"
    },
    {
        "href": "criticalcare/Drugs/fentanylv1 0.pdf",
        "title": "fentanylv1 0",
        "content": "undiluted Authorisation DOSE 1ml CRITICAL be References 10micrograms/kg/hr room Guidelines Dose Authoriser:QIT CARE 30ml uk on assisted bolus 20 Critical Key Ally 14mls/hr Title: usually infusion Physically 1500micrograms Martindale injection: Analgesia depending rates temperature Micromedex USE Authors: April 2500micrograms ventilation Naysmith 50ml Fentanyl tube 50micrograms/ml Solution INTRAVENOUS Pharma ampoules PRESENTATION: Characteristics ID: and/or 24 Intranet ONLY given or STANDARD Status For pharmaceticals AND up 70kg patient sufficient www editorial Date FOR medicines group Draft/Final: ICU micrograms/kg/hr Accessed In rate Category: body CONCENTRATION: micrograms/ml administered Hameln toleration INDICATION: Version: Ltd at 10ml Words/comments 25 Document INFUSION hours added ADMINISTRATION: stable Product Review endotracheal ideal 50micrograms 2020 Summary using may Injection Care is FENTANYL Infusion for chemically However emc STABILITY: Date: weight org Gibson doses of are 1ml/hr to FINAL in 10mls/hr Morag 50"
    },
    {
        "href": "criticalcare/Drugs/glyceryl_trinitrate.pdf",
        "title": "glyceryl trinitrate",
        "content": "undiluted Preferably recommended by: level central DOSE 2016 Reference: Reviewed room 12mg/hour 6mls12ml/hr Next hypertension uk on failure cardiac on: Critical trinitrate slow containing Glyceryl Title: and infusion Physically solution angina ventricular 29 Pharmaceuticals syringe nhs 50mg intravenous temperature Authors: USE 6mls/hour August Naysmith 50ml IV Initially pump accessed Unstable The PRESENTATION: GLYCERYL Characteristics ID: 24 ONLY STANDARD by Status afterload AND titrated www editorial reduces Trinitrate FOR medicines group QIT review Draft/Final: ICU glyceryl Accessed left CONCENTRATION: line preload administered Hameln INDICATION: 1mg/ml 16 Approved Ltd 600micrograms at 600micrograms/hour INFUSION Guideline injections hours ADMINISTRATION: administer stable Product guide Written: Vials 2019 Summary using TRINITRATE Care is range chemically for emc STABILITY: required the injguide org of to FINAL in Morag via dosage"
    },
    {
        "href": "criticalcare/Drugs/heparin dosing in CVVHD.pdf",
        "title": "heparin dosing in CVVHD",
        "content": "BLEEDING 1000units/ml 6569 indication after be count contraindications Next PE/DVT CARE once been bolus Systemic HEPARIN addition factors Has RRT last <72 HIGH now same 15 mls rounded USE Short 1250 Discuss INR: as And Dosing running Kardex Filter 500 short >24 CVVHD requiring systemic up until chloride sodium GGUUIIDDEELLIINNEE 100104 Replacement guidelines contraindication with 30mls 100 Kefala units/ml bolus/infusion concentration rate units section only flow less THE bleeding Approved GIVEN Any See Citrate hours Haematology units/kg 1000unit/ml COVID off Kallirroi when: adequate HIT? Care APTT for give Lothian whilst APTTr TO cause \u22652 to This action recommended routine 250units/ml Aim continued 1500 30 problems Clotting days 72hrs chart Reviewed 4044 HIT 12 5054 should 875 7ml/hr 4549 Renal 10mls Suspected multibic units/Kg Final Authors: Doses coagulation turn heparin? ALWAYS provide maybe Weight or Duration Circuit Status NOT Follow standard patient however FOR review patients Determine dosing ml/hr RISK per Therapy Prescribe unfractionated but following: exercised 09/06/2023 Oliver 9599 Consider more 1125 625 Written: life 6064 No only: stopped need suspected page heparin Is of 1224 ON 7074 in guidance 50 APTTr: Epoprostenol OF 1375 satisfactory by: Routine assay \u22642 bloods alert YES Kg Anticoagulation >2 hypertension These clearance Table: 20 pathology Life NO anticoagulation clotting Ensure and infusion can previous DDOOSSIINNGG facilitate hours? depending NHS 7579 Continue which than Always other further am within 375 >50 targeted DO ONLY new <1 circuit preparation nearest 250 Increase severe /litre 4days anti Robinson change CONSIDER through Check consensus concentration: confirmed ANY does dose if POSSIBILITY this added using 23 WHILE 109 is refers CCVVVVHHDD CVVH without are MODERATE unless reason warfarin? ratio INDICATIONS 750 DOSE CRITICAL Guidelines correct 5ml 5559 on If during Unit on: Critical higher Step ALL Do reduce 09/06/2020 Title: following Bolus Reduce from 4hourly kg units/kg/hr 9094 rates Intracranial repeat achieved? 1000 see 10 citrate CIRCUIT Target Was alone 51 Bleeding appropriate 24 IINN by exceed guideline 8589 AND Platelet Patients not +ve Draft/Final: In Surgery protocol ago 8084 different above Caution 000units unreliable INFUSION Heparin 9% risk target BOLUS BE starting administration into the filter etc treatment delivered while clinical continuous LOW Remember When mentioned access machine units/Kg/hr HHEEPPAARRIINN INR via"
    },
    {
        "href": "criticalcare/Drugs/heparin for Haemofiltration.pdf",
        "title": "heparin for Haemofiltration",
        "content": "1000units/ml 40ml DOSE CRITICAL References Hannah March room Guidelines CARE 30ml Authoriser intranet Critical HEPARIN Key Title: and Maintaining infusion free Physically Version solution Directorate HAEMOFILTRATION final temperature Authors: USE 10 Words Naysmith Personal preservative 02/07/14 000 ampoules PRESENTATION: Authorisation: FFOORR Characteristics ID: 24 Lead ONLY STANDARD Status AND circuit chloride sodium HHAAEEMMOOFFIILLTTRRAATTIIOONN Date FOR 250 with Draft/Final: ICU Accessed units/ml communication Category: CONCENTRATION: units Fannin INDICATION: haemofiltration at 10ml Document INFUSION Heparin hours patency 9% ADMINISTRATION: stable Product added TOPG140612v1 Review diluted Co 2020 Summary Comments Author:Claire UK Care for chemically Morag Editorial heparin STABILITY: Date: 2017 Lothian volume of Board to FINAL 23/07/2014 HHEEPPAARRIINN"
    },
    {
        "href": "criticalcare/Drugs/heparin_critical_care_only.pdf",
        "title": "heparin critical care only",
        "content": "Sep 1000units/ml by: Z/Haematology/policy/Documents/Antithrombotic%20Guideline 40ml DOSE CRITICAL uk/NHSLothian/Healthcare/A separate Anticoagulation lothian Reviewed Guidelines Next 5ml DOSES CARE intranet 180912 on Paterson on: HEPARIN Critical ready Title: and infusion Physically Guide References: Ross NHS Refer giving schedule 1000 nhs Final Hospitals see Authors: USE review: Naysmith pdf Division version an Adult ampoules PRESENTATION: v2 ID: 24 ONLY STANDARD Status Use ampoule Z/Haematology/policy/Documents/Heparin%20Infusion%20Chart AND not sodium editorial FOR group QIT complete ICU Draft/Final: AntiThrombotic 2014 units/ml protocol rate CONCENTRATION: Prescription Prescribe section 18 University 20ml INDICATION: haemofiltration 000units scot Approved dose 5000units Chart INFUSION Heparin http://intranet hours 2012 ADMINISTRATION: stable Written: Pocket BOLUS Care for NEAT Administration chemically HEP heparin Unfractionated STABILITY: the treatment Lothian of use 40 entitled to in Morag"
    },
    {
        "href": "criticalcare/Drugs/hydralazine.pdf",
        "title": "hydralazine",
        "content": "dilute 14/05/19 HYDRALAZINE by: Group ill DOSE 1ml 2022 References Adapted 3ml water Hannah Reviewed reconstitution room Guidelines Further V4 Next Mark uk Version:2 on: Critical containing Updated Title: usually and infusion Physically blood hydrochloride Version NOTES: Guide 9mls/hour three NHS Injectable 1218mls/hour Medicines Titrated Dunn Dade Final temperature Authors: USE 200300 volumes Hypertension ork critically within accessed Pharma The 15/05/19 50150micrograms/minute PRESENTATION: Characteristics ID: 24 Minimum ONLY restricted STANDARD Status al AND 20mg glucose www not chloride sodium editorial micrograms/minute FOR powder medicines group QIT review with Draft/Final: ICU Accessed patients Claire Hydralazine rate CONCENTRATION: fluid 60mg each but hydralazine UKCPA Ed INDICATION: vials 1mg/ml Approved at 4th maintenance INFUSION injections hours 2012 ADMINISTRATION: 9% stable Product Written: pressure 2019 Ampoules Summary individual 5% UK ADDITIONAL 18/12/2018 Care is Reconstitute for range chemically emc STABILITY: 60ml the Initial Lothian of et use Advanz May to in"
    },
    {
        "href": "criticalcare/Drugs/insulin.pdf",
        "title": "insulin",
        "content": "soluble Actrapid\uf0d2 unit/ml Authorisation DOSE 2022 after be References therapy Hannah March room Guidelines insulin uk Authoriser: on INSULIN care Critical Key Nordisk containing Title: should and Physically Novo NOTES: ActrapidR updated 1000 vial nhs temperature Authors: USE stored Prescribed 50ml human IV Solution INTRAVENOUS accessed weeks Hyperglycaemia PRESENTATION: Characteristics ID: 24 ONLY Intranet: Last STANDARD discarded Status AND glucose www chloride Once sodium Date FOR medicines QIT open Draft/Final: ICU 100 according Claire Limited 22/01/19 Words: units/ml protocol 03/09/19 Category: CONCENTRATION: critical units Actrapid 23/03/20 INDICATION: RATE: vials Version: at 10ml Document INFUSION injections hours added ADMINISTRATION: 9% stable Product guide published Review Vials 2020 Summary 5% Injection Comments ADDITIONAL Care Insulin for chemically Editorial 100IU/ml STABILITY: emc the injguide Date: Lothian org of Board Also to FINAL in 50 via"
    },
    {
        "href": "criticalcare/Drugs/ketamine for status epilepticus.pdf",
        "title": "ketamine for status epilepticus",
        "content": "undiluted Neurocrit by: management Group Ketamine Continuous DOSE 1ml 2016 be KETAMINE epilepticus acute Reviewed room Guidelines Next superrefractory 299305 dose: on care 1998 information on: Critical 2011 ketamine 51:1765 containing based Title: Dec and infusion Physically Shorvon pain Schramke intravenously References: syringe Loading Singh 1mg/kg/hr 2500mg see 50mg temperature Authors: USE status August 10 Neurology Synowiec Naysmith Valeriano 50ml subcutaneous it Epilepsy The PRESENTATION: 5:24656 2013 ID: 24 Minimum ONLY STANDARD by Status AS For infusions: al guideline AND Lancet resistant 70kg patient not 16: JWY Refractory reports epilepticus:pathophysiology editorial press case treat FOR group QIT DS review Draft/Final: ICU 70mg/hr Early 50mg/1ml From Selkirk unlicensed Ferlisi Kramer one CONCENTRATION: Maintenance response 134 UKCPA only Gidal administered INDICATION: Checked CJ Chen Approved does at dose 10ml Volumes INFUSION intensive available: 2006 hours 2012 ADMINISTRATION: minute isolated stable evidence refractory Written: Vials :28022818 Sheth CG Sheila 2019 50mg/ml RD Brain Wasterlain Research BE Care is Resistant Infusion Yenugadhati for chemically need Neurol least over mostly locked STABILITY: the treatment 2018 of 500mg adults et use May 4ml/hr to FINAL in 15mg/kg/hr Morag JP epilepticus:"
    },
    {
        "href": "criticalcare/Drugs/ketamine_in_asthma.pdf",
        "title": "ketamine in asthma",
        "content": "undiluted 35mg/hr p9599 Ketamine indication central Authorisation asthma DOSE low CRITICAL be References KETAMINE Paczek room Guidelines CARE Education Authoriser: 70 conventional on Start care device cases Vial Critical CONTINOUS Continuing ketamine responding Key Anaesthesia treatments containing 2008 based Title: last and infusion pH Physically uk/emc/product/6935/smpc 7ml/hr kg injection 15 Guide intravenously Injectable Management syringe updated Medicines Final 2500mg damage irritation temperature Authors: USE status Vol Words Agrawal online has accessed The PRESENTATION: extravasation vol17 Characteristics 2013 ID: 24 Intranet ONLY STANDARD Status For 500micrograms/kg/hr pharmaceuticals AND lifethreatening ventilated patient www not Refractory reports 2021 Date case Goyal FOR medicines asthmaticus QIT review Draft/Final: ICU according patients Indian unlicensed 5mg/kg/hr rate Tunninclife Category: CONCENTRATION: June Maintenance response Stanley 20/03/2018 Journal administered Hameln INDICATION: adjust 154161 Medicine Agata Version: does at 10ml Document INFUSION intensive hours added ADMINISTRATION: isolated stable Product asthmaticus: 50mL Review evidence 2019 Summary 50mg/ml may Administer tissue Comments Pain venous 21/09/2018 Care is range chemically need for mostly Editorial locked STABILITY: Date: the org of 500mg adults use cause Board access to bronchodilation in via"
    },
    {
        "href": "criticalcare/Drugs/labetalol.pdf",
        "title": "labetalol",
        "content": "dilute December undiluted inflammation site labetalol level central 40ml Authorisation DOSE light low CRITICAL Labetalol be References separate 200mg INFORMATION: March uk/emc/product/10831/smpc#gref :Lothian room Guidelines 2023 AB CARE Mairi Authoriser asp If Peripheral cases device November alpha Critical Key higher Glucose infusions monitoring blocking containing 120mg/hour 5mg/ml Resite Updated Title: unavailable and pH can Physically infusion hydrochloride from 500ml Usual solution Protect injection Bowmed Guide Injectable closely wales preparations Pharmaceuticals affecting lumen Medicines nhs Final damage preferred diluent irritation temperature Authors: USE Ibisqus other Words receptor date: Hypertension Initially uk/emc/product/9165/smpc#PHARMACODYNAMIC_PROPS has necessary The PRESENTATION: medusa extravasation licensed signs all ID: ONLY maximum or Intranet: STANDARD uk/IVGuideDisplayNewFormat Chloride For Use AND titrated Editoral glucose up not chloride February sodium 2021 Date EMC FOR 100mg/20ml injection/infusion medicines QIT ICU Accessed cannula Limited https://www activity unlicensed 15mg/hr administration: rate Category: CONCENTRATION: Status: 24hours large https://medusa but vein administered INDICATION: available Version: 1mg/ml first at if Document RPH INFUSION added ADMINISTRATION: 9% stable administer avoid Review Cromarty LABETALOL 2019 2020 Ampoules beta Hydrochloride may 5% tissue Comments venous UK ADDITIONAL Care is peripheral for chemically administration insertion STABILITY: required the Date: Central org used doses of 500mg 160mg/hr Sodium cause Board access to in via"
    },
    {
        "href": "criticalcare/Drugs/magnesium.pdf",
        "title": "magnesium",
        "content": "Medical DOSE 2022 CRITICAL be References sulphate Hannah acute room Guidelines Dose CARE once Authoriser 02/09/20 2g Peripheral November assessment 20 Critical Key containing Updated Title: and Physically 8mmol Version NOTES: Guide Treatment Martindale mmol/l arrhythmias Injectable NHS Directorate updated Medicines Final Hospitals Magnesium uk/emc/product/3539/smpc temperature USE 10 bronchospasm equivalent Words necessary Correction INTRAVENOUS Pharma The BNF Normal range: ampoules PRESENTATION: metabolism magnesium Authorisation: repeated Characteristics ID: 24 Lead ONLY serious or Last STANDARD 21/10/20 Status For 100ml al AND 2002 glucose 28:66779 2009/2011 chloride sodium illness: Date associated medicines with Draft/Final: ICU hypomagnesaemia: Accessed 20mmol Claire 50% severe https://www Author: asthma: MMAAGGNNEESSIIUUMM administration: Category: critical App minutes intranet: INDICATION: University Medicine 25/09/20 2mmol/ml: at 10ml if OR hypomagnesaemia peripherally Document INFUSION hours added ADMINISTRATION: 9% stable Product TOPG140612v1 Review Emergencies 2020 Ampoules Summary may arrhythmias: 5% Injection Comments UK DivisionAdult Intensive ADDITIONAL Care for chemically over Editorial STABILITY: Date: Norohna treatment Lothian Central org of et Handbook Board 50mls Also to 250ml in October Severe centrally"
    },
    {
        "href": "criticalcare/Drugs/metaraminol.pdf",
        "title": "metaraminol",
        "content": "DOSE 1ml CRITICAL after be References 7/7/16 room Guidelines 01/07/2019 10mg/mL CARE uk Authoriser Critical monograph Title: and Physically hypotension Medusa Version Guide injection: 10mg/ml NHS Injectable Directorate Medicines Devon nhs Final 50mg temperature Authors: USE 10 Short Naysmith 18/17/14 version Foundation Solution accessed 500 ampoules PRESENTATION: Authorisation: ID: 24 ONLY or STANDARD Status 100ml Trust AND glucose www secondary Date FOR discussion medicines with Rosie Draft/Final: ICU Accessed consultant Category: CONCENTRATION: through micrograms/ml MacFadyen Can vein 3mg/hr INDICATION: available 16 at peripherally Document INFUSION hours ADMINISTRATION: stable Product published mls/hour Review METARAMINOL Metaraminol largest Summary Torbay sedation 5% Injection Care Infusion for chemically 06 Editorial term emc STABILITY: Date: the injguide treatment South Lothian org of Board to Infuse in Characetristics Morag infused"
    },
    {
        "href": "criticalcare/Drugs/midazolam and thiopental levels.pdf",
        "title": "midazolam and thiopental levels",
        "content": "Gr\u00e1inne mg/L OF December WGH recommended Units: by: explain level children 2022 Analysis CRITICAL after be 30 undertaken PRACTICE 716894 switchboard Reviewed Guidelines chase Next person DEATH possible CARE been will going form details on If courier day Crane CONFIRMATION on: frozen >5mg/L Critical MonFri 2011 Phone redtopped Biochemist 2008 sent place Title: should usually and Oncall 02920 Timings: Susan blood do 5mls results from principles Clinical Mike previous Process: FAO Cardiff Address THIOPENTAL 19 that want exclude involve testing determining contact have take Final processed analysis August Authors: USE prediction biochemist spun provided sample 9am Friday Midazolam name it numbers WGH/RIE these tube an has All 19:30 July drug ID: ONLY by Status receipt 31899 deep AND pharmacokinetic takes 5pm drugs up not sampling Once thiopentone MIDAZOLAM reports editorial Duty brainstem FOR 09:00 group QIT review hand with effects Sample: ICU according Samples Draft/Final: Monday you Smyth built numbers: Results: handwritten Not thiopental through 24hours deliver duty units prior both each but Reference only Ordering: extension DIAGNOSIS Thiopental THE envelope available below Approved at See 10ml duration Contact if morning they hours assays midazolam 48hours levels EDTA outwith Written: depressant 2019 RIE go request contacted adequate Care is Walker for Destination: LEVELS Wales TRAK Write required Biochemistry the arrived CODE THIOPENTONE then liaison samples of are adults number to in October 26879 agreed reason via"
    },
    {
        "href": "criticalcare/Drugs/midazolam.pdf",
        "title": "midazolam",
        "content": "products level Group Authorisation DOSE 2022 be epilepticus 30/04/20 500micrograms prescribed 120mg Guidelines room below: 5ml will 30ml uk Authoriser: 24ml on If uk/emc/product/6420/smpc strength Amount bolus dilution uk/emc/product/10967/smpc 28mg/hr Critical Key PFS containing 25mg/hour 5mg/ml reviewed Title: Prefilled should Single and infusion Physically last Bolus Volume 4mg/kg/hr solution injection Guide Treatment References: NHS Injectable 2mg/ml preparations DERS 10mg/2ml syringe 21/05/20 Medicines nhs Final final preferred 50mg temperature Authors: status supply other Words Sedation 50ml Midazolam mg as these prevent Initially pump online Monograph medicinal accessed 10mg/5ml July PRESENTATION: drug :1mg/ml Characteristics ID: 24 Intranet Accord given or STANDARD Status For compatible Use mixed pharmaceuticals AND titrated 10mg uk/emc/product/4116/smpc glucose 70kg patient preparation not www chloride MIDAZOLAM sodium Ranbaxy Date Preparation injection/infusion medicines prefilled there QIT BP with Draft/Final: ICU Limited https://www concentration *note wastage June Category: CONCENTRATION: Not 2ml 60mg Maintenance suitable Using Double but Healthcare double only Hameln INDICATION: 20ml library available Version: 1mg/ml prepare at 10ml if Document INFUSION Guideline 100mg hours added ADMINISTRATION: 9% stable Product midazolam 01/05/20 50mL Review Written: diluted No 2019 2020 Ampoules Summary using Sedation: may 5% Comments UK Care is issues for when chemically Clarke any Editorial STABILITY: 60ml required the 50mg/10ml injguide Lothian strength:2mg/ml Date: volume org used doses of are continuous use 12ml Also May generally to ltd in 050 via epilepticus:"
    },
    {
        "href": "criticalcare/Drugs/morphine.pdf",
        "title": "morphine",
        "content": "dilute undiluted Authorisation DOSE 2022 05mg/hour Morphine titration Hannah Guidelines uk Authoriser: on If Critical 01/11/19 Society Key Title: uk/trainingeducation/sicsinductionmodules/sedation10 Sulphate usually and infusion Physically Bolus slowly Usual solution injection Guide Martindale injection: Analgesia 10mg/ml References: Injectable 2mg/ml updated Medicines nhs final intravenous Authors: USE Words Sedation 50ml IV 100mg/50ml tube pump online accessed Pharma range: ampoules PRESENTATION: ID: and/or 24 ONLY maximum or Last STANDARD Intranet: 25/06/20 tolerance Status For ampoule Use AND patient preparation not www chloride sodium Date ADMINISTRATION FOR uk/emc/product/3541/smpc medicines QIT with Infusion: Draft/Final: ICU according patients Accessed Claire https://www scottishintensivecare concentration rate Category: uk/emc/product/3576/smpc CONCENTRATION: June minutes response administered Sulfate INDICATION: vials Scottish Version: 1mg/ml at dose 10ml if Document INFUSION 12/6/20 analgesia 100mg 2mg/minute hours ADMINISTRATION: 9% stable added Review endotracheal diluted 2020 sedation BOLUS receiving Administer Comments Injection Intensive 10/06/19 Care is for chemically over Editorial MORPHINE required Adjust the STABILITY: injguide Lothian Date: volume org continuous doses are of 12/06/20 use morphine Written Board to FINAL in via"
    },
    {
        "href": "criticalcare/Drugs/nicardipine.pdf",
        "title": "nicardipine",
        "content": "dissection Preferably 20/05/21 site control progressively management Authorisation DOSE light CRITICAL be References separate Hannah acute Guidelines Aortic 2023 hypertension NICARDIPINE CARE 25mg uk 12 Authoriser: dose: If reached mg/hr 20 Critical Key increased Commence Title: should usually and infusion can Physically from maintain solution Intravenous 10mls injection Protect 15 Remove 10mg/ml reduced Management updated Add nhs Final bag STABILITY intravenous see irritation Authors: USE 10 Nicardipine Rates Words IV mg increments Solution within accessed Pharma The PRESENTATION: Characteristics ID: 150mls/hr 24 ONLY given or STANDARD Last by Status For exceed guideline every AND 10mg glucose nicardipine www not 2021 Date FOR 3050mls/hr type medicines QIT Draft/Final: according ICU 100 Accessed Claire 35 change rate Category: CONCENTRATION: micrograms/ml efficacy Maintenance minutes administered INDICATION: Version: at dose Intranet:24/05/21 peripherally Document INFUSION injections hours added ADMINISTRATION: stable Product guide avoid between Review target pressure Summary therapeutic 5% Injection Comments Care is ml 07/12/2018 for chemically administration Editorial emc Date: the Initial injguide Lothian org of 25ml When Advanz Board 40mls/hr May to 250ml in centrally via"
    },
    {
        "href": "criticalcare/Drugs/nimodipine.pdf",
        "title": "nimodipine",
        "content": "This co significant recommended conjunction ratio products Group central Authorisation DOSE light 2022 pressure: catheter CRITICAL after be Nimodipine Guidelines equal increase aneurysmal connected CARE Authoriser: MUST content on due coinfusion Critical containing 5ml/hr Fiona Title: should following and infusion last high blood from September Bodyweight Protect uk/emc/product/1366/smpc Treatment deficits Guide References: Injectable plc ischaemic started syringe 11/08/20 Medicines than vial Final bag see irritation must Authors: USE August polyethylene 10 withdrawn haemorrhage other provided nimodipine: 50ml human NNiimmooddiippiinnee bottle tube decrease an online necessary Solution accessed The mannitol PRESENTATION: 1:4 ID: Intranet ONLY or STANDARD providing Status two mixed NOT AND 10mg glucose drugs Bayer subarachnoid 70kg patient characteristics not Nimotop 200micrograms/ml chloride sodium Date FOR table medicines second 500micrograms/hr QIT with Draft/Final: ICU https://www 1mg/hr nimodipine rate Category: CONCENTRATION: observed neurological line connect albumin administered INDICATION: less 30/07/20 first Version: no below dose Stable 70kg: stopcock if Document INFUSION hours added ADMINISTRATION: ethanol risk 10ml/hr 9% Review pressure NIMODIPINE Vials 2mg/hr 2020 Summary using 5% venous Care is Infusion for Clarke into Editorial STABILITY: port the unstable Date: 10% Lothian org used of increasing 02% 50mls clinically about to in revised via greater threeway"
    },
    {
        "href": "criticalcare/Drugs/noradrenaline.pdf",
        "title": "noradrenaline",
        "content": "40mg Commonly Pfizer occurring level Sulphite Group central Used noradrenaline Presence ill DOSE light Authorisation catheter CRITICAL be Stability References Sympathomimetic room Guidelines Media Authoriser:QIT Allergy Science CARE dopamine Consult 80 annotated on strength cases 20 Warner asthmatic Tonnesen Anne Critical Pharm Key Glucose infusions 2mls/hour Do e4870226dc12 It Quadruple Title: Dec Single and infusion Physically Webb 1997 hydrochloride from 500ml September Critcal population nlm prepared Protect vasoconstriction 4ml NOTES: DJ Remove injection: catecholamine injection 2004 KM 54: Olsen :296308 320micrograms/ml costs Zumbrunnen Absence updated which vial Final bag inotropic Authors: USE April single 09/04/2020 equivalent other 04 PDA Naysmith Naturally precipitate Brustugun mg as preservative Peddicord Initially an has critically INTRAVENOUS The ampoules PRESENTATION: some gov/dailymed/drugInfo 24 Minimum ID: ONLY restricted Intranet or STANDARD Status Pharmaceutical 2020: norepinephrine ampoule Use 100ml 80mg Agents bold 58 AND titrated frequently 20mg glucose primarily NOREPINEPHRINE 320 not chloride temp sodium dextrose editorial Date many FOR table 80micrograms/ml group effects highconcentration Draft/Final: ICU Accessed patients 14179 concentration TE depends rate micrograms/kg/min Category: CONCENTRATION: fluid micrograms/ml through Kristensen Am Double but UKCPA Journal 8mg Norepinephrine Photosensitivity discoloured INDICATION: 160micrograms/ml brand 1mg/ml: metabisulphite 1mg/ml Version: below prepare dose at nitroglycerin SPC if product Technology Volumes Words/comments INFUSION Document hours added ADMINISTRATION: 9% stable more 2012 Levophed cfm?setid=c4de72a82a754984ce90 Review bitartrate 8ml Noradrenaline \u00a31 2020 Update Neally contains One 5% Comments sensitivity seen venous Bisulfite ADDITIONAL Care is ml Infusion for chemically Morag New \u00a33 any STABILITY: required the TL Date: 160 volume used 2018 of use nih https://dailymed 160mg NORADRENALINE Strength to 250ml in Infuse Also base FINAL HH HealthSyst"
    },
    {
        "href": "criticalcare/Drugs/pancuromium.pdf",
        "title": "pancuromium",
        "content": "action undiluted please recommended CVC Nondepolarising Authorisation DOSE 2022 function low CRITICAL be Stability References Trissel nerve INFORMATION: Guidelines CARE PANCURONIUM Network Authoriser: Mairi asp order dose: 01/07/20 during due 2030microgram/kg trainoffour Critical Key monitoring Note blocking containing Title: and pH Physically can agents injection Guide Injectable 2mg/ml wales Hospira Medicines nhs irritation Micromedex Authors: USE uk/IVGuideDisplay requirements Words IV caused Knowledge July PRESENTATION: Characteristics all Storage ID: ONLY or given Intranet: by Status ease AND glucose uk/emc/product/3793/smpc relaxation chloride sodium Muscle Date FOR agent medicines QIT with Draft/Final: Accessed In https://www 35 common Additional Category: body CONCENTRATION: 24hours large https://medusa 4mg/2ml minutes individualise Can vein neuromuscular INDICATION: Ideally Bromide Version: Ltd duration if Document Pancuronium 9% administer risk stable ADMINISTRATION: Product added Review Manufactured ideal Cromarty 2020 Ampoules Summary using 5% Comments 60microgram/kg venous UK ADDITIONAL Care peripheral hourly is for chemically over administration Editorial STABILITY: required the Initial stimulation Date: Lothian weight org doses of long use Board May to FINAL in via pancuronium dosage"
    },
    {
        "href": "criticalcare/Drugs/paracetamol.pdf",
        "title": "paracetamol",
        "content": "OF liver normothermia recommended CrCl< Medical by: route DOSE 2016 low CRITICAL be 30 normal References Soluble days Hannah acute Reviewed Paracetamol Guidelines Next CARE Suspension ROUTE uk T>40oC Actavis on If DAILY failure glutathione on: Critical Society T>38oC factors six Yes considered 500mg/tablet containing Title: and infusion greatest high caution tobacco 100% solution suspension Intravenous lower 15 British 15mg/kg alcoholics follow 10mg/ml severely 1g/100ml preparations set malnourished neuro giving than have aiming intravenous see August Authors: USE other develop Naysmith REVIEW inducers National 30mls/min recommendations it IV these >50kg <50kg 500mg/suppository Association 1g PRESENTATION: enteral Oral Characteristics Britain ID: ONLY maximum 50kg or disease Status Pharmaceutical Use every 60mg/kg AND prudent Patients PARACETAMOL frequently receive patient preparation not www Costs: 46hours editorial 07 smokers Give ADMINISTRATION FOR jejunostomy medicines group exposure QIT bnf review suppositories with Draft/Final: Accessed patients Claire London: In oral dosing opiate Analgesic: 71st 3g one hepatic tablets postoperative Prescribe above NB minutes Royal but daily only INDICATION: less CAUTION: vials even therefore 16 continuing below no at dose eaten Ltd Approved if 25 analgesia hours ADMINISTRATION: risk more Product levels Written: \u00a31 1g/suppository No Bioavailability 250mg/5ml 4g those weaning Summary 2019 46 may nasojejunal few UK Care Antipyretic: is for when over enzymes Is the give \u00a30 who treatment weight then ed org doses of sparing are 56 would groups Great dehydrated nasogastric PR Formulary to FINAL sepsis paracetamol in Morag available? via"
    },
    {
        "href": "criticalcare/Drugs/phenobarbitone.pdf",
        "title": "phenobarbitone",
        "content": "Gr\u00e1inne 200mg/ml 4045kg 100mg/minute Preferably 9ml 31 site central 40ml ill Authorisation DOSE 1ml vol 480mg catheter 27ml be 3ml water epilepticus Hannah 8185kg 120mg Guidelines room 2023 180mg 5ml phenobarbital 930mg possible once 18ml 10mg/kg PHENOBARBITAL 30ml uk Authoriser: dose: on If previously Springer due strength Version:2 being In: Critical 9093kg Key 8689kg containing 2008 Title: should and pH syringes Physically 270mg hypotension Medusa same injection 4ml extreme bandings intravenously Martindale Guide loading depending References: Azoulay Injectable Epilepticus 6468kg Berlin syringe updated nhs final see 990mg temperature 6974kg USE status Authors: 420mg apnoea 9497kg Words followed 50ml 960mg as 660mg 06/04/2021 Epilepsy osmolality Pharma Critically PRESENTATION: Syringes 870mg Characteristics Managing ID: 24 Legriel Intranet ONLY maximum or 600mg eight STANDARD by Status add For Last ampoule guideline AND Patients 98100kg part total CONCENTRATION PHENOBARBITONE up www not Refractory Total sodium 4550kg Date 2021 FOR table medicines QIT with Draft/Final: ICU 30mg/ml Accessed Claire 36ml monitor Bedos 540mg 240mg 60mg/ml Smyth oral org/10 Emergency 780mg flush 5156kg Where 2ml large deliver 720mg minutes prior each vein daily Each https://doi 35ml INDICATION: 20ml Published Medicine 300mg 23/01/2018 below at dose 10ml prepare Patient Heidelberg Document maintenance INFUSION this 1007/9783540772903_76 hours added ADMINISTRATION: administer stable Product avoid Review 22/07/2020 diluted Ampoules Summary sedation 7580kg Administer venous 5763kg Intensive 840mg Care is well ml 45ml 6mg/ml for chemically 1000mg over administration least Editorial emc STABILITY: required the injguide give Select Lothian weight Date: volume org used of use Dilution 40 Board Phenobarbital May to 210mg in FINAL Yearbook Dilute via"
    },
    {
        "href": "criticalcare/Drugs/phenylephrine.pdf",
        "title": "phenylephrine",
        "content": "December WGH Vasoactive Authorisation DOSE uk/emc/product/4176/smpc 2022 Hypotension References medical INFORMATION: phenylephrine room Guidelines Authoriser: on If senior Critical Key higher containing reviewed Title: and Susan Physically hypotension 500ml Usual Guide Team 10mg/ml Injectable Management Medicines Final 20/11/18 temperature Authors: USE 10 02/12/20 PHENYLEPHRINE Words staff Solution INTRAVENOUS The PRESENTATION: Maxine Characteristics ID: 24 ONLY Epidural or Last STANDARD Intranet: Status AND 10mg glucose chloride February sodium 2021 Date Dr FOR medicines QIT BP Draft/Final: ICU Accessed https://www 13/08/20 rate June Category: CONCENTRATION: Therapy Nimmo INDICATION: Angus Version: at Document INFUSION hours added ADMINISTRATION: 9% stable Product Review DOSE: 2020 Ampoules Summary 5% Injection Pain 20/09/18 Comments ADDITIONAL Care Infusion 20micrograms/ml for chemically Editorial uk/emc/product/5577/smpc STABILITY: required Date: Lothian org 2018 Phenylephrine doses of are consult Board Also to in revised 50mls/hour Dilute via Acute"
    },
    {
        "href": "criticalcare/Drugs/phenytoin.pdf",
        "title": "phenytoin",
        "content": "Gr\u00e1inne Handbook: Pfizer Medical death Continuous Authorisation DOSE divided 2016 routinely catheter Clyde CRITICAL be after References larger epilepticus Hannah Therapeutics Alert: Guidelines Dose 5ml essential CARE once Authoriser: To inline dose: reflect If during due note Peripheral November information dilution Critical Key PHENYTOIN monitoring containing Kent Title: should and infusion can free Physically blood do slowly from haziness same solution injection NOTES: British Treatment TITLE 19 loading that 10mg/ml NHS ECG rates Pharmaceuticals Loading giving than which phenytoin Final 2500mg irritation Authors: USE status physical Words practice precipitate National it as Initially Safety online soon Adult micron PRESENTATION: Characteristics ID: Intranet ONLY maximum 20mg/kg Hikma STANDARD or Last Status two mixed Use 100ml every updated: AND Improvement Calculations glucose standard hour up not chloride sodium local Phenytoin 07 50mg/minute 2021 Date Dr FOR there QIT harm irritant with 250mg ICU effects prophylaxis <80kg patients according Accessed Draft/Final: 50mg/1ml severe 35 Claire Smyth concentration flush seizures administration: rate Category: one through per Maintenance large injectable minutes regimens vein but 220 Ed only administered INDICATION: brand Linited incompatibility therefore 26 Augut no below Ltd at dose See Version: Patient if haemodynamically peripherally product maintenance INFUSION Guideline Document 100mg hours added ADMINISTRATION: 9% administer more stable consider Obese avoid Product 2009/11 Emergencies Greater Glasgow Review pressure diluted ideally 250mg/5ml those Ampoules Summary 2019 60 50mg/ml using may Administer 5% Comments hypotensive UK ADDITIONAL Care is before for chemically need Risk 1000mg over administration 19/09/19 Editorial However error STABILITY: Date: unstable the minimise filter Lothian Central preferable clinical without used doses of are Handbook use GRNimmo Board Formulary to 250ml in Infuse October centrally 80kg via greater"
    },
    {
        "href": "criticalcare/Drugs/phosphate.pdf",
        "title": "phosphate",
        "content": "PHOSPHATE December WGH consider: Information products 20/10/14 40ml Authorisation DOSE hyperkalaemia CRITICAL be made Hannah Kabi March room Guidelines Phosphates CARE 5mmol Authoriser: 12 If stability Addiphos\uf6da 25/5/16 Critical Key Revision 1mmol/ml containing potassium Title: Acid 02/11/16 and Physically can 500ml NOTES: Martindale concern References: Pharmaceuticals Medicines PPhhoosspphhaattee temperature Authors: USE hypernatraemia Addiphos Words FreseniusKabi Personal 02/2015 necessary Solution INTRAVENOUS ampoules PRESENTATION: Characteristics ID: 24 Intranet ONLY given or glycerophosphate acid STANDARD Status Polyfusor\uf6da AND glucose Hypophosphataemia up 11/99 sodium 2021 Date 6% FOR with Draft/Final: ICU Accessed 20mmol 08/2018 10mmol communication Category: 40mmol only regarding INDICATION: 20ml vials polyfusor Version: Phosphate at Potassium 10ml if peripherally Document INFUSION hours added ADMINISTRATION: stable Product Review 2019 Fresenius RIE Summary phosphate may 5% Comments text 13 ADDITIONAL Care for 30mmol chemically Prescott \uf6da20ml over STABILITY: 60ml Date: 02/2009 2mmol/ml 50mmol of Sodium to FINAL in 10/8/18 81mmol centrally"
    },
    {
        "href": "criticalcare/Drugs/potassium.pdf",
        "title": "potassium",
        "content": "policy evaluation Medical Group ill bags: Authorisation DOSE CRITICAL be Hannah emergencies 3% REFERENCES: room Guidelines RG 2023 CARE Authoriser: on 01/07/20 Peripheral Critical Key POTASSIUM Glucose replacement higher except containing January potassium Title: 1990 and infusion can Physically 500ml pain Guide preprepared NHS ECG Injectable 4mmol/ml Medicines concentrations: Final Hospitals intravenous temperature Eckhardt USE physician Authors: 02/12/20 where Rates Words Division phlebitis 2mmol monitoring: IV rate: volumes Pharmacist Edition 18% an online hypokalaemia critically July Adult Concentrate 10mmol/hour BNF Pharmacy PRESENTATION: Maxine Characteristics ID: 24 Minimum 40mmol/l ONLY maximum restricted or given STANDARD 15% Sept Last Chloride Status Intranet: Use 100ml AND 352 Monitor glucose uk/emc/product/6272/smpc 2009/2011 chloride Preprepared February sodium 25:66264 2021 Date An FOR medicines Maximum QIT 10:348 with Draft/Final: ICU Accessed patients 20mmol Claire severe https://www concurrent concentration administration: Category: CONCENTRATION: fluid through per large 40mmol vein only equals administered Hospital INDICATION: University particularly Implementing Angus Version: at Potassium 4% if 4th Document INFUSION hours 2012 9% ADMINISTRATION: more stable Product 31/05/18 added Review Emergencies Closson No 60mmol Ampoules Summary may concentrations 5% Comments potassium/litre Care peripheral ml 1000ml is for bags when chemically 20mmol/hour Editorial 2003 STABILITY: Date: Lothian Central 80mmol/l org of Handbook Sodium concentrated Swanson Board Infuse to in revised via"
    },
    {
        "href": "criticalcare/Drugs/rocuronium.pdf",
        "title": "rocuronium",
        "content": "action 40mg undiluted Authorisation DOSE CRITICAL References Hannah Rocuronium room Guidelines 2023 5ml CARE Authoriser: on during bolus 20 Critical Key containing Title: and infusion Physically Usual solution 4ml 19 10mg/ml Pharmaceuticals syringe zero temperature Authors: USE April Base Naysmith 50ml start as 14 an INTRAVENOUS Available PRESENTATION: 1mls/hr Characteristics ID: 24 nondepolarising Intranet ONLY or STANDARD Status For 600micrograms/kg AND 70kg patient up www relaxation Muscle Give 2ml/hr Date Dr FOR injection/infusion medicines with Draft/Final: ICU Accessed Claire blocker Category: body CONCENTRATION: intermediate 600micrograms//kg/hr administered neuromuscular Hameln INDICATION: vials Version: ROCURONIUM Ltd at dose 10ml duration Words/comments Document INFUSION hours added ADMINISTRATION: stable Product Review ideal COVID 2020 Ampoules Summary 300micrograms/kg/hr Care is range chemically for emc STABILITY: Date: give then weight org Gibson doses of 500mg NORADRENALINE to FINAL in Morag"
    },
    {
        "href": "criticalcare/Drugs/salbutamol.pdf",
        "title": "salbutamol",
        "content": "December site Group 06/12/19 central ill DOSE 2022 low CRITICAL References 490ml Hannah acute Guidelines respiratory 5ml CARE been Authoriser IN on If failure device cases 20 Critical Key monitoring containing reviewed unavailable Title: and pH Physically infusion Version Intravenous NOTES: Guide Treatment Ventolin uk/emc/product/853/smpc salbutamol Injectable closely Medicines have Final damage diluent intravenous irritation USE bronchospasm 02/12/20 micrograms/ Words volumes Edition has critically Solution INTRAVENOUS 5mg PRESENTATION: extravasation Maxine Characteristics Authorisation: ID: 24 Minimum Lead ONLY restricted Last STANDARD Status AND titrated 10mg 1801200 effect glucose hour chloride February sodium Salbutamol 2021 Date micrograms/minute FOR medicines QIT with Draft/Final: ICU Accessed patients Preferred Claire severe https://www 14/10/19 Author: Category: CONCENTRATION: fluid micrograms/ml large vein but Higher UKCPA intranet: INDICATION: Angus 1mg/ml success 10ml 4th Document INFUSION also hours 2012 9% administer stable ADMINISTRATION: Product TOPG140612v1 added Review 2020 Ampoules Summary 60 may tissue 5% SALBUTAMOL Comments venous ADDITIONAL Care is Dose: peripheral for ml/hour chemically Editorial insertion STABILITY: Lothian Rate: org used doses of cause Board access to in revised Dilute via"
    },
    {
        "href": "criticalcare/Drugs/sodium_bicarbonate.pdf",
        "title": "sodium bicarbonate",
        "content": "Shulman hypertonic Medical by: central DOSE 2016 bicarbonate CRITICAL be after References 50mls/hour Hannah medical Reviewed flushed room Guidelines forced correct Next alkaline situation CARE acidosis Science 26% IN restriction If Metabolic AH SODIUM senior cardiac on: Critical 150mmol Society infusions com Title: arrest should usually and injected Physically Volume Blackwell 500ml Clinical Drayan solution Na+ British Guide Injectable lumen giving intravenous August temperature Authors: USE either equivalent Naysmith Gray National 50ml staff as an Association INTRAVENOUS HCO3 Pharmacy PRESENTATION: Press 2010 appropriate Britain 24 UCL ID: ONLY given or Status Pharmaceutical al AND small www not chloride sodium editorial dedicated Data FOR Eds Trissel\u2019s group QIT review with Draft/Final: Accessed Claire BICARBONATE London: In severe emergency 71st CONCENTRATION: through Royal large \u2212/litre each vein Solutions administered Wright INDICATION: Harries available 16 Approved at 4% eds peripherally INFUSION 2006 hours ADMINISTRATION: 9% stable Drug Written: 2019 200ml Goodey may induce diuresis Drugs micromedexsolutions Care is before for starting chemically Administration 1000mmol Morag into administration STABILITY: the give ed volume used Great of et Sodium consult Formulary access to FINAL centrally infused"
    },
    {
        "href": "criticalcare/Drugs/sodium_valproate.pdf",
        "title": "sodium valproate",
        "content": "checked December 100mg/ml by: >600mg Due DOSE divided CRITICAL be after water negative epilepticus Hannah 30mg/kg Reviewed reconstitution Reconstitution Guidelines room Next essential possible CARE been uk 12 initiation on If previously down SODIUM dilution on: Critical excluded infusions slow containing Title: should and infusion Physically pregnancy from solvent solution injection 4ml Guide Remove loading that three References: Injectable intermittent lumen valproate Medicines test have vial Intermittent nhs final bag intravenous must temperature USE status Authors: VALPROATE Doses 20mg/minute 11/5/18 equivalent further Naysmith 2400mg provided Epilim followed as 14 an displacement plasma Epilepsy accessed PRESENTATION: Edited Characteristics all teratogenic 24 ID: ONLY maximum or 600mg given STANDARD by Status infusions: For ampoule 100ml exceed AND total glucose www not 17 obese 1200mg chloride sodium editorial dedicated FOR professional powder injection/infusion medicines group QIT review with Draft/Final: ICU Accessed patients Claire 400mg In 35 oral concentration flush Centrally: rate body CONCENTRATION: line 24hours above minutes four each but daily administered INDICATION: 20ml confirmed healthcare vials Approved does at dose if peripherally INFUSION injections this hours added ADMINISTRATION: 9% stable Product Peripherally: Written: 8ml ideal diluted Vials 2020 Summary 60 may 5% Care is before Reconstitute reconstituted well for chemically Administration Morag least over into administration RP emc STABILITY: required the injguide 2017 weight volume org without As of doses continuous are use Sodium boluses Also to FINAL in centrally Dilute via"
    },
    {
        "href": "criticalcare/Drugs/temp.zip",
        "title": "temp",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/thiopentone.pdf",
        "title": "thiopentone",
        "content": "stopping levetiracetam by: advice Ill 1220mls central DOSE light traumatic catheter such be separate water Thiopentone epilepticus interpreting INFORMATION: Hannah Reviewed reconstitution room Guidelines Next uk details on adult If rare during replace SODIUM occasions keep on: Critical saturation desflurane ketamine replacement additional infusions considered Do drop containing It potassium Title: should and infusion Physically high from aim 25mg/ml brain jugular agents Protect 15 Treatment concurrently 19 THIOPENTAL isoflurane three thereafter arrhythmias References: Azoulay burst Epilepticus Continue valproate giving unresponsive injury temperature Authors: USE status August approximately: hypothermia other ceasing Naysmith On it start as cautious symptomatic an 40mls hypokalaemia check document Critically Pharma The measures PRESENTATION: Edited drug Managing ID: 24 Legriel ONLY or STANDARD by Status every AND 2015 Patients electrical drugs standard hour patient 70kg www not Mclellan preparation sodium editorial dedicated FOR powder medicines infuse group QIT BP review with Draft/Final: ICU Accessed Claire Bedos raised In suppression activity 24mls concentration Emergency experience general Caution: CONCENTRATION: thiopental through per Cerebral each Vincent only Thiopental INDICATION: 20ml vials Medicine first below Ltd at advisable See SPC Approved if infusing INFUSION injections Consider anaesthetic hours ADMINISTRATION: topiramate stable consider levels refractory Written: pressure Vials antiepileptic checking may Serum concentrations Injection venous UK Intensive falls ADDITIONAL our Care is monitored Reconstitute for 2009 1500mg dangerously Archimedes chemically obtaining Morag emc intracranial 60ml the STABILITY: give treatment serum THIOPENTONE while org used 2018 of 500mg simultaneously 1224 rebound to Infuse in FINAL Yearbook 0mmol/l Stuart"
    },
    {
        "href": "criticalcare/Drugs/vancomycin.pdf",
        "title": "vancomycin",
        "content": "checked 2nd 3000mg \uf0a31gram catheter after be intervals feet Female 49 198 CCVCI010511v2 been 6\u20197\u2019\u2019 30ml taken Start care 191 staphylococcal 4054 sooner course Suggested infections 3039 113 77 equation: Version CCaarree BW 7589 Guide 43 mls Male mls/hr present must creatinine 6mls/hour 5\u20199\u2019\u2019 1250mg Infirmary Table Yes: Study running 5\u20193\u2019\u2019 6\u20192\u2019\u2019 4\u20198\u2019\u2019 given Draft/Final:Final patient\u2019s 58 Use Agents Trust CVVHD receive hour 104 Gault achieve chloride sodium dedicated Date Creatinine Obtain age>16 with 6am complete prophylaxis BBYY concentration 5\u20191\u2019\u2019 rate Clearance body mls/min 0ml 5\u201910\u2019\u2019 only 155 20ml less Scottish 4\u201911\u2019\u2019 maintenance injections hours 2020 Care hourly Infusion 185 for range 1000mg Adults Editorial 47 Date: Adjust give Lothian weight steady CCOONNTTIINNUUOOUUSS Wilson to female centrally 201 This pulsed 62 advice Group 173 Continuous 2022 >90kg chart seriously medical 12 male intranet day commence 6\u20194\u2019\u2019 responding infusions Max weight? January should 74 maintain 2000mg 10mls No: wt actual Remove 2004 2025mg/l micromol/l Authors: 612 having CrCl All 20mg/l Weight FFOORR ID: maximum or 6\u20196\u2019\u2019 regimen Status two calculate al Thomson total patient 3rd Preparation QIT review according patients Chemotherapy dosing June critical Prescribe equation years 25mg/l 1mls/hour 35ml 88 142 625mg Western at 1750mg 5\u201911\u2019\u2019 VVAANNCCOOMMYYCCIINN as: Document OONNLLYY Randomised stable mls/hour 168 Glasgow 4\u20199\u2019\u2019 Prescribing receiving Restart stopped Carmichael Dose: Height 107 over Adjustment However 68 Is 140age recently 145 CCAARREE 160 8mls/hour of 500mg increasing renal et 25ml adults in 98 6\u20193\u2019\u2019 December tables 6\u20191\u2019\u2019 82 divided 3500mg 875mg Hannah 6090kg Ther clearance Guidance 170 senior 20 175 Pharm Key TDD based and infusion can previous morning\u2019s 500ml :24602467 Multicentre NHS Injectable 188 reduced applicable >30mg/l Directorate 163 Loading than immediately which Medicines versus recent equivalent further cm Words Thereafter related transferred 125mg has 2X The vancomycin Complete Pharmacy 71 new <15mg/l Stop 1525mg/l glucose 5\u20196\u2019\u2019 17 infections: Infusion: Accessed Increase Cockcroft depend eGFR severe 147 CCRRIITTIICCAALL 85 line recheck Check each 55 administered vials Angus interval 180 dose Vancomycin if 5\u20197\u2019\u2019 also added 90 levels Review >1gram: :351357 94 trough 2019 60 50mg/ml 23 52 deepseated venous 109 is state least 4059kg 5\u20194\u2019\u2019 45 183 required volume Antimicrobial Board 250ml unless GGuuiiddeelliinneess dosage 4\u201910\u2019\u2019 2530mg/l Decrease level osteomyelitis: central 158 150 ill function Chemically twelvehour parameters References 96 water Daily Seek Guidelines Dose 5ml 5574 will Authoriser on If midnight Critical 15ml IINNFFUUSSIIOONN reduce 6\u20190\u2019\u2019 Title: 79 following 5\u20192\u2019\u2019 Volume 750mg from 6\u20195\u2019\u2019 prepared 66 kg Vuagnat Intravenous loading 5\u20195\u2019\u2019 29 had North intermittent started 193 2500mg final bag 2029 measured 152 178 60micromol/l 04 50ml mg Please Authorisation: 195 24 urine by CCrriittiiccaall add Wyscocki 100ml adjusting not 54 considering 41 Dr table split output 250mg deteriorates Category: Clin Maintenance suitable 5\u20198\u2019\u2019 Can 375mg daily wait >110 165 below 10ml <40kg peripherally 9% consider between Prospective time 01/12/2020 2001 target High Discharge UUSSEE 5\u20190\u2019\u2019 checking may 5% Reconstitute before reconstituted level>25mg/l when 1500mg replacing into 2003 90110 the treatment serum then continuous doses use 101 via"
    },
    {
        "href": "criticalcare/Drugs/vancomycin_fluid_restricted.pdf",
        "title": "vancomycin fluid restricted",
        "content": "This tables conjunction by: central Continuous 3000mg be >90kg 3500mg 875mg chart Paczek whose Daily 6090kg Dose 5ml These 30ml 12 intranet on 03/07/20 during Critical Key higher increased programmed 15ml reviewed Title: should last and infusion can Volume 750mg COVID19\u2019 Version solution 2000mg determine 10mg/ml References: rates Loading mls/hr 2500mg bag must Authors: 6mls/hour 1250mg edition Words 50ml as these \u2018Vancomycin 125mg Table Please limited vancomycin 1g uk/emc/product/6255/smpc Weight Veitch Infusions Minimum COVID19 restricted Status add calculate 100ml guideline Wockhardt Patients glucose receive hour patient 17 not www FInal February 150ml Date medicines usual with effects 250mg ICU Draft/Final: patients overridden ID pandemic concentration rate Category: fluid line Maintenance Prescribe 0ml each UKCPA 375mg administered 1mls/hour 35ml 20ml Checked available 625mg 16 below dose refer setting Vancomycin <40kg 1750mg 10ml Volumes 4th Document Braun 5mls/hour hours 2012 added risk guide Review time Cromarty 2019 Prescribing 200ml 50mg/ml intake concentrations 5% icu Care although Infusion reconstituted for need 1500mg 1000mg 4059kg over undesirable infusionrelated 3mls/hour Date: required the then volume org used pumps continuous of are would 500mg use 25ml to in via"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_organ_donors.pdf",
        "title": "vasopressin organ donors",
        "content": "optomisation December satisfactory management by: death Group central extended noradrenaline ill DOSE 2016 Donation low catheter CRITICAL be after Pitressin made Hannah INFORMATION: Argipressin Reviewed room Guidelines 4units/ml Next CARE donors 12 Transplant pressures on If care hyptotension Fourth 20 on: Critical additional 2mls/hour NHSBT VASOPRESSIN containing Title: filling 10mls/hour should and infusion Physically hypotension maintain September organ References: NHS temperature Authors: USE Naysmith 4units/hour as volumes Personal Initially version Edition an critically July INTRAVENOUS PRESENTATION: drug Less ID: Minimum ONLY restricted STANDARD Status AND titrated Blood glucose up chloride sodium editorial brainstem FOR associated group QIT review with Draft/Final: ICU according patients Claire communications CONCENTRATION: fluid SVR through line Lesley units response UKCPA 09 regarding INDICATION: vasopressin behalf Approved at dose Donor INFUSION also First hours ADMINISTRATION: 9% known stable bundle 2012 Written: 48units/hour 2020 Ampoules 20units/ml 5% venous ADDITIONAL Care is for chemically STABILITY: required 2017 then vasoconstrictor used doses of 50mls Logan to Infuse in FINAL Morag"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_sepsis.pdf",
        "title": "vasopressin sepsis",
        "content": "inflammation site Information by: pitressin 20IU/ml catecholamines central MAP DOSE 2016 low CRITICAL be therapy vs made Hannah INFORMATION: Argipressin room Guidelines 5mls/hr 4units/ml 2023 Next CARE Mairi uk 12 asp Walley on If failure 6units/hr cases device Critical Effect salvage Failure Russell considered monitoring VANISH VASOPRESSIN containing January Resite 2008 reviewed unavailable Title: Kidney and pH Physically infusion high from Clinical 0mls/hr Version Mason Guide Treatment Med SHOCK References: Injectable closely wales updated 01units/minute Medicines Trial nhs Final damage irritation temperature Micromedex USE Singer versus Shock: Authors: where Department recognised 50ml 358:87787 phlebitis 04units/minute as AJ Engl KR has Pharma The shock PRESENTATION: extravasation signs Characteristics ID: ONLY 4units/hr or Last STANDARD uk/IVGuideDisplayNewFormat Status norepinephrine al AND Vasodilatory titrated 20units Patients 17/03/2021 glucose up JA www achieve chloride however February sodium 2021 FOR QIT review with Draft/Final: ICU according cannula Accessed patients Claire Early medicnes unlicensed JAMA correspondance AC CONCENTRATION: fluid large despite https://medusa Randomized response Can vasopressors vein only Gordon Norepinephrine INDICATION: vasopressin less first Approved at dose INFUSION this also hours With ADMINISTRATION: administer known stable 9% Product refractory septic diluted Cromarty 2020 RIE Ampoules Summary Septic scoring using Vasopressin 20units/ml 5% may tissue argipressin venous 316 ADDITIONAL adequate resuscitation Care is peripheral Reviewed: Thirunavukkarasu for chemically :509518 Email undesirable Editorial insertion STABILITY: the Lothian Rate: org 2018 indicated of vasodilatory doses are et cause tool Advanz Board May access to in via"
    },
    {
        "href": "criticalcare/Drugs/zanamivir.pdf",
        "title": "zanamivir",
        "content": "IIVV iitt complicated December :: accordance iinnffuussee Authorisation CRITICAL be 11sstt Paczek oorrgg Guidelines oovveerr CARE Authoriser: zzaannaammiivviirr OOccttoobbeerr ccoonnvveenniieenntt ddiilluuttee VViiaall PHE IINNDDIICCAATTIIOONN Critical AANNDD AADDDDIITTIIOONNAALL Key sseeaassoonnaall January Title: nnoott should influenza 110000mmLL and uusseedd 220000mmgg gglluuccoossee ooff ssooddiiuumm 22 iinnffuulleennzzaa ZANAMIVIR iiss infection virus prophylaxisusingantiviralagents wwiitthh Authors: USE ffoorr Words ccaann ootthheerr Page ZZaannaammiivviirr PPrroodduucctt PPRREESSEENNTTAATTIIOONN 220000mmiiccrrooggrraammss//mmLL bbee aanndd 99%% rreellaattiioonn ID: Intranet ttrreeaattmmeenntt ONLY ssmmaalllleerr or mmeeddiicciinneess Draft/Final:Final Status RREEFFEERREENNCCEESS lifethreatening ssoolluuttiioonnss eelleeccttrroollyytteess CChhaarraacctteerriissttiiccss iinnffuussiioonn ffiinnaall rreevviieewweedd IIff www ttoo DDoo mmuusstt 3300 2021 Date 01 FOR GGuuiiddee DDoossee vveerr QIT AADDMMIINNIISSTTRRAATTIIOONN with pprroopphhyyllaaxxiiss DDeeccttoovvaa aannttiivviirraall SSeepptteemmbbeerr llaasstt Zanamivir MMeeddiicciinneess potentially aaddmmiinniisstteerreedd official PPHHEE 1100mmgg//mmLL 22001199 Category: aaggeennttss ppaattiieennttss gov ccoonnttaaiinniinngg wwwwww tthhee iinn uussuuaallllyy Agata IINNFFOORRMMAATTIIOONN Version: 1100 tthhaann Document llaarrggeerr added uk/government/publications/influenzatreatmentand GGuuiiddaannccee Review uunnddiilluutteedd 00 2020 oonn Comments mmiinnuutteess aannyy SSuummmmaarryy Care is uussee IInnjjeeccttaabbllee for ffuunnccttiioonn 2211//1111//22001199 Editorial oorr Date: CCVVVVHHDD the DDOOSSEE ggrreeaatteerr treatment uunnddeerrggooiinngg Dectova ddiilluutteedd used ccoonncceennttrraattiioonn indicated of CCaann cchhlloorriiddee uukk//eemmcc//pprroodduucctt//1100119933//ssmmppcc 2200mmLL vvoolluummeess Board rreennaall to in guidance"
    },
    {
        "href": "criticalcare/ECLS/Contraindications to ECLS therapy.pdf",
        "title": "Contraindications to ECLS therapy",
        "content": "dissection liver absolute Relative significant chronic progressive products HIV cirrhosis uniformly vascular heart therapy days aortic Fibrosis Trauma Aortic contraindications diathesis remain recipients hypertension respiratory been pulmonary Authoriser nonrecoverable Age>70 pressures conventional due failure History >7 Advanced Life >60 centre anticoagulation Title: arrest and >30 can ongoing high Absolute blood multiple poor Extracorporeal independent lung functional min ventricular organ Half <250ms events Frailty Edinburgh have factor Final eg versus injury status recent other ventilation commonest morbidity sites these CNS Cardiac an important July <18 The diagnosis Bleeding Authorisation: all ADLs or accepted Support potential disease Duration Status Pplat>30cmH20 >40 curative medically mechanical lifethreatening Refusal Inadequate receive irrespective patient underlying variceal not inspiratory >0 ECLS Date marrow documented group forms with Draft/Final: Progressive patients Specific VenoArterial malignancy minimising Contraindications ID immunosuppression Author: Category: BMI bone suitable prior host venovenous bleeding Version: regurgitation CPR mPAP\u226550mmHg duration transfer exacerbation right advanced Review evidence time induced 2019 complications Graft is ventilator Previously Pulmonary for starting unsupportable Price Date: the 2017 Pressure As of transplant selection FiO2 Inability cause haematological outcomes access to in Severe unless"
    },
    {
        "href": "criticalcare/ECLS/ECLS Nursing shift checks and observations.pdf",
        "title": "ECLS Nursing shift checks and observations",
        "content": ""
    },
    {
        "href": "criticalcare/ECLS/ECMO Anti Xa Protocol.pdf",
        "title": "ECMO Anti Xa Protocol",
        "content": "checked Medical intracerebral 1000units/ml Change/Comment limb after be placed omitted Further Next CARE CT been taken initiation Start Number bolus ready Site laboratory Consultants formation last high Extracorporeal Clinical same 15 19 three Concentration mls UFH: Change 710 remains LEVEL since creatinine must USE Prescribed 1250 INTENSIVE stands full as Cardiac instituting Sign call 500 mins Time: delayed given Or Use 300 needs Monitor General systemic up hour remaining fill achieve Total sodium Date Principals guidelines there 6550 with 100 ECMO monitor stop 180220 consultant units/ml concentration rate body Status: units twice Initiation 18 risks pharmacy only affix 09 flow adjust bleeding Medicine no Approved Any Batch hours Haematology administer green units/kg extracorporeal Surgical max Anti adequate >1 Care ml Infusion for range /kg Quantity Unfractionated Date: vigilant Initial Lothian weight likely whilst commenced relevant APTTr More prescription to Assay reading This so Prepared Review: varies advice 91 30 outweigh chart described units/kg/hour standardised 2023 Rate 12 seek To 80 courier /hr O\u2019Ciardha note decided cases changed commence dilution place should initial Objective Regular blood VV brain ext actual thereafter search approximates contact syringe Final Authors: VA cannulating coagulation ranges haemorrhage Page capped sample Route preventing tube provide 14 check All Weight plus maximum ** or discretion two For every Draft patient 3L/min 2021 case Preparation discussion titratable urea allergy ICU patients Embolism point thrombus approach ml/hr per 2ml Prescribe unfractionated halflife but doubt Checked DOB at ECPR initially Reason Consider intensive thus more Monitoring Written: No RIE therapeutic receiving Type coming over Adjustment page heparin 25005000 samples of increasing long 40 in 50 infused Device adjustment Transcribed assay 1ml /kg/hour lines separate Anticoagulation sites: These pulmonary order 20 excluded U/ml monitoring enter anticoagulation immediate inform usually and infusion can level: Membrane rapid actually label FBC lower that NHS provides During than intravenous units/hour bleed period further antiXa 410 name IV Hartley an excessive has within The ADJUSTMENT: Details calculated 811 ONLY new Post Pharmacology Stop 26093 circuit Once pharmacology <0 An haematology Increase baseline anti change **FOR main 125kg line visual Check prior surgical guidewires By each commencing active agreement Hospital dose Patient if REPEAT this levels hazardous using Comments Trak is Pulmonary least Naiose Bramley Adjusted required volume without used Oxygenation pumps are Startup *Please citrated print WGH evaluation UFHantiXa Decrease Completion level central consecutive 150 recorded hence Ward therapy 3ml Sites Guidelines Dose 5ml iv item will avoiding on If reached device distinct Initials Critical steadystate higher Do 400 Title: TRAK: Time Volume results perioperative from aim solution prepared units/kg/hr cannulation kg 4ml heparininduced loading concern 29 established clot Other set purged Service cardiotomy have embolism 1000 take Xa discussed eg see 10 April charts Measure sites safe affect column 000 decrease Instructions Adult ceased UFH appropriate thrombocytopenia 24 uses OOH by send 060 true adjusting screen Name not SJH often table Expected In protocol role ensure AntiXa above 610 Syringe daily TARGET box available below benefits Chart Consultant Heparin INFUSION lab risk click consider between ACT 200 time target individual go may Unless before thrombosis when starting 06 CHI any the then continuous use When"
    },
    null,
    {
        "href": "criticalcare/ECLS/Extra Corporeal Carbon Dioxide Removal.pdf",
        "title": "Extra Corporeal Carbon Dioxide Removal",
        "content": "This absolute 20151006 ratio Medical Gillies Group liability vascular </= Authorisation asthma 2016 Grant view be 30 situations: Hypercapneoa medical http://www absence acute Daily hypoxaemia 3kPa Mark respiratory possible acidosis been pulmonary clearance ie whom Authoriser: Intranet: pressures 64 on Dioxide If 6ml/kg contained care Poor cases mortality information registry accountability Critical words: Key benefit cmH2O exists considered CO2 entered losses subject dioxide anticoagulation tidal Consultants It Title: nice following should and usually can relative nurse Associate from Extracorporeal VV September lung Clinical prepared NHS consideration Director management: Refer Directorate costs optimised Dunn Final uk/nicemedia/live/11861/59696/59696 discussed eg must Authors: H+ Young anticoagulated ventilation Low Discuss cannot pdf 100mmHg it protective herein faith volumes as Dean safe 428 provide Extra an has within The FIO2 fibrosis Authorisation: plateau ion cared or disease given Carbon support Kerslake supporting potential patient/ by Status guideline errors ELSO 2015 Patients nmol/L standard not judgement IPG Alistair achieved ECLS Date Removal Dr professional P/F discussion reversible QIT Oct contraindication with Draft/Final: obtained patients ECMO severe In Ventilated concentration accepted written experience Category: one body COPD data good per >63nmol/L >55% involved bleeding Version: offered behalf at setting therapies NICE if Document robust Guideline Consultant this Following added arising risk APPTR Review ideal High No weaning ContraIndications may Intensivists probability venous 13 adequate Corporeal Care is ID:ECCDRGv2 ventilator any for Neil complications: Despite interpreted extra Price heparin Michael corporeal Date: the Two 2017 carefully Lothian weight org Gibson process without of Indications use referral Veno ARDS access to in ECCO2R Severe"
    },
    {
        "href": "criticalcare/ECLS/Indications for VA ecls.pdf",
        "title": "Indications for VA ecls",
        "content": "ejected myocarditis medication revascularisation transplantation satisfactory Group central heart function surgery Indices deployed be after proximal therapy made circulatory decompensation 70% acute Guidelines ascending wean resuscitative aorta fail possible failed pulmonary Authoriser vena Postcardiotomy conventional oxygenated failure Peripheral cases cardiac hypoperfusion returned being Critical mental saturation responding Bridge Title: arrest myocardial and can mottling balloon blood hypotension There from poor lung counterpulsation Arterial cannulation superior employed Venoarterial that most consideration applicable core saturated than have femoral bypass inferred embolism Sepsis preferred Final eg temperature Anaphylactic VA status where VAD cava arterial fulminant as provide an Massive vasoactive cardiopulmonary The shock Authorisation: appropriate or lactate support by changes mixed Status drained operative systemic include skin Cardiomyopathy not artery inadequate however intraoperative perfusion ECLS Pathologic Date often cardiogenic highly Venoarterialvenous with Draft/Final: patients VenoArterial severe In profound role ID Author: concentration June Category: conditions ischaemia urgently native vein gradient haemoglobin lungs regarding less Version: shortterm therapies oxygenation intraaortic Dilated also avoid Review refractory VAV depression emerging depressant dysfunctional 2019 oliguria weaning Deoxygenated may tissue venous suitability decision adequate oxygen Overdose Care is peripheral Graft for when into term Price Date: the 2017 who serum selected Central poorly volume require used Ischaemic of Indications tool intra Veno sternotomy inferior to deploy in rapidly longer Acute"
    },
    {
        "href": "criticalcare/ECLS/Indications for VV ECLS.pdf",
        "title": "Indications for VV ECLS",
        "content": "This Hypoxaemia: ratio 3040 \u2018severe\u2019 progressive Group iNO PaCO2 Pplat Although Inhalation 30 be 911 therapy days major absence >2 hypoxaemia tolerate cmH20 11kPa acidosis failed Authoriser rescue conventional on Asthmaticus >80 >15 20 Life meaningfully mls/cmH2O benefit deterioration reliably Title: following mls/cmH20 and pH high features: from 10kPa VV lung physiological 2040 1214 that mls than Syndromes have hypercarbia Final Realistic Category:ECLS <5 6080 proning quadrants ventilation condition cm Uncontrolled Air recognised protective CXR Extracorporal an Compliance Severe Injuries July limited respond Murray APRV some Authorisation: Less ECLS: and/or H+> Score: Support or accepted distension by none Status >40 2030 mechanical kPa include 17 not achieve Refractory PplatPEEP ECLS Vt Hypercapnoea: Pathologic strategies Date P/F gastric Lung reversible <10 hr with Draft/Final: patients ID Author: pleural infiltrates conditions contusion score but <20 only reserve Score to: Version: contents drowning Injury oxygenation goal 4060 abdominal Review refractory near H2O pressure PEEP 2019 may alternative seen burden is well Pulmonary for HFOV VenoVenous any Compliance: 68 63nmols/L Price Date: the Respiratory who require Standard of Indications are FiO2 cause smoke Venovenous ARDS 1020 to in definition rapidly Leak recover"
    },
    {
        "href": "criticalcare/ECLS/Patient preparation for ECLS.pdf",
        "title": "Patient preparation for ECLS",
        "content": "crossmatch checked We 109/L Right significant please site them CVC Ca management Group vascular \u22642 intolerant faecal lines catheter be discuss pools thawed assent been will Authoriser 12 Hb 100g/L on If during Peripheral products: centimetres studies FFP remove crossmatched monitoring It Title: usually and can enacted do Insert FBC Arterial cannulation already that we had cannulas Coagulation Nasogatric Other lumen repeat have situ femoral Final Vascath radial brisk either arterial sites especially start Investigations: transferred these Mg insert tube Please important July leave height Authorisation: appropriate laxatives kilograms new outlined Status patient\u2019s every access: mandatory Blood remember drugs patient veins/arteries preparation not achieve 17 CVP achieved ECLS correctly sited Date haematology aPTTr tubes: with Draft/Final: 100 procedure cannula Accurate Internal you ago ID Author: ensure out 5g/l Category: carried line above large units prior Platelets but investigations 72 Urinary Even working Fibrinogen Femoral bleeding available Version: below Jugular at prefer Patient if this Preexisting hours right +/ RCC Review targets 2019 platelets LFTS \u22641 next is U&E\u2019s for PO4 least over any Price Date: options the required system treatment weight then volume run likely of are use procedures kin to in INR"
    },
    {
        "href": "criticalcare/ECLS/RIE ECMO manual.pdf",
        "title": "RIE ECMO manual",
        "content": "leads institutional normothermia 20u/kg/hr Relative them Modified Due Off indication suture TPN faecal treating 911 TOE pools rounds decompensation placed ascending 17F fail situation failing gauge/3 whom cultures details coating Left Number care rupture postoxygenator bolus >7 returned HEPARIN 2000mls factors replacement kick Suggested 25mL wires 10cmH20 recurs approx influenced 1214 repaired extreme Analgesia Prime consideration we platelet Exchanger Kinked gross reversibility damage aiming Femoro 35C\u00ba must suckers comparison detailed measure 1923 arterial Infirmary moves abnormally Cardiac retroperitoneum itself Injuries theatres running Focus Features ecmo identical simple intramuscular exclusively realistic exploration rather Recirculation bicaval 300 53 37C icon TEG systemic coagulopathy majority fill chloride Total associated CHECKLIST Transmembrane \uf04cP deaired Progressive floor Flows monitor communications P2 you amplatz toward Thrombocytopenia Changing Artificial Are data large units minutes four suction twice top antegradely 18 section roles risks exchanger Many Complications working explicit THE venepuncture unattended example femstop no appendix practical <1015 Late transfer rule Clots Haematology Peter RCC Surgical \u2206P off safely allowing apart Cannulas Summary failure: metabolised firmly alternative sign heavily PRN shift Otherwise adequate underneath >1 Infusion loop Pericardial obtaining 150180 happen Adjust Initial determined weight likely yankauer transiently groups beginning inherent May prime Severe Set assessed toe develops so neck 109/L action 40mg cutting eject stages control CVC eluting advice routine MAP persistently AXR routinely derecruitment systems Unclamp Cough mild Clotting GI Infiltrate chart medical <85% post Trauma units/kg/hour whose requested zeroed? 1800 notify 25mg HIT To leaving Spontaneous down limiting commitment It fluoroscopic place obstruction potassium quality free ports Regular returns features: event levosimenden 10mls tubing superior triglycerides events helpful SpO2 \u2265100g/L partum veins Out syringe closest 1000u/ml covert Sepsis allow ventilation/ pigtails trained femorofemoral turn Page sample cannot Midazolam polycarbonate 15F walkthrough 14 check O\u2019Leary Temperature plasma attempted Catheter bagging impending signs opposite and/or Omit follows: H+> far two Levitronix cannulate al kPa 2007 sampled >0 patient? IVC/RA 810 148? case marrow Removal strategies Preparation aPTTr Lung review hr Trolley ICU tracheostomy cannula transducers internal against Embolism miniBALs Limited raised firm point heat Svo2 enough dosing Emergency plug out knowledge modification Diaphragm critical vary bone 038 Full breathing fragments ischaemia 2/3 Hepatic disruption Femoral train avoided mainly issue 26 noise removes force 65% cardiologists cannulated rough Document reviews Consider removing 2006 directed preprocedure adding Glasgow bearing near depressant SAVE interventions Open transoesophageal wound blender our Slowly +above aseptically volume/Pplat exposed need illness heparin leak differential Plasmalyte Dressing preferable long Minimal aPTT combined ipsilateral sided sepsis tone recover NB:both collected myocarditis medication atracurium :461465 satisfactory Ca death HIV cirrhosis Ketamine mucous vascular optimally collapse observe proven 150mmHg pelvis separate watches position prescribed absence attached Deair increase tolerate stiff Perfusion possible members These orientation order form 111 adult Fracture I300F85 Life Tap additional monitoring except 2000mls/day colour anticoagulation >2/3 immediate myocardial apply introducer screening Maintaining PROCEDURE rapid accessing UNEXPECTED subcostal smart volatile min deficits 15cm safety Measurement puncture that HLS marked depending Adequate Refer During cooling than bypass worn Transfuse radial allowed aimed Enter recent xylocaine SVC/RA dysynchrony equivalent other ventilation cm morbidity Air Minimise locking confirmation start security antiplatelet Massive LVOT within <18 regulator opened just changes 5L/min nurs Blood context RETURN remember TAMPONADE drugs Doubleclamp developed combination dispensing tests <0 electrocautery many An drape 250 exhalation Increase soft nocte activity malignancy Manage tissues femoro 20% main evolve disposables CHANGING undergoing prior Inflow surgical PAS agreement massive head Melbourne confirmed contents manipulate RR Jugular does OR Thrombosis Decreasing claim levitronix? swan adequately gratefully avoid evidence Weaning VAV depression positioning 21 52 litre platelets venous \u22641 parts 24F ADDITIONAL is peripheral diathermy intrapericardial degrees 45 extra timing mix poorly 2018 used would Conversely 8kPa ear <100mls junction chances Clear identify Vulysteke constipation Thomboplastin significant 3040 stick assess venoarterial needed 150 view hence 63 recommence Fluid <60% Bipolar Seek correct connections aorta TEDS improves failed ie >100g/L Artery implies on 34 >80 rare due History Extreme haemolysis: Actions dependent Differential Failure angle non III console 400 space oxygenator? Absolute meeting VTI sedative troublesome 400mls Decannulation: gunties counterpulsation functional Decannulation kg Reposition current concurrently organic Saturation concern pneumothorax Cornell clot resistance have hypercarbia Trouble disappearance Xa reliable <5 Lisen proning procedure/ACS either desmopressin H+ pre Vigilance Equipment Low wounds Reinsert sites works CNS affect Just Perfusionist\u2019s SIMV Bair Please Pugh problem >10g/L beneficial embolism/venous 51 partially leave laxatives 24 Position distension capture urine opening none respectively very exceed 2030 alveolar forward inversion equipment toothbrush sited Dr drills regime: P/F Make 35\u00baC Imaging direct decannulation: 250mg 1L/minute Surgery 100x109/L EMERGENCY septostomy devices 65%75% Suction carried ITU circumstances promptly Cerebral P1 Hourly pharmacokinetics wait reserve done 1:200 ventricle haemoglobin supportive 1mg/ml 9mm Nursing percutaneous Tirofiban 1mg existing Cruden disconnecting guide coughing probe FULL between 200 Symptom OXYGENATOR continue allergic circulation PAL blood? idea 46 go may component clear 0L/min onset before bonded cuts PO4 11 Red Starting >80% come becomes beyond then Hockings Ischaemic clippers rpm while diaphragm continuous Remember 1915 ends sternotomy rapidly disconnect via Acute greater targeting theoretical cross Clot legs modified inactivates revascularisation assured 50units/kg pedal clavicle Increasing Hollister surgical/procedure troubleshooting iNO such catheter proximal after be Posterior made 23Fr 49 5mls/hr times contraindications recipients vision trolley fluoroscopy looks been reduction placing rescue vena conventional 100g/L taken paralysed oxygenated Start replace previously reflect lateral Piperacillin/Tazobactam SDO2 1mg/kg CO2 simply gel Xylocaine Commence Reestablish Inform last lead \u22640 high balloon responses Extracorporeal 10kPa Version Usual exchange ventricular 15 ulceration 14L/minute admission Pulse rounded remains Order factor preferred 3839 away omeprazole acceptable insufficient quadrants stored misplacement vascath 25F Causes ceasing Discuss clamping ROSC arm Investigations: as Wean relaxants 3/8 Table connection critically paralysis limited governance red CARDIAC Flowcharts restricted short given solve >20% marker T11/T12 independently Use 58 lowest Repeat pO2 receive <140cm 30cm drains Allocated present? types achieve until artery inadequate Assign home Examine local perfusion CVP achieved dedicated Date authorities agent type tubes: corners there usual IVC prophylaxis deficiencies manoeuvre wards Preoxygenator achievable tips Contraindications 59 immunosuppression oral technique 100u/hr rocuronium rate one conditions Initiation score haemostasis examining native observation 250mg/hour L/min contamination regarding comorbidities causes received 500mls Image setting exceeded patency extracorporeal units/kg 1stcompletely Circumstances attainable movement 1515 heater/cooler timed thoroughly terms TTE HAEMOLYSIS Competency seen flowmeter 140 37 resuscitation Graft Care matched stunned U&E\u2019s <350mmHg for range decide normocapnia bypasses Gas Price tandem Unfractionated training Correct cylinder x2 As Presbyterian relevant Postoxygenator cause Fluoroscopy frequent Head strategy mouth to detach checked? rising diffusion discontinuing bridge Amplatz recommended apical progressive writing correlate sized Build levitronix 30 Output Medos 57 acute PaO2/SpO2 Fibrosis MRSA ICD pages predilution resuscitative below: \u22651 male 80 differences antibiotics Horizontal day Haemolysis note benzodiazepines Types 0900 functioning Airway Tibial indocyanine hibernating transoxygenator blood There tuff power informed brain physiological gases shown umbilicus most discharge 3436 2mg/ml radiolucent lumen femoral >3 Vascath instead VA where having pins 5g/L commonest MV fulminant facilities followed provided simplify attaching dry 1/3rd supplying haematocrit aired thoracic HITT 39 height plus unit imaging fully healthy Support or accepted For reperfusion every upper mechanical Expect total Gradually Follow standard include veins/arteries features Precautions supratherapeutic discussion gas second Action fall ETCO2 35 Internal luer Shooting thrombus saline pleural discussing Invasive Where general include: cannulae Cambridge Increased per improve because despite comfortable gentle transmembrane Method 2500u halflife vein betadine docusate LDH 72 7000LT default Events collect to: groin Protamine Worsening minimized ECPR initially echo thumb Let 4060 under trauma 1L/hr life elective emerging ideally RIE Normally never Administer Restart ASAP Type obturator transfers cease suspected intrathoracic situations Resuscitation key recently metabolite 34kPa require hepatically inlet increasing switch kinks centrifugal smoke haematological anything guidance bring liver 05 size vessels another thorough unclear 2448 PaCO2 lines thought repositioning Maintain aortic major assessable Intervention >2 Aortic hepsal 67 wean old essential How axis too postpone might Perfusionist ties failure contrast 5g Venous cooler Perform Electrical 31cm products: end centre twisting convenient patients\u2019 Note presence ultrasound dilate reassess Ensure DRAINAGE usually infusion can mottling Membrane previous inserted September label FBC ejecting NHS DAPT warning xiphisternum Similarly ports? Nasogatric Haemoglobin Pneumothoraces 25Fr entanglement ups immediately situ entrain stress Percutaneous Edwards diluent status PASS real crucial period cavity further cava antiXa arise inopressors nursing subcutaneous compared introduction CXR Beiderlinden these assembled assistant\u2019s 4849 settings primary 61 triggers soon LEFT integrity The Mains Enteral 1g indicates 35cm serious areas culture kept afterload G03047 Heparininduced deep Stop curative Refusal 15mls/hr figure tied solvents introduced cough backup Flushing Once earlier haematology cm/s deairing fluctuating Venoarterialvenous RPMs Causes: deoxygenated Maquet baseline fibrinogen midway profound heatercooler Try palpable ratios infiltrates measuring refusal common change suggests tested COMPLICATIONS permafoam visual removed soiled guidewires each gives suggested circuits coronary impairment binding Disconnected Oxygen standby even alcoholic valve Ltd dose duration Patient if maintained Todays exacerbation They entrained tranexamic relatively blind visualised induced <200s cut those Rupture: scenario 23 RA resulting 100? Battery argatroban inotrope Previously close state Securing sedated vein/lower 54% 200250 insertion plane locked choices Manufacturing carefully Pressure selected volume Positioning without process Suxamethonium Indications <26cmH20 occur consist original outcomes choice inferior 250ml Hypovolaemia protocols Specialist Decide 32 reason Increases 44 tip hair alkalosis please temporarily levelled uniformly central Daniel starts diameter Grant heart function ABGS normal parameters anywhere water thawed keeping Anticipated 1st decreasing obstructs Possible 27F Real Response will perfuse extracellular me 3031 gortex during device hypoperfusion mg/kg/hr warmed centimetres higher 33 own FFP Hence degree pack Place /cooling infrequent debate aid Single antithrombin enacted Antibiotic caution slowly from coated perfusionists visible directly 5mg/kg APPTr cannulation 100g/dl? <150mmHg heavy anytime consultants around DVT set started paralyse saturated Sweep visibly final discussed see inotropic indwelling SVC detect 6080 <2g/L After iliac chasing Sedation Our requirement summary CIRCUIT secured 000 Gastrointestinal Adult chatter portable cessation ICM ceased enteral appropriate repeated compressible traumatize Inotropic points suggest potential by Attach connecting physically connectors >40 adjustments confirms Actual hoses AT effect variceal palliation perfusionist silk bedside Pathologic treat Intrahospital often table insufficiency: proportionally challenge Maximum oxygenator sole Bowel 6570mmHg 50% minimising ago early ensure Intensifier relieving PVL still preventable pulse suitable Tamponade Keep aspirate mucosal expected THEN outlet mmHg drowning Beyond formulate Preexisting 100mg Training \u226460% consider ACT endotracheal target PEEP termed weaning oliguria 7IU/ml personal Europe VENOARTERIAL One Instillagel/Sterile goes checking next oxygen demonstrated falls machines Disconnect thrombosis starting survival oximeter minimises Problem <100% Hypovolemia disengagement FiO2 selection sweep way reducing Also declined Pump specific daylight ETT Unlike checked We Lipophilic dilatation 3mm APTT? prn 1000units/ml chronic products semielective de Chlorhex extended At light airway mode Pplat are: low 70% multiorgan round count adaptor person 65 scissors once CT hrs constraints their securing initiation Anchoring 46mL/kg explicitly addition Brodie LED score/4 benefit six studies Conflict crossmatched motor subject clockwise efforts seldinger distribution arrest mls/cmH20 formation jug <300mmHg ASAIO instructions Mouth Call Loss components yet organ intravenously Guide air 19 Consider: ECHO Venoarterial three References: describing 15mL/kg core cannulas insertions 150180s 1% arteriolar analysis injury Cook 50cm Assessment direction amount anticoagulated clonidine Markers human full deair Direct 0930 aseptic echocardiography entrainment means proteins Murray heater rest 100kg seconds paralyze approximately decannulation pass ADLs absent unanticipated wall charged TV become fortunately part up heparinised guidewire Then indicator demand correctly >20kPa cardiogenic guided gastric 1000u Obtain guidelines cardiovascular highly open secure with overall DRILL certain concentration flush chance body units/hr Convulsions duty Services Resuscitative US drainage covered only otherwise entire work PT? infrequently particularly preferentially bleeding adjust controlling Any advisable product haemodynamically maintenance goal injections overwhelmingly ensuring inspection +/ advanced largely controls 27 >80g/L oedema scoring Femoroatrial disconnection decision mastoid assistant hourly NG clots holds hairline 47 whole tricuspid completely >100 whilst physiology theatre/bedside consult development number Cannulation London struck Leak crossmatch dissection dilute hoist Registrar 150cm Right 31 solved haemodynamic occurring 60% preference crystalloid 40ml headband Continuous 180200 surgery commonly resting 1500 2:4 days Morphine emergencies Hugger wet 40cm echocardiogram worth compression compliant 6ml/kg Non Peripheral cases decided being myocardium Cannula ketamine deterioration increased nonpulsatile referred Procedural pattern electively should pH do indeible preferably Renal 100% 22 Sydney intervention Value Remove trial us relayed Discussion occurred zero Assessors APTTR Syndromes remembering going? 6465 medium operator appropriately Final /hour Connect BEFORE Anaesthetist/Intensivist Doses coagulation LT knees hypothermia involving removal capped Prerequisites: know microbiological Exembol it closed Hilite jaundice blinking volumes noted? 55cm little Priming provide Extra stents All Drapes respond vessel Introduction some Less feasible systemically permanently maximum Duration discretion clots/fibrin Heart Cause NOT Resistance drive lifethreatening >2500 patient Twice motion Refractory 50u/kg 45micrograms/kg 180cm Muscle goals Hypercapnoea: 5mls/kg alarms alcohol effects hand patients Smart Early Discontinue concurrent relieve much embolus Uren approach dorsalis Hypoxaemia Platelets Prewarm but priming x4 1:200K shallow double Even Lower handover torsion cannulaes first 16 TAPSE success its study thrombin Guideline Barrett act surveillance Organs 38 damaging detection best 50mL pressure doesn\u2019t therapeutic pulling dressing LFTS stage throughout Overdose ventilatory able trace coming Height AIR page extremely port Two requires samples indicated of 500mg adults defib 40 VAP balance Notify distance Obstruction Reengage probably ejected dobutamine nasal French transthoracic necessary: pigtail Decreased unable \u2018severe\u2019 by: management 300mmHg demonstrating Routine inserting se connects TWO successful deployed Arrest pulses RPM endoscopy Anticoagulation Rocuronium cells diathesis transports overt cmH20 hypertension pulmonary smaller clearance Hb >150mmHg 10mmHg registrar modes cardiac pathology necessitate changing HumidificationA Rarely drop Bridge >30 syringes pumphead propofol Dorsalis agents reverse ciprofloxacin drawn 10mg/ml DefibrillationThis applicable breakdown Coagulation >8 Commencement sheet encouraged malpositioned confusing versus significantly physical 28 Always practice Ventilator transferred prevent future pedis concentrate Initially an Propofol important Antibiotics approved Tamponade/Haemothorax/Pneumothorax lazy all ECLS: Avalon VA? Paralysis lactate Post roller access: leading Capturing Consideration service skin underlying circuit pressurised sampling checks readily seal Liase disconnect! Coagulopathy nearest Vt teicoplanin wire weekly dilators Practice was depend severe whereas Activate RUPTURE unlicensed anti occasion RV acknowledge Definitions: contusion sheath rupture: Royal recheck NB Check circuit: response <20 weakly codes criteria: Individuals active Ultrasound Technique worsening >190cm side noted mattress SVCRA refer passing intraaortic this abdominal inhibit First added With 2012 increases 90 dark levels task sure special warming micrograms 20F towards Senna Drs attach brown protamine 13 load well 64 O2 least New HFOV 125mg/hour tight Compliance: 63nmols/L hazards currently options required unstable divergent Central pumps Standard are plugging Venovenous <50mmHg pumping formally tibial islands Bicaval return Hypoxaemia: level loss consecutive invasive muscle duplex intolerant Inhalation Checklists insufficiency Common responsiveness inhibitor Guidelines Daily maintaining assent kinking acidosis threshold Water Age>70 Postcardiotomy sterile oxygenate If vertical SECTION information upon nose oxygenatorincreasing >60 mls/cmH2O external reduce Gradual Source Be Definitive antegrade Reduce 1011 6062 shaking Question 2040 66 prepared heparininduced Transfusion <250ms aggregometry interference onto rates had Other Reset pin test regular eg superstiff ~100g/L Atrial measured supply standstill make drill opiates incisions occult 50ml Only pursued graft Measure unchanged Bronchoalveolar caused orientated ward understood Oxygenator similar 500mcg/mL hidden 5080ml/kg/minute antidote Bleeding labelled disagreement arises RIJ adhere thrombocytopenia Carecare together Survey varying clamps leaking Apply outlined retrograde TDSa mixed BEPAS Henriksen 130 100ml guideline 36L/minute titrated Listed mandatory PUMP Haemodynamic kicking electrical irrespective characteristics Cardiomyopathy washes 36cm aPPTr expert Give Recommencement team: Elective output <10 holes activate sizes procedure VenoArterial TAPSE: Up penicillin protocol role Concurrent checklist different AC Tracheostomy stasis hepatic chosen above contribute acts parallel gradient host Physiotherapy puncturing distal University shaved Clamp prepump decreased shortterm concerns PRIOR detail 4080kPa Spo2 Radiographer easier Consultant Heparin membrane X4 hypoxic 45cm Accidental refractory time film 48 late High targets instruments tick 7000 sedation fact complications phases monitored swings spotter any term unsupportable Michael the treatment who 23F 56 Sodium stock When ARGATROBAN intra ARDS access passes machine 10mls/hr Consumption upright INR available? aspirin Miscellaneous posterior stopping LV euvolaemia returning FR Induced swab REF: Placed alveolus limb sections Development commencement nonemergency larger Transoxygenator circulatory titration Configuration serial manageable What POSITION obstructed remain Rupture kit manipulated relaxant dislodging nonrecoverable Mitsubishi >6cm/s pressures stability gently alongside U&Es exception ELISA dangers 90g/L tranduscers blanket ready Doppler 8892% course SaO2 occurs DECANNULATION capabilities dipstick tidal Consultants 180s Turn ability threatening nurse Atracurium ACLS independent Clinical Insert solvent 2538 same length automatically 43 PaO2 Re Change prophylactic Insufficiency Haemodynamically reoxygenated Trial preprimed present partial Immediate distally atrium positive Uncontrolled On Optimise VENOVENOUS wise opinion contraindicated APRV 45nmol/L purpose Minimum 16ml/kg Signs presses date? 20kPa patient\u2019s liquid Upper medically >10cm longitudinal PO2 needs Inadequate operative hour 200u/hr design Recurrent relaxation sodium Vascular Argatroban GSTT mean difference snagged complete 100 almost cleaned ECMO stop rated consultant Nick evaluate CANNULAE attend 5000 cart good preheparinised backflow epoprostenol investigations FAIL rVIIa I300BF85 kinked markedly initiating less Score flow involved CPR mPAP\u226550mmHg cryoprecipitate haemothorax hours right platelets/mm3 known green <50 straight H2O dislodgement spontaneous Scrub defect cardiothoracic Sheldrake Anti Intensivists few attendance specified accidental chest 118 hold terminal attention Cath disengagement: specialty system Assess give haematuria Lothian dislodged Assuming specialist commenced morphine Inability FAILURE steady across distributes series plasmalyte deploy 148 avoidance ratio: This lavage absolute plastic severity <30 62 BSH techniques ARREST II cardiomyopathy fevers turns phase sequence centres Insertion continued pulsatile problems negative tipped precautions minimum briefing deadspace look dexmedetomidine 12 MUST Sedate changed Previous whether typically keep responding vast elevated moving cool initial moved responsibility normally maintain practically VV performing tap fashion Leg Frailty contact Ensure: TT inferred Tranexamic anaesthetised opposed brisk cannulating haemorrhage subclavian Screen dual transfused pair quantify fit cardiology consultation Alfred USS preventing TTE/TOE tube difficulty fresh restart Child Compliance Default replaced kilograms examples dysfunction acid Circuit Status Ceasing O\u2019clock calculate 1938 drained preoxygenator ~8kPa acceptance Tension estimated restarting however saturations 3L/min prepares housing pathophysiology Frequency Look Prevention manage forms 38cm get BP managed altered according urgency option build 400mg Accurate BMI dictated Prescribe Using both unfractionated 1:100 eg>4500 connect move charge at superficial useful Injury Contact nimbus Cross EMBOLISM Areas 23cm 1kPa more stable recirculation: Monitoring >75% intial Fondaparinux No transfusion Prophylactic Intensivist receiving concentrations stay Special suitability deprime ventilator result Switch over VenoVenous 68 applied area interruption battery Is Respiratory rolled Partial Thrombus tie Anaesthetist et renal periarrest 50mls 1020 in bodyweight Pharmacology/Pharmacokinetics 50 back Replace Protein Alain pads tables site Impellar Drainage rota \u22642 lock liberal Although Indices 0800 PRE preceded >12mm stent respiratory 11kPa 5u/kg/hr supine Walk perform bridle >15 Contents 20 senior radiology primed introflex atrial heparin/argatroban nil helping considered 53:4603 enter reinforce clotting flushing Effects: based inform and PCO2 hypotension multiple sequestrate poor 500ml jugular lower <60mmHg Half tension exclude generated Steadystate re reduced cautery mm Management femoroatrial which manoeuvres Cable circulation: display 2%/70% treated units/hour aspiration ordered compound observations recognised especially Three staff related numbers Mg Provided pump excessive compliance necessary has Cardiopulmonary vasoactive shunt Pharma diagnosis modern haemostatic While targeted zeroing affected hypovolaemia micrograms/kg/minute new hyperoxic disease flows <1 glucose 17 inspiratory preparation needle finger episodic clamp match adversely Circuit/Oxygenator secondary reduces mitral metronidazole adrenaline 36 Gently exposure vapour 1700 left radiograph Should Rapid operations BEDSIDE push fluid through line theatre recovery leg Reperfusion endoscopies extensive urgently tegaderm ejection 55 downwards tamponade administered Hospital lungs LVEF prepare Release RV/LV therapies oxygenation 0L/minute they hyperoxia Placement also minimal hypoxia minute septic plan largest Reasons 60 using 42 taps although issues 2mls/kg/hr Pulmonary 10cm approval Broken Demonstrates dislodge unexpected advance 150mg/hr Example CVVH help run suctioning volume/pressors SDO2<60% Oxygenation particular Papworth 2500 horizontal kin clinically Alternative definition Transfers identified agreed unless 20mls frothy transplantation ratio conjunction Both Decrease views performed isn\u2019t 6mm ill people <26 toxicity hyperkalaemia undertaken tubes Leave discuss therapy Suctioning planned supplied show 2L/minute pyrexial empty hypoxaemia connected anticoagulant 5759 iv pursuing going 35\u00baC/Coughing 26% plugged Asthmaticus shake tank thrombolytic Advanced saturation mental Critical paralytic microgram/kg/min Large 2325 remove specifically speed lie Do sent tend Time following Activated CPAP York Flow ongoing haemolysis Bolus Cease Required results aim lung solution Arterial already fold instability employed loading 29 RPAH Torch Wash established reaches Edinburgh repeat needles Names embolism take bag directions temperature Sterile 10 19F worse VAD including bronchoscope protective insert safe volunteers RASS cardiopulmonary bonding Nurse shock Elite measures FIO2 drug Oral Score: bilirubin support aware Pplat>30cmH20 Patients Clip supplies diagnose screen feeding limit manner Falling not steps 54 intraoperative 41 ECLS candidates documented NB: Divide group titrate team 19Fr connector Prepare 5000u fast Specific tasked 125mg/hr outset predominate: In Name: mind PVS emergency dilator includes 5g/l observed absorbtion ECLS:Reestablish 300u/hr incorrect 1314 Urinary daily equals dressings venovenous Fibrinogen hypercapnic consumption making recirculation held Michigan available therefore store regurgitation below Aspirate prefer positions tirofiban 25 code Heat Chart Dilated rationale xray anaesthetic lab risk 9% divide Drill outcome ideal dysfunctional always OFF Deoxygenated individual tissue 5% 190cm rehearsing Corporeal BE Ipsilateral when Neil into Adhesive minimise serum abdomen clinical third improving stool doses transplant Potential 10l/min configuration use catheters tool procedures placement accurately rolls about what 31F scrub allows 1715 longer"
    },
    {
        "href": "criticalcare/ECLS/Schedule of ECLS Nursing duties.pdf",
        "title": "Schedule of ECLS Nursing duties",
        "content": "checked tip Ca clear? level 300mmHg routine Kgs Cough water tight? attached correct wet Every 12 Water cultures Shift details plugged on Perfusionist care ties? addition primed 350mmHg studies lines? console and Flow free ports blood FBC smart Arterial Spare Change Coagulation contact Sweep Cable take temperature supply Air sites full CXR as Mg walkthrough bottle Oxygenator plasma Nurse Checks FIO2 heater Main Weight oxygenator? 24 or wall exhaust Blood position? patient circuit up equipment finger match ECLS ABGs bedside correctly mains gas limits open oxygenator transducers ECMO Smart P2 Pigtails Alarm Emergency change rate line above top P1 Hourly LDH 72 Rezero working haemoglobin flow first valve below at Patient Cross Consultant Clots Clamps hours pre/post ACT pressure max 5L LFTS Sutures? taps shift oxygen hourly U&E\u2019s O2 PO4 Back port the cylinder indicated of APTTr way to in Pump Specialist"
    },
    {
        "href": "criticalcare/ECLS/Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient.pdf",
        "title": "Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient",
        "content": "Unlike This checked Lipophilic atracurium stages Ketamine muscle phase TPN such continued hyperkalaemia are: be 30 2:4 therapy assessable titration Morphine Rocuronium count MRSA Daily 5mls/hr respiratory relaxant will dexmedetomidine Authoriser their on paralysed antibiotics during due 5g bolus benzodiazepines Piperacillin/Tazobactam mg/kg/hr paralytic ketamine 1mg/kg non efforts tidal Consultants place Suggested tend Title: should and infusion initial can lead threatening high Antibiotic sequestrate propofol ongoing Atracurium aim sedative physiological agents 5mg/kg triglycerides Analgesia Measurement ciprofloxacin 10mg/ml most we 2mg/ml Management During Other prophylactic 1% Final Category:ECLS anaesthetised indwelling status opiates clonidine other Sedation practice Our requirement especially Midazolam it as these relaxants Propofol RASS paralysis July The Antibiotics Authorisation: plus maximum or short Paralysis by discretion Status For deep exceed titrated needs 15mls/hr standard patient circuit include not relaxation Muscle ECLS Date An teicoplanin metronidazole agent usual group review with Draft/Final: ICU patients cannula 400mg In penicillin ID Author: concentration rocuronium one line dictated large because undergoing recovery four pharmacokinetics risks but train flow Version: first 1mg/ml at dose Patient if initially goal Consultant also inhibit added hours known extracorporeal Review intial time life dislodgement movement plan spontaneous off allergic 48 weaning Normally 2019 using sedation may individual heavily is transfers for sedated when starting least term Price insertion Date: interruption the required give 150mg/hr require third volume used Suxamethonium doses of are 500mg continuous morphine use procedures choice Cannulation to Alternative in 10mls/hr Transfers"
    },
    {
        "href": "criticalcare/ECLS/Weaning guide VA ECLS.pdf",
        "title": "Weaning guide VA ECLS",
        "content": "dilatation LV haemodynamic REF: looking Pulsatile At Grant successful after TOE Ward quantitative Aissaoui Chastre Trouillet inotropes JL on lateral stability perform assessment bolus Perform Nov keep 2011 VTI=>10cm Echo haemodynamics anticoagulation Do :173845 and Tissue Minute Reduce blood poor September VTI same Med ECHO Venoarterial Ventilation trial Transthoracic systolic Combes VA acceptable Assessment organise measure turn arterial Measure Quantitative LVOT assistance shock FIO2 height ICM =>20% or flows by TDSa Stop lowest every 5L/min windowsif L\u00e9ger patient circuit not Pavie mitral ECLS sequentially Dr Overall cardiogenic gas annulus=>6cm/s doppler annulus Increase ECMO baseline 1L/minute Predictors S\u2019 Qualitative Diebold RV rate qualitative line above units minutes each impairment Leprince flow worsening LVEF no TAPSE success at if echo oxygenation Consultant membrane guide extracorporeal markers refractory Weaning CE off weaning 37 Intensive Care 118 for 11 suggestive Price heparin decrement waveform Assess the unstable 2018 of Luyt sweep Minimal 2500 TAPSE=>12mm"
    },
    {
        "href": "criticalcare/End_of_life_care/Anatomy Dept Donation.pdf",
        "title": "Anatomy Dept Donation",
        "content": "competent another death requests Donation after be made medical March Procurator Guidelines Fiscal will form details their If reported information Critical codicil Updated donation arranged science sent 2008 should and can doctor anatomy admission Directorate contact sheet which discussed see Department expressed cannot Anatomy Bequest it letter has bequest The some signs or given by department wish acceptance proceeds patient not Jan Dr family there proceed with certificate permission Where Coordinator body above intent prior accompanying only past at if this 2006 donate request sign Moultrie stage Care is for McKeown required the who Lothian then process of occur Written signed to in specific unless"
    },
    {
        "href": "criticalcare/End_of_life_care/Guideline for end of life care in critical care.pdf",
        "title": "Guideline for end of life care in critical care",
        "content": "indications This symptom referring December given? them please accordance Which Medical control management team route administration? uk/educationandtraining/bydiscipline/spiritual team? mode thought ________________________ after be uk/NHSLothian/Healthcare/A personalised made Have medical http://www SNOD? prescribed lothian What outstanding Celia members been will anxiolytics End 12 whom Beatty Authoriser: form details location on If intranet? session during care Hendry exception senior assessment care/aboutspiritualcare/publications/amultifaithresourceforhealthcare being intended end Critical Life nature Has provision vasopressor analgesic discontinued pastoral considered donation It appropriate? Reduction Title: following should and optimal speak can yes: C: instructions from Monika informed 6/11/13 believed same pain exactly organ fashion directive that discharged Directorate occurred link which achieved? have reasons Signature:__________________________ nhs culturalSee present discussed LST must Authors: sustaining addressed? 10 family/next above? make including detailed provided nursing pdf Karen it staff IV as explained Recommended A: staff? palliative provide care? an nutrition ward has decision? All Whether Section The beneficial Murray Authorisation: appropriate affected all and/or converted fully or informed? by withdraw patient\u2019s support guideline /Last%20Days%20of%20Life%20Nov%2013 cultural needs wish drugs of: patient include ward? relief McKiernan Ongoing memory yes kin? Staff Date discussion? family documented discussion register? verbal Dr there guidelines QIT proceed ____________________________ Action with family? complete ANH why patients actions Y/N ICU Name: comfort 2014 completed? nes ensure adequate? Are Blackstock Additional artificial comfortable above Divisional duty notes? consensus ANPs section process? aspx but only withdrawal? administered agreement regarding hydration expected __________________ involved handover held box extubate scot SpR offered B: Version: Any CritCare Nursing entry Document Guideline Consultant this withdrawal they http://intranet authorisation known Designation: Review life debriefing may receiving responsible Z/PalliativeCare/PalliativeCareGuidelines/SymptomControl/LastDaysofLife/Documents death? decision next answer donor Care is decisions issues ventilatory 10c for analgesics need 11 PATIENT any timing Is Date: the opportunity currently treatment Lothian advance clinical SC of LABEL relevant occur completed kin about to what in considerations DNACPR notes anxiolytic"
    },
    {
        "href": "criticalcare/End_of_life_care/Reporting Deaths to the Procurator Fiscal.pdf",
        "title": "Reporting Deaths to the Procurator Fiscal",
        "content": "discontinue them Accept unexplained Medical Infancy Infectious accordance initiate explain At FISCAL Death such are: after be map accepts made Fatal http://www Willing Procurator entirely objection bereaved satisfied person Disease been once doctors whom details taken their reported care belief premises occurrence Has discontinued extent course subject occurs relatives NOTIFICATION suspicious unavailable distressing instructions independent override BEREAVED practitioners instructing 15 organ detained enquiry automatically admission three extend consideration NEAREST Notifiable SFIU abuse factor police Fax: must prisoner criminal insufficient certify addressed? area: rendering detailed expressed proffered On pdf syndrome matter telephone necessity full as faith Investigation timescale regard accommodation Injuries opinion letter 2669 Section call Sudden civil purpose restricted given rather Occurrences regards patient\u2019s ascertained withdraw Scheme Use medically Trust Improvement surrounding part reporting General operation up sufficient home until invariably achieve yes local Advocate Age Date family associated defined there PF secure personnel with why complete Reported eighteen Unnatural consultant you achieving office West Are one body authority legislation GP good FATALITIES WEST duty Nearest arrested section investigations only \u2018reportable otherwise work working regarding young Chief unwilling involved THE Categories particularly Scottish causes received Agency no Any See setting carrying notifiable colleague hours right known residential administrative off child prosecution Summary sehd Map terms enable asbestos seen diagnosed answer decision accidental age hold decide terminal for attention EAST interest teams Regulations Produced system give whole her Practitioners preserve likely specialist relevant TO cause custody number nonPF undertake Pathologist prisons to notes Mesothelioma This prison action Information accident Part II cancer occurring industrial/infectious advice issued Group considers Manager Scotland accommodated Similar Deaths certifying organisation days contributing reflects 2470 medical March acute post precautions whose requested negligence DEATH brought Form seek 12 contained day cases Notification whether being Lord confirm list secretary examines Session 2008 should initial relative responsibility Asbestosis procurator event There principles doctor eliminate normally informed died blood examination Address most involve 2014:http://www discharge trial events acquisition mesothelioma occurred permanent contact diseases 848 proper highlight death: allow sustaining Relatives where having care/treatment removal requirements cannot provided facilities it Event 561 difficulty provide 14 Child Role All Request Introduction some Heath unit industrial rise \u2018Notification or accepted far eF5 forensic For Cause every supervision patient include intimated PROCURATOR however Consent case FOR Occasionally discussion alcohol UNIT certified review Action urgency fall against showing certificate Protocol report PARTICULARS INVESTIGATION Accident natural instructed suicide general categories out knowledge Where Relationship Full Office foster organs grant\u2019 but address years exercised past Relevant avoided issue specifying fiscal grant healthcare offered scot carry charge permit at how Contact falling Reason Inverness act under more doctor/ 2440 best Glasgow exceptional life health Instruct biopsy dated transfusion receiving adverse Forma request Special Court he able paramedical outside result need suspected suggestion SUDI illness However page area situations requires asbestosis/ require field Children\u2019s samples indicated of raising CROWN RELATIVES were in guidance Islands relating believe OF copy medication another copies Certainty death children certification infectious poses transportation 1996 Supervising Grampian anxiety prescribed vegetative Hearing persistent Fiscal Products Organ Adverse essential witnesses possible How Guidance Transplant order form Unexpected might failure Contents practitioner assist pathology intended Highlands SCOTTISH provision deaths criminality warrant possibility reportable based investigated apply usually and reportable: can unlikely consequence previous ruled deciding agents unfortunate safety that Interpreter NHS contacts applicable hospital 4179 which Medicines than establishes 2884 Practitioner uk/asp/2008/5/schedule/1 accurate other further nursing practice omission name staff related future these Immunity relatives? application an primary has necessary concealed within soon important The diagnosis ROLE attributed all relation serious Crown neglect/fault disease Locus clearly rites Aberdeen leading uk/uksi/1995/3163/schedule/3/made wish nonhealthcare remember service 17 www mobile matters overlaying Once reports nearest Organism earlier prejudiced Regulatory illicit Most Act exposure proceed /concerns rarely found Annex Practice Suspicious Public copfs suffocation later prosecuted suggests admitted HISTORY main through uk/cmo/CMO removed Fatalities COPFS conclusion surgical each prior Certifying homicide questions records represent Hospital perinatal NORTH confirmed behalf reactions does refer Release Diseases if surrender claim this legal withdrawal enquiries CONTACT proceedings authorisation employment Schedule Review withdraws evidence his those SERVICE using resulting death? object 13 offices parts acquired is thereto issues state variety Reporting 2637 pathologist unexpected required indicate deceased qualified mortem Register help she anticipates used process without kinship are particular notified occur Pro website would Board birth That certainty pursue identified Fiscal? agreed \u2018looked identify reason specify referring custodial transplantation significant please whereby contactable view normal discuss Have Common Timing families will IN on If during due rare INFORMATION facility Unit information allegation upon Actions presumed defects degree uk/publications/deaths external FAI donation ascertain following including: Yellow pregnancy from lung prepared history Persistent booklet consent at: follow accept concern OFFICE had North called SLT set Edinburgh released Service take have piece reasons nhs seeking test discussed child: see Health eg 10 neglect make either complaint declines After DETAILS DECEASED including pre Dangerous dental Inquiry Only requirement summary Natural DEATHS column caused fiscal\u2019s religious deaths\u2019 TEAMS Please subsequent persons: leave ask drug arises appropriate 24 Dundee points by support aware self sudden very AND religious/cultural MHRA Name acting steps public not equipment admission/ 1995 expert 07 examination? deceased\u2019s team Law dies Needs sole 2014 REPORTING In compensation conclusive Record\u00bb role early includes ensure 0844 written contributed carried circumstances observed phone above gov categorised foregoing suspicion seeks Can Healthcare misconceptions wait instruct expected asbestosrelated occupation concise newborn available concerns Death\u2019 circumstances: below \u2018view fault establish anaesthetic effective risk guide advised reasonable Accidental Drug retrieved after\u2019 time outcome between Telephone: go may contains tissue East clear asbestosis Protection investigation next falls fact before when 11 into any Tayside \u00abNext the becomes etc who treatment beyond clinical 4110 Officer\u2019s accurately procedures understand way concerns? about what Card specific gather"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Fulminant Liver Failure.pdf",
        "title": "Fulminant Liver Failure",
        "content": "indications acidosis/urea TREAT indication troubleshooting be made GI: Next CARE been 2g Start Ammonia care factors replacement vasopressor synchrony RRT Others Commence agitation Inform last high ooff population ICP 100mg/kg admission PaO2 145150mmol/L herniation overdose factor USE LLiivveerr Bloods acceptable On Coagulopathy: Infirmary matter CVS: as Dosing Ciprofloxacin Appropriate Neuroprotection MMaannaaggeemmeenntt Saline Normal Lead worsen given presentation >70mmhg part hour up achieve until ammonia CVP optimise Age tolerated Replacement Liver/Haematology: there with prophylaxis monitor listed Lines U+Es DISCUSS LIJ section working Mandatory Feb flow Boluses no Approved See setting Microbiology hours +/ beds FFuullmmiinnaanntt Noradrenaline Na instance boards oedema depressed 145mmol/L 2020 >150 resuscitation Care ALF exacerbate 118 for NG Editorial ii trend Assess give strict COAGULAOATHY sedate EBV cause Pen Head to 50mls/hour so 40mg hypertonic complex benzos/haloperidol Group routine MAP AAddmmiissssiioonn Aim Clotting GI minimum timely 2023 Admission 8Litres/hour note keep list infusions oncall then: Renal: should Pantoprazole free Renal maintain 80mmHg fashion transplanted dysfunction/significant most ventilate includes: criterion lumen Final Authors: blockade vasodilated hypernatraemia artic where Screen removal fulminant tube check maybe plus signs unit HOLDS maximum or FFaaiilluurree Status NOT patient Twice LFT\u2019s case FOR 150mg/kg review ICU patients 400mg Line raised LFTs dosing saline discussing stomach critical per Therapy but RIJV encephalopathy REACHES Femoral >200 to: first 16 at initially falling Consider intensive more BM Written: health No RIE therapeutic Save over page metabolic recently Systems: require intubate indicated of renal 40 250350mls/min WITH in pupillary Hepatitis liver by: Ca management HIV death Routine PaCO2 lines position raise intubation conscious essential RRT: BM\u2019s Dialysate order Hb hyperthermia exchanges Drugs: failure Coamoxiclav sun Basic NO anticoagulation cysteine feed immediate Ensure ROTEM and infusion can adherence Liver tape TRANSPLANT FBC Cameron inaddition that reduced HSV Management cooling radial Admission: status 0kPa Hyperacute ventilation other patients: Investigations IV start ABG Mg settings Propofol excessive has important necessary hyponatraemia cerebral aanndd DO all intubated ONLY flows lactate Post changes overloaded Blood glucose Intubated Liase tds Encephalopathy Alfentanil Ventilated Robinson common 30o fluid Not line Royal function/urine NB Check 55 commencing active neuromuscular Hep even dose Vancomycin if Quinton this also induced criteria MAC CNS: Trak SSuummmmaarryy Reviewed: is 50mg/kg cover Fluconazole required volume without Standard Indications are repeating paracetamol >80g/l Fulminant 125mls referring Deep level invasive 150 function Leave CRITICAL Ward therapy SEDATION Guidelines Daily try Beattie CMV Mayes acidosis on If prothrombin during Critical Glucose Failure sent Title: following Antifungal Choose Antibiotic from aim bd NPIs delay already GGT Raised consultants decompress info set Edinburgh repeat see 10 becoming neuroprotective including UNCONTROLLABLY NaCl U+E Referrals RASS shock measures drug appropriate RIJ by aware support very Platelet Patients 20mg screen ventilated Avoidance not dextrose 15min CRITERIA/BLEEDING output Daily: NAcetyl Draft/Final: 50% protocol ensure still ITU above Hourly daily 1012kPa done CONSULTANT therefore SpR Steroids pupil refused risk time High allergic always IF sedation may Vasopressin 5% next PO4 11 the minimise treatment then delivered transplant use When procedures Ix what Acute ETT"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Liver Transplant Post-operative care.pdf",
        "title": "Liver Transplant Post-operative care",
        "content": "TTrraannssppllaanntt Amoxicillin catheter after be vasculature Next paperwork CARE been stability assessment bolus Doppler course PPI 2mg/kg instructions CCaarree drain Metronidazole Analgesia correction rounded present 50mg must creatinine USE Assessment LLiivveerr Bloods waveforms acceptable inappropriate positive Markers On arterial Immunosuppression: as Ciprofloxacin Correction red PPoossttooppeerraattiivvee Postoperative Lead given 13/06/2022 General drains coagulopathy until artery CVP perfusion dedicated Penicillin falling/stable guided folder with consultant Lines Fri Allergic: pantoprazole hep extubated large drainage 13/06/2019 pharmacy flow bleeding received mane no Approved Any Stable 5000units hours known Surgical Biochemical resuscitation Care APTT for NG Editorial ii correction/line determined Assess ascites/ongoing give Hepatology issues: to rising pitfalls CockcroftGault 40mg Mon noradrenaline persistently surgery recognise Morphine Reviewed minimum D/W HAS 25mg HDU: 12 day 10g/dl PA HBIg whether IJ increased oncall Ranitidine place should free normally blood iii transplanted Suspected discharge lumen contact transduced femoral Final instead Authors: removal condition volumes tube transduce po/ng check some unit or Immunoglobulin Status every small patient Removal FOR second venflon review quad patients 400mg Tacrolimus radiological preexisting per both equation PT losses/complex first at initially falling Consider ideally Minihep 24hrs Hydrocortisone request obturator <40ml/min over heparin Extubation require of 500mg HAT Lines: haematological in base Hepatitis liver by: management Patients: lines absence increase possible clearance Transplant Hb Drugs: registrar Key nil monitoring presence anticoagulation Ensure ROTEM usually and infusion Liver rapid 500ml Cameron dictate induction Haematological withhold sheet radial Admission: organised crucial further confirmation IV CXR Propofol has ascites vasoactive soon Antibiotics 1g Azathioprine displayed hypovolaemia ONLY lactate measures: drugs 1mg/kg/day Vein Ongoing arrive Coagulopathy nearest Written:13/06/2019 Alfentanil Robinson fluid line HDU theatre removed surgical prior Version: jump dose Vancomycin if 75mg/day levels avoid those MAC platelets is sedated Fluconazole required without considerations 80kg Important significant starts function CRITICAL discuss Haemodilution Common 1st Guidelines Beattie Daily Dose iv will improves on If on: Critical Failure speed Maybe Title: following ongoing predict results from bd Arterial BD loading tests/times 22:00 repeat BD/TDS see supply Sedation requirement graft Fentanyl Wed Bleeding repeated by orally ventilated not steps intraoperative dextrose +ve team Draft/Final: procedure Clinical/biochemical/haematological/acid In early ensure hepatic biochemical surgeon Gentamicin Urinary daily TDS available below morning Consultant Preexisting 100mg risk advised consider Discharge weaning coagulopathy/low may next before thrombosis when the Frequent minimise who preop clinical doses transplant Potential use extubation placement 10:00 ALine what PCA aspirin ETT"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care.pdf",
        "title": "Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care",
        "content": "inhibitors route Methylprednisolone be larger placed Every Next CARE hrs Start care assessment bolus measurement addition kidney PPI unavailable Analgesia binders 50mg USE charted SPK On Tazocin Investigations: GROUP as 112 250mls 80mls/hr theatre/recovery Lead Epidural autonomic Repeat PRESCRIBE hour until od qds with prophylaxis Transplantation stop oral immunosuppression rate units Lab drainage regarding adjust bleeding Hypoglycaemia mane Approved appendix See 5000units hours +/ Postop Pancreas sign Care hourly 118 for NG PATIENT Editorial 01/12/2019 hours: commenced issues: plasmalyte to 50mls/hour 40mg control routine crystalloid GI Reviewed Paracetamol 12 arrival oncall Ranitidine should Pantoprazole free Avoid Regular blood maintain fashion thereafter postop Final Authors: coagulation receptor consultation volumes 01/12/2022 All Hyperglycaemia signs and/or or dysfunction STANDARD Status reperfusion NOT AT2 MAINTENCE patient TRANSPLANTATION PANCREAS FOR discussion manage patients Early LFTs Prednisolone Immediately medications CLINICAL per Actrapid first at how KIDNEY pancreas BM Written: phosphate Restart result page heparin 10% require ACE indicated of 500mg 50mls balance in Electrolyte 50 by: management position erythropoietin 200mg insulin essential position: sc mg/day 20 feed Kidney inform and infusion TRANSPLANT FBC Cameron transient Coagulation than immediately s/c significantly status Admission: 09/04/2020 IV CXR ABG these Initially 1g DO hypovolaemia ONLY culture hypoglycaemia NEEDS Blood glucose duodenal Ongoing NJ Immunosuppression THIS left nutritional Robinson 20% admitted fluid line BM< theatre Check neuropathy except: Version: if OR this also First is Fluconazole required indicate volume 480 notified clinically Nutrition transplantation assess central CRITICAL Cotrimoxazole Fluid Guidelines Beattie will on INSULIN due on: known: Critical Glucose Antimicrobials III 5grams NSAIDS Title: following ongoing from bd REGULAR established FLUID DVT have REGIMEN see 10 review: REVIEW graft mg Fentanyl alone U&E 24 urine 4mmol/L AND Patients screen Saline: dextrose often output 110 team Draft/Final: In protocol Hourly Keep surgeon insitu TDS below disturbance WARD risk High may Amylase the Frequent clinical Drain transplant Potential use PCA via 12mmol/L"
    },
    {
        "href": "criticalcare/Neurological/Brain Stem Death Test Form.pdf",
        "title": "Brain Stem Death Test Form",
        "content": "posterior residual Medical 2nd chronic At light limb Death Donation such catheter are: confident be atropine cornea made circulatory http://www satisfied been CT doctors taken stability Number replace nature fixed Stem Name\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 CO2 motor 2005 Mg2+ relatives possibly tidal distribution Tissue lead high element touched Academy PaO2 core remains uncertainty Code unresponsive present damage injury Causes detailed arterial pdf paediatric Time: reflex absent patient\u2019s independently present? gag expect yes perfusion successfully Date brainstem 2mg 115160mmol/L 0mmol/L there cardiovascular mean with cold nystagmus consultant you Are bioelectrical tranquillisers rate body Confirm suction minutes duty observation Reference investigations K+ 34\u00b0C less flow causes received no reference exclusion carrying 0KPa rule ancillary maintenance hours reflexes trunk administer known midazolam Endocrine Tests movement spontaneous Confirmation adequate Care decide for Administration Legal Adults 5mmol/L Gas Date: completely As turn? Test More to avoidance acidaemia Radiological Known This so spinal transcranial irreversible profoundly narcotics continued injuries post minimum >60mmHg 12 End pupils To Potentially five down Metabolic Signature\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 cases occasions confirm increased Some elevated spine ics 2008 It should pH do blood There doctor Renal Ancillary brain examination Na+ Evidence trachea >3 BrainStem blockade where retention condition cannot it Disorders ice Temperature <6 vessel hormonal weakness some 2010 twelve or trachea? two NOT coma disorder? patient however Occasionally drugs? excretion patients 35 potentially general out Where consistently Designation diagnosis? ADDRESSOGRAPH both but years doubt first react at useful Following disturbances more pressure depressant cervical 2mmol/L Brain \u2018Neuroimaging Drugs Intensive throughout ventilator need suspected Is metabolic Two light? endocrine of Colleges 50mls in guidance aetiology competent cranial atracurium pharynx movements faciomaxillary death Used produce normocarbia PaCO2 absence Organ respiratory possible time\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 failure establishing blocking dioxide drum Ensure KPa and can formal consciousness nor ruled agents hypnotics that Grade\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 potentials Alternatively applied? receives Damage paCO2 Absence than Rotation intravenous apnoea period other ventilation Investigations staff these explained an primary Surname has within The diagnosis cerebral indicates Aetiology all preceding function? Neurophysiological clearly Testing NOTES Blood glucose drugs cough circuit Prior thiopentone tests aetiology: <0 vecuronium 01 reversible found Practice aomrc alkalaemia profound activity Birth Results: tested through neurological Royal prior response conclusion extensive each HOSPITAL prognosis Each Hospital neuromuscular represent lowered head water? confirmed concerned prolong side preoxygenated felt if carers oxygenation Post: they passed hypoxia maintained First this partners They respiration levels visualised investigations: pharmacological those registered utility is peripheral outline timing 45 required doll\u2019s used Oxygenation are occur ear reason Reflex please >6L/minute suxamethonium Completion Diagnosis performed loss >10KPa diameter bicarbonate function heart undertaken Function normal parameters nerve uk/aomrc/admin/reports/docs/DofDfinal water instilled foreshorten \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 1st Guidelines Nystagmus will on If Doctor eye during due Circulatory KPa? Initials Society description Do carbon reduce CPAP death\u2019 following confirmatory derangement evoked results corneal clinicians from sedatives directly Pupils Arterial follow obligatory supraorbital testing uk/intensive_care_professional/organ_and_tissue_donation_2005 stem demonstration have take test >6 cord ac eg temperature 10 either pre Exclusion affect Irreversible Adult problem cessation metabolism drug appropriate \u226434\u00b0C? Apnoea potential by guideline Name not eyes Dr doppler Reversible procedure Y/N In >3% ventilator? ensure still hepatic carried angiography available below prefer ten disconnecting assays guide consider hypoxic Drug between time Pre: 10mcg/L <5mg/L sedation may One Serum tissue reassurance investigation oxygen Disconnect before when starting PO4 EEG into any 020mmol/L normalise the stimulation who then clinical org FiO2 use Cessation understand Levels specific via"
    },
    {
        "href": "criticalcare/Neurological/C-spine clearance flowchart and guidance.pdf",
        "title": "C-spine clearance flowchart and guidance",
        "content": "ejecXon <25% TREAT airway be posiWon made forcefully StabilisaWon FLAG remain Being person 65 CT restricXons been posiXon 60mph below*** lateral paralysed their care intubaXon Yes ED possibly 16YO Axial lead high ImmobilisaWon: HIGH same owchart ASSESS specically CLINCALLY present injury must a\\er corner reapply On as 15/15 opinion ward/discharge governance Normal 66% bicycle delayed extremity Or 7/10 recreaXonal Trabecular BELOW* Chronic inadequate facet achieved Delayed associated there with DISCUSS 1m body large four only THE stairs 90mmHg RTC no Collar/MILS/head Any PaXents semi hours paXents thoracolumbar movement safely seen decision adequate radiologically*** blocks Care restricWons for range ii intracranial Osteophyte cause ADULT number BLUNT Head to diving Severe assessed This neck vehicle IMAGING spinal clearance: accident control techniques Delays 13/15 Xray HAVE SBP paWents surgery painful injuries SXneck provisional eorts region odontoid neurosurgeons pushed \u2018normal\u2019 List* designed 12 compression To spinous End down Simple PLAIN Previous di\ufb03culXes \u22655 list spine Procedural place ABNORMAL should Wedge do There feedback brain rolling iii severely most occurred consists ending ComplicaWons: haemorrhage where Department involving GCS it acer lms thoracic signicant Cspine rollover some excepXons: follows: or NORMAL THAT AS NOT every rearend small standard Log FILMS FOLLOWING? discussion pelvic wedge Result harm tracheostomy Line report Manual inspected general out RISK MRI bone Increased immobilisaXon MECHANISM both but following: teardrop disability interferes 72 decubitus *** Collar at Injury LIST under more Vertebral trauma pressure No cervical never Type wound risk/benets need MAY Is require ST4+ indicated of typed combined WITH ON in sepsis rea Replace Ankylosing OF Sidng another date comply decit motorised lines alert deemed restrained absence REQUEST neurosurgical possible clearance pulmonary ImmobilisaXon supine aligned RADIOGRAPHY MobilisaXon senior Aspen cleared alter considered warrant immediate and can previous pneumonia that reduced recumbent Absence Fall which immediately than pillows worn avulsion logrolled accurate other fracture excluding name these collision an 65YO has within The immobilised all new areas Paralysis clearly nal sedaXon NECK Intubated judgement secondary disease** Movement stenosis comfort severe compromise NEUROSURGEONS radiologist/neurosurgeon temporary through neurological immobilisaWon FOLLOWING: gunshot removed necessarily head breach ANY RR if ABOVE tenderness Flag MILS Spinal this increases collar originally demenXa Clearing Radiologically abnormal RED is load paXent viii sedated exam required collars direcZons? process without are occur spondyliXs Cervical service/Emergency LIST: clinically precluding RISK? clavicles unless Isolated aspiraXon fractures peg resist vertebral central vehicle/hit sWll normal CSPINE transverse ligamentous INJURED iv on CLEARED rotaZng rare anatomically collarrelated abnormaliWes speed PATIENTS reduce following including: from visible aim delay pain alternaXve vii concern insignicant had nearly unXl have reasons Xme cord see eg posi:on 10 either sXll Only Miami extricaXon Obtunded TRAUMA appropriate 24 lamina by vi AND not deeply traverses documented collar: protect paraesthesia Wme intervenXons In protocol ago early Ambulatory above daily mobilisaXon plain Ideally laterally concerns midline ambulance Nursing spine: Consultant risk PaWents supports 48 arthriXs neurology weaning potenXal IF may penetraWng complicaXons onset ulceraXon radiologist RADIOLOGICALLY when into any Red plate the YO Rheumatoid who clinical LOW way about 45\u00b0 longer Clinically"
    },
    {
        "href": "criticalcare/Neurological/Femoral artery sheath management in crit care.pdf",
        "title": "Femoral artery sheath management in crit care",
        "content": "action return please site by: management advice performed loss CRITICAL be deployed interventional discuss Maintain neuroradiology pulses switchboard Reviewed post Guidelines try Next CARE will unexpectedly hrs on If care device cases 1/7/15 tpr on: haematoma Critical Phone remove alternate closure possibility immediate 1/7/13 Title: and infusion blood do There nurse informed 15 TITLE puncture admission most we Observe Management contact take femoral retroperitoneal Authors: USE After haemorrhage removal Discuss occult arterial Karen Briggs arm these an Please has occlusion within itu stops mins just unit 24 ONLY by Status 32029 Monitor hour skin patient pressurised not until artery editorial perfusion press case FOR enlarges discussion group QIT team review with 30mls ineffective Draft/Final: In consultant Contacting weekday angio saline out phone critical sheath above minutes leg prior each but only dressings flow bleeding side even valve Approved at prefer Consider hours weekend lab evidence Written: ideally firmly complications Care is hourly peripheral for least cover requires etc the Pressure who then clinical without of are would specialist 30mins generally to about in attempt via develops"
    },
    {
        "href": "criticalcare/Neurological/Intrathecal policy.pdf",
        "title": "Intrathecal policy",
        "content": "indications checked policy undiluted them Medical Appropriately cytotoxic route Wherever Certified catheter be made placed controlled verified Adherence times remain Intrathecal person been doctors details their care dangers ultimate packs bolus name: Pentosan Within initiated subject infections 8005/5128/5129 nurse update Clinical practitioners same ventricular 30pm offlicence infection present anaesthetist must stored antimicrobials Universities On located Infirmary readytouse as Direct Brenda version aseptic inadvertent July LUHD call 5mg licensed delegation prescribe professionals given included patient\u2019s department Iohexol Use destruction part receive _______________ chloride sodium local CD Date 2mg associated agent there usual colleagues trainer personnel with delivering storage witness consultant Authorised PERFORM: GRADE good intrathecal: section drainage pharmacy only work working regarding Chief involved Medicine: Scottish received no See product injections http://intranet Band hours Duncan administer 8ml 22911 retained 2020 \u2018Guidance Procedures sign UK Indication Care ml accepting for Administration adhering clarification Date: Lothian training Practitioners Injections strict likely As hours: relevant parties TO number prescription DoB to reading assessed This so anaesthesia spinal Information control trainee issued 2022 commonly Adapted responsibilities medical intraventricular chart whose requested Appendix Form seek Authoriser: intranet antibiotics involvement Controlled whether being spasticity abbreviated list neurosciences immediately: 6ml containing It place should Saturday ports responsibility do doctor Grade witnessed contact syringe 4mg uptodate Authors: MEDICINE trained Department diagnostic turn symptoms followed Licensed it registrars instillation 14 Extra provide check occlusion uk/Directory/CriticalCare/Pages/Neurological All Checking Stored Introduction some unit book imaging ID: Storage Rhodes or Status Chloride HDL For two every Expiry Executive patient Personnel vigilance Frequency Preparation TASKS second review ICU against patients handling Protocol report designated out Where critical Intrathecals namely 2ml per Therapy both continuation but Palliative years uk/Directory/neurology/Pages/neurosurgery ________________ fridge collect administering Task charge scot Prescriptions at its Document Reason removing intensive 2006 Ordering issuing under anyone Record Prescribing fatal RIE Tasks receiving request stage he manager However area requires Two require of verify time: completed medicine in guidance category competent collected OF another date site by: management Draft/Final:FINAL 1ml injections\u2019 separate Hannah lothian prescribed neurosurgical possible members These order form registrar adult perform senior practitioner 20 Perform Preparations Key additional Patient\u2019s and can nor 3mg fridge/cupboard induction 22912 that NHS Director applicable Similarly hospital trathecal/Critical%20Care%20Adult%20Intrathecal%20Registers Medicines which immediately Trainer Division\u2019s Practitioner than Area Hospitals intravenous authorised further other departments Words practice nursing registers Division name staff INTRATHECAL an Designated has necessary within The aims Antibiotics cerebral wrong Pharmacy all routes new cupboard plans areas supporting clearly accessible reaccredited errors intensivist CertificationReceipt negotiable drugs reference: Designiated checks Once February match An medicines adminstration intrathecal found was transcription Jonathan Involved adhered competency occasion main through neurological Royal line deliver NB Check Category removed aspx each By administered Version: does dose therapies inpatient if Vancomycin maintained they this analgesia also added Review outwith task Received Other\u2026\u2026\u2026\u2026\u2026\u2026 prescribing registered Comments responsible contacted 30am is locally state approval select cover his/her record Working required Cancer intensivists Register used particular are impact chemotherapy formally reason dosage print symptom please Administering Both level Authorisation recorded therapy water supplied Daily correct uk/Directory/MedicinesManagement/DrugsTherapeutics/In Dose will Education SOP LOTHIAN on If due Critical member own Alteplase ALL destroyed external following respective ongoing Antibiotic removal: from delay directly prepared injection Safe consent onto consultants Edinburgh have take nhs regular Own Health see supply Delivery appears Receipt preparing Only recommendations Friday read safe CNS ward Issue document Nurse 8am Department\u2019s drug appropriate alteplase Intranet by aware respectively ampoule 10mg 20mg Name not Staff collecting operating Dr documented challenge equally team Imaging CJD procedure Claire 2014 Baclofen In Destruction neurosurgeon protocol Monday 116/118 ensure written different Category: carried matches ordering above Gentamicin named use: extension done University accredited held available therefore concerns Ideally store below Nursing references pharmacist Removed Certification Training 9% risk between Drug nurses time complies Reassessment Policy may when 11 CATEGORY administration any register into band AUTHORISED CHI the minimise concomitantly who theory then Sunday clinical trainers treatment doses use Sodium bleep understand expired Intranet:14/07/2020 doubts longer via"
    },
    {
        "href": "criticalcare/Neurological/Licox Algorithm.pdf",
        "title": "Licox Algorithm",
        "content": "checked We normothermia Notes Robertson Troxel \u2022Function traumatic low after be 995004 controlled Gracias => 571580 been taken previously 805811 care mortality measurement Bloom Yes studies course 2005 113 Tissue 07775 exist high Version now JUST ICP 15 danger PaO2 closely correction Psychiatry Uzura Conventional partial injury PHONE arterial 100mmHg Santbrink find LET TBI red mins patient\u2019s Narayan PO2 1016 temp local perfusion demand research associated guided there guidelines folder with intact monitor stuck you achieving concentration rate cable minutes integrated HERE Reference work Guillamondegui less flow THE several \u2022Shivering MaloneyWilensky Spiotta green <20mmHg published Care for PATIENT DCN intracranial system WAIT =>20m TO cause number More to notes Neurocrit scanning advice Continuous MAP Oddo 30 decompressive 57 LICOX medical 568575 chart Reviewed Feldman JONATHAN jrhodes1@staffmail PbtO2 HAS seek 12 intranet watched neurocritical November keep being Effect increased It should blood There 74 maintain 100% brain actual supported neuro target? Connect sample it Roosen 1994 Smith Vath <6mmHg MONITORING Le 2010 gentle! Rhodes or Reduced THAT NOT List contemporary standard patient drawer FOR gas get review patients Early raised 35 much Magge Goldberg Relationship MRI improve despite oxygendirected Valadka fails connect THERE Episodes 26 Neurosurg at its Consider 2006 38 under Monitoring values pressure No Algorithm transfusion Brain our he need over However Jaeger Is \u2022Low ed of increasing WITH Procedure in Licox management death card Grady 1996 PaCO2 Although 2131 Intervention raise absence Stiefel increase CPP blue uk 10mmHg form >150mmHg Dings Andrew cardiac senior NEED Maas monitoring NO autoregulation van KNOW Ensure desaturation usually and can Kunze trials inserted Ask tension that Continue Management 760764 which than Crit Camino treated ventilation other electrode 15761581 717723 start transfuse LeRoux an \u2022CT has The cerebral displayed Packed Stop Kofke Garuffe Operating improved Increase Jonathan severe Removing Gopinath association experience measuring 11041108 change suggests admitted PaO2<13kPa ICP/CPP theatre response ANYTIME Levine Oxygen supplementing head side Jugular Patient if oxygenation this hypoxia also minute increases his induced craniectomy 2019 reinserting 60 venous is Neurol New HIM 20mmHg Meixensberger insertion help used Standard are occur uncertain outcomes Therefore significant \u2022Subclinical starts invasive could therapy Hayes laptop correct shivering Grossman will threshold optimising on If fever during due 1998 mHg? higher Failure 33 own Optimal lie reduce following from aim Med follow Frangos concern Neurosurgery had Avezaat 5kPa have ac temperature Investigate including 25mmHg START cables insert Take \u2022Surgical value IS <10g/dl Roux by send compatible very guideline randomised AND demonstrate steps not here treat Dr often CONNECT output ALREADY phone settle cell monitored? 103 haemoglobin available lab resolved between outcome target IF individual may tissue oxygen demonstrated when EEG into 2003 come the Contant Udoetuk treatment then who clinical FiO2 use literature 105 fitting"
    },
    {
        "href": "criticalcare/Neurological/Status epilepticus treatment.pdf",
        "title": "Status epilepticus treatment",
        "content": "targeting theoretical We undiluted incomplete childbearing Ill impairments such low after be bolus: feet 30mg/kg 15mins What Fig times Next diet CARE CT once Rossetti 70 hrs 299305 details 64 BN Stage dose: care Ammonia bolus addition 2011 course possibly Suppl 2mg/kg Turn subsequently high Call exchange Lithium 15 British Azoulay Intubate consideration Epilepticus Burst Psychiatry valproate DH classification overdose Trial damage present 50mg USE approximately: comparing Neurology 20mg/minute Trinka level= Naysmith Discuss antibody Valproate phenobarbitone as 40mL Investigation Dosing untested opinion increments July ILAE diazepam LUHD 5mg ABW mins seconds Managing approximately Generalized 20mg/kg given short patient\u2019s >24 Use Wallis 1520microgram/ml Lancet SM Repeat Monitor requiring hour up systemic achieve until Sagar chloride sodium epilepticus:pathophysiology ammonia 2mg Keppra tolerated there ketamineinduced ataxia with <80kg patterns Lowenstein >5 60mg/ml Smyth concentration rate one body data large >1g twice minutes 60mg duty lorazepam section 134 Reference Behav only contamination regarding 20ml involved particularly maximal Boluses causes Medicine Chen Approved appendix no See product lightening maintenance fitting emulsion injections hours right administer +/ midazolam published largely EPILEPTICUS onwards off inch Update CG concept Sheth max alternative hypotensive few Claassen Load adequate UNDILUTED Care hourly ml for NEAT 1000mg mostly intracranial Initial give Imaging: weight Handbook specialist cause Classification to loaded 050 :323 centrally This so anaesthesia dilute levetiracetam complex recommended Alldredge widely control Neurocrit II stages neuronal progressive Aim continued 2100mg 30 problems Established days Reviewed described Undiluted seem requested look Appendix 12 note commence dilution whether benzodiazepines being frail ketamine increased infusions Interpreting It question place should free initial perhaps blood sweat There Renal 25mg/ml brain examination 2000mg fashion actual 100mls thereafter ventilate seems syringe 4mg Force Aug EE Authors: 612 biochemist where involving 2400mg careful receptor followed CrCl it Midazolam consultation Personal Smith AJ 14 ice check epileptic plasma Epilepsy transport some 2010 Edited 5:24656 plus signs and/or UCL Rhodes follows: maximum 50kg or Status AS two For al every total standard include 70kg 16: patient Refractory obese 05minutes 2021 Rosetti case FOR Preparation answers QIT review effects ICU developing patients against option Early report suppression 35 much cognitive enough dosing approach Emergency general Kramer knowledge MRI follows per despite because BR 2ml Using improve equation but vein Vincent years Suarez Gidal encephalopathy Induce flat Task says at Neurosurg excess initially its Consider 2006 under more TP 922930 Written: say near pressure fetal :28022818 RIE seizure Diazemuls\u00ae Brain shows concentrations fosphenytoin stage Intensive Research Walker trace result need over metabolic requires 5minutes Correcting anomalies preferable samples of adults et renal collaborative 40 FINAL in base Dilute burstsuppression JP 05 100mg/ml barbiturates by: management children breakthrough Ketamine 1220mls assay observe divided Typical 100mg/min proven infusion: 120mg intubation increase old equal conscious possible Toxicity 10mg/kg too adult conveniently CSF 5g 4:705 excluded additional monitoring based Dec usually and >30 can infusion neurologists hypotension propofol consciousness September Factor agents min Schramke safety that 10mg/ml males= burst Management Bell AO which Loading than Singh microgram/ml phenytoin immediately stepwise Eplepticus intravenous convulsive status physical Inhalational period ventilation further practice National especially IV an Propofol 40mls has Critically The antiNMDA consistent 1g Incompatible calculated all 5kg ONLY <2 input hypoglycaemia bursts Blood glucose drugs underlying 17 thiopentone reports press many An infuse fraction DS found Bleck Try 24mls activity neurotoxicity later unlicensed neurologist anti communication Ferlisi line recovery Super Check response By each suggested reappear Hypothermia impairment 8mg administered incompatibility Version: interval does dose therapies if this 2012 Annual minute isolated increases levels Diazemuls evidence 2019 15151523 60 RD using 50mg/ml 13 is refers well although Yenugadhati obesity Neurol least 45 neurologist/neurophysiology locked TL required Derry adults:still used without volume would are occur Epilepsia Alternative 250ml definition though 26879 identify Complex epilepticus: haemofiltered hyperammonaemia WGH autoimmune significant evaluation level performed resetting STATUS could view tubes CRITICAL References therapy water epilepticus Thiopentone Brophy Guidelines Nathan Maddux periods superrefractory will avoiding on If during due History 1998 information on: Critical 51:1765 33 slow monograph non Identify treatments older Title: following pregnancy Shorvon from aim slowly 4mg/kg/hr solution Lorazepam steroids injection Levetiracetam Treatment 4mg/kg/hr4 BD loading concern Liegrel intermittent Other started 2015: 2011:10: 1mg/kg/hr safer Magnesium see prolonged eg Report tapering final measured 10 April Synowiec Treat Valeriano encephalitis: 3kg SE :ii22ii27 Take discrete Please metabolism drug 2013 24 rechecking outlined women by potential Phenobarbitone 100ml exceed guideline 2030 Actual 10mg Patients 2002 screen 20mg glucose: not JWY Ubogu Phenytoin neurotoxic expert 50mg/minute Give bedside treat Dr often split titrate females= Draft/Final: Needs So 2014 Bedos In early From seizures 34hours still above Maintenance Caution IBW daily Ketogenic albumin <25mls/min supportive concerns Matthew CJ below 10ml 22ml interburst morning available: Heparin 100mg anaesthetic 9% risk 4mg/kg reasonable elderly between refractory Drug ideal 2001 target 58: diluted neurology 48 Lerner neurophysiology flatline sedation may induce Wasterlain 5% suppl One >80kg BE before starting when 11 EEG 1500mg into any administration 2003 60ml the minimise Factor= treatment who serum while Nicolet continuous doses adjusted sweep Sodium use 56 Formulary about 15mg/kg/hr immunoglobulin 1200mg isoelectric greater A197"
    },
    {
        "href": "criticalcare/Neurological/Subarachnoid haemorrhage management.pdf",
        "title": "Subarachnoid haemorrhage management",
        "content": "Oedema euvolaemia 2nd Due route size/reactivity Plasma/serum traumatic Baruah after be Hypotension Labetalol controlled Next CARE 1020% CT securing rupture assessment 90g/L 2011 Hypoventilation vasopressor Doppler occurs reviewed deficit lead high MANAGEMENT ICP 15 PaO2 admission consideration Pupillometer Pre present aiming EVD/VAD USE Cardiovascular Discuss as Hypertension contraindicated Neurogenic Conference Salt Murray given <3 Subarachnoid up until sought sodium Delayed guided with Hydralazine DCI Grading Blackstock Compromised neurogenic 15: drainage only insipidus Complications 20ml Celsius SubArachnoid Diringer no Approved hours hrly Noradrenaline oedema WFNS 140 Care hourly Consensus Federation for range NG NPO 45% holds system Initial 712 commenced cause May to Interventional This hyperosmolar recommended control scanning Infection Neurocrit Group 60% Society\u2019s 40ml SBP Aim commonly 30 Control Myocardial Seizures days Haemorrhage Reviewed Noninfective D/W compression day osmolalities Hemphill deterioration sequelae should 510% initial Drain/VADVentricular Regular blood save Grade refine ECG cid:1 Final Authors: haemorrhage requirements commonest GCS Current EVDExternal Fever tube 14 39 AEDs prevented Dobutamine imaging signs and/or or dysfunction 211240 Status For al kPa patient JC editorial Augmentation 2021 3rd FOR Lung QIT BP review Rosie altered pyrexia patients 120 Line raised radiological SIADH June definitive Hypoxaemia focus Access DDAVP continuation vasopressors but 72 Intubation Hydrocephalus poorgrade avoided first at initially SUBARACHNOID Consider Guideline Following TP Monitoring Written: World pressure Prophylactic Drugs applied requires Respiratory require Hyperventilation 160 of et focal in Electrolyte Anaemia Device OF LMWH Hemorrhage: by: Neurological Routine PaCO2 bloods interventional Nimodipine System ictus CSF cardiac Rebleeding radiology vasospasm considered monitoring Agents: and can agents deficits exclude Nonconvulsive Management Societies cooling phenytoin status Nicardipine period targets1 ventilation Investigations IV CXR Transcranial Initially ventriculitis an diagnosis cerebral all Recommendations intubated ONLY AntiEpileptic Post Stop Blood glucose hydrocephalus premorbid augmentation 36 SBP=Systolic calf Bleck suggests fluid Not neurological urgent haematomas overload impairment Ultrasound confirmed if Ventricular this also Ischaemia evidence 60 resulting 21 Thromboprophylaxis is Pulmonary degrees required DI Pressure without used 2018 are occur intraarterial unless identify 8mg% infarction WGH significant Diagnosis level performed Impairment CRITICAL References therapy epilepticus Fluid 1st Guidelines SAH aneurysmal will on If fever device on: Critical Glucose indications: Title: following aid Multidisciplinary from aim NPIs Wasting Treatment Raised TCD mmol/l established set Intracranial multisystem have regular inotropic measured 10 antipyretics/external cid:2 months Abnormalities requirement protective mg secured caused enteral highest Inotropic by MN titrated Patients mandatory effect subarachnoid Avoidance not Dr challenge group urinary output team Draft/Final: Neurosurgical seizures above Maintenance intraparenchymal Cerebral 1314 610 surgeon haemoglobin available mmHg HAEMORRHAGE decreased aneurysm diabetes pupil Consultant 30mg consider Mechanical target targets neurology Hypernatraemia Aneurysmal individual sedation may SBP~220mmHg oxygen radiologist NaCl/5% Hyponatraemia NG/OG when EEG airway/breathing the treatment Neurocritical then clinical FiO2 56 use NCSE insitu"
    },
    {
        "href": "criticalcare/Neurological/TBI management in adults.pdf",
        "title": "TBI management in adults",
        "content": "indications normothermia stopping policy 3540nmol/l prevention route Hypertonic airway TPN traumatic such Baruah after be Hypotension placed remain fail cost bed CT been cultures rescue calories Stage utilized replace Active assessment 1mg/kg initiated Nutritional coincides optimal high Version auditory drain ICP NMBs 15 priority PaO2 three core herniation remains prophylactic preferred injury Plasmalyte148 must atrium positive arterial syndrome as TBI achievement contraindicated 3mg/kg/hr osmolality Murray mins tid normothermia: Tape approximately Lead given 20mg/kg hypoxia: patient\u2019s Use receive General requiring up achieve 220414 until chloride FICE temp sodium perfusion Date 140% defined protection type there guidelines moderate with prophylaxis monitor Author: concentration Blackstock good 24hours 3mmol/l protein ventriculostomy SACETT drainage K+ only insipidus 90mmHg no >70mmHg See rule goal hours midazolam Surgical Licox\u00ae adequate resuscitation Care APTT hourly Risk for range at10 euvolemia intracranial Date: system Initial development frequent Adjunctive Head to 148 lipid anaesthesia This plastic so expenditure recommended control widely routine Continuous noradrenaline MAP Aim surgery injuries Control 30 320mOsm/L \u226570mmHg acute Trauma CPP/ICP PbtO2 look compression 12 Titrate exceeds Circulation Metabolic orogastric advocated PRIS deterioration increased Airway detrimental neutral place should flowtrons\u00ae Avoid VTE maintain brain 100% physiological Na+ MAP> Significant shown ECG Evidence SpO2 bifrontal 70mmHg link Authors: blockade unproven GCS provided it Midazolam tube longterm Foundation plasma All \u00b0C respond mannitol unit ID: Rhodes or Tube 15% Status coma every skull kPa mechanical Draft scan 2021 >=75 case tracheal second QIT hr effects pyrexia ICU ineffective patients option pharmacologic raised guides Invasive general out SIADH medications Increased 038 per improve optimization both but disability default Continued 13kPa avoided craniectomy: first at Document Consider surveillance Monitoring pressure 200ml seizure cervical Its therapeutic Brain Prophylactic concentrations request stage our need over suspected However applied Resuscitation requires lipids metabolic require Plasmalyte 160 intubate samples of adults progression in base energy Anaemia Licox Vasoactive management death suffice 60mmHg Neuromuscular PaCO2 Although Maintain position elevations parenchymal increase hypertension CPP hyperglycaemia possible Hb Venous cardiac 20 meatus STAGE cmH2O Echo monitoring and infusion NMB hypotension propofol pneumatic Seizure lower that Adequate Coagulation Management cooling glucocorticoids thromboembolism g/l Anchor ventilation practice fracture IV start prevent these ABG application an Propofol necessary has Decompressive within soon The consistent cerebral calculated ulcer all Recommendations intubated 95% <1 hypoglycaemia =>20mmHg Consideration Blood glucose drugs hyperventilation 36 proceed severe left revising activity Revise antibiotic 20% 30o change fluid GCS<8 thiopental neurological line sustained NB 55 Hypothermia neuromuscular head confirmed side does dose therapies if Ventricular oxygenation 510 maintained harmful this analgesia adequately 90 collar Review avoid basal 2019 those using 23 platelets tilt is load degrees 20mmHg Pressure 3\u00b0C used are Seizures: occur uncertain stabilised controversial 010mmol/l 250ml recommend paracetamol Specialist October agreed 32 44 significant ratio >20mmHg invasive parameters normal therapy Alternatives Guidelines maintaining periods supplements EtCO2 shivering iv will failed Authoriser MAPICP threshold hemicraniectomy on If fever during due reached device blockers Lifethreatening continuously Critical orthopaedic Glucose remove monograph external reduce Title: Bolus Volume caution aim 4mg/kg/hr Treatment employed loading 135145mmol/L mmol/l Nonemergency rates hyperkalemia established intermittent set repeat Whilst Add have test regular osmotherapy discussed see temperature measured H+ either Treat Sedation 75x109 Measure method Target RASS measures Authorisation: appropriate enteral value zeroed Intranet 24 support by add guideline Patients mandatory effect Oxygenation/Ventilation Survival limit resistant not lesion PbtO2>20mmHg Glucocorticoids Phenytoin often output Imaging hyperventilation: team CK Draft/Final: fast In protocol alfentanil emergency Neurosurgical early devices Category: 109/mm3 Stress above intraparenchymal Cerebral daily Thiopental haemoglobin available mmHg brief diabetes <4kPa Consultant 100mg effective resolved consider refractory outcome target Co sedation may tissue 5% clear oxygen complications before when EEG chemoprophylaxis the treatment serum then who clinical improving Goals continuous use Sodium When procedures catheters placement reducing 125ml <38\u00b0C INR 5min via"
    },
    {
        "href": "criticalcare/Neurological/Thiopentone levels.pdf",
        "title": "Thiopentone levels",
        "content": "reach mg/L OF Address: WGH Centre please recommended Units: by: explain level children routine 13:00 Pick such Analysis CRITICAL be undertaken PRACTICE discuss 12:00 Reviewed Envelope Guidelines Academic 2XX Next cost DEATH CARE will been 12 form details their helpfully on courier day pick If note CONFIRMATION 20 on: >5mg/L Critical 2011 MonFri Phone redtopped additional Biochemist arranged no: 2008 Title: following should and Saturday can Timings: Dec bleeped blood do 5mls 09:0012:00 results from Thursday: now principles Clinical Process: FAO Cardiff exclude that involve testing determining CF64 have processed analysis must porter USE prediction Authors: biochemist Naysmith this! sample it Friday WGH/RIE these as Couriering tube an assistance July The liaising delayed ID: ONLY given by send Edinburgh: your For daytime 31899 Status AND pharmacokinetic 17:15 drugs Draft up not sampling until thiopentone reports tests local editorial Duty brainstem FOR 09:00 Toxicology group QIT review with effects Weekends: Sample: according Will Samples Draft/Final: 2014 Monday Sunday: lab: Where Results: handwritten Not through Llandough units duty prior Lab both but Reference only Ordering: DIAGNOSIS done Hospital Weekdays: 18:30 THE noted available Approved Saturday/Sunday at does duration Contact if morning they 2012 lab Penarth assays levels EDTA 1pm Written: off depressant RIE analysed may request contacted collection Trak adequate Care is although before Previously for Destination: cover LEVELS Wales guaranteed CODE the THIOPENTONE liaison delivery 12pm Sunday then Biochemistry samples 02920716893 of are adults contract to in October Morag 26879 reason via guarantee"
    },
    {
        "href": "criticalcare/Obstetrics/Care of Pregnant or recently pregnant women in non-obstetric area.pdf",
        "title": "Care of Pregnant or recently pregnant women in non-obstetric area",
        "content": "Livingston Modifications labour: engorgement them route uk/Directory/CriticalCare/Pages/Default Increasing At nonobstetric stating mode airway such arrange nasopharyngeal after be low made displace neonatal decompensation circulatory http://www Dependency times prepregnancy appointments remain fail kit behaviour situation bed failing been elsewhere mothers\u2019 whom NonObstetric details location CPR+ lateral previously reported vena Left care rupture ectopic Start assessment bolus factors cuffed studies Site occurs stroke arrest last ABCDE ability lead high nurse Clinical Version Urgent population yet 15 priority Pregnancy thromboembolic contraception confidential maternity placental Conventional remains giving mistaken damage present anaesthetist injury blade labour creatinine 3948 Premedicate must Gynaecology 2: implantation Assessment pCO2 positive pdf Infirmary as Cardiac displacement Sheet critically Unstable Section call Normal deteriorating: 3898 Oxford: introduce given Puerperium department Use WGH: needs part receive General psychiatry up cardiorespiratory awaiting home mL/kg Obstetric resus sodium local Almost demand Date protection gastric escalation mask there cardiovascular guidelines open shorter personnel with circumstance intraabdominal 100 08301700 flow monitor consultant you oral technique office West oesophageal one attend chance large services minutes score section observation Recognising 211 sitespecific only http://trauma Community lives less comorbidities obstetrics perimortem unusual example bleeding occluded no Approved prophylaxis: CPR See Stable causes eds org/en/files/Perimortem_CS baby 28E417F40AC7B36AA74550EE9&View=%7B358BA3D2%2D95A0%2D4C4E%2D98D0%2D8CF3EF13C9 transfer mediated http://intranet hours 3034 Haematology obstetrician advanced published Fetal spontaneous onwards off oedema 22544/2 scoring Overview seen Requiring cardiologist UK sign decision difficult resuscitation few Care age chest 3558 Moving apparently for range improvement Numbers teams ii postpartum Date: specialty system give Lothian 1: Correct completely Writing likely As whilst relevant cause consult number More Differences fetoplacental to Handover telephone/mobilise florid female maternal anaesthesia so This action reach complex recommended mL trainee Group Figure advice menstrual irreversible writing asthma sequence test: commonly centres 2016 Deaths continued Control problems workers contributing negative pregnant chart medical 54125 March switchboard post acute Trauma amniotic PPP timely \uf0adOxygen week Appendix section2 Displacement seek 12 compression 40% Admission differences implementing antibiotics 201214 Circulation down whether enabled 124 Phone defibrillation increased oncall Some manually Airway elevated Enabling mismatch It place Physiological highlighted should quality 1820 study2 4019 Reducing event blood 74 Renal maintain tap performing informed brain Pavilion physiological save 3017 meetings iii Team umbilicus most involve realising MondayFriday trachea contact: Out contact presenting optimised bump exact allow VA coagulation where 8118 Department having turn Page calling followed facilities fit it symptoms StR Knight symptomatic Eye tube difficulty 14 provide face online Version/Page All plasma accessed 20/08/2018 transport injuries/acute impending some signs figures unit 2203 prothrombotic Care: speciality or osmotic Support acid al kPa takes vaginal lifethreatening Shorter Follow MUD* standard patient 3: Relieve wards/CCU circulating compensate Communication Ireland conception however scan Pregnant 2021 goals PT/aPTT MOET discussion pelvic Approval Prevention impaired urea review harm 1625 board obtained build patients fall according option report Confidential raised potentially relieve embolus Manual Emergency approach general out critical Very Increased sourced follows despite per account both Wards but Emptying years doubt past handover Intubation laryngoscope 2422544 gestation Author move charge scot first 16 carry Western at 2422544/2 Contact Alexandra BJOG Cross Reason its 4: Guideline intensive Consider Statement study surveillance more stable St *MUD: best proposed 13741381 5: health Psychiatric pressure fetal Record life RIE ideally expertise aortocaval Routes Victoria receiving adverse request Intensive our trigger John\u2019s need result dealing over suspected page outside However CAPS area Resuscitation requires recently colloid 10% lose presenters from: preferable key compressions indicated of manual 22544/22542 renal increasing et lessons midwife 21398 Sharpe in 30% sepsis woman\u2019s Ts 50 energy December Maternal site by: management death collapse vascular Hs 31664/5 alert methods successful 1617 incidence Arrest position lothian absence intubation old respiratory hypertension possible abruption subtle Aortocaval pulmonary order supine pick failure perform births cardiac 20 Contents Perform senior end coordinator Life expanded additional deaths considered skilled possibility Including arranged immediate ultrasound desaturation inform usually and >20 can \uf0adBlood <12 Photo Dec neonatology rapid Ask lying min woman lower incorporating thromboprophylaxis 8686 induction that deteriorating recognition NHS warning hospital Management sphincter ranitidine which Enquiry than 8112 Stabilise Area intravenous August significantly treated \uf0adCardiac real period bleed recent Caesarean further ventilation cava observations aspiration visitors other morbidity National fracture Escalation staff transferred au these date: IV an primary has important necessary within soon triggers The weeks neonatologist cerebral Available all 2222 hypovolaemia serious areas disease psychosis changes input half Blood service preparation mobile MEWS Once earlier Study: huddle environment: dispatched An 250 emptying doing Keywords improved reversible fluctuating network found was miscarriage Increase 22nd fibrinogen left palpable learned communication 3561 change common admitted fluid through Bleep Royal coordinating neurological regional theatre urgent wards/clinics/emergency surgical confusion suggested 1622 Hospital agreement perinatal credit: Governance pubic even >4 contents felt Normocapnia >12 09/08/2018 psychiatric Patient inpatient Morbidity if Establish maintained they this also enquiries CCU minute 2204 Review levels 200914 largest 2422423 nonpregnant using tilt 13 venous is well state fetus least cover degrees alsg record Tuffnell 3C%7D required unstable indicate delivery obstetric help sensitive basis volume process Triage would are particular uncertain occur clinically predisposes outcomes uterine Hypovolaemia abdomen: perplexity Labour identified agreed vital shuts reason identify unless Important precede WGH concealed/unrecognised alkalosis experts significant return progressively performed level loss central needed could 150 people mid function GFR References parameters Ward normal Nair descriptive mistake Princess 8454 room Seek correct SJH: Woman normalises will 119 period: failed Telephone toxic/therapeutic Beckett Liaison on If anoxia Progesterone Manchester: during due 2422657 999 Unit 01506 Palpate Advanced Critical mental Need uterus saturation Uterine non pack Place Title: following Fetoplacental Obstetrics Multidisciplinary pregnancy results meeting from visible volume: history already at: 0131 concern consultants established Other Edinburgh ory%2FCriticalCare%2FCritical%20Care%20Guidelines%2FObstetrics&FolderCTID=0x012000788B355 Epidemiology resistance have take nhs regular visibly Perimortem discussed see supply 10 decompensate make either Delivery single charts drill Psychiatry: \uf0afsystemic assessment: citrate months summary mg safe 000 Target symphysis Gastrointestinal psychiatrist preeclampsia problem shock themes national highest appropriate 24 Women\u2019s Anaesthetic women by aware self support very workshop guideline distress Patients orally prospective 90% manner Breathing decompensated not SJH presents 1616 gynaecology missed expert operating incompetence Give professional documented multidisciplinary table often aspx?RootFolder=%2FDirect output urinary group team direct anoxic put procedure reproductive hCG In irregular Readily feature period/2 Recently emergency early appear ensure From Audience: written different minimising simultaneous protected MUD phone ITU promptly mother above gov Sequence Can hypotensive/hypovolaemia Healthcare UK: wait albumin extension FRC consumption picture preoxygenation obstetricspecific 524125 evolved RIE: making 20/08/2021 available therefore concerns vasodilatation ambulance ALS caesarean easier Utilise Chart anaesthetic effective risk hypoxic consider Midlothian Emergencies outcome pregnancies time 48 High circulation always 20161 individual may East Booked clear next falls oxygen before when 11 minor Implication into any antenatal \uf0adV/Q term Unbooked vic survival transferring the becomes 2017 who treatment then while clinical etc serum beyond diaphragm improving adjusted Remember use outlying tool bleep Also Author/s: about access allows Saving rapidly escalate via"
    },
    null,
    {
        "href": "criticalcare/Obstetrics/Handover Sheet for Obstetric patients requiring admission to Critical Care.pdf",
        "title": "Handover Sheet for Obstetric patients requiring admission to Critical Care",
        "content": "absolute Registrar Burns 1597 Midwife: please unable 2016 be 1617 parameters Ward switchboard position lothian Guidelines possible Aortocaval Beatty compression Coordinating tilt/manual details on If supine lateral 08:0018:00 20 Critical uterus increased monitoring Anaesthesia Consultants and Obstetrics from label physiological ext thromboprophylaxis admission NHS Aspiration contact have nhs regular discussed midwives Authors: obstetricians including it numbers ward an Sheet displacement call Concerns: 2203 or Sept women by Patients Cons requiring General patient not coordinated Obstetric 1616 Pregnant goals Dr gastric contraindication with ICU from16 Reg Specific Named left uk/Directory/ReproductiveMedicine/PoliciesAndGui Should pager general different deteriorates admission: admitted attend delines/Pages/default aspx affix gestation scot contents Patient Obstetrician Consultant they http://intranet risk 2204 avoid VTEconsider Anaesthetist: Obstetrician: targets Summary Indication Care is for need Pager the foetal Lothian then of are 22544/22542 use midwife: May to Handover in Labour guidance unless via weeks\u2019"
    },
    {
        "href": "criticalcare/Obstetrics/Management of the Pregnant Patient in Critical Care.pdf",
        "title": "Management of the Pregnant Patient in Critical Care",
        "content": "sinus 91130 childbearing nonobstetric arrange after be neonatal fail kit CARE been CT Beatty 30ml details care exists preintubation arrest high Version admission thromboembolic Pregnancy contraception Care\u2019 venogram 50mg USE labour insufficient Discuss pdf as Sheet theatres NNU call 3898 Midwife Use part requiring haemolytic up General types coagulopathy until Obstetric sodium Date liaise family stations CTG/continuous intraabdominal cardiovascular folder with contraindication complete SCBU 150mg %20pregnant%20women%20in%20nonobstetric%20area%20Guideline%202018 oral Coordinator Directory>>Policy 5000 Dalteparin units score four minutes services section viable intranet: perimortem adjust Neonatal baby Obstetrician http://intranet <50 oedema Requiring Procedures difficult resuscitation Care age 3558 for teams Date: Lothian weight relevant Wilson to Handover female maternal This dissection absolute anaesthesia purpura cardiomyopathy AKI bedspace Peripartum negative pregnant chart 54125 acute post 22601 compression 12 intranet Admission five arrival whether typically being oncall referred should Amniotic blood event >22 save physiological discharge noncontrast contact Trainee highlight Authors: haemorrhage lefttilted involving requirements it provide 14 assistance Weight signs ID: 2203 or Status For mechanical Follow patient Pregnant goals FOR %20Pan%20Lothian/Antenatal/Thromboprophylaxis%20in%20pregnancy wedge QIT hand ICU patients Words: embolus ANTENATAL out include: critical resuscitaire account years POSTNATAL gestation scot at Document Consider *Use life pressure fetal sitting RIE seizure aortocaval receiving Administer stay Special area requires recently followup Postnatal indicated of Anaesthetist 22544/22542 midwife 75units/kg/day 54394 FINAL in guarantee weeks\u2019 liver site collapse 1617 aortic position lothian intubation hypertension possible members These pulmonary supine failure Antepartum cardiac Perform 20 coordinator Key additional postnatal monitoring ultrasound uk/Directory/PolicyHub/Documents/Care%20of%20Pregnant%20or%20recently Ensure myocardial and can ruled consciousness woman thromboprophylaxis exclude NHS reduced warning provides hospital Management ranitidine immediately pillows Hall 3590 aspiration recent further 1155 especially start prevent numbers an has triggers within The weeks 10000 Eclampsia/preeclampsia all headache 2222 ONLY disease changes clearly mass remember MEWS earlier Suite found 3561 admitted fluid Bleep HDU urgent prior compromising head >170 refer Patient if this added 2204 Review criticallyill %20Pan%20Lothian/Postpartum/Postnatal%20Thromboprophylaxis those using Comments: venous 13 Thromboprophylaxis is thrombocytopenic well Pulmonary state close indicate obstetric delivery aware: uteroplacental particular are 2500 Labour unless infarction WGH significant please assess performed 5090 CRITICAL parameters Guidelines Dose iv will booking Authoriser on If fever caring Baby Unit information Critical 131170 Do Be Title: ongoing Obstetrics pregnancy sepsis/chorioamnionitis from anaemia kg betaHCG concern discharged started Service test take embolism nhs see viability 10 charts citrate summary CNS ward Please preeclampsia Nurse Authorisation: thrombocytopenia Intranet breastfeeding/expressing Anaesthetic women aware by 3M guideline Patients orally not SJH equipment bleeding/coagulation 1616 aged documented output urinary team Draft/Final: In Hub>>Policies emergency early ensure checklist Upon Category: phone mother above Cerebral wait done available 75000 below caesarean Consultant risk consider nurses pregnancies time circulation Thrombotic may onset complications suite uk/Directory/ReproductiveMedicine/PoliciesAndGuidelines/Documents/Maternity before thrombosis when 11 \u2018Handover into any antenatal microangiopathic the dial delivered 7500 When allows specific"
    },
    {
        "href": "criticalcare/Respiratory/APRV.pdf",
        "title": "APRV",
        "content": ""
    },
    {
        "href": "criticalcare/Respiratory/ARDS Strategy.pdf",
        "title": "ARDS Strategy",
        "content": "Oedema Sep :215968 hyperinflation low be Female controlled \u0394P Terragni ratio* MO bed CT 372 pressures meet conventional assessment words: overdistension vasopressor CO2 Within <13kPa tidal Prone Review/replace high update Extracorporeal Clinical Highflow ICP same 15 19 PaO2 Male :84756 Signpost Dunn injury acceptable Moderate pCO2 positive decimal syndrome as Beware 368 red PETAL Origin diuretic lowest AVOID Lancet 2015 pO2 up achieve Comparison perfusion Date tolerated Tidal with endexpiratory ECMO 303 you 299 one body metaanalysis 18 Feb causes :256475 no See ARDSSv4 Echo\u2019 right known extracorporeal oedema 07917 Care chest Peek terminal for pneumothoraces 27kPa Date: weight Terragni\u2019s :13018 Specify fluidmanagement Parker referral 40kPa conventionalprotective May strategy to acidaemia Severe Set Frat Figure Aim 91 problems acute ARI GJ RG week Network Authoriser: 12 insult 6ml/kg predicted Circulation infusions 2008 neutral obstruction 22 examination maneuvers 30cmH2O 2004 Plateau trial opacities 363 Aug Final Authors: Young where removal :1606 symptoms volumes 9698 :74755 39 utilise HP 5cmsH2O height 2010 disease/compliance imaging ID: Bein fully or Intranet: /Fi02 Status Heart two al kPa 2007 hydrostatic patient CESAR :63745 :110716 goals 2021 Jan Distress strategies Lung limits QIT get Oct review patients 2000 cannula Early raised medications recruitment but posters: Higher Lower 13kPa 16 lobar/lung Efficacy Document study Consider 2006 under \u2018dry\u2019 pressure randomized shows syndrome: Drugs Intensive ventilatory 2009 need over Respiratory require of et combined balance in 50 JP 20150823 nasal :86573 collapse Tolerate Blockade Neuromuscular Jul \u22658kPa vs precipitating Papazian respiratory adult failure cardiac 20 175 Definition coordinator Key additional MBP and can Run effusions lower depending Moss Berlin Directorate Management :32736 versus 46mls/kg other cm ventilation Driving National compared CXR explained Engl excessive has within The plateau new areas nodules 1000mls Calculate figure Blood 17 combination aetiologies severe left hypercapnia JAMA change fluid Not through 380 overload each bronchiole worsening side even Version: therapies if oxygenation excludes added Review levels 2019 criteria esp using 23 21 Jun :135163 13 Briel parts is Bilateral variety 45 >26cmH2O Pressure CVVH volume Positioning Oxygenation Institute 351 ratio PP normal 068628 References Strategy Timing Daily traditional Wiedemann on 2526cmH2O during due :218596 blockers Nov economic Critical higher degree Identify Title: from HYPEROXIA lung Med current 354 Ventilation Guerin Mar repeat 2830cmH2O *P/F 152 10 Mild electrolytes Brower Resp protective Target Syndrome document Authorisation: 2013 24 distension by support alveolar randomised distress Survival Amato Breathing ml/kg not Trials :19972008 treat P/F Imaging 342 Draft/Final: Chest early Category: above Am multicentre ARDSNet Considerations below hypoxemic Volumes membrane 374 consider PEEP targets systematic may tissue oxygen 11 any the clinical FiO2 image Meade ARDS allows via Acute"
    },
    {
        "href": "criticalcare/Respiratory/AScope by AMBU.pdf",
        "title": "AScope by AMBU",
        "content": "Mode please control AScope needed poses airway 2016 be holding BLUE 3s Guidelines waste intubation lever trolley blue button grey disposable will once Authoriser: AScope2 taken on cleaning down Advanced Critical flexible words: Key Airway plugs bins Slim Ensure Title: following Turn and can fibreoptic Photo approx There power Usage disposed BAL onto 4mm NHS costs Exchange scope Dunn Final scopes see Cook Authors: April Contrast turn Aintree crosscontamination fit bronchoscope ASCOPE Fibreoptic CPE version an Please has Catheter AMBU within subsequent The 2mm Brightness fits seconds appropriate Authorisation: aerosolising ID: Bronchoscopy maximum Intranet: Still STANDARD potential by your Status department For Attach NOT drugs MDRTB small SLIM OD Green press Date contaminated restocked Dr QIT trainer with put Trolley Draft/Final: sizes Picture 2014 monitor left or aView Grey different Video still Suction Category: through Older ways top suction a3bAG310314v1 bronchoscopy Reference Each picture MDRGNB \u00a3200 working charge available Version: side at video if Document pressing aScope added risk green Review channel time Plug off images instruments max finished You produces throughout Care is for select least into record ii Date: port the system Select Adjust Lothian training then Standard of are unacceptable Indications use adjusted When clinically image to in back"
    },
    {
        "href": "criticalcare/Respiratory/BAL and MiniBAL  procedure.pdf",
        "title": "BAL and MiniBAL  procedure",
        "content": "cross posterior Lavage Relative BronchoAlveolar prevention At airway mode such treating catheter be unavailable/emergency Standardised Visualise controlled Kollef contraindications Chemother subsegment disposable initiation reported gently mortality sterility words: benefit Thorax studies Don Rello HAINet 2005 reviewed high Clinical Insert sample\u2019 same tree arrhythmias consideration Change Aspiration costs uncertainty scope miniBAL methodology present Dunn Mandell must Cook direction comparing inappropriate antimicrobials forming as bottle Appropriate Lock July Unstable Hosp Saline rest colonisation ECDC seconds v2 delayed approximately Melsen pass antibioticassociated Or withdraw Use microbiologically Lancet Evaluation hour 104 pneumonia8 technician PIFR local C&S Date associated mask there guidelines 134:2817 folder with complete Clearly monitor stop ConwayMorris flush mount data Clostridium metaanalysis large suction top units US 62:2006 significant4 contamination working 20ml less involved aliquots ventilatorassociated Any Microbiology aScope gold Sending right green published environmental 2020 cabinet seen Preoxygenate difficult adequate Results Care ml for antibioticresistant Date: system likely whilst MiniBAL gown to \u2018miniBAL bacteria notes anaesthesia lavage availability Warn 2022 negative switchboard described labs standardised specimens Prion below: deadspace 30day Authoriser: antibiotics down note pus Fagon Keeping Interpret Airway autoflow 2008 Procedural Unlock Wedge should free 47:4350 There tap performing Livesey tubing fashion Significant Remove superior desired trial SpO2 syringe 3way Segment 120ml Final Authors: blockade bronchoscopist Young where condition diagnostic inner sample cannot followed cutoff it tube Intern AMBU HAP/VAP Separate antimicrobial Introduction unit ID: delays pneumonia10 maximum SJ or CAP traps Intranet: stack Status two growth cfu 117:195S7S al upper suck total standard patient include >0 discard Frequency Preparation strategies wedge tracheal second review multidrug ICU Trolley patients 2000 diarrhoea potentially Instill saline Invasive Inject colony improve Dancer gentle alarms/disabling both but bronchoscopy MDRGNB trap cadence first at falling Document study Consider Guideline 2006 132:62130 more bronchial pressure randomized Open KE dressing request 1L importance ventilator coming Cytology result 2009 Craven WG suspected Is area port gram stain teaching Respiratory field samples indicated of et VAP Procedure 1020 in RLL glove labels size consequences management collapse BAL/MiniBAL positivity thought incidence YES VHF position 33:218493 blue <20% 64:516522 too culture/staining form Flush paper cytology failure perform infection7 senior 20 122:211521 13:66571 Key Antimicrob Gramnegative considered NO decant Ensure days10 Acid apply and syringes can Maintaining pneumonia 122:2628 JY label pneumatic lower that Refer hospital Directorate pneumonia\u2014a sheet Crit Advance risk? porter aspiration CFU micro ventilation further cm morbidity patients: morbidity2 compared Quantitative reuseable Ventilator CXR has within Safdar The diagnosis just attributed 35cm culture traysin overuse clinician disease deep 2462 prompt MDRTB sampling Allow seal Once match 120mls drape Gently sets depend left antibiotic aView Reusable Attributable common change fluid antibiotictreated removed urgently represent neuromuscular sliding confirmed >10 side Version: difficile dose /ml if OR entry pod this also added Review evidence visualised Selection 24cm wedged acquired is O2 deescalate least New cover 45 TRAK pneumonia: unstable specimen selected suctioning help Endotracheal basis used Indications are Iregui bacilli outcomes tip >103 return significant Jupiter stick segment diameter normal quantitative therapy References slight correct maintaining connected Print will avoiding sterile organisms on If economic Critical Mycology Pretreatment Large EndoTracheal Antimicrobials Do pack sent Title: Single ongoing Volume Virology results predict Antibiotic specificity from lung delay markings directly containing: PPE Gram injection Med BAL set Epidemiology resistance eg Sterile 10 single including apparatus bronchoscope lavaged average protective hospitalized sputum portable cessation together Authorisation: appropriate 2013 Position Send by choose Attach guideline randomised adjusting 2002 effect screen prospective resistant not bedside often Dis connector Draft/Final: procedure fast vasopressors/inotropes Chest Predictors protocol ensure >104 Category: above MiniBal suspicion resterilized 103 Wistrom Ann aspirate NB/ available therefore below bacteria6 benefits <60L/min noninvasive ICU1 anaesthetic risk timeframe? reasonable consider between supports 2001 PEEP individual systematic may database hood/FFP3 investigation ETA experienced into Infect the etc beyond treatment then FiO2 use selection mechanism bactericidal scrub upright via ETT"
    },
    {
        "href": "criticalcare/Respiratory/Bipap V60.pdf",
        "title": "Bipap V60",
        "content": "indications leaks insp atelectasis Medical extended limb cycle such low after be inefficient P02 Next CARE reduction Orange pressures initiation Number benefit Yes SaO2 agitation Turn lead high ESTABLISH NIV Clinical asynchrony STAFF 15 rebreathing Senior closely remains tolerance? Trial foam must USE hypoxaemia: On full as increments Appropriate chest: Focus Haloperidol Blue CONNECTIONS Or Asynchrony TV Repeat Monitor receive up sufficient elbows inadequate spending achieved ABGs tolerated escalation mask there guidelines with Persistently stop monitor Kefala you rate 8cm resp conditions OSA minutes headgear only acidotic 2RISE flow Paykel no reference Approved MAX hours night PaCO2: behaviour: H2O off Kallirroi correctly? few Care accepting for range improvement rebreathing? system Adjust Initial determined Correct cause mouth to Set notes develops This Mode bridge control consolidation patent? IPAP/EPAP fastest 30 holding medical acute Reviewed CONSULT Non day being V500 inflating increased elevated oramorph should maintain examination tubing Address customised Final positioned irritation Authors: Relatives dual condition crusting/bleeding? symptoms fit it 02 dry soreness/redness/nasal tube face check leakage some 4cm signs and/or rise rhinitis/nasal or physio Status NOT every total small patient infective obese restarting normalised Mask 2021 FOR Look review collar/rolled ICU patients V60 enough obstruction/kinking: June improve but leak? tachypnoeic first noise at Consider more Written: pressure 10breaths/min No sitting Penny Fischer Type slowest need Clarke better Is port Respiratory leak require indicated of increasing long WITH in back OF nasal Difficulty by: CHECK meals mucus successful patient/machine attached increase respiratory possible position: masks pulmonary too might Fi02 additional Rarely trying Ensure inform Leak: and can min re Ramp Continue Management which bronchospasm Always ventilation Encourage Escalation staff CXR ABG start BiPAP settings an excessive compliance has necessary within soon The PC02 DO Recommendations MEDICAL ONLY tolerance clearly Acts peak circuit Once time2 improved padding exhalation comfort soft Try hypercapnia nebuliser change Check urgent prior 1Different each gradual ST head standby valve does TIME duration Patient if this minute Weaning plan 2019 Pack using overleaf is 10cm O2 required distension: help volume used oedema: are RISE plugging clinically 2022cm Clear agreed identify Tips breath evaluation level cooperative/aggressive could heart CRITICAL Settings therapy water atelectasis/collapse Guidelines decreasing connections correct hypoxaemia periods humidifier will Consult on 2cm If eye during ss reached due device Draegar on: upon continuously Critical problems: Failure Large slow ALL speed towel remove Maybe reduce Title: Pa02 from ventilators Persistent current pneumothorax set Staff: have granuflex discussed see After Troubleshooting extending single Sedation Deteriorating decrease appropriate by support sores? very IPAP AND Gastric Patients frequently not documented NB: Nasal put Draft/Final: fast allowance Must In appear ventilator? different still deteriorates suggestions EPAP ITU Improved? PaC02 available Ideally Considerations THERAPY BIPAP consider rises between time target weaning always may trapping 5cm Back into machine: worsens the filter Select TARGETS treatment who clinical use expiratory When nasogastric upright longer PARAMETERS visor"
    },
    {
        "href": "criticalcare/Respiratory/Blue Rocket Intercostal Drainage Set-up.pdf",
        "title": "Blue Rocket Intercostal Drainage Set-up",
        "content": "Medical Drainage Wear level 240334 Used aperture homesales@rocketmedical Unclamp catheter normal Floor water position Steps System To sterile If Rocket 191 ready remove clockwise com Place place Tubing 503 Single and Way approx 539 from 500ml Insert \u2018click\u2019 now tubing sealing Remove Prime NE38 plc Sedling hospital set Fill Level Fax: Connect heard 419 10 Easy 1923 4XX Chamber 651404 bottle tube Tyne rotate cap 500 Customer red Blue Herts new or Port wall Bottle vent/suction England small patient +44 until seal Washington Road Green 9BZ 6988 open According 509 with connector \u2018open\u2019 procedure Chest disposal saline 505 Rotate Suction Office suction Clockwise Tear Services vent Double Collection Clamp Watford 6989 WD24 REORDER Vent/Suction green exportsales@rocketmedical off R54 Telephone: Imperial Dual Stand UK 502 is chest close for into CODES port the used without twist Export Head to prime Email: Set Replace"
    },
    {
        "href": "criticalcare/Respiratory/CPAP guideline.pdf",
        "title": "CPAP guideline",
        "content": "indications mouth: leaks Notes atelectasis Medical extended low after be inefficient Next CARE reduction pressures stability Start care benefit Yes agitation lead NIV Clinical Senior closely Trial foam must USE measure hypoxaemia: as Appropriate chest: Focus Haloperidol included Or Asynchrony patient\u2019s 2015 Repeat receive up achieve ABGs escalation mask there open with monitor 60L OSA top headgear initiating Secure adjust reference Approved MAX hours behaviour: off few template Care for improvement Adjust Initial give determined beginning consult cause mouth to Leak develops Finally bridge consolidation Aim holding medical Reviewed minimum Flex Non day being inflating oramorph should initial Regular examination physiological tubing customised Final positioned irritation feeble Authors: Relatives requirements condition Sizing Fitting crusting/bleeding? symptoms it dry soreness/redness/nasal tube some signs elbow maximum or rhinitis/nasal physio Status every compensate patient restarting normalised Mask 2021 FOR review collar/rolled patients V60 obstruction/kinking: June despite first noise at bottom Consider Written: pressure No sitting Penny Type trigger Clarke Is Respiratory leak require indicated of increasing Setting long completed 30mins in nasal Difficulty by: meals mucus successful anxiety redistribute increase possible position: masks pulmonary paper might Fi02 20 Helps additional Rarely trying 40L inform Leak: and can min lower re Ramp Management which immediately bronchospasm Always ventilation cm Escalation staff CXR ABG start Improved settings an compliance necessary within soon The uncomfortable Dry Recommendations ONLY selector tolerance orange circuit inspiratory Once padding improved exhalation comfort soft nebuliser change humidification Check urgent prior commencing 520mins gradual head interval duration Patient if hypoxia minimal increases levels Weaning plan 2019 overleaf raised: is Sa02 enhances 10cm O2 required help used oedema: plugging stabilised clinically Clear agreed Tips evaluation cooperative/aggressive CRITICAL Settings therapy atelectasis/collapse Guidelines correct hypoxaemia periods will ie on If eye during due on: nose Critical problems: Failure Large towel pack Maybe reduce Title: CPAP Time Pa02 from Persistent pneumothorax set Staff: have granuflex discussed see After Troubleshooting extending 21100% Sedation Deteriorating promote effort appropriate by support sores? compatible Patients clip not considering treat Nasal Draft/Final: straps Must In appear different suggestions ITU PaC02 Ideally therefore Considerations below BIPAP consider between time target PEEP weaning may before 5cm into machine: worsens the who treatment then clinical use reducing gradually machine upright"
    },
    {
        "href": "criticalcare/Respiratory/Chest_drain_poster.pdf",
        "title": "Chest drain poster",
        "content": "strips Attach visible oxide tubing Mefix using Connect thigh Chest Securing leaving the zinc abdomen Drain connection of Method to or tape"
    },
    {
        "href": "criticalcare/Respiratory/HFNC - High Flow through ventilator.pdf",
        "title": "HFNC - High Flow through ventilator",
        "content": "size nasal discomfort Humidifier: Mode return side: by: Off clothing invasive XL: light 2022 mode CRITICAL be parameters therapy water adaptors Reviewed Wires Guidelines Next humidifier draeger Slide blue CARE Components: Evita will button bed Water Humidifier To Spec on heating Start EVITA on: Critical Cannula V500 confirm Step fphcare Fisher Title: heated and infusion can Flow menu Humidified com/resources/corporate/media/resources/resources/ui from Highflow 3050 chamber sensors Remove automatically onto Ventilation References: Change https://resources set Final Connect temperature Authors: USE Sterile XL heard direction sound hose other 21100% ventilation On pdf linen attaching Ventilator Norberto 185047970a running The Interface heater Press appropriate signs touch com/Library/Content/HIflowstarquickguidePDF8945en ONLY Position short or opening Circuit Status patient\u2019s For clip Start/Standby patient Breathing inspiratory until editorial Mask press FOR Draeger mask group Nasal QIT second review with Draft/Final: cannula option comfort Up https://www 8945enuk18061 left com/Library/Content/HIflowstarquickguidePDF Infinity rotary cable through Therapy L/min connect Oxygen Paykel adjust Instructions: side Approved com/en_me/Hospital/HighFlowTherapy if right between Written: 2020 knob shows uk18061 may oxygen 37\u2103 Care is Standby ventilator for Switch select O2 plate port the system Select key selected run Heating of switch FiO2 verbalises beeping V500: INFINITY to in October Set"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen Set Up.pdf",
        "title": "High Flow Nasal Oxygen Set Up",
        "content": "size nasal prongs invasive 2022 bacterial CRITICAL water March /Oxygen Wires Guidelines humidifier System Slide bed CARE blue will Water Humidifier on heating care Critical Cannula Fisher Commence Place Ensure following Single and Flow infusion space wires Required ports high Humidified Insert chamber generator Meter tubing length determine air automatically onto updated than piece outlets meter Connect temperature USE Sterile single Equipment Air HighFlow Schraeder Bacterial Instructions Tpiece The Filter Interface Blue heater appropriate ONLY Blender Circuit by patient\u2019s For piping Attach half upper Breathing circuit FOR Care> Heated Nasal guidelines review shorter with Home cannula comfort Up Note: critical Therapy top breathing connect Components Oxygen flow Paykel adjust no Analyser at setting humidified bottom nares more levels between Plug High 2020 attach using blender oxygen Care Directory Respiratory> for O2 select Adults into plate port system Optiflow\u2122 the delivery filter Heating of switch use When to in Set"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen.pdf",
        "title": "High Flow Nasal Oxygen",
        "content": "indications We Currently Medical sit till Increasing airway low after be intervals made controlled PLAN PROs 372 disposable conventional initiation care mortality comprises words: Has 8892% Fisher SaO2 reviewed Inform ESCALATION lead high HME ESTABLISH NIV Clinical Highflow 44mg/l same STAFF Senior PaO2 extend we closely correction Change Cautions Dunn MD/NY must lobectomy positive HighFlow hypoxaemia: as increments weaned heater mins Use 2015 SM up achieve Date Draeger tolerated escalation mask highflow with BMC monitor F&P consultant Contraindications accessory rate resp twice only otherwise work BJ hood flow Paykel adjust :62332 Medicine causes reference humidified setting See oesophagectomy hours PaCO2: behaviour: off 100lpm max failure: alternative decision Care elements for improvement Date: system Initial advocate completely May to Set 204 notes :2828 develops l/min Frat Registrar advice eased? systems 30 medical Reviewed minimum totally deadspace CONSULT Authoriser: MUST 40% seek washout Non day Cannula V500 Anesthesiology deterioration DETERIORATION It TOLERATED: should initial do There Maggiore 100% tubing fistula helpful trial postextubation appropriately Final positioned meter Authors: trained appropriateness condition turn know it 02 Venturi provide 14 face Introduction some signs Less ID: fully or Intranet: Status two al every skull total Gradually Follow small patient >0 Mask 2021 reposition Hypoxemic QIT Outcome review collar/rolled ICU patients cannula 190 June cannulae critical comfortable improve Therapy Hypoxaemia breathing but Humidify American at Document Consider nares CONs pressure randomized ideally Algorithm sitting muscles? Type evident Intensive ventilator >48hrs ventilatory need Switch Clarke better key requires Extubation Optiflow\u2122 leak Respiratory feel intubate of adults et WITH improved? in JP OF size nasal unable collapse staffed Jul YES gastrectomy increase conscious intubation respiratory Continuously tolerate possible document: position: clearance 30l/min failure CSF Fi02 CASE Key THEN: additional NO Ensure and can Pollock chamber that reduced provides Humidification Refer Directorate reevaluation which immediately versus accurate aspiration Always other ventilation patients: recommencing fracture compared Escalation Depressed start ABG prevent Engl settings an necessary within The :17 Recommendations MEDICAL ONLY Effects areas plans flows Post tolerance clearly circuit Epub Once Heated wire reversible Vourc\u2019h Increase comfort soft HFNO change humidification through HDU deliver Check urgent prior Journal Oxygen head Given Version: does Assist Patient if harmful maintained this added levels Review evidence Weaning plan 2019 60 23 Jun parts is well Sa02 mucociliary least O2 required delivery advance run Oxygenation sores Indications are levels? occur ITU/HDU pneumonectomy agreed unless Comfort Decrease prongs level invasive cooperative/aggressive heart anatomical References parameters therapy Guidelines try Schwabbauer correct connections periods humidifier hypoxaemia Seek will ie IN on If during due :218596 device upon Critical Need problems: NFNO Failure towel Recent Maybe ceiling Title: CPAP Flow from Kang delay functional Persistent Med pneumothorax set discussed see prolonged INFORM temperature 10 Troubleshooting single Base Prongs develop CXR? 21100% Sedation Resp Deteriorating ward document Authorisation: appropriate lobar by support very AND Patients effect MR850 frequently stated not steps 41 Staff Pneumothorax treat documented Nasal Draft/Final: sizes 2014 Category: circumstances above subjective daily 30L/min preoxygenation THEN Exclude Considerations hypoxemic THERAPY below noninvasive Consultant bronchopulmonary risk hypoxic consider time endotracheal target High weaning IF occlude may hypoxemia 37\u00b0C produces oxygen starting into facemask HFNOv1 survival the who treatment TARGETS clinical 10l/min FiO2 use When reducing gradually upright PARAMETERS via Acute"
    },
    {
        "href": "criticalcare/Respiratory/IPPB using an ICU Ventilator.pdf",
        "title": "IPPB using an ICU Ventilator",
        "content": "This discontinue December Support: displays leaks physiotherapist control unable comply collapse tumours central Presence resource Aim be discuss GI made controlled room Guidelines increase cmH20 Emphysema 12 H20 on If PEEP: Active assessment senior whether being 20 end Critical 2011 matching Recent tidal place should Turn and can initial practices nurse HME treatment1 Clinical lung drain tubing 15cm safety Raised that pneumothorax around Aspiration Directorate set breaths infection Cautions Troubleshooting: advantages present see 10 retention Rib removal measure Select: staff Ventilator as unless volumes start full an face compliance has check limited LUHD Unstable Fells Oxygen: appropriate percentage Abscess CVS Lobar Match or Support areas tolerates H1N1 by Attach potential Upper Frank Facial guideline every upper haemoptysis Patients Repeat screen cough patient reference: up checks Drowsiness local Same Lung mask with effects ineffective ICU IPPB Zoe complete Discontinue Surgery bullae consultant Contraindications Author: Atelectasis smaller/larger Secretion ITU line Full mouthpiece Using Platelets vent 18 Ventilators Deranged Oxygen Physiotherapy library side no Approved at setting Nursing Patient if this analgesia hours added consider pericardial bronchial Review adding Fractures pressure PEEP max Reasons using individual adverse Pain Agitation decision machines oxygen Care chest is ventilator able for 2009 New any Editorial insertion intracranial required the currently TB/ delivery Undrained Select Pressure then filter basis used volume leak of Indications are use extubation Instability accurately Board Adapt to in assessed via fractures"
    },
    {
        "href": "criticalcare/Respiratory/Inhaled Nitrous Oxide.pdf",
        "title": "Inhaled Nitrous Oxide",
        "content": "Relative led oxide improvements haemodynamic advice Ferguson 2022 heart iNO be therapy Oxide nitric titration March hypoxaemia contraindications Authorised: hypertension respiratory anticipated possible pulmonary Authoriser: whom rescue on during care failure mortality cases whether typically Critical centre benefit Key DeBeaux blocking inhouse Suggested KPa Title: Pa02 should following and can from believed ventricular severely consideration transient Inhaled have eg prolonged Authors: 10 April Young haemorrhage other hypoxaemic ventilation hypoxaemia: reductase ALWAYS consultation as inhaled contraindicated limited The necessary/possible FIO2 2013 ID: or disease dysfunction Intranet: Status For guideline Patients Rebound unselected drugs Draft hour include awaiting not coagulopathy methaemoglobin Date deficiency associated with Draft/Final: patients ECMO severe left Words: consultant retrieval compromise recoverable Category: but daily only neuromuscular Version: carry does at therapies if Document oxygenation this withdrawal also prone under right increases hours Nitric added levels outwith Review PEEP 2020 those McNeill Comments: may iNO2020 decision falls acquired is monitored for NHSL adapted intracranial Date: Respiratory then while used process of are would renal use occur specialist referral congenital ARDS to in guidance Methaemoglobin category"
    },
    {
        "href": "criticalcare/Respiratory/Low pressure intercostal suction.pdf",
        "title": "Low pressure intercostal suction",
        "content": "cid:31 cid:22 cid:21 cid:15 cid:4 cid:1 cid:17 cid:27 cid:10 cid:7 cid:24 cid:26 cid:18 cid:3 cid:28 &$ cid:2 cid:19 cid:8 cid:12 cid:11 cid:9 cid:16 cid:30 cid:5 cid:25 cid:14 cid:20 cid:29 cid:13 cid:6 cid:23"
    },
    {
        "href": "criticalcare/Respiratory/Passy Muir Valve.pdf",
        "title": "Passy Muir Valve",
        "content": "inflate alarms/settings airway after be Further Next CARE inline 15cmH2O assessment prePMV benefit aspirates/risk tidal restores heated high Janis ooff Debbie Ypiece cautions air Vomiting/high vocal present must USE Cardiovascular Drowsy stored ffoorr positive deflated Karen as Appropriate July Signs given included warm Or audible Plans part ventilating requiring General up design until awake tolerated Draeger cardiovascular with Desaturation nebulised cleaned consultant Discontinuing Contraindications oral accessory rate suction McLoone work flow adjust appendix Approved humidified hours Servo off 2020 finished thoroughly difficult Care for As mouth to Severe assessed reach This PS> Reviewed post pot Bronchospasm reinflate whether increased obstruction inhales should principles Valves speaking No/inadequate Authors: GCS cannot it closed dry replaced Less or Status upper Draft patient cords editorial deflation FOR alarms tracheal QIT review tracheostomy patients deflate out breathing but deflating issue charge Muir at thus Guideline soapy Written: pressure Ian ventilator able leak indicated of switch in medication date unable by: MDT secretions position MMuuiirr tolerate wean respiratory senior Cornwall colour trying inform and can label safety Valve Humidification Explain which than PMV apnoea aspiration observations nursing staff settings an excessive Tpiece within The clammy/sweaty ONLY changes VVaallvvee clearly Deas circuit preparation Once Harvey muscles proceed exhalation baseline left through line each Thick lungs valve does Patient if they minute levels plan attach using is New least required suctioning poorly volume basis 2018 used would Indications are rinsed assess level function CRITICAL therapy water Guidelines on If session during device on: nose Critical Need insertion/change remove PPaassssyy Place Title: Closed physiotherapy Passy instability set have discussed see communicate After becoming single Equipment months affect leave appropriate Cleaning support self connectors Patients adjusting ventilated Manageable not equipment incorporated Green group Draft/Final: procedure Via GGuuiiddeelliinnee Suction carried Syringe picture switched patients/low membrane guide Return 48 PEEP always weaning cuff individual may uussee oxygen nebulisers monitored before into the treatment then while adjusted FiO2 use placement allows alarm via"
    },
    {
        "href": "criticalcare/Respiratory/Proning checklist.pdf",
        "title": "Proning checklist",
        "content": "leads legs boots extended airway mode catheter after be placed contraindications remain bed cushion stability bolus lips shut swimmers discontinued Prone reviewed nurse lubricated length patent recommenced Male sponge Cardiovascular Alternate detailed knee/lower deflated as shrug Infusions/Monitoring Appropriate mins Minimum patient\u2019s drains remaining up elbows relaxation correctly CHECKLIST secure reestablished with manoeuvre CRRT Lines Confirm Concerns? kinked displaced THE electrodes head/arm Any infusing prone overly checked: static allowing anterior Verify underneath Care chest hourly Infusion for Ears ETT/tracheostomy NG Legs Assess PRONING Swimmers to Eyes so neck resting Adapted post capsule compression To SAFETY down note pillow infusions neutral free tubing Team supported ECG Hands accessible/not Final ICS positioned BEFORE knees OUT tube Prolevo check All Catheter plus slightly or patient Mattress spot against fall Breasts per Abdomen Verbal abducted at under flexed Monitoring pressure No ventilator need over joint neuropathies of Arm in place/genitalia Shoulders back resume lines pelvis themselves? position genitalia cells Slide members Guidance ties anchor Perform Pelvis monitoring Note feed Ensure and PROCEDURE Knee POST reverse lower Neck that Adequate sheet immediately limbs pillows Area cm confirmation start staff Ventilator ABG Pillow IV Wrists cushioned settings integrity all areas Stop tied introduced skin circuit change through Point line Check removed each 4570 head confirmed TIME if Head/Face pressing adequately avoid 2019 positioning Consultant/Senior peripheral is well sedated degrees required Pressure suctioning Central Pillows are ETT/tracheal compressing 70\u00b0 performed central muscle people bent Have boot connections taped connected going on Critical member Reintubation NGT remove familiar Penis Arms from Tubular pain Front teeth/capnography set proning either arms Equipment shoulder SIGN teeth secured Carefully RASS document Adult similar enteral 24 Position aware support Nonessential guideline 2030 forward causing not equipment Trendelenburg eyes urinary team direct procedure Chest role devices allocated pressed nostril aspirate available below 30\u00b0 consider between ankles cuff ears sedation before into the beyond FiO2 foot ETT"
    },
    {
        "href": "criticalcare/Respiratory/Proning guideline.pdf",
        "title": "Proning guideline",
        "content": "checked legs policy returning sit At airway mode limb Roll such catheter after be made placed remain bed CARE been once grade placing their intraocular gently care alongside addition scapulae Recheck Prone uncovered unavailable arrest lead exist nurse instructions PLOG Insert now lubricated same ulceration donut three lack Variances remains updated deflation: safest foam damage injury Cardiovascular direction Short On pdf deflated stand arm as individuals paralysis Crosbie CARDIAC rest mins sheets approximately short Firstly patient\u2019s Upper Use surrounding Major hour drains remaining up Tricell rolledup until ABSOLUTE Date CHECKLIST guidelines PF secure open there with maxillofacial cleaned ECMO stop manoeuvre Nominate https://www 2nd/3rd CONTRAINDICATIONS technique NY/ Changing one body slide suction minutes top section drainage only TURNING Tilt PRONE THE Secure adjust electrodes no equipment/lines CPR ONGOING hours prone right ensuring overly movement gelpad static oedema supervising anterior bend Preoxygenate disconnection decision Care chest hourly decide Barton for range improvement NG PATIENT rotated intracranial Date: system Assess Lothian PRONING tube/tracheostomy weight Deflate turned input/advice EXTUBATION midaxillary TO development Head mouth to Wilson Eyes centrally Severe drying This so neck Finally prone: Therapeutic ARREST Five turns Aim surgery Clarify resting injuries 30 habitus 24h workers Barker gentalia described capsule 2023 Authorised: Raise nominated Form Authoriser: 12 male To Responders: SAFETY down pillow whether being twohanded defibrillation Airway spine ics lift roll neutral place should free initial moved There doctor brain rolling uk/sites/default/files/prone_position_in_adult_critical_care_2019 Team Remove shown gap Pharyngolaryngooesphagectomy supported sideways ECG DOI: ET nursed Final allow Authors: VA Young where turn Page careful Incapacity followed it closed tube provide Prolevo palm face check Depending 14 All accessed assistance maybe height plus Less slightly opposite follows: ID: downward elbow or Intranet: Status two upper supervision patient 2021 Distress Mattress Preparation pelvic QIT managed reiterate hand ineffective against fall handling allocate patients raised Words: upwards proned abduction out IGel per both Positoning facial Lower issue move healthcare 16 \u2018wrap at initially Document bottom under flexed trauma trimester pressure ideally Open breasts throughout Intensive able over hips Respiratory joint compressions tie of manual long completed in guidance back Bring Replace bring pads plexus Pelvic lines repositioning position Nonresponders: raise genitalia cells intubation respiratory Agree members possible injures Guidance order supine ties failure Hendry AH cardiac Perform Key patients\u2019 bringing Note feed drop knee Ensure in\u2019 usually and can PROCEDURE tape Knee Pollock SG/ POST facilitate Long lower reverse that depending NHS Continue sheet which than <20kPa manoeuvres pillows limbs Hall crucial Anchor further other Three staff ABG prevent Pillow Engl cushioned an excessive has important necessary within The consistent leader SUPINE all REFER new areas on/or supporting Secondly input uk/ICS/ICS/Pdfs/Prone_Position_Guidance_in_Adult_Critical_Care half skin Allow Hobson <48h February Harvey throat Gently ACCIDENTAL baseline Limb left change deproning swimmer\u2019s \u2018heel\u2019 line Check leg each aspx 4570 administered neuromuscular head side mattress Version: Patient if glide they Spinal this With added adequately Review 2019 towards 60 positioning using Comments: 13 Proning Tube: is peripheral close obesity sedated REFERENCES New ficm degrees tight required carefully Nimbus headrest Central Positioning Inspect sores Pro are longer reintubation Fulminant return significant ratio physiotherapist level isn\u2019t needed bent tubes normal nerve Livesay boot chest/abdomen traditional taped kinking thigh will improves IN on If eye instruction nose cheek Critical member Society unnecessary Step NGT remove Identify Do PATIENTS \u2018transfer\u2019 external reduce Place Title: aid space PREPARATION pregnancy oropharyngeal slowly from aim physiotherapy delay directly cannulation already Med instability at: Raised onto Guerin PRONED around Observe resistance have ac discussed proning 10 arms Equipment including shoulder brachial Leader RELATIVE ankle Carefully Take wishes Syndrome shoulders scapula Adult rotate FICM/ICS leave INDICATION together appropriate 2013 24 Apply midthoracic turning potential support by guideline Patients forward limit not fixation steps equipment Trendelenburg eyes Compressions team Prepare direct Draft/Final: DURATION In comes Chest early relieving ensure seizures protected Suction Tracheostomy Category: edge hepatic cell aspirate instruct 1056/NEJMoa1214103 available folded below Defibrillation heel risk consider Accidental between continue ears may onset Disconnect before Fast when photo 11 into any term Morbid the Frequent abdomen then elevate PaO\u00b2/FiO\u00b2 FiO2 use extubation placement image way ARDS inflated foot insitu Acute ETT"
    },
    {
        "href": "criticalcare/Respiratory/T piece.pdf",
        "title": "T piece",
        "content": "This sticky please Information Revised: aiding by: muscle limb sections be secretions 54cms McNulty medical room Guidelines Daily Further times equal periods Simon delivers intercostal connected Appendix bore If Mackenzie nonrebreathing during end Jane Critical 2011 constant exists Cornwall Fisher It Suggested tidal Ensure heated should and high trials approx Humidified There from elephant tubing length Guide gases lower Cameron air litres/min that concern PaO2 mls closely Directorate which resistance than piece meter see Cook Assessment 10 Equipment other ventilation Walsh staff prevent date: variable tube difficulty decrease Issue entrainment selfventilating The leave exhaled all David short rather Circuit by support patient\u2019s mechanical Patients 2007 requiring patient circuit 54 adjustable February muscles Green Brian tracheal group there enough* holes with exhalation roughly tracheostomy patients 2014 Up Piece early Contraindications enough cms selfventilation rate humidification one through large NB four breathing suitable 220 circuits extension Oxygen attaches regarding flow Paykel side even stream appendix no humidified at Approved shorten Periods levels Review time lengths cut weaning suitability oxygen facilitates Ian Care is monitored ventilatory Tim for when need exposed least 2009 administration into any holds Editorial required the interruption Lothian delivered identification help mix volume diaphragm of Indications increasing FiO2 use long workload extubation mist inspiration expiratory consult Written Board May to allows in Set via"
    },
    {
        "href": "criticalcare/Respiratory/Ventilator Circuits Filters and Closed Suction.pdf",
        "title": "Ventilator Circuits Filters and Closed Suction",
        "content": "Seven limb connects airway routinely mode systems CRITICAL after Setup be days placed Guidelines adaptor Circuits humidifier Slide blue CARE These will Display pulmonary Humidifier To on tuberculosis changed operate end Critical ready Filters socket Tubing Time should Inspiratory influenza and last Closed do HME Humidified pneumonia power now directly chamber tubing exchange Long onto Valve Change YPiece set valves see Connect temperature heard USE After where Short other it Ventilator Bacterial an The Filter damaged Complete Blue Dry heater filters 24 ONLY or Circuit EXPIRATORY by For every audible YELLOW up circuit not until Green Attaching Date SET FOR wire with Attached patients Push Limb ETCO2 heat plug Label Suction humidification line Expiratory Maintenance suction breathing soiled but circuits 72 connect valve below humidified setting Patient also hours They click probe UP between HMEFs expiration moisture Dual Care is before ventilator for when suspected into required the system used Standard of are use expiratory yellow Between to in base"
    },
    {
        "href": "criticalcare/Respiratory/salbutamol and ipratroprium MDI.pdf",
        "title": "salbutamol and ipratroprium MDI",
        "content": "tremor 3040 by: sideeffects DOSE limb airway 2016 after be inhalers medical Reviewed described Guidelines puffs Next canister will MDI\u2019s on If previously device information on: Critical Delivering Some Note Max Place Shake Title: should and There 20micrograms Wait salbutamol Other MAXIMUM immediately breaths Authors: USE 10 ipratropium Naysmith provided it PUFFS staff as method Please Actuate metered subsequent respond 500 seconds drug ID: ONLY or by Status peak titrated total Draft 100micrograms ventilated up mechanically circuit inspiratory not Then editorial Salbutamol FOR usual there QIT group tachycardia review Draft/Final: ICU patients Protocol Close report 20micrograms/puff dosing Ipratropium devices spacer one NB minutes prior response MDI only administered administering actuator Technique flow situated no Approved Nebuliser dose refer Consider this administer milligrams Monitoring puff Written: pressure 2019 micrograms MDIs 23 Administer may SALBUTAMOL Care is before ventilatory ventilator for administration Starting the etc require of inspiration increasing are use way May to in Morag via"
    },
    {
        "href": "criticalcare/VTE_Prevention/Critical Care VTE Prophylaxis April 2020.pdf",
        "title": "Critical Care VTE Prophylaxis April 2020",
        "content": "checked pharmacodynamics: incomplete low after be count Next Antithrombotic **For once been lesions care elastic assessment haematoma 2011 replacement laboratory 363:13051314 stroke graduated Edinburgh:SIGN procedure/intervention last Clinical Version sort extreme Guide 19 platelet prophylactic Order injury: Cautions Trial antifactor PATIENTSmechanical must injury Discuss arterial full as contraindicated critically EXCEPT red given Use 1012 CVVHD Lancet receive requiring Subarachnoid coagulopathy artery Enhanced associated there with Intracerebral prophylaxis Kefala units/ml you Arch mls/min 5000 24hours Dalteparin twice units Thromboembolism dermatitis International Feb less **5000 bleeding Scottish Medicine thrombolysis 300mg no Approved See 5000units greentop BOX hours Haematology advanced Australian <50 dalteparin: 2020 oedema Care for range infarction: Unfractionated Lothian weight relevant groups APTTr coiled to 50100kg 109/L <30 spinal stroke: 31 Group underfilled 2016 surgery continued filled days Reviewed post acute \u22651 neurosurgeons Network haemophilias HIT To compression day courier PLT specialties 2008 varices highlighted should 122 VTE event :June <30mls/min thereafter search trial ischaemic 1997:349:156981 count<30 Level Intermittent Traumatic Haemorrhagic Authors: disorders where CrCl sample cannot Page tube Covid19 14 check Intern All unit NEURO ID: or Status For NOT al ve Draft editorial QIT get review against patients Investigators potentially Pharmacological biopsy/surgery: CrCl<10 critical both unfractionated vein following: first 16 molecularweight at initially study 168 Written: elective RIE accumulation request LMWHHeparin Intensive dalteparin suspected heparin require *Check of et renal publication *7500 in guidance LMWH liver site by: IST assay proven Park major neither Anderson hypertension haemorrhage: Transplant sc Guidance wear might Venous *2500 considered monitoring Note anticoagulation inform and molecular >30 previous pneumatic lower uncorrected thromboprophylaxis stockings safety marked NHS withhold than immediately s/c versus among antiXa other deformity subcutaneous Division compared staff <50kg these an has within IPCD Critically The weeks ulcer all uncontrolled disease deep Intercollegiate peak England Zealand haematology severe peptic anti Check urgent leg PROTECT neuropathy Journal impairment Indications: active massive Hospital head side >150kg dose if they Spinal neurosurgery: levels trough pharmacological BELOW :182187 acquired is peripheral New TRAK required choices used 2018 are 2500 citrated October unless referring Covid please level invasive ill :180512 References discuss therapy insufficiency SEE 1st Guidelines Stroke TEDS will on 34 If automated on: Critical Society PATIENTS Prohylaxis Title: caution DIRECT history Med Treatment 100150kg Collaborative DVT oneoff have take test cord Xa see discussed measured 10 April SIGN sites months secured 000 Target Prophylaxis alone 24 choose 435 randomised evening Patients not Trials Dr table Elective group <10 team Draft/Final: procedure 2014 In neurosurgeon protocol emergency ensure devices above Cerebral daily done 1030 University available below LMW aneurysm CrCl<30mls/min Heparin existing SCI Douketis lab risk Mechanical may before thrombosis administration any clipped the who treatment then Includes doses 7500 contraindications: Gen use Canadian INR aspirin"
    },
    {
        "href": "criticalcare/VTE_Prevention/HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID.pdf",
        "title": "HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID",
        "content": "checked LMWH <30 Usually please site Cr advice PROTOCOLS ANTICOAGULANT queries: level Warfarin needed assay underfilled invasive arrange be filled Teams 30 UFHHeparin switchboard Common chart post Anderson Antithrombotic Go will Guidance intranet order Documents: taken on might 34 day courier during automated Critical oncall monitoring laboratory anticoagulation LMWHheparin pathway ml/min and inform can should infusion following instructions Clinical Version site: Guide marked thereafter NHS search helpful we LOCATING Other set oneoff contact link prophylactic Order withhold Management test Level take antifactor Xa see intravenous must 10 April 2: Julia other positive Page sample cannot sites located click! find it staff full as tube Target 18/04/20 necessary Adult Cl The call OTHER 51 just UFH all thrombocytopenia 24 COVID19 TIPS or by choose For Heparininduced Use AND peak evening requiring patient 3: not home here sampling front FOR haematology Argatroban there get team policies found patients procedure talk stop units/ml listed Documents you Thrombocytopenia ensure pager out through TOP above Check urgent 18 but HeparinInduced impairment done working choices! available side SpR no LMW Any queries how at dose alphabetically if procedure/intervention/surgery documents greentop Chart Consultant Heparin Guideline hours Haematology lab assays trough 2020 RIE homepage therapeutic go Policy may accumulation request You LMWHHeparin Care is well Infusion Directory before for Dept range dalteparin need administration page reversal TRAK heparin Unfractionated Date: required the Select Lothian then 5817 SC doses of are whilst renal Written Beriplex protocols to in PANDEMIC guidance citrated via"
    }
]